1	Int	NN	O	int	_	0	SENT_1	[p1l88t83r135b109],
2	.	.	O	.	_	0	SENT_1	[p1l88t83r135b109],

1	J.	NNP	O	J.	nn	2	SENT_2	[p1l151t83r174b109],
2	Cancer	NNP	O	Cancer	_	0	SENT_2	[p1l192t83r311b109],
3	:	:	O	:	_	0	SENT_2	[p1l192t83r311b109],
4	97	CD	NUMBER	97	dep	2	SENT_2	[p1l326t82r372b115],
5	,	,	O	,	_	0	SENT_2	[p1l326t82r372b115],
6	700-705	CD	NUMBER	700-705	number	7	SENT_2	[p1l386t82r518b109],
7	(	CD	NUMBER	(	appos	2	SENT_2	[p1l535t83r631b115],
8	2002	CD	DATE	2002	dep	7	SENT_2	[p1l535t83r631b115],
9	)	CD	NUMBER	)	number	10	SENT_2	[p1l535t83r631b115],
10	©	CD	NUMBER	©	dep	2	SENT_2	[p1l89t131r112b155],
11	2002	CD	DATE	2002	num	14	SENT_2	[p1l133t128r206b155],
12	Wiley-Liss	NNP	O	Wiley-Liss	nn	14	SENT_2	[p1l220t128r394b162],
13	,	,	O	,	_	0	SENT_2	[p1l220t128r394b162],
14	Inc.	NNP	ORGANIZATION	Inc.	dep	10	SENT_2	[p1l409t129r463b154],
15	.	.	O	.	_	0	SENT_2	[p1l409t129r463b154],

1	DOI	NNP	O	DOI	_	0	SENT_3	[p1l89t177r154b204],
2	10.1002	CD	NUMBER	10.1002	num	1	SENT_3	[p1l172t177r344b211],
3	/	:	O	/	punct	4	SENT_3	[p1l172t177r344b211],
4	ijc	NN	O	ijc	dep	1	SENT_3	[p1l172t177r344b211],
5	.	.	O	.	_	0	SENT_3	[p1l172t177r344b211],

1	10054	CD	NUMBER	10054	_	0	SENT_4	[p1l351t177r439b204],

1	INHIBITION	NN	O	inhibition	_	0	SENT_5	[p1l89t237r385b275],
2	OF	IN	O	of	_	0	SENT_5	[p1l415t237r482b275],
3	GLUTATHIONE	NN	MISC	glutathione	nn	4	SENT_5	[p1l511t237r894b275],
4	S	NN	O	s	prep_of	1	SENT_5	[p1l924t237r1376b275],
5	.	.	O	.	_	0	SENT_5	[p1l924t237r1376b275],

1	—	NN	O	—	_	0	SENT_6	[p1l924t237r1376b275],
2	.	.	O	.	_	0	SENT_6	[p1l924t237r1376b275],

1	TRANSFERASES	NN	O	transferase	_	0	SENT_7	[p1l924t237r1376b275],
2	BY	IN	O	by	dep	1	SENT_7	[p1l1407t237r1480b274],
3	ANTIMALARIAL	NN	O	antimalarial	pobj	2	SENT_7	[p1l1509t237r1923b275],

1	DRUGS	NNS	O	drug	_	0	SENT_8	[p1l89t315r268b353],
2	POSSIBLE	JJ	O	possible	amod	3	SENT_8	[p1l299t315r548b353],
3	IMPLICATIONS	NNS	O	implication	dep	1	SENT_8	[p1l576t315r954b353],
4	FOR	IN	O	for	dep	1	SENT_8	[p1l985t315r1090b353],
5	CIRCUMVENTING	VBG	O	circumvent	pcomp	4	SENT_8	[p1l1119t315r1571b353],
6	ANTICANCER	NN	O	anticancer	dobj	5	SENT_8	[p1l1599t315r1947b353],

1	DRUG	NN	O	drug	nn	2	SENT_9	[p1l89t393r241b431],
2	RESISTANCE	NN	O	resistance	_	0	SENT_9	[p1l269t393r596b431],

1	Stanley	NNP	PERSON	Stanley	nn	2	SENT_10	[p1l90t479r200b514],
2	MUKANGANYAMA1	NN	O	mukanganyama1	_	0	SENT_10	[p1l214t474r488b511],
3	,	,	O	,	_	0	SENT_10	[p1l214t474r488b511],
4	Mikael	NNP	PERSON	Mikael	nn	5	SENT_10	[p1l503t479r608b506],
5	WIDERSTEN2	NNP	PERSON	WIDERSTEN2	conj_and	2	SENT_10	[p1l621t474r810b511],
6	,	,	O	,	_	0	SENT_10	[p1l621t474r810b511],
7	Yogeshkumar	NNP	O	Yogeshkumar	nn	9	SENT_10	[p1l825t479r1035b514],
8	S.	NNP	O	S.	nn	9	SENT_10	[p1l1048t480r1075b506],
9	NAIK1	NNP	O	NAIK1	conj_and	2	SENT_10	[p1l1090t474r1187b511],
10	,	,	O	,	_	0	SENT_10	[p1l1090t474r1187b511],
11	Bengt	NNP	PERSON	Bengt	nn	12	SENT_10	[p1l1202t480r1291b514],
12	MANNERVIK2	NNP	O	MANNERVIK2	conj_and	2	SENT_10	[p1l1303t474r1492b506],
13	and	CC	O	and	_	0	SENT_10	[p1l1506t479r1559b506],
14	Julia	NNP	PERSON	Julia	nn	16	SENT_10	[p1l1572t479r1643b506],
15	A.	NNP	O	A.	nn	16	SENT_10	[p1l1655t480r1689b506],
16	HASLER1	NNP	O	HASLER1	conj_and	2	SENT_10	[p1l1704t474r1848b506],
17	*	CD	NUMBER	*	num	18	SENT_10	[p1l1704t474r1848b506],
18	1Department	NN	O	1department	dep	2	SENT_10	[p1l91t515r283b554],
19	of	IN	O	of	_	0	SENT_10	[p1l295t521r329b554],
20	Biochemistry	NNP	O	Biochemistry	nn	22	SENT_10	[p1l336t520r539b554],
21	,	,	O	,	_	0	SENT_10	[p1l336t520r539b554],
22	University	NNP	ORGANIZATION	University	prep_of	18	SENT_10	[p1l559t522r711b554],
23	of	IN	ORGANIZATION	of	_	0	SENT_10	[p1l725t521r759b554],
24	Zimbabwe	NNP	ORGANIZATION	Zimbabwe	nn	26	SENT_10	[p1l766t520r928b551],
25	,	,	O	,	_	0	SENT_10	[p1l766t520r928b551],
26	Harare	NNP	LOCATION	Harare	prep_of	22	SENT_10	[p1l944t522r1060b551],
27	,	,	O	,	_	0	SENT_10	[p1l944t522r1060b551],
28	Zimbabwe	NNP	LOCATION	Zimbabwe	nn	29	SENT_10	[p1l1076t521r1232b547],
29	2Department	NN	O	2department	appos	22	SENT_10	[p1l89t554r283b594],
30	of	IN	O	of	_	0	SENT_10	[p1l295t560r329b594],
31	Biochemistry	NNP	O	Biochemistry	prep_of	29	SENT_10	[p1l336t560r539b594],
32	,	,	O	,	_	0	SENT_10	[p1l336t560r539b594],
33	Biomedical	NNP	O	Biomedical	nn	39	SENT_10	[p1l555t560r727b586],
34	Centre	NNP	O	Centre	nn	39	SENT_10	[p1l741t560r846b591],
35	,	,	O	,	_	0	SENT_10	[p1l741t560r846b591],
36	Uppsala	NNP	ORGANIZATION	Uppsala	nn	37	SENT_10	[p1l867t560r989b594],
37	University	NNP	ORGANIZATION	University	dep	39	SENT_10	[p1l1006t561r1164b594],
38	,	,	O	,	_	0	SENT_10	[p1l1006t561r1164b594],
39	Uppsala	NNP	LOCATION	Uppsala	appos	22	SENT_10	[p1l1184t560r1313b594],
40	,	,	O	,	_	0	SENT_10	[p1l1184t560r1313b594],
41	Sweden	NNP	LOCATION	Sweden	appos	39	SENT_10	[p1l1330t560r1443b587],
42	'	POS	O	'	_	0	SENT_10	[p1l1374t83r1418b99],

1	-	:	O	-	_	0	SENT_11	[p1l1374t83r1418b99],
2	T	NN	O	t	dep	5	SENT_11	[p1l1374t83r1418b99],
3	“	CD	NUMBER	“	number	4	SENT_11	[p1l1374t83r1418b99],
4	__	CD	NUMBER	__	num	5	SENT_11	[p1l1442t98r1450b104],
5	Publication	NN	O	publication	_	0	SENT_11	[p1l1490t81r1608b98],
6	of	IN	O	of	_	0	SENT_11	[p1l1618t81r1639b98],
7	the	DT	O	the	det	9	SENT_11	[p1l1646t81r1680b98],
8	International	NNP	ORGANIZATION	International	nn	9	SENT_11	[p1l1690t81r1824b98],
9	Union	NNP	ORGANIZATION	Union	prep_of	5	SENT_11	[p1l1835t81r1898b98],
10	Against	IN	ORGANIZATION	against	_	0	SENT_11	[p1l1907t81r1989b102],
11	Cancer	NNP	ORGANIZATION	Cancer	prep_against	9	SENT_11	[p1l1998t81r2072b98],

1	A	DT	O	a	det	2	SENT_12	[p1l88t756r146b809],
2	strategy	NN	O	strategy	nsubj	10	SENT_12	[p1l188t762r475b826],
3	to	TO	O	to	aux	4	SENT_12	[p1l514t762r587b809],
4	overcome	VB	O	overcome	infmod	2	SENT_12	[p1l631t772r983b809],
5	multidrug	JJ	O	multidrug	amod	6	SENT_12	[p1l1028t755r1375b826],
6	resistance	NN	O	resistance	dobj	4	SENT_12	[p1l1418t756r1767b809],
7	in	IN	O	in	_	0	SENT_12	[p1l1812t756r1869b809],
8	cancer	NN	O	cancer	nn	9	SENT_12	[p1l1914t772r2148b809],
9	cells	NNS	O	cell	prep_in	4	SENT_12	[p1l10t831r159b883],
10	involves	VBZ	O	involve	_	0	SENT_12	[p1l192t830r468b883],
11	treatment	NN	O	treatment	dobj	10	SENT_12	[p1l498t836r864b883],
12	with	IN	O	with	_	0	SENT_12	[p1l892t830r1043b883],
13	a	DT	O	a	det	14	SENT_12	[p1l1077t847r1115b883],
14	combination	NN	O	combination	prep_with	10	SENT_12	[p1l1145t830r1584b883],
15	of	IN	O	of	_	0	SENT_12	[p1l1618t830r1689b883],
16	the	DT	O	the	det	17	SENT_12	[p1l1712t831r1826b883],
17	antineoplastic	JJ	O	antineoplastic	prep_of	14	SENT_12	[p1l1858t830r2145b883, p1l11t905r231b976],

1	agent	NN	O	agent	nsubj	6	SENT_13	[p1l255t911r450b976],
2	and	CC	O	and	_	0	SENT_13	[p1l472t906r594b959],
3	a	DT	O	a	det	4	SENT_13	[p1l620t922r658b959],
4	chemomodulator	NN	O	chemomodulator	nsubj	6	SENT_13	[p1l679t906r1295b959],
5	that	WDT	O	that	rcmod	4	SENT_13	[p1l1314t906r1458b959],
6	inhibits	VBZ	O	inhibit	_	0	SENT_13	[p1l1482t905r1734b959],
7	the	DT	O	the	det	8	SENT_13	[p1l1755t906r1869b959],
8	activity	NN	O	activity	dobj	6	SENT_13	[p1l1892t905r2148b975],
9	of	IN	O	of	_	0	SENT_13	[p1l10t980r81b1034],
10	the	DT	O	the	det	12	SENT_13	[p1l93t980r207b1034],
11	resistance-causing	JJ	O	resistance-causing	amod	12	SENT_13	[p1l230t980r867b1050],
12	protein	NN	O	protein	prep_of	8	SENT_13	[p1l889t980r1162b1051],
13	.	.	O	.	_	0	SENT_13	[p1l889t980r1162b1051],

1	The	DT	O	the	det	2	SENT_14	[p1l1185t980r1321b1034],
2	aim	NN	O	aim	nsubj	6	SENT_14	[p1l1343t980r1470b1034],
3	of	IN	O	of	_	0	SENT_14	[p1l1493t980r1564b1034],
4	our	PRP$	O	we	poss	5	SENT_14	[p1l1578t997r1700b1034],
5	study	NN	O	study	prep_of	2	SENT_14	[p1l1719t980r1906b1050],
6	was	VBD	O	be	_	0	SENT_14	[p1l1923t997r2053b1034],
7	to	TO	O	to	aux	8	SENT_14	[p1l2073t986r2145b1034],
8	investigate	VB	O	investigate	xcomp	6	SENT_14	[p1l11t1055r388b1125],
9	the	DT	O	the	det	10	SENT_14	[p1l426t1055r541b1109],
10	effects	NNS	O	effect	dobj	8	SENT_14	[p1l581t1055r807b1109],
11	of	IN	O	of	_	0	SENT_14	[p1l848t1055r918b1109],
12	antimalarial	JJ	O	antimalarial	amod	13	SENT_14	[p1l951t1055r1369b1109],
13	drugs	NNS	O	drug	prep_of	10	SENT_14	[p1l1411t1055r1603b1125],
14	on	IN	O	on	_	0	SENT_14	[p1l1643t1071r1725b1109],
15	human	JJ	O	human	amod	18	SENT_14	[p1l1770t1055r2007b1109],
16	recombinant	JJ	O	recombinant	amod	18	SENT_14	[p1l2051t1071r2145b1109, p1l10t1130r386b1184],
17	glutathione	NN	O	glutathione	nn	18	SENT_14	[p1l422t1130r821b1200],
18	S-transferase	NN	O	s-transferase	prep_on	13	SENT_14	[p1l860t1130r1320b1184],
19	(	CD	NUMBER	(	num	22	SENT_14	[p1l1359t1130r1605b1200],
20	GSTs	NNS	O	gst	nn	22	SENT_14	[p1l1359t1130r1605b1200],
21	)	NN	O	)	nn	22	SENT_14	[p1l1359t1130r1605b1200],
22	activity	NN	O	activity	dep	18	SENT_14	[p1l1644t1130r1900b1200],
23	in	IN	O	in	_	0	SENT_14	[p1l1937t1130r1994b1183],
24	the	DT	O	the	det	25	SENT_14	[p1l2032t1130r2146b1184],
25	context	NN	O	context	prep_in	8	SENT_14	[p1l10t1211r279b1258],
26	of	IN	O	of	_	0	SENT_14	[p1l318t1204r389b1258],
27	searching	VBG	O	search	prepc_of	25	SENT_14	[p1l422t1205r756b1275],
28	for	IN	O	for	_	0	SENT_14	[p1l793t1204r895b1258],
29	effective	JJ	O	effective	amod	33	SENT_14	[p1l933t1204r1227b1258],
30	and	CC	O	and	_	0	SENT_14	[p1l1268t1205r1390b1258],
31	clinically	RB	O	clinically	advmod	32	SENT_14	[p1l1433t1205r1732b1274],
32	acceptable	JJ	O	acceptable	amod	33	SENT_14	[p1l1770t1205r2145b1275],
33	inhibitors	NNS	O	inhibitor	prep_for	27	SENT_14	[p1l11t1279r342b1333],
34	of	IN	O	of	_	0	SENT_14	[p1l369t1279r440b1333],
35	these	DT	O	these	det	36	SENT_14	[p1l457t1280r646b1333],
36	enzymes	NNS	O	enzyme	prep_of	33	SENT_14	[p1l672t1296r998b1349],
37	.	.	O	.	_	0	SENT_14	[p1l672t1296r998b1349],

1	Human	JJ	O	human	amod	3	SENT_15	[p1l1030t1280r1284b1333],
2	recombinant	JJ	O	recombinant	amod	3	SENT_15	[p1l1315t1279r1766b1333],
3	GSTs	NNS	O	gst	nsubjpass	10	SENT_15	[p1l1792t1279r1981b1333],
4	heterologously	RB	O	heterologously	advmod	5	SENT_15	[p1l2010t1280r2145b1333, p1l10t1356r416b1426],
5	expressed	VBN	O	express	partmod	3	SENT_15	[p1l446t1356r794b1426],
6	in	IN	O	in	_	0	SENT_15	[p1l830t1355r887b1408],
7	Escherichia	FW	LOCATION	escherichia	nn	8	SENT_15	[p1l922t1356r1292b1409],
8	coli	FW	O	coli	prep_in	5	SENT_15	[p1l1324t1356r1439b1409],
9	were	VBD	O	be	auxpass	10	SENT_15	[p1l1467t1372r1642b1409],
10	used	VBN	O	use	_	0	SENT_15	[p1l1677t1356r1831b1409],
11	for	IN	O	for	_	0	SENT_15	[p1l1864t1355r1965b1409],
12	inhibition	NN	O	inhibition	nn	13	SENT_15	[p1l1997t1355r2145b1408, p1l11t1430r208b1484],
13	studies	NNS	O	study	prep_for	10	SENT_15	[p1l235t1430r495b1484],
14	.	.	O	.	_	0	SENT_15	[p1l235t1430r495b1484],

1	GST	NN	MISC	gst	nn	3	SENT_16	[p1l521t1430r678b1484],
2	AI-I	NN	MISC	ai-i	nn	3	SENT_16	[p1l699t1430r852b1483],
3	activity	NN	O	activity	nsubjpass	5	SENT_16	[p1l888t1430r1144b1500],
4	was	VBD	O	be	auxpass	5	SENT_16	[p1l1163t1447r1293b1484],
5	inhibited	VBN	O	inhibit	_	0	SENT_16	[p1l1318t1430r1621b1484],
6	by	IN	O	by	_	0	SENT_16	[p1l1648t1430r1727b1500],
7	artemisinin	NN	O	artemisinin	agent	5	SENT_16	[p1l1748t1430r2144b1484],
8	with	IN	O	with	_	0	SENT_16	[p1l7t1505r158b1559],
9	an	DT	O	a	det	11	SENT_16	[p1l204t1521r281b1559],
10	|	NN	O	|	nn	11	SENT_16	[p1l331t1505r470b1576],
11	C5o	NN	O	c5o	prep_with	5	SENT_16	[p1l331t1505r470b1576],
12	of	IN	O	of	_	0	SENT_16	[p1l514t1505r585b1559],
13	6	CD	NUMBER	6	num	14	SENT_16	[p1l622t1505r656b1559],
14	MM	NN	O	mm	prep_of	11	SENT_16	[p1l705t1505r839b1574],
15	,	,	O	,	_	0	SENT_16	[p1l705t1505r839b1574],
16	whilst	IN	O	whilst	mark	20	SENT_16	[p1l881t1505r1088b1559],
17	GST	NN	O	gst	nn	18	SENT_16	[p1l1131t1505r1288b1559],
18	Ml-I	NN	O	ml-i	nsubjpass	20	SENT_16	[p1l1334t1505r1490b1558],
19	was	VBD	O	be	auxpass	20	SENT_16	[p1l1543t1521r1674b1559],
20	inhibited	VBN	O	inhibit	dep	5	SENT_16	[p1l1719t1505r2022b1559],
21	by	IN	O	by	_	0	SENT_16	[p1l2069t1505r2148b1575],
22	quinidine	NN	O	quinidine	agent	20	SENT_16	[p1l10t1580r329b1650],
23	and	CC	O	and	_	0	SENT_16	[p1l351t1580r474b1634],
24	its	PRP$	O	its	poss	26	SENT_16	[p1l500t1580r577b1634],
25	diastereoisomer	NN	O	diastereoisomer	nn	26	SENT_16	[p1l600t1580r1174b1634],
26	quinine	NN	O	quinine	agent	20	SENT_16	[p1l1194t1580r1449b1650],
27	with	IN	O	with	_	0	SENT_16	[p1l1469t1580r1619b1634],
28	IC5os	NN	O	ic5o	prep_with	20	SENT_16	[p1l1647t1580r1819b1651],
29	of	IN	O	of	_	0	SENT_16	[p1l1842t1580r1912b1634],
30	I2	NN	O	i2	nn	31	SENT_16	[p1l1939t1580r2005b1633],
31	p.M	NN	O	p.m	prep_of	28	SENT_16	[p1l2032t1580r2142b1649],
32	and	CC	O	and	_	0	SENT_16	[p1l10t1655r132b1708],
33	I7	NN	O	i7	nn	35	SENT_16	[p1l173t1655r239b1708],
34	p.	NN	O	p.	nn	35	SENT_16	[p1l270t1655r403b1724],
35	M	NN	O	m	prep_of	28	SENT_16	[p1l270t1655r403b1724],
36	,	,	O	,	_	0	SENT_16	[p1l270t1655r403b1724],
37	respectively	RB	O	respectively	advmod	20	SENT_16	[p1l433t1655r868b1725],
38	.	.	O	.	_	0	SENT_16	[p1l433t1655r868b1725],

1	GST	NN	O	gst	nn	2	SENT_17	[p1l897t1654r1054b1708],
2	M3-3	NN	O	m3-3	nsubjpass	4	SENT_17	[p1l1083t1654r1248b1708],
3	was	VBD	O	be	auxpass	4	SENT_17	[p1l1276t1671r1406b1708],
4	inhibited	VBN	O	inhibit	_	0	SENT_17	[p1l1434t1655r1737b1708],
5	by	IN	O	by	_	0	SENT_17	[p1l1767t1655r1846b1724],
6	tetracycline	NN	O	tetracycline	agent	4	SENT_17	[p1l1869t1661r2145b1724, p1l10t1729r170b1783],
7	only	RB	O	only	advmod	4	SENT_17	[p1l208t1730r354b1799],
8	with	IN	O	with	_	0	SENT_17	[p1l387t1729r537b1783],
9	an	DT	O	a	det	11	SENT_17	[p1l577t1746r654b1783],
10	|	NN	O	|	nn	11	SENT_17	[p1l698t1729r837b1801],
11	C5o	NN	O	c5o	prep_with	4	SENT_17	[p1l698t1729r837b1801],
12	of	IN	O	of	_	0	SENT_17	[p1l875t1729r946b1783],
13	47	CD	NUMBER	47	num	14	SENT_17	[p1l976t1729r1055b1783],
14	pM	NN	O	pm	prep_of	11	SENT_17	[p1l1096t1730r1229b1798],
15	.	.	O	.	_	0	SENT_17	[p1l1096t1730r1229b1798],

1	GST	NN	O	gst	nn	2	SENT_18	[p1l1269t1729r1426b1783],
2	PI-I	NN	O	pi-i	nsubj	7	SENT_18	[p1l1466t1730r1604b1783],
3	was	VBD	O	be	cop	7	SENT_18	[p1l1652t1746r1782b1783],
4	the	DT	O	the	det	7	SENT_18	[p1l1817t1730r1931b1783],
5	most	RBS	O	most	advmod	6	SENT_18	[p1l1971t1736r2147b1783],
6	susceptible	JJ	O	susceptible	amod	7	SENT_18	[p1l10t1805r396b1876],
7	enzyme	NN	O	enzyme	_	0	SENT_18	[p1l432t1822r706b1875],
8	to	TO	O	to	_	0	SENT_18	[p1l740t1811r812b1859],
9	inhibition	NN	O	inhibition	prep_to	7	SENT_18	[p1l850t1805r1176b1859],
10	by	IN	O	by	_	0	SENT_18	[p1l1216t1806r1294b1875],
11	antimalarials	NNS	O	antimalarial	prep_by	7	SENT_18	[p1l1328t1805r1781b1859],
12	with	IN	O	with	_	0	SENT_18	[p1l1814t1805r1965b1859],
13	lC5o	NN	O	lc5o	nn	14	SENT_18	[p1l2006t1805r2145b1876],
14	values	NNS	O	value	prep_with	11	SENT_18	[p1l8t1880r223b1934],
15	of	IN	O	of	_	0	SENT_18	[p1l254t1880r325b1934],
16	I	PRP	O	I	prep_of	14	SENT_18	[p1l360t1880r404b1946],
17	,	,	O	,	_	0	SENT_18	[p1l360t1880r404b1946],
18	2	CD	NUMBER	2	conj_and	16	SENT_18	[p1l437t1880r492b1946],
19	,	,	O	,	_	0	SENT_18	[p1l437t1880r492b1946],
20	I	PRP	O	I	conj_and	16	SENT_18	[p1l536t1880r581b1946],
21	,	,	O	,	_	0	SENT_18	[p1l536t1880r581b1946],
22	4	CD	NUMBER	4	conj_and	16	SENT_18	[p1l612t1880r669b1946],
23	,	,	O	,	_	0	SENT_18	[p1l612t1880r669b1946],
24	and	CC	O	and	_	0	SENT_18	[p1l700t1880r822b1934],
25	I3	NN	O	i3	nn	26	SENT_18	[p1l867t1880r930b1934],
26	p.M	NN	O	p.m	conj_and	16	SENT_18	[p1l968t1880r1078b1949],
27	for	IN	O	for	_	0	SENT_18	[p1l1110t1880r1212b1934],
28	pyrimethamine	NN	O	pyrimethamine	prep_for	26	SENT_18	[p1l1241t1880r1801b1951],
29	,	,	O	,	_	0	SENT_18	[p1l1241t1880r1801b1951],
30	artemisinin	NN	O	artemisinin	prep_for	26	SENT_18	[p1l1832t1880r2145b1934, p1l12t1955r134b2021],
31	,	,	O	,	_	0	SENT_18	[p1l1832t1880r2145b1934, p1l12t1955r134b2021],
32	quinidine	NN	O	quinidine	conj_and	28	SENT_18	[p1l181t1955r521b2025],
33	,	,	O	,	_	0	SENT_18	[p1l181t1955r521b2025],
34	quinine	NN	O	quinine	conj_and	28	SENT_18	[p1l569t1955r824b2025],
35	and	CC	O	and	_	0	SENT_18	[p1l870t1955r993b2009],
36	tetracycline	NN	O	tetracycline	conj_and	28	SENT_18	[p1l1040t1955r1476b2025],
37	,	,	O	,	_	0	SENT_18	[p1l1040t1955r1476b2025],
38	respectively	RB	O	respectively	advmod	7	SENT_18	[p1l1526t1955r1962b2025],
39	.	.	O	.	_	0	SENT_18	[p1l1526t1955r1962b2025],

1	The	DT	O	the	det	3	SENT_19	[p1l2009t1955r2146b2009],
2	IC5o	NN	O	ic5o	nn	3	SENT_19	[p1l13t2030r153b2101],
3	values	NNS	O	value	nsubj	13	SENT_19	[p1l185t2030r401b2084],
4	obtained	VBN	O	obtain	partmod	3	SENT_19	[p1l435t2030r739b2084],
5	for	IN	O	for	_	0	SENT_19	[p1l773t2030r875b2084],
6	artemisinin	NN	O	artemisinin	prep_for	4	SENT_19	[p1l906t2030r1323b2096],
7	,	,	O	,	_	0	SENT_19	[p1l906t2030r1323b2096],
8	quinine	NN	O	quinine	prep_for	4	SENT_19	[p1l1358t2030r1632b2100],
9	,	,	O	,	_	0	SENT_19	[p1l1358t2030r1632b2100],
10	quinidine	NN	O	quinidine	prep_for	4	SENT_19	[p1l1667t2030r1987b2100],
11	and	CC	O	and	_	0	SENT_19	[p1l2021t2030r2144b2084],
12	tetracycline	NN	O	tetracycline	prep_for	4	SENT_19	[p1l8t2105r424b2174],
13	are	VBP	O	be	_	0	SENT_19	[p1l452t2121r563b2158],
14	below	IN	O	below	_	0	SENT_19	[p1l592t2105r799b2158],
15	peak	JJ	O	peak	amod	17	SENT_19	[p1l825t2105r990b2175],
16	plasma	NN	O	plasma	nn	17	SENT_19	[p1l1016t2105r1263b2175],
17	concentrations	NNS	O	concentration	prep_below	13	SENT_19	[p1l1288t2105r1812b2158],
18	obtained	VBN	O	obtain	partmod	17	SENT_19	[p1l1839t2105r2144b2158],
19	during	IN	O	during	_	0	SENT_19	[p1l10t2179r235b2250],
20	therapy	NN	O	therapy	prep_during	18	SENT_19	[p1l265t2180r538b2250],
21	of	IN	O	of	_	0	SENT_19	[p1l570t2179r640b2233],
22	malaria	NN	O	malaria	prep_of	20	SENT_19	[p1l668t2179r932b2233],
23	with	IN	O	with	_	0	SENT_19	[p1l961t2179r1111b2233],
24	these	DT	O	these	det	25	SENT_19	[p1l1144t2180r1333b2233],
25	drugs	NNS	O	drug	prep_with	18	SENT_19	[p1l1366t2180r1577b2250],
26	.	.	O	.	_	0	SENT_19	[p1l1366t2180r1577b2250],

1	It	PRP	O	it	nsubj	2	SENT_20	[p1l1615t2180r1664b2233],
2	seems	VBZ	O	seem	_	0	SENT_20	[p1l1696t2196r1913b2233],
3	likely	RB	O	likely	advmod	2	SENT_20	[p1l1948t2179r2145b2249],
4	,	,	O	,	_	0	SENT_20	[p1l1948t2179r2145b2249],
5	therefore	RB	O	therefore	advmod	2	SENT_20	[p1l8t2255r361b2321],
6	,	,	O	,	_	0	SENT_20	[p1l8t2255r361b2321],
7	that	IN	O	that	complm	11	SENT_20	[p1l393t2256r538b2309],
8	GSTs	NNS	O	gst	nsubjpass	11	SENT_20	[p1l571t2255r760b2309],
9	may	MD	O	may	aux	11	SENT_20	[p1l795t2272r941b2325],
10	be	VB	O	be	auxpass	11	SENT_20	[p1l975t2256r1054b2309],
11	inhibited	VBN	O	inhibit	ccomp	2	SENT_20	[p1l1089t2255r1392b2309],
12	in	FW	O	in	nn	13	SENT_20	[p1l1426t2258r1482b2308],
13	vivo	FW	O	vivo	advmod	11	SENT_20	[p1l1517t2258r1644b2309],
14	at	IN	O	at	_	0	SENT_20	[p1l1678t2261r1746b2309],
15	doses	NNS	O	dose	prep_at	11	SENT_20	[p1l1777t2256r1969b2309],
16	normally	RB	O	normally	advmod	17	SENT_20	[p1l2003t2272r2145b2309, p1l12t2330r200b2400],
17	used	VBN	O	use	partmod	15	SENT_20	[p1l223t2330r377b2384],
18	in	IN	O	in	_	0	SENT_20	[p1l405t2330r462b2383],
19	clinical	JJ	O	clinical	amod	20	SENT_20	[p1l487t2330r723b2384],
20	practice	NN	O	practice	prep_in	17	SENT_20	[p1l750t2330r1047b2401],
21	.	.	O	.	_	0	SENT_20	[p1l750t2330r1047b2401],

1	Using	VBG	O	use	partmod	11	SENT_21	[p1l1077t2330r1272b2400],
2	the	DT	O	the	det	5	SENT_21	[p1l1293t2330r1406b2384],
3	substrate	NN	O	substrate	nn	5	SENT_21	[p1l1431t2330r1756b2384],
4	ethacrynic	JJ	O	ethacrynic	amod	5	SENT_21	[p1l1780t2330r2145b2400],
5	acid	NN	O	acid	dobj	1	SENT_21	[p1l10t2405r168b2471],
6	,	,	O	,	_	0	SENT_21	[p1l10t2405r168b2471],
7	a	DT	O	a	det	9	SENT_21	[p1l201t2421r239b2459],
8	diuretic	JJ	O	diuretic	amod	9	SENT_21	[p1l269t2405r538b2459],
9	drug	NN	O	drug	nsubj	11	SENT_21	[p1l571t2405r731b2475],
10	also	RB	O	also	advmod	11	SENT_21	[p1l761t2405r895b2459],
11	used	VBD	O	use	_	0	SENT_21	[p1l929t2405r1083b2459],
12	as	IN	O	as	mark	27	SENT_21	[p1l1117t2421r1186b2459],
13	a	DT	O	a	det	14	SENT_21	[p1l1218t2421r1256b2459],
14	modulator	NN	O	modulator	nsubjpass	27	SENT_21	[p1l1288t2405r1660b2459],
15	to	TO	O	to	aux	16	SENT_21	[p1l1688t2411r1761b2459],
16	overcome	VB	O	overcome	infmod	14	SENT_21	[p1l1793t2421r2145b2459],
17	drug	NN	O	drug	nn	18	SENT_21	[p1l10t2480r170b2550],
18	resistance	NN	O	resistance	dobj	16	SENT_21	[p1l198t2480r547b2534],
19	in	IN	O	in	_	0	SENT_21	[p1l576t2480r632b2533],
20	tumour	NN	O	tumour	nn	21	SENT_21	[p1l659t2486r930b2534],
21	cells	NNS	O	cell	prep_in	16	SENT_21	[p1l955t2480r1123b2546],
22	,	,	O	,	_	0	SENT_21	[p1l955t2480r1123b2546],
23	GST	NN	O	gst	nn	25	SENT_21	[p1l1152t2480r1308b2534],
24	Pl-I	NN	O	pl-i	nn	25	SENT_21	[p1l1339t2480r1476b2533],
25	activity	NN	O	activity	appos	21	SENT_21	[p1l1516t2480r1772b2550],
26	was	VBD	O	be	auxpass	27	SENT_21	[p1l1794t2496r1924b2534],
27	inhibited	VBN	O	inhibit	advcl	11	SENT_21	[p1l1953t2480r2145b2534, p1l11t2555r141b2608],
28	by	IN	O	by	_	0	SENT_21	[p1l182t2555r261b2624],
29	tetracycline	NN	O	tetracycline	agent	27	SENT_21	[p1l295t2554r731b2624],
30	,	,	O	,	_	0	SENT_21	[p1l295t2554r731b2624],
31	quinine	NN	O	quinine	agent	27	SENT_21	[p1l770t2555r1045b2625],
32	,	,	O	,	_	0	SENT_21	[p1l770t2555r1045b2625],
33	pyrimethamine	NN	O	pyrimethamine	agent	27	SENT_21	[p1l1086t2555r1626b2625],
34	and	CC	O	and	_	0	SENT_21	[p1l1664t2555r1786b2608],
35	quinidine	NN	O	quinidine	agent	27	SENT_21	[p1l1826t2555r2146b2625],
36	with	IN	O	with	_	0	SENT_21	[p1l7t2629r158b2683],
37	ICSO	NN	O	icso	nn	38	SENT_21	[p1l197t2629r337b2701],
38	values	NNS	O	value	prep_with	27	SENT_21	[p1l368t2630r584b2683],
39	of	IN	O	of	_	0	SENT_21	[p1l618t2629r689b2683],
40	I8	NN	O	i8	prep_of	38	SENT_21	[p1l727t2629r814b2695],
41	,	,	O	,	_	0	SENT_21	[p1l727t2629r814b2695],
42	27	CD	NUMBER	27	prep_of	38	SENT_21	[p1l850t2629r947b2695],
43	,	,	O	,	_	0	SENT_21	[p1l850t2629r947b2695],
44	45	CD	NUMBER	45	prep_of	38	SENT_21	[p1l982t2629r1058b2683],
45	and	CC	O	and	_	0	SENT_21	[p1l1095t2630r1217b2683],
46	70	CD	NUMBER	70	num	48	SENT_21	[p1l1255t2629r1331b2683],
47	p.	NN	O	p.	nn	48	SENT_21	[p1l1369t2630r1502b2698],
48	M	NN	O	m	prep_of	38	SENT_21	[p1l1369t2630r1502b2698],
49	,	,	O	,	_	0	SENT_21	[p1l1369t2630r1502b2698],
50	respectively	RB	O	respectively	advmod	27	SENT_21	[p1l1539t2629r1975b2700],
51	.	.	O	.	_	0	SENT_21	[p1l1539t2629r1975b2700],

1	The	DT	O	the	det	3	SENT_22	[p1l2009t2630r2146b2683],
2	ubiquitous	JJ	O	ubiquitous	amod	3	SENT_22	[p1l12t2705r376b2776],
3	expression	NN	O	expression	nsubj	9	SENT_22	[p1l404t2705r774b2776],
4	of	IN	O	of	_	0	SENT_22	[p1l805t2705r876b2759],
5	GSTs	NNS	O	gst	prep_of	3	SENT_22	[p1l897t2705r1086b2759],
6	in	IN	O	in	_	0	SENT_22	[p1l1115t2705r1171b2758],
7	different	JJ	O	different	amod	8	SENT_22	[p1l1201t2705r1501b2759],
8	malignancies	NNS	O	malignancy	prep_in	5	SENT_22	[p1l1530t2705r1980b2776],
9	suggests	VBZ	O	suggest	_	0	SENT_22	[p1l2007t2722r2145b2776, p1l9t2786r184b2850],
10	that	IN	O	that	complm	21	SENT_22	[p1l213t2780r358b2834],
11	the	DT	O	the	det	12	SENT_22	[p1l386t2780r500b2834],
12	addition	NN	O	addition	nsubj	21	SENT_22	[p1l531t2780r815b2834],
13	of	IN	O	of	_	0	SENT_22	[p1l849t2780r920b2834],
14	nontoxic	JJ	O	nontoxic	prep_of	12	SENT_22	[p1l945t2780r1248b2834],
15	reversing	VBG	O	reverse	partmod	14	SENT_22	[p1l1282t2780r1605b2850],
16	agents	NNS	O	agent	dobj	15	SENT_22	[p1l1634t2786r1861b2851],
17	such	JJ	O	such	_	0	SENT_22	[p1l1892t2780r2044b2834],
18	as	IN	O	as	_	0	SENT_22	[p1l2077t2797r2146b2834],
19	antimalarials	NNS	O	antimalarial	prep_such_as	16	SENT_22	[p1l10t2855r463b2909],
20	could	MD	O	could	aux	21	SENT_22	[p1l493t2855r677b2909],
21	enhance	VB	O	enhance	ccomp	9	SENT_22	[p1l710t2855r999b2909],
22	the	DT	O	the	det	23	SENT_22	[p1l1027t2855r1141b2909],
23	efficacy	NN	O	efficacy	dobj	21	SENT_22	[p1l1172t2855r1433b2925],
24	of	IN	O	of	_	0	SENT_22	[p1l1461t2855r1532b2909],
25	a	DT	O	a	det	26	SENT_22	[p1l1554t2871r1593b2909],
26	variety	NN	O	variety	prep_of	23	SENT_22	[p1l1618t2855r1862b2925],
27	of	IN	O	of	_	0	SENT_22	[p1l1890t2855r1962b2909],
28	alkylating	JJ	O	alkylating	amod	29	SENT_22	[p1l1984t2855r2145b2925, p1l12t2930r204b3000],
29	agents	NNS	O	agent	prep_of	26	SENT_22	[p1l232t2936r478b3000],
30	.	.	O	.	_	0	SENT_22	[p1l232t2936r478b3000],

1	©	RB	O	©	advmod	2	SENT_23	[p1l10t3012r56b3059],
2	2002	CD	DATE	2002	_	0	SENT_23	[p1l97t3007r245b3058],
3	Wiley	NNP	PERSON	Wiley	dep	2	SENT_23	[p1l278t3006r603b3073],
4	.	.	O	.	_	0	SENT_23	[p1l278t3006r603b3073],

1	—	NN	O	—	_	0	SENT_24	[p1l278t3006r603b3073],
2	.	.	O	.	_	0	SENT_24	[p1l278t3006r603b3073],

1	Liss	NNP	ORGANIZATION	Liss	_	0	SENT_25	[p1l278t3006r603b3073],
2	,	,	ORGANIZATION	,	_	0	SENT_25	[p1l278t3006r603b3073],
3	Inc.	NNP	ORGANIZATION	Inc.	appos	1	SENT_25	[p1l636t3008r744b3059],
4	.	.	O	.	_	0	SENT_25	[p1l636t3008r744b3059],

1	Key	NN	O	key	_	0	SENT_26	[p1l9t3137r137b3203],
2	Words	NNS	O	word	dep	1	SENT_26	[p1l185t3137r401b3189],
3	:	:	O	:	_	0	SENT_26	[p1l185t3137r401b3189],
4	glutathione	NN	O	glutathione	nn	5	SENT_26	[p1l453t3136r796b3204],
5	S-transferases	NNS	O	s-transferase	dep	1	SENT_26	[p1l844t3137r1297b3204],
6	;	:	O	;	_	0	SENT_26	[p1l844t3137r1297b3204],
7	antimalarials	NNS	O	antimalarial	dep	5	SENT_26	[p1l1349t3136r1777b3198],
8	;	:	O	;	_	0	SENT_26	[p1l1349t3136r1777b3198],
9	inhibition	NN	O	inhibition	dep	7	SENT_26	[p1l1831t3136r2142b3198],
10	;	:	O	;	_	0	SENT_26	[p1l1831t3136r2142b3198],
11	drug	NN	O	drug	nn	12	SENT_26	[p1l8t3211r149b3278],
12	resistance	NN	O	resistance	dep	9	SENT_26	[p1l179t3213r503b3273],
13	;	:	O	;	_	0	SENT_26	[p1l179t3213r503b3273],
14	chemomodulator	NN	O	chemomodulator	dep	5	SENT_26	[p1l535t3211r1049b3264],

1	During	IN	O	during	_	0	SENT_27	[p2l89t71r313b144],
2	treatment	NN	O	treatment	prep_during	8	SENT_27	[p2l334t80r636b128],
3	of	IN	O	of	_	0	SENT_27	[p2l656t71r725b128],
4	many	JJ	O	many	amod	5	SENT_27	[p2l741t89r916b144],
5	cancers	NNS	O	cancer	prep_of	2	SENT_27	[p2l938t89r1192b138],
6	,	,	O	,	_	0	SENT_27	[p2l938t89r1192b138],
7	there	EX	O	there	expl	8	SENT_27	[p2l1216t71r1373b128],
8	is	VBZ	O	be	_	0	SENT_27	[p2l1394t71r1444b128],
9	often	RB	O	often	advmod	8	SENT_27	[p2l1467t71r1629b128],
10	development	NN	O	development	nsubj	8	SENT_27	[p2l1650t71r2062b144],
11	of	IN	O	of	_	0	SENT_27	[p2l2083t71r2152b128],
12	drug	NN	O	drug	nn	13	SENT_27	[p2l9t156r153b229],
13	resistance	NN	O	resistance	prep_of	10	SENT_27	[p2l182t156r497b212],
14	in	IN	O	in	_	0	SENT_27	[p2l527t156r588b211],
15	a	DT	O	a	det	16	SENT_27	[p2l619t173r652b212],
16	tumour	NN	O	tumour	prep_in	13	SENT_27	[p2l681t164r912b212],
17	that	WDT	O	that	nsubj	20	SENT_27	[p2l940t156r1060b212],
18	was	VBD	O	be	cop	20	SENT_27	[p2l1089t173r1209b212],
19	originally	RB	O	originally	advmod	20	SENT_27	[p2l1242t156r1550b229],
20	sensitive	JJ	O	sensitive	rcmod	16	SENT_27	[p2l1583t156r1859b212],
21	to	TO	O	to	_	0	SENT_27	[p2l1889t164r1948b212],
22	treatment	NN	O	treatment	prep_to	20	SENT_27	[p2l1979t164r2144b212, p2l8t248r183b296],
23	.	.	O	.	_	0	SENT_27	[p2l1979t164r2144b212, p2l8t248r183b296],

1	This	DT	O	this	det	4	SENT_28	[p2l207t240r345b296],
2	resistance	NN	O	resistance	nn	4	SENT_28	[p2l366t240r681b296],
3	compromises	NNS	O	compromise	nn	4	SENT_28	[p2l702t240r1125b313],
4	cancer	NN	O	cancer	_	0	SENT_28	[p2l1147t257r1355b296],
5	chemotherapy	NN	O	chemotherapy	nn	8	SENT_28	[p2l1374t240r1825b313],
6	and	CC	O	and	_	0	SENT_28	[p2l1847t240r1960b296],
7	overall	JJ	O	overall	conj_and	5	SENT_28	[p2l1980t257r2144b296, p2l10t324r86b380],
8	survival	NN	O	survival	dep	4	SENT_28	[p2l128t324r382b380],
9	of	IN	O	of	_	0	SENT_28	[p2l422t324r491b380],
10	the	DT	O	the	det	11	SENT_28	[p2l524t324r619b380],
11	patients	NNS	O	patient	prep_of	8	SENT_28	[p2l657t324r998b397],
12	.	.	O	.	_	0	SENT_28	[p2l657t324r998b397],

1	”	NN	O	”	ccomp	7	SENT_29	[p2l657t324r998b397],
2	Frequently	RB	O	frequently	advmod	1	SENT_29	[p2l1037t324r1400b397],
3	,	,	O	,	_	0	SENT_29	[p2l1037t324r1400b397],
4	resistance	NN	O	resistance	nsubjpass	7	SENT_29	[p2l1441t324r1755b380],
5	is	VBZ	O	be	auxpass	7	SENT_29	[p2l1795t324r1844b380],
6	also	RB	O	also	advmod	7	SENT_29	[p2l1886t324r2011b380],
7	acquired	VBN	O	acquire	_	0	SENT_29	[p2l2052t342r2144b380, p2l9t408r212b481],
8	to	TO	O	to	_	0	SENT_29	[p2l237t417r296b464],
9	drugs	NNS	O	drug	prep_to	7	SENT_29	[p2l323t408r497b481],
10	not	RB	O	not	neg	11	SENT_29	[p2l525t416r626b464],
11	used	VBN	O	use	partmod	9	SENT_29	[p2l650t408r796b464],
12	in	IN	O	in	_	0	SENT_29	[p2l821t408r881b464],
13	the	DT	O	the	det	14	SENT_29	[p2l906t408r1002b464],
14	treatment	NN	O	treatment	prep_in	11	SENT_29	[p2l1028t416r1330b464],
15	of	IN	O	of	_	0	SENT_29	[p2l1355t408r1424b464],
16	that	DT	O	that	det	18	SENT_29	[p2l1445t408r1564b464],
17	particular	JJ	O	particular	amod	18	SENT_29	[p2l1587t408r1895b481],
18	cancer	NN	O	cancer	prep_of	14	SENT_29	[p2l1920t426r2142b464],
19	.	.	O	.	_	0	SENT_29	[p2l1920t426r2142b464],

1	This	DT	O	this	det	2	SENT_30	[p2l9t492r147b548],
2	phenomenon	NN	O	phenomenon	nsubj	12	SENT_30	[p2l183t492r597b565],
3	has	VBZ	O	have	aux	5	SENT_30	[p2l632t492r735b549],
4	been	VBN	O	be	auxpass	5	SENT_30	[p2l771t492r922b549],
5	termed	VBN	O	term	_	0	SENT_30	[p2l957t492r1178b549],
6	multidrug	JJ	O	multidrug	amod	10	SENT_30	[p2l1213t492r1526b565],
7	resistance	NN	O	resistance	nn	10	SENT_30	[p2l1562t492r1876b549],
8	(	CD	NUMBER	(	num	10	SENT_30	[p2l1915t493r2144b562],
9	MDR	NN	ORGANIZATION	mdr	nn	10	SENT_30	[p2l1915t493r2144b562],
10	)	NN	O	)	xcomp	5	SENT_30	[p2l1915t493r2144b562],
11	and	CC	O	and	_	0	SENT_30	[p2l10t576r123b633],
12	renders	VBZ	O	render	conj_and	5	SENT_30	[p2l160t576r393b633],
13	cells	NNS	O	cell	nsubj	26	SENT_30	[p2l435t577r577b633],
14	resistant	JJ	O	resistant	dep	26	SENT_30	[p2l618t576r885b633],
15	to	TO	O	to	_	0	SENT_30	[p2l923t585r982b633],
16	chemotherapeutic	JJ	O	chemotherapeutic	amod	17	SENT_30	[p2l1022t576r1589b649],
17	agents	NNS	O	agent	prep_to	14	SENT_30	[p2l1631t585r1830b649],
18	in	IN	O	in	_	0	SENT_30	[p2l1871t576r1932b632],
19	many	JJ	O	many	amod	22	SENT_30	[p2l1970t594r2146b649],
20	cancer	NN	O	cancer	nn	22	SENT_30	[p2l9t678r217b717],
21	patients	NNS	O	patient	nn	22	SENT_30	[p2l249t661r544b734],
22	.3	NN	NUMBER	.3	prep_in	17	SENT_30	[p2l249t661r544b734],
23	Among	IN	O	among	_	0	SENT_30	[p2l581t661r819b733],
24	the	DT	O	the	det	25	SENT_30	[p2l854t661r950b717],
25	mechanisms	NNS	O	mechanism	prep_among	26	SENT_30	[p2l985t660r1378b717],
26	involved	VBN	O	involve	xcomp	12	SENT_30	[p2l1414t660r1693b717],
27	in	IN	O	in	_	0	SENT_30	[p2l1727t660r1787b716],
28	the	DT	O	the	det	30	SENT_30	[p2l1822t661r1918b717],
29	multidrug-resistant	JJ	O	multidrug-resistant	amod	30	SENT_30	[p2l1952t660r2144b717, p2l9t745r449b818],
30	phenotype	NN	O	phenotype	prep_in	26	SENT_30	[p2l471t745r804b818],
31	are	VBP	O	be	cop	32	SENT_30	[p2l831t762r924b801],
32	alterations	NNS	O	alteration	rcmod	30	SENT_30	[p2l951t745r1279b801],
33	in	IN	O	in	_	0	SENT_30	[p2l1306t745r1367b800],
34	drug	NN	O	drug	nn	35	SENT_30	[p2l1391t745r1535b818],
35	transport	NN	O	transport	prep_in	32	SENT_30	[p2l1560t753r1844b818],
36	resulting	VBG	O	result	partmod	35	SENT_30	[p2l1867t745r2146b818],
37	in	IN	O	in	_	0	SENT_30	[p2l8t829r69b884],
38	impaired	JJ	O	impaired	amod	39	SENT_30	[p2l96t829r379b902],
39	entry	NN	O	entry	prep_in	36	SENT_30	[p2l407t837r568b902],
40	or	CC	O	or	_	0	SENT_30	[p2l596t847r662b885],
41	enhanced	VBN	O	enhance	amod	42	SENT_30	[p2l687t829r988b885],
42	efﬂux	NN	O	efﬂux	conj_or	30	SENT_30	[p2l1016t829r1200b885],
43	of	IN	O	of	_	0	SENT_30	[p2l1228t829r1297b885],
44	the	DT	O	the	det	45	SENT_30	[p2l1318t829r1414b885],
45	drug	NN	O	drug	prep_of	42	SENT_30	[p2l1442t829r1585b902],
46	from	IN	O	from	_	0	SENT_30	[p2l1614t829r1768b885],
47	the	DT	O	the	det	49	SENT_30	[p2l1794t829r1889b885],
48	tumour	NN	O	tumour	nn	49	SENT_30	[p2l1917t837r2148b885],
49	cell	NN	O	cell	prep_from	45	SENT_30	[p2l9t913r213b969],
50	.45	CD	NUMBER	.45	nsubj	58	SENT_30	[p2l9t913r213b969],
51	In	IN	O	in	_	0	SENT_30	[p2l251t915r315b969],
52	addition	NN	O	addition	nn	53	SENT_30	[p2l353t913r612b969],
53	alterations	NNS	O	alteration	prep_in	50	SENT_30	[p2l650t913r978b969],
54	in	IN	O	in	_	0	SENT_30	[p2l1016t913r1077b969],
55	drug	NN	O	drug	nn	56	SENT_30	[p2l1113t913r1257b986],
56	metabolism	NN	O	metabolism	prep_in	53	SENT_30	[p2l1294t913r1667b969],
57	may	MD	O	may	aux	58	SENT_30	[p2l1702t931r1837b986],
58	result	VB	O	result	rcmod	42	SENT_30	[p2l1873t913r2051b969],
59	in	IN	O	in	_	0	SENT_30	[p2l2086t913r2147b969],
60	impaired	JJ	O	impaired	amod	61	SENT_30	[p2l9t997r292b1070],
61	activation	NN	O	activation	prep_in	58	SENT_30	[p2l326t997r639b1054],
62	of	IN	O	of	_	0	SENT_30	[p2l673t997r742b1053],
63	pro-drugs	NNS	O	pro-drug	prep_of	61	SENT_30	[p2l768t997r1077b1070],
64	or	CC	O	or	_	0	SENT_30	[p2l1113t1015r1178b1053],
65	enhanced	VBN	O	enhance	amod	66	SENT_30	[p2l1210t997r1511b1053],
66	inactivation	NN	O	inactivation	conj_or	30	SENT_30	[p2l1543t997r1920b1054],
67	of	IN	O	of	_	0	SENT_30	[p2l1954t997r2023b1053],
68	the	DT	O	the	det	69	SENT_30	[p2l2050t997r2146b1053],
69	drug	NN	O	drug	prep_of	66	SENT_30	[p2l9t1081r200b1154],
70	.5	CD	NUMBER	.5	num	69	SENT_30	[p2l9t1081r200b1154],

1	The	DT	O	the	det	2	SENT_31	[p2l89t1181r211b1237],
2	group	NN	O	group	nsubj	49	SENT_31	[p2l247t1199r430b1254],
3	of	IN	O	of	_	0	SENT_31	[p2l467t1181r536b1237],
4	proteins	NNS	O	protein	prep_of	2	SENT_31	[p2l565t1181r820b1254],
5	implicated	VBN	O	implicate	partmod	4	SENT_31	[p2l857t1181r1194b1254],
6	in	IN	O	in	_	0	SENT_31	[p2l1229t1181r1289b1237],
7	these	DT	O	these	det	8	SENT_31	[p2l1324t1181r1486b1238],
8	processes	NNS	O	process	nsubj	10	SENT_31	[p2l1521t1199r1825b1254],
9	have	VBP	O	have	aux	10	SENT_31	[p2l1861t1181r2011b1238],
10	become	VBN	O	become	prepc_in	5	SENT_31	[p2l2045t1181r2144b1237, p2l9t1283r180b1322],
11	known	VBN	O	know	dep	10	SENT_31	[p2l213t1265r430b1322],
12	as	IN	O	as	_	0	SENT_31	[p2l466t1283r527b1322],
13	resistance	NN	O	resistance	nn	16	SENT_31	[p2l561t1265r1122b1322],
14	—	NN	O	—	nn	16	SENT_31	[p2l561t1265r1122b1322],
15	related	JJ	O	related	amod	16	SENT_31	[p2l561t1265r1122b1322],
16	proteins	NNS	O	protein	prep_as	11	SENT_31	[p2l1154t1265r1525b1338],
17	.5	CD	NUMBER	.5	number	18	SENT_31	[p2l1154t1265r1525b1338],
18	—	CD	NUMBER	—	num	19	SENT_31	[p2l1154t1265r1525b1338],
19	9	CD	NUMBER	9	dobj	11	SENT_31	[p2l1154t1265r1525b1338],
20	These	DT	O	these	nsubj	21	SENT_31	[p2l1559t1266r1749b1322],
21	include	VBP	O	include	ccomp	10	SENT_31	[p2l1783t1265r2016b1322],
22	the	DT	O	the	det	29	SENT_31	[p2l2050t1266r2146b1322],
23	efﬂux	NN	O	efﬂux	nn	29	SENT_31	[p2l9t1350r193b1406],
24	pumps	NNS	O	pump	nn	29	SENT_31	[p2l235t1367r465b1423],
25	,	,	O	,	_	0	SENT_31	[p2l235t1367r465b1423],
26	P-glycoprotein	NN	O	p-glycoprotein	dep	29	SENT_31	[p2l511t1350r986b1423],
27	170	CD	NUMBER	170	num	29	SENT_31	[p2l1036t1350r1146b1406],
28	(	NN	O	(	nn	29	SENT_31	[p2l1192t1350r1430b1419],
29	P	NN	O	p	nsubj	32	SENT_31	[p2l1192t1350r1430b1419],
30	—	CD	NUMBER	—	num	32	SENT_31	[p2l1192t1350r1430b1419],
31	l70	NN	O	l70	nn	32	SENT_31	[p2l1192t1350r1430b1419],
32	)	NN	O	)	xcomp	21	SENT_31	[p2l1192t1350r1430b1419],
33	and	CC	O	and	_	0	SENT_31	[p2l1477t1350r1589b1406],
34	multidrugresistance-associated	JJ	O	multidrugresistance-associated	amod	47	SENT_31	[p2l1632t1350r2144b1423, p2l8t1434r533b1490],
35	protein	NN	O	protein	nn	47	SENT_31	[p2l561t1434r787b1507],
36	(	CD	NUMBER	(	num	47	SENT_31	[p2l820t1434r1028b1503],
37	MRP	NN	ORGANIZATION	mrp	nn	47	SENT_31	[p2l820t1434r1028b1503],
38	,	,	O	,	_	0	SENT_31	[p2l820t1434r1028b1503],
39	glutathione-conjugate	NN	O	glutathione-conjugate	dep	47	SENT_31	[p2l1062t1434r1758b1507],
40	pump	NN	O	pump	nn	47	SENT_31	[p2l1788t1434r2141b1507],
41	)	CD	NUMBER	)	num	47	SENT_31	[p2l1788t1434r2141b1507],
42	.1	CD	NUMBER	.1	num	47	SENT_31	[p2l1788t1434r2141b1507],
43	°	NN	O	°	nn	47	SENT_31	[p2l1788t1434r2141b1507],
44	»	CD	NUMBER	»	num	47	SENT_31	[p2l1788t1434r2141b1507],
45	11	CD	NUMBER	11	num	47	SENT_31	[p2l1788t1434r2141b1507],
46	Altered	JJ	O	altered	amod	47	SENT_31	[p2l8t1518r248b1574],
47	target	NN	O	target	dep	48	SENT_31	[p2l279t1526r460b1591],
48	proteins	NNS	O	protein	conj_and	10	SENT_31	[p2l489t1518r745b1591],
49	include	VBP	O	include	dep	62	SENT_31	[p2l778t1518r1012b1574],
50	topoisomerase	NN	O	topoisomerase	nsubj	58	SENT_31	[p2l1044t1518r1505b1591],
51	II	CD	NUMBER	ii	num	50	SENT_31	[p2l1537t1519r1588b1573],
52	and	CC	O	and	_	0	SENT_31	[p2l1622t1518r1734b1574],
53	thymidylate	JJ	O	thymidylate	amod	54	SENT_31	[p2l1765t1518r2146b1591],
54	synthetase	NN	O	synthetase	nsubj	58	SENT_31	[p2l11t1603r387b1676],
55	.5	CD	NUMBER	.5	num	58	SENT_31	[p2l11t1603r387b1676],
56	DNA	NN	O	dna	nn	58	SENT_31	[p2l423t1604r595b1659],
57	repair	NN	O	repair	nn	58	SENT_31	[p2l627t1603r815b1676],
58	enzymes	NNS	O	enzyme	xcomp	49	SENT_31	[p2l847t1621r1123b1676],
59	involved	VBN	O	involve	partmod	58	SENT_31	[p2l1159t1603r1438b1659],
60	in	IN	O	in	_	0	SENT_31	[p2l1471t1603r1531b1659],
61	resistance	NN	O	resistance	prep_in	59	SENT_31	[p2l1564t1603r1878b1659],
62	include	VBP	O	include	_	0	SENT_31	[p2l1912t1603r2146b1659],
63	O6	NN	O	o6	dobj	62	SENT_31	[p2l10t1676r345b1761],
64	—	CD	NUMBER	—	num	66	SENT_31	[p2l10t1676r345b1761],
65	methyl	NN	O	methyl	nn	66	SENT_31	[p2l10t1676r345b1761],
66	guanine	NN	O	guanine	nsubj	62	SENT_31	[p2l390t1688r842b1761],
67	.	.	O	.	_	0	SENT_31	[p2l390t1688r842b1761],

1	—	NN	O	—	_	0	SENT_32	[p2l390t1688r842b1761],
2	.	.	O	.	_	0	SENT_32	[p2l390t1688r842b1761],

1	DNA	NN	O	dna	nn	2	SENT_33	[p2l390t1688r842b1761],
2	methyltransferase	NN	O	methyltransferase	_	0	SENT_33	[p2l886t1688r1454b1761],
3	that	WDT	O	that	nsubj	4	SENT_33	[p2l1498t1688r1618b1744],
4	removes	VBZ	O	remove	rcmod	2	SENT_33	[p2l1660t1706r1929b1744],
5	druginduced	JJ	O	druginduced	amod	6	SENT_33	[p2l1975t1688r2144b1761, p2l8t1773r261b1829],
6	lesions	NNS	O	lesion	dobj	4	SENT_33	[p2l292t1772r511b1829],
7	in	IN	O	in	_	0	SENT_33	[p2l544t1773r604b1828],
8	the	DT	O	the	det	11	SENT_33	[p2l636t1773r731b1829],
9	O6	NN	O	o6	nn	11	SENT_33	[p2l764t1760r1136b1845],
10	—	NN	O	—	nn	11	SENT_33	[p2l764t1760r1136b1845],
11	position	NN	O	position	prep_in	4	SENT_33	[p2l764t1760r1136b1845],
12	of	IN	O	of	_	0	SENT_33	[p2l1168t1772r1237b1829],
13	guanine	NN	O	guanine	prep_of	11	SENT_33	[p2l1264t1773r1593b1845],
14	.	.	O	.	_	0	SENT_33	[p2l1264t1773r1593b1845],

1	”	NN	O	”	tmod	14	SENT_34	[p2l1264t1773r1593b1845],
2	The	DT	O	the	det	4	SENT_34	[p2l1624t1773r1747b1829],
3	detoxifying	VBG	O	detoxify	amod	4	SENT_34	[p2l1779t1772r2146b1845],
4	enzymes	NNS	O	enzyme	nsubj	8	SENT_34	[p2l9t1875r285b1931],
5	that	WDT	O	that	nsubjpass	7	SENT_34	[p2l307t1858r426b1914],
6	are	VBP	O	be	auxpass	7	SENT_34	[p2l446t1875r540b1914],
7	involved	VBN	O	involve	rcmod	4	SENT_34	[p2l560t1858r840b1914],
8	include	VBP	O	include	rcmod	1	SENT_34	[p2l859t1858r1092b1914],
9	glutathione-dependent	JJ	O	glutathione-dependent	amod	10	SENT_34	[p2l1113t1858r1829b1931],
10	enzymes	NNS	O	enzyme	dobj	8	SENT_34	[p2l1848t1875r2143b1931],
11	,	,	O	,	_	0	SENT_34	[p2l1848t1875r2143b1931],
12	glutathione	NN	O	glutathione	nn	13	SENT_34	[p2l9t1942r367b2015],
13	transferases	NNS	O	transferase	nsubj	14	SENT_34	[p2l396t1942r771b1998],
14	(	VBP	O	(	_	0	SENT_34	[p2l804t1942r1060b2011],
15	GST	NN	O	gst	dobj	14	SENT_34	[p2l804t1942r1060b2011],
16	)	CD	NUMBER	)	number	17	SENT_34	[p2l804t1942r1060b2011],
17	13	CD	NUMBER	13	dep	15	SENT_34	[p2l804t1942r1060b2011],
18	and	CC	O	and	_	0	SENT_34	[p2l1093t1942r1205b1998],
19	glutathione	NN	O	glutathione	nn	20	SENT_34	[p2l1235t1942r1593b2015],
20	peroxidase	NN	O	peroxidase	dobj	14	SENT_34	[p2l1620t1942r2015b2015],
21	?	.	O	?	_	0	SENT_34	[p2l1620t1942r2015b2015],

1	The	DT	O	the	det	4	SENT_35	[p2l89t2041r211b2098],
2	major	JJ	O	major	amod	4	SENT_35	[p2l252t2041r438b2114],
3	cytosolic	JJ	O	cytosolic	amod	4	SENT_35	[p2l478t2041r763b2114],
4	isoforms	NNS	O	isoform	nsubjpass	9	SENT_35	[p2l805t2041r1082b2098],
5	of	IN	O	of	_	0	SENT_35	[p2l1125t2041r1194b2098],
6	GST	NN	O	gst	nn	7	SENT_35	[p2l1230t2042r1379b2098],
7	s	NNS	O	s	prep_of	4	SENT_35	[p2l1384t2059r1408b2098],
8	are	VBP	O	be	auxpass	9	SENT_35	[p2l1452t2059r1546b2098],
9	grouped	VBN	O	group	_	0	SENT_35	[p2l1587t2042r1848b2114],
10	into	IN	O	into	_	0	SENT_35	[p2l1888t2041r2009b2098],
11	the	DT	O	the	det	15	SENT_35	[p2l2050t2042r2146b2098],
12	Alpha	NN	O	alpha	nn	15	SENT_35	[p2l8t2126r204b2199],
13	(	NN	O	(	nn	15	SENT_35	[p2l242t2126r366b2195],
14	A	NN	O	a	nn	15	SENT_35	[p2l242t2126r366b2195],
15	)	NN	O	)	prep_into	9	SENT_35	[p2l242t2126r366b2195],
16	,	,	O	,	_	0	SENT_35	[p2l242t2126r366b2195],
17	Mu	NN	O	mu	nn	20	SENT_35	[p2l406t2127r515b2182],
18	(	CD	NUMBER	(	num	20	SENT_35	[p2l556t2126r693b2195],
19	M	NN	O	m	nn	20	SENT_35	[p2l556t2126r693b2195],
20	)	NN	O	)	prep_into	9	SENT_35	[p2l556t2126r693b2195],
21	,	,	O	,	_	0	SENT_35	[p2l556t2126r693b2195],
22	Pi	NN	O	pi	nn	25	SENT_35	[p2l733t2126r798b2181],
23	(	NN	O	(	nn	25	SENT_35	[p2l838t2126r929b2195],
24	P	NN	O	p	nn	25	SENT_35	[p2l838t2126r929b2195],
25	)	NN	O	)	prep_into	9	SENT_35	[p2l838t2126r929b2195],
26	and	CC	O	and	_	0	SENT_35	[p2l971t2126r1083b2182],
27	Theta	NNP	O	Theta	nn	29	SENT_35	[p2l1120t2126r1302b2182],
28	(	CD	NUMBER	(	num	29	SENT_35	[p2l1341t2126r1436b2195],
29	T	NN	O	t	prep_into	9	SENT_35	[p2l1341t2126r1436b2195],
30	)	CD	NUMBER	)	num	31	SENT_35	[p2l1341t2126r1436b2195],
31	classes	NNS	O	class	dep	29	SENT_35	[p2l1477t2126r1695b2182],
32	according	VBG	O	accord	_	0	SENT_35	[p2l1736t2126r2047b2199],
33	to	TO	O	to	prepc_according_to	9	SENT_35	[p2l2086t2134r2145b2182],
34	structural	JJ	O	structural	amod	37	SENT_35	[p2l11t2210r309b2266],
35	and	CC	O	and	_	0	SENT_35	[p2l344t2210r456b2266],
36	catalytic	JJ	O	catalytic	conj_and	34	SENT_35	[p2l489t2210r757b2283],
37	properties	NNS	O	property	pobj	9	SENT_35	[p2l789t2210r1187b2283],
38	.	.	O	.	_	0	SENT_35	[p2l789t2210r1187b2283],

1	”	NN	O	”	nn	3	SENT_36	[p2l789t2210r1187b2283],
2	GST	NN	O	gst	nn	3	SENT_36	[p2l1221t2210r1369b2266],
3	Alpha	NN	O	alpha	nsubjpass	6	SENT_36	[p2l1401t2210r1597b2283],
4	is	VBZ	O	be	auxpass	6	SENT_36	[p2l1628t2210r1677b2266],
5	constitutively	RB	O	constitutively	advmod	6	SENT_36	[p2l1712t2210r2146b2283],
6	expressed	VBN	O	express	dep	29	SENT_36	[p2l9t2295r323b2368],
7	in	IN	O	in	_	0	SENT_36	[p2l344t2295r404b2351],
8	human	JJ	O	human	amod	9	SENT_36	[p2l425t2295r642b2351],
9	livers	NNS	O	liver	prep_in	6	SENT_36	[p2l663t2295r856b2362],
10	,	,	O	,	_	0	SENT_36	[p2l663t2295r856b2362],
11	whilst	IN	O	whilst	mark	16	SENT_36	[p2l881t2295r1075b2352],
12	GST	NN	MISC	gst	nn	13	SENT_36	[p2l1096t2296r1245b2352],
13	Mu	NN	MISC	mu	nsubjpass	16	SENT_36	[p2l1266t2297r1375b2351],
14	is	VBZ	O	be	auxpass	16	SENT_36	[p2l1396t2295r1446b2351],
15	variably	RB	O	variably	advmod	16	SENT_36	[p2l1469t2295r1729b2368],
16	expressed	VBN	O	express	dep	6	SENT_36	[p2l1752t2295r2066b2368],
17	in	IN	O	in	_	0	SENT_36	[p2l2086t2295r2147b2351],
18	human	JJ	O	human	amod	19	SENT_36	[p2l8t2382r225b2438],
19	tissues	NNS	O	tissue	prep_in	16	SENT_36	[p2l246t2382r607b2438],
20	.15	CD	NUMBER	.15	number	21	SENT_36	[p2l246t2382r607b2438],
21	’16	CD	NUMBER	’16	num	23	SENT_36	[p2l246t2382r607b2438],
22	GST	NN	O	gst	nn	23	SENT_36	[p2l630t2382r778b2438],
23	Pl-l	NN	O	pl-l	dep	16	SENT_36	[p2l799t2382r942b2437],
24	is	VBZ	O	be	cop	29	SENT_36	[p2l970t2382r1019b2438],
25	the	DT	O	the	det	29	SENT_36	[p2l1042t2382r1138b2438],
26	most	RBS	O	most	advmod	27	SENT_36	[p2l1159t2391r1314b2438],
27	abundant	JJ	O	abundant	amod	29	SENT_36	[p2l1336t2382r1627b2438],
28	GST	NN	O	gst	nn	29	SENT_36	[p2l1648t2382r1797b2438],
29	isoform	NN	O	isoform	_	0	SENT_36	[p2l1817t2382r2066b2438],
30	in	IN	O	in	_	0	SENT_36	[p2l2086t2382r2147b2437],
31	human	JJ	O	human	amod	33	SENT_36	[p2l8t2467r225b2524],
32	erythrocytes	NNS	O	erythrocyte	nn	33	SENT_36	[p2l256t2467r707b2540],
33	”	NN	O	”	prep_in	29	SENT_36	[p2l256t2467r707b2540],
34	and	CC	O	and	_	0	SENT_36	[p2l741t2468r854b2524],
35	is	VBZ	O	be	auxpass	38	SENT_36	[p2l884t2467r934b2524],
36	also	RB	O	also	advmod	38	SENT_36	[p2l969t2467r1093b2524],
37	in	IN	O	in	advmod	38	SENT_36	[p2l1125t2467r1186b2523],
38	expressed	VBN	O	express	conj_and	29	SENT_36	[p2l1218t2467r1532b2540],
39	human	JJ	O	human	amod	40	SENT_36	[p2l1562t2468r1779b2524],
40	skin	NN	O	skin	dobj	38	SENT_36	[p2l1813t2467r2017b2534],
41	,18	CD	NUMBER	,18	dobj	29	SENT_36	[p2l1813t2467r2017b2534],
42	the	DT	O	the	det	43	SENT_36	[p2l2050t2468r2146b2524],
43	iris	NN	O	iris	nsubjpass	38	SENT_36	[p2l8t2553r107b2609],
44	of	IN	O	of	_	0	SENT_36	[p2l131t2553r200b2609],
45	the	DT	O	the	det	46	SENT_36	[p2l215t2553r310b2609],
46	eye19	NN	O	eye19	prep_of	43	SENT_36	[p2l332t2553r497b2626],
47	and	CC	O	and	_	0	SENT_36	[p2l521t2553r634b2609],
48	human	JJ	O	human	amod	49	SENT_36	[p2l653t2553r870b2609],
49	kidney	NN	O	kidney	prep_of	43	SENT_36	[p2l890t2553r1185b2626],
50	?	.	O	?	_	0	SENT_36	[p2l890t2553r1185b2626],

1	”	NN	O	”	dep	108	SENT_37	[p2l890t2553r1185b2626],
2	There	EX	O	there	dep	108	SENT_37	[p2l1205t2553r1390b2609],
3	is	VBZ	O	be	dep	108	SENT_37	[p2l1411t2553r1460b2609],
4	a	DT	O	a	dep	108	SENT_37	[p2l1485t2571r1518b2609],
5	general	JJ	O	general	dep	108	SENT_37	[p2l1538t2553r1771b2626],
6	association	NN	O	association	dep	108	SENT_37	[p2l1793t2553r2147b2609],
7	between	IN	O	between	dep	108	SENT_37	[p2l7t2640r274b2696],
8	increased	VBN	O	increase	dep	108	SENT_37	[p2l316t2640r618b2696],
9	GST	NN	O	gst	dep	108	SENT_37	[p2l661t2640r809b2696],
10	expression	NN	O	expression	dep	108	SENT_37	[p2l852t2640r1192b2713],
11	and	CC	O	and	dep	108	SENT_37	[p2l1236t2640r1349b2696],
12	drug	NN	O	drug	dep	108	SENT_37	[p2l1391t2640r1535b2713],
13	resistance	NN	O	resistance	dep	108	SENT_37	[p2l1577t2640r1965b2706],
14	,	,	O	,	_	0	SENT_37	[p2l1577t2640r1965b2706],
15	”	CD	NUMBER	”	dep	108	SENT_37	[p2l1577t2640r1965b2706],
16	e.	NN	O	e.	dep	108	SENT_37	[p2l2014t2659r2058b2696],
17	g.	NN	O	g.	dep	108	SENT_37	[p2l2067t2659r2138b2712],
18	,	,	O	,	_	0	SENT_37	[p2l2067t2659r2138b2712],
19	GST	NN	ORGANIZATION	gst	dep	108	SENT_37	[p2l10t2726r158b2782],
20	Alpha	NN	ORGANIZATION	alpha	dep	108	SENT_37	[p2l204t2725r399b2798],
21	has	VBZ	O	have	dep	108	SENT_37	[p2l444t2725r547b2782],
22	been	VBN	O	be	dep	108	SENT_37	[p2l594t2725r745b2782],
23	linked	VBN	O	link	dep	108	SENT_37	[p2l791t2725r990b2781],
24	to	TO	O	to	dep	108	SENT_37	[p2l1036t2734r1095b2781],
25	drug	NN	O	drug	dep	108	SENT_37	[p2l1143t2725r1286b2798],
26	resistance	NN	O	resistance	dep	108	SENT_37	[p2l1333t2725r1647b2782],
27	with	IN	O	with	dep	108	SENT_37	[p2l1694t2725r1835b2782],
28	nitrogen	NN	O	nitrogen	dep	108	SENT_37	[p2l1881t2725r2146b2798],
29	mustards	NNS	O	mustard	dep	108	SENT_37	[p2l8t2812r444b2878],
30	,22	CD	NUMBER	,22	dep	108	SENT_37	[p2l8t2812r444b2878],
31	»	CD	NUMBER	»	dep	108	SENT_37	[p2l8t2812r444b2878],
32	23	CD	NUMBER	23	dep	108	SENT_37	[p2l8t2812r444b2878],
33	GST	NN	MISC	gst	dep	108	SENT_37	[p2l472t2812r620b2868],
34	Mu	NN	MISC	mu	dep	108	SENT_37	[p2l645t2813r754b2868],
35	with	IN	O	with	dep	108	SENT_37	[p2l779t2812r920b2868],
36	nitrosoureas24	NN	O	nitrosoureas24	dep	108	SENT_37	[p2l944t2812r1392b2868],
37	and	CC	O	and	dep	108	SENT_37	[p2l1418t2812r1531b2868],
38	GST	NN	MISC	gst	dep	108	SENT_37	[p2l1556t2812r1704b2868],
39	Pi	NN	MISC	pi	dep	108	SENT_37	[p2l1729t2812r1793b2867],
40	with	IN	O	with	dep	108	SENT_37	[p2l1819t2812r1960b2868],
41	alkylating	JJ	O	alkylating	dep	108	SENT_37	[p2l1985t2812r2144b2885, p2l9t2897r188b2970],
42	agents	NNS	O	agent	dep	108	SENT_37	[p2l216t2897r493b2970],
43	.25	CD	NUMBER	.25	dep	108	SENT_37	[p2l216t2897r493b2970],
44	Increased	VBN	O	increase	dep	108	SENT_37	[p2l520t2898r826b2954],
45	GST	NN	O	gst	dep	108	SENT_37	[p2l852t2898r1000b2954],
46	levels	NNS	O	level	dep	108	SENT_37	[p2l1026t2897r1209b2954],
47	have	VBP	O	have	dep	108	SENT_37	[p2l1235t2898r1385b2954],
48	been	VBN	O	be	dep	108	SENT_37	[p2l1409t2898r1560b2954],
49	suggested	VBN	O	suggest	dep	108	SENT_37	[p2l1588t2898r1900b2970],
50	to	TO	O	to	dep	108	SENT_37	[p2l1925t2906r1984b2954],
51	play	VB	O	play	dep	108	SENT_37	[p2l2009t2897r2146b2970],
52	a	DT	O	a	dep	108	SENT_37	[p2l10t3001r43b3039],
53	role	NN	O	role	dep	108	SENT_37	[p2l71t2983r194b3039],
54	in	IN	O	in	dep	108	SENT_37	[p2l224t2983r285b3039],
55	determining	VBG	O	determine	dep	108	SENT_37	[p2l315t2983r699b3056],
56	the	DT	O	the	dep	108	SENT_37	[p2l730t2983r825b3039],
57	decreased	VBN	O	decrease	dep	108	SENT_37	[p2l856t2983r1170b3039],
58	sensitivity	NN	O	sensitivity	dep	108	SENT_37	[p2l1202t2983r1527b3056],
59	of	IN	O	of	dep	108	SENT_37	[p2l1558t2983r1627b3039],
60	tumour	NN	O	tumour	dep	108	SENT_37	[p2l1652t2991r1883b3039],
61	cells	NNS	O	cell	dep	108	SENT_37	[p2l1912t2983r2055b3039],
62	to	TO	O	to	dep	108	SENT_37	[p2l2086t2992r2145b3039],
63	alkylating	JJ	O	alkylating	dep	108	SENT_37	[p2l10t3070r326b3143],
64	agents	NNS	O	agent	dep	108	SENT_37	[p2l360t3078r559b3143],
65	such	JJ	O	such	dep	108	SENT_37	[p2l594t3070r737b3126],
66	as	IN	O	as	dep	108	SENT_37	[p2l769t3087r830b3126],
67	chlorambucil,26-29	JJ	O	chlorambucil,26-29	dep	108	SENT_37	[p2l863t3069r1454b3136],
68	acrolein3	NN	O	acrolein3	dep	108	SENT_37	[p2l1487t3070r1800b3126],
69	°	NN	O	°	dep	108	SENT_37	[p2l1487t3070r1800b3126],
70	and	CC	O	and	dep	108	SENT_37	[p2l1832t3070r1945b3126],
71	ifosfamide	NN	O	ifosfamide	dep	108	SENT_37	[p2l1974t3070r2144b3126, p2l10t3155r275b3212],
72	.31	CD	NUMBER	.31	dep	108	SENT_37	[p2l1974t3070r2144b3126, p2l10t3155r275b3212],
73	GST	NN	MISC	gst	dep	108	SENT_37	[p2l304t3156r452b3212],
74	Pl-l	NN	MISC	pl-l	dep	108	SENT_37	[p2l474t3156r616b3211],
75	is	VBZ	O	be	dep	108	SENT_37	[p2l646t3155r695b3211],
76	also	RB	O	also	dep	108	SENT_37	[p2l720t3155r845b3211],
77	the	DT	O	the	dep	108	SENT_37	[p2l868t3155r964b3211],
78	most	RBS	O	most	dep	108	SENT_37	[p2l986t3164r1141b3211],
79	prevalent	JJ	O	prevalent	dep	108	SENT_37	[p2l1161t3155r1460b3228],
80	isoform	NN	O	isoform	dep	108	SENT_37	[p2l1480t3155r1729b3211],
81	expressed	VBN	O	express	dep	108	SENT_37	[p2l1751t3155r2065b3228],
82	in	IN	O	in	dep	108	SENT_37	[p2l2086t3155r2147b3211],
83	tumour	NN	O	tumour	dep	108	SENT_37	[p2l8t3250r239b3298],
84	cell	NN	O	cell	dep	108	SENT_37	[p2l263t3242r376b3298],
85	lines	NNS	O	line	dep	108	SENT_37	[p2l401t3242r548b3298],
86	and	CC	O	and	dep	108	SENT_37	[p2l576t3242r688b3298],
87	neoplastic	JJ	O	neoplastic	dep	108	SENT_37	[p2l712t3242r1034b3315],
88	tissues21a32a33	NN	O	tissues21a32a33	dep	108	SENT_37	[p2l1059t3242r1472b3298],
89	and	CC	O	and	dep	108	SENT_37	[p2l1500t3242r1613b3298],
90	may	MD	O	may	dep	108	SENT_37	[p2l1636t3260r1772b3315],
91	be	VB	O	be	dep	108	SENT_37	[p2l1796t3242r1870b3298],
92	a	DT	O	a	dep	108	SENT_37	[p2l1896t3260r1929b3298],
93	useful	JJ	O	useful	dep	108	SENT_37	[p2l1952t3242r2146b3298],
94	marker	NN	O	marker	dep	108	SENT_37	[p2l8t3328r235b3384],
95	for	IN	O	for	dep	108	SENT_37	[p2l259t3327r352b3384],
96	clinical	JJ	O	clinical	dep	108	SENT_37	[p2l377t3327r610b3384],
97	resistance	NN	O	resistance	dep	108	SENT_37	[p2l635t3327r950b3384],
98	to	TO	O	to	dep	108	SENT_37	[p2l975t3336r1034b3384],
99	cytostatic	JJ	O	cytostatic	dep	108	SENT_37	[p2l1062t3327r1365b3400],
100	drugs	NNS	O	drug	dep	108	SENT_37	[p2l1393t3328r1566b3400],
101	in	IN	O	in	dep	108	SENT_37	[p2l1594t3327r1654b3383],
102	different	JJ	O	different	dep	108	SENT_37	[p2l1681t3327r1955b3384],
103	types	NNS	O	type	dep	108	SENT_37	[p2l1979t3336r2145b3400],
104	of	IN	O	of	dep	108	SENT_37	[p2l9t3413r78b3469],
105	cancers	NNS	O	cancer	dep	108	SENT_37	[p2l103t3413r510b3469],
106	.34	CD	NUMBER	.34	dep	108	SENT_37	[p2l103t3413r510b3469],
107	—	CD	NUMBER	—	dep	108	SENT_37	[p2l103t3413r510b3469],
108	33	CD	NUMBER	33	_	0	SENT_37	[p2l103t3413r510b3469],

1	Drug	NN	O	drug	dep	117	SENT_38	[p3l88t31r250b102],
2	resistance	NN	O	resistance	dep	117	SENT_38	[p3l276t29r591b85],
3	in	IN	O	in	dep	117	SENT_38	[p3l617t29r677b85],
4	cancer	NN	O	cancer	dep	117	SENT_38	[p3l703t47r911b86],
5	cells	NNS	O	cell	dep	117	SENT_38	[p3l936t29r1078b85],
6	can	MD	O	can	dep	117	SENT_38	[p3l1107t47r1215b85],
7	be	VB	O	be	dep	117	SENT_38	[p3l1239t29r1314b85],
8	overcome	VBN	O	overcome	dep	117	SENT_38	[p3l1341t47r1654b86],
9	by	IN	O	by	dep	117	SENT_38	[p3l1678t29r1757b102],
10	administration	NN	O	administration	dep	117	SENT_38	[p3l1785t29r2144b86, p3l8t116r131b172],
11	of	IN	O	of	dep	117	SENT_38	[p3l171t116r239b172],
12	a	DT	O	a	dep	117	SENT_38	[p3l274t134r308b172],
13	nontoxic	JJ	O	nontoxic	dep	117	SENT_38	[p3l344t116r622b172],
14	reversing	VBG	O	reverse	dep	117	SENT_38	[p3l661t116r957b189],
15	agent	NN	O	agent	dep	117	SENT_38	[p3l998t124r1169b189],
16	together	RB	O	together	dep	117	SENT_38	[p3l1206t116r1469b189],
17	with	IN	O	with	dep	117	SENT_38	[p3l1506t116r1646b172],
18	the	DT	O	the	dep	117	SENT_38	[p3l1684t116r1780b172],
19	anticancer	JJ	O	anticancer	dep	117	SENT_38	[p3l1820t116r2148b172],
20	agent	NN	O	agent	dep	117	SENT_38	[p3l10t202r257b274],
21	.39	CD	NUMBER	.39	dep	117	SENT_38	[p3l10t202r257b274],
22	This	DT	O	this	dep	117	SENT_38	[p3l291t201r430b258],
23	co-administration	NN	O	co-administration	dep	117	SENT_38	[p3l466t201r1029b258],
24	of	IN	O	of	dep	117	SENT_38	[p3l1063t201r1132b258],
25	an	DT	O	a	dep	117	SENT_38	[p3l1162t219r1234b258],
26	anticancer	JJ	O	anticancer	dep	117	SENT_38	[p3l1269t201r1596b258],
27	agent	NN	O	agent	dep	117	SENT_38	[p3l1630t210r1800b274],
28	and	CC	O	and	dep	117	SENT_38	[p3l1834t201r1947b258],
29	a	DT	O	a	dep	117	SENT_38	[p3l1981t219r2014b258],
30	chemomodulator	NN	O	chemomodulator	dep	117	SENT_38	[p3l2047t201r2144b258, p3l9t287r476b343],
31	has	VBZ	O	have	dep	117	SENT_38	[p3l495t287r599b343],
32	been	VBN	O	be	dep	117	SENT_38	[p3l621t287r772b343],
33	shown	VBN	O	show	dep	117	SENT_38	[p3l796t287r1001b344],
34	to	TO	O	to	dep	117	SENT_38	[p3l1022t296r1081b343],
35	increase	VB	O	increase	dep	117	SENT_38	[p3l1104t287r1364b343],
36	the	DT	O	the	dep	117	SENT_38	[p3l1386t287r1482b343],
37	therapeutic	JJ	O	therapeutic	dep	117	SENT_38	[p3l1504t287r1857b360],
38	effect	NN	O	effect	dep	117	SENT_38	[p3l1880t287r2061b343],
39	of	IN	O	of	dep	117	SENT_38	[p3l2083t287r2152b343],
40	the	DT	O	the	dep	117	SENT_38	[p3l8t374r104b430],
41	drug	NN	O	drug	dep	117	SENT_38	[p3l144t374r477b447],
42	.1	NN	NUMBER	.1	dep	117	SENT_38	[p3l144t374r477b447],
43	v40	NN	O	v40	dep	117	SENT_38	[p3l144t374r477b447],
44	’41	CD	NUMBER	’41	dep	117	SENT_38	[p3l144t374r477b447],
45	The	DT	O	the	dep	117	SENT_38	[p3l521t374r643b430],
46	antimalarial	JJ	O	antimalarial	dep	117	SENT_38	[p3l684t373r1063b430],
47	drugs	NNS	O	drug	dep	117	SENT_38	[p3l1103t374r1295b446],
48	,	,	O	,	_	0	SENT_38	[p3l1103t374r1295b446],
49	quinine	NN	O	quinine	dep	117	SENT_38	[p3l1338t373r1576b446],
50	and	CC	O	and	dep	117	SENT_38	[p3l1616t373r1729b430],
51	meﬂoquine	NN	O	meﬂoquine	dep	117	SENT_38	[p3l1767t373r2143b446],
52	,	,	O	,	_	0	SENT_38	[p3l1767t373r2143b446],
53	have	VBP	O	have	dep	117	SENT_38	[p3l8t459r157b515],
54	been	VBN	O	be	dep	117	SENT_38	[p3l193t459r344b515],
55	used	VBN	O	use	dep	117	SENT_38	[p3l379t459r526b515],
56	in	IN	O	in	dep	117	SENT_38	[p3l562t459r622b515],
57	clinical	JJ	O	clinical	dep	117	SENT_38	[p3l659t459r892b515],
58	trials	NNS	O	trial	dep	117	SENT_38	[p3l929t459r1086b515],
59	as	IN	O	as	dep	117	SENT_38	[p3l1126t477r1187b515],
60	potential	JJ	O	potential	dep	117	SENT_38	[p3l1224t459r1504b532],
61	drugs	NNS	O	drug	dep	117	SENT_38	[p3l1541t459r1715b532],
62	in	IN	O	in	dep	117	SENT_38	[p3l1753t459r1814b515],
63	reversing	VBG	O	reverse	dep	117	SENT_38	[p3l1849t459r2145b532],
64	multidrug	JJ	O	multidrug	dep	117	SENT_38	[p3l8t546r322b619],
65	resistance	NN	O	resistance	dep	117	SENT_38	[p3l346t546r661b602],
66	in	IN	O	in	dep	117	SENT_38	[p3l685t546r746b601],
67	cancer	NN	O	cancer	dep	117	SENT_38	[p3l771t563r979b602],
68	patients.8s41-44	NN	O	patients.8s41-44	dep	117	SENT_38	[p3l1001t546r1464b619],
69	Besides	IN	O	besides	dep	117	SENT_38	[p3l1489t546r1735b602],
70	their	PRP$	O	they	dep	117	SENT_38	[p3l1761t546r1907b602],
71	known	VBN	O	know	dep	117	SENT_38	[p3l1929t546r2147b602],
72	role	NN	O	role	dep	117	SENT_38	[p3l8t631r131b687],
73	as	IN	O	as	dep	117	SENT_38	[p3l161t649r222b687],
74	inhibitors	NNS	O	inhibitor	dep	117	SENT_38	[p3l253t631r557b688],
75	of	IN	O	of	dep	117	SENT_38	[p3l588t631r658b687],
76	P-glycoprotein	NN	O	p-glycoprotein	dep	117	SENT_38	[p3l681t631r1172b704],
77	,	,	O	,	_	0	SENT_38	[p3l681t631r1172b704],
78	these	DT	O	these	dep	117	SENT_38	[p3l1204t631r1367b687],
79	chemomodulators	NNS	O	chemomodulator	dep	117	SENT_38	[p3l1396t631r1967b688],
80	have	VBP	O	have	dep	117	SENT_38	[p3l1997t631r2146b688],
81	been	VBN	O	be	dep	117	SENT_38	[p3l7t718r158b774],
82	suggested	VBN	O	suggest	dep	117	SENT_38	[p3l195t718r508b791],
83	to	TO	O	to	dep	117	SENT_38	[p3l542t726r601b774],
84	have	VB	O	have	dep	117	SENT_38	[p3l637t718r786b774],
85	intracellular	JJ	O	intracellular	dep	117	SENT_38	[p3l821t718r1209b774],
86	protein	NN	O	protein	dep	117	SENT_38	[p3l1241t718r1467b791],
87	targets	NNS	O	target	dep	117	SENT_38	[p3l1502t726r1712b791],
88	that	WDT	O	that	dep	117	SENT_38	[p3l1749t718r1868b774],
89	may	MD	O	may	dep	117	SENT_38	[p3l1902t736r2037b791],
90	be	VB	O	be	dep	117	SENT_38	[p3l2072t718r2146b774],
91	involved	VBN	O	involve	dep	117	SENT_38	[p3l8t803r288b860],
92	in	IN	O	in	dep	117	SENT_38	[p3l307t803r368b859],
93	drug	NN	O	drug	dep	117	SENT_38	[p3l389t803r532b876],
94	distribution	NN	O	distribution	dep	117	SENT_38	[p3l554t803r997b860],
95	.45	CD	NUMBER	.45	dep	117	SENT_38	[p3l554t803r997b860],
96	GSTs	NNS	O	gst	dep	117	SENT_38	[p3l1020t804r1198b860],
97	have	VBP	O	have	dep	117	SENT_38	[p3l1220t803r1369b860],
98	the	DT	O	the	dep	117	SENT_38	[p3l1389t804r1485b860],
99	capacity	NN	O	capacity	dep	117	SENT_38	[p3l1507t803r1770b876],
100	to	TO	O	to	dep	117	SENT_38	[p3l1791t812r1851b860],
101	bind	VB	O	bind	dep	117	SENT_38	[p3l1871t803r2013b860],
102	and	CC	O	and	dep	117	SENT_38	[p3l2034t803r2147b860],
103	detoxify	VB	O	detoxify	dep	117	SENT_38	[p3l9t889r273b962],
104	many	JJ	O	many	dep	117	SENT_38	[p3l319t907r494b962],
105	drugs15	NN	O	drugs15	dep	117	SENT_38	[p3l541t889r772b962],
106	and	CC	O	and	dep	117	SENT_38	[p3l821t889r950b956],
107	,	,	O	,	_	0	SENT_38	[p3l821t889r950b956],
108	therefore	RB	O	therefore	dep	117	SENT_38	[p3l998t889r1303b956],
109	,	,	O	,	_	0	SENT_38	[p3l998t889r1303b956],
110	are	VBP	O	be	dep	117	SENT_38	[p3l1353t907r1446b945],
111	possible	JJ	O	possible	dep	117	SENT_38	[p3l1491t889r1753b962],
112	targets	NNS	O	target	dep	117	SENT_38	[p3l1798t897r2008b962],
113	for	IN	O	for	dep	117	SENT_38	[p3l2055t889r2148b945],
114	chemomodulation	NN	O	chemomodulation	dep	117	SENT_38	[p3l9t976r586b1032],
115	of	IN	O	of	dep	117	SENT_38	[p3l616t976r685b1032],
116	drug	NN	O	drug	dep	117	SENT_38	[p3l709t976r852b1049],
117	resistance	NN	O	resistance	_	0	SENT_38	[p3l881t976r1212b1032],
118	.	.	O	.	_	0	SENT_38	[p3l881t976r1212b1032],

1	In	IN	O	in	_	0	SENT_39	[p3l89t1077r154b1131],
2	cases	NNS	O	case	prep_in	19	SENT_39	[p3l186t1094r351b1132],
3	where	WRB	O	where	advmod	6	SENT_39	[p3l385t1076r578b1132],
4	GSTs	NNS	O	gst	nsubjpass	6	SENT_39	[p3l611t1076r789b1132],
5	are	VBP	O	be	auxpass	6	SENT_39	[p3l824t1094r918b1132],
6	thought	VBN	O	think	rcmod	2	SENT_39	[p3l950t1076r1195b1149],
7	to	TO	O	to	aux	8	SENT_39	[p3l1225t1085r1285b1132],
8	play	VB	O	play	xcomp	6	SENT_39	[p3l1317t1076r1453b1149],
9	a	DT	O	a	det	10	SENT_39	[p3l1487t1094r1520b1132],
10	role	NN	O	role	dobj	8	SENT_39	[p3l1550t1076r1673b1132],
11	in	IN	O	in	_	0	SENT_39	[p3l1706t1076r1766b1131],
12	drug	NN	O	drug	nn	13	SENT_39	[p3l1799t1076r1942b1149],
13	resistance	NN	O	resistance	prep_in	10	SENT_39	[p3l1974t1076r2144b1132, p3l8t1170r192b1228],
14	,	,	O	,	_	0	SENT_39	[p3l1974t1076r2144b1132, p3l8t1170r192b1228],
15	chemomodulation	NN	O	chemomodulation	nsubj	19	SENT_39	[p3l227t1161r804b1218],
16	of	IN	O	of	_	0	SENT_39	[p3l836t1161r906b1218],
17	therapy	NN	O	therapy	prep_of	15	SENT_39	[p3l931t1162r1169b1234],
18	could	MD	O	could	aux	19	SENT_39	[p3l1202t1161r1378b1218],
19	involve	VB	O	involve	_	0	SENT_39	[p3l1408t1161r1647b1218],
20	countering	VBG	O	counter	xcomp	19	SENT_39	[p3l1679t1161r2018b1234],
21	the	DT	O	the	det	24	SENT_39	[p3l2050t1162r2146b1218],
22	increased	VBN	O	increase	amod	24	SENT_39	[p3l8t1247r310b1303],
23	GST	NN	O	gst	nn	24	SENT_39	[p3l332t1247r480b1304],
24	activity	NN	O	activity	dobj	20	SENT_39	[p3l503t1247r756b1320],
25	.	.	O	.	_	0	SENT_39	[p3l503t1247r756b1320],

1	This	DT	O	this	nsubjpass	4	SENT_40	[p3l781t1247r920b1303],
2	might	MD	O	might	aux	4	SENT_40	[p3l943t1247r1129b1320],
3	be	VB	O	be	auxpass	4	SENT_40	[p3l1148t1247r1223b1303],
4	achieved	VBN	O	achieve	_	0	SENT_40	[p3l1246t1247r1528b1303],
5	by	IN	O	by	_	0	SENT_40	[p3l1548t1247r1626b1320],
6	using	VBG	O	use	agent	4	SENT_40	[p3l1648t1247r1819b1320],
7	inhibitors	NNS	O	inhibitor	dobj	6	SENT_40	[p3l1841t1247r2145b1303],
8	of	IN	O	of	_	0	SENT_40	[p3l9t1334r79b1390],
9	glutathione	NN	O	glutathione	nn	10	SENT_40	[p3l117t1334r475b1407],
10	synthesis46	NN	O	synthesis46	prep_of	7	SENT_40	[p3l520t1334r867b1407],
11	or	CC	O	or	_	0	SENT_40	[p3l911t1351r977b1390],
12	by	IN	O	by	_	0	SENT_40	[p3l1017t1334r1095b1407],
13	using	VBG	O	use	agent	4	SENT_40	[p3l1138t1334r1309b1407],
14	GST	NN	O	gst	nn	15	SENT_40	[p3l1355t1334r1503b1390],
15	inhibitors	NNS	O	inhibitor	dobj	13	SENT_40	[p3l1545t1334r1849b1390],
16	such	JJ	O	such	_	0	SENT_40	[p3l1896t1334r2039b1390],
17	as	IN	O	as	_	0	SENT_40	[p3l2083t1351r2144b1390],
18	ethacrynic	JJ	O	ethacrynic	amod	19	SENT_40	[p3l9t1419r339b1492],
19	acid	NN	O	acid	prep_such_as	15	SENT_40	[p3l381t1419r587b1476],
20	.47	CD	NUMBER	.47	num	19	SENT_40	[p3l381t1419r587b1476],
21	In	IN	O	in	_	0	SENT_40	[p3l627t1421r692b1475],
22	the	DT	O	the	det	23	SENT_40	[p3l731t1419r826b1476],
23	context	NN	O	context	prep_in	44	SENT_40	[p3l866t1428r1100b1475],
24	of	IN	O	of	_	0	SENT_40	[p3l1139t1419r1208b1475],
25	searching	VBG	O	search	prepc_of	23	SENT_40	[p3l1244t1419r1546b1492],
26	for	IN	O	for	_	0	SENT_40	[p3l1586t1419r1678b1475],
27	effective	JJ	O	effective	amod	31	SENT_40	[p3l1716t1419r1994b1476],
28	and	CC	O	and	_	0	SENT_40	[p3l2034t1419r2147b1475],
29	clinically	RB	O	clinically	advmod	30	SENT_40	[p3l9t1506r304b1579],
30	acceptable	JJ	O	acceptable	amod	31	SENT_40	[p3l348t1506r683b1579],
31	inhibitors	NNS	O	inhibitor	prep_for	25	SENT_40	[p3l725t1506r1029b1562],
32	that	WDT	O	that	nsubj	34	SENT_40	[p3l1072t1506r1192b1562],
33	may	MD	O	may	aux	34	SENT_40	[p3l1232t1524r1367b1579],
34	enhance	VB	O	enhance	rcmod	31	SENT_40	[p3l1411t1506r1670b1562],
35	the	DT	O	the	det	37	SENT_40	[p3l1712t1506r1808b1562],
36	cytotoxic	JJ	O	cytotoxic	amod	37	SENT_40	[p3l1851t1506r2145b1579],
37	effects	NNS	O	effect	dobj	34	SENT_40	[p3l9t1591r218b1648],
38	of	IN	O	of	_	0	SENT_40	[p3l247t1591r315b1648],
39	antineoplastic	JJ	O	antineoplastic	amod	40	SENT_40	[p3l337t1591r778b1664],
40	agents	NNS	O	agent	prep_of	37	SENT_40	[p3l806t1600r1024b1664],
41	,	,	O	,	_	0	SENT_40	[p3l806t1600r1024b1664],
42	we	PRP	O	we	nsubj	44	SENT_40	[p3l1053t1609r1144b1648],
43	have	VBP	O	have	aux	44	SENT_40	[p3l1169t1592r1318b1648],
44	investigated	VBN	O	investigate	rcmod	19	SENT_40	[p3l1344t1591r1730b1664],
45	the	DT	O	the	det	46	SENT_40	[p3l1755t1592r1850b1648],
46	effect	NN	O	effect	dobj	44	SENT_40	[p3l1877t1591r2058b1648],
47	of	IN	O	of	_	0	SENT_40	[p3l2083t1591r2152b1648],
48	antimalarials	NNS	O	antimalarial	prep_of	46	SENT_40	[p3l10t1677r419b1733],
49	on	IN	O	on	_	0	SENT_40	[p3l448t1695r526b1733],
50	human	JJ	O	human	amod	53	SENT_40	[p3l551t1677r768b1733],
51	recombinant	JJ	O	recombinant	amod	53	SENT_40	[p3l794t1677r1195b1733],
52	GST	NN	O	gst	nn	53	SENT_40	[p3l1221t1677r1369b1734],
53	activity	NN	O	activity	prep_on	48	SENT_40	[p3l1398t1677r1634b1750],
54	in	FW	O	in	nn	55	SENT_40	[p3l1664t1679r1720b1733],
55	vitro	FW	O	vitro	advmod	44	SENT_40	[p3l1748t1679r1909b1734],
56	.	.	O	.	_	0	SENT_40	[p3l1748t1679r1909b1734],

1	Activity	NN	O	activity	nsubjpass	5	SENT_41	[p3l1943t1677r2144b1733, p3l8t1764r90b1836],
2	of	IN	O	of	_	0	SENT_41	[p3l114t1764r184b1820],
3	GST	NN	O	gst	prep_of	1	SENT_41	[p3l202t1764r350b1820],
4	was	VBD	O	be	auxpass	5	SENT_41	[p3l373t1781r493b1820],
5	detected	VBN	O	detect	_	0	SENT_41	[p3l518t1764r783b1820],
6	in	FW	O	in	nn	7	SENT_41	[p3l807t1766r864b1820],
7	vitro	FW	O	vitro	advmod	5	SENT_41	[p3l887t1766r1035b1820],
8	using	VBG	O	use	xcomp	5	SENT_41	[p3l1058t1764r1229b1837],
9	various	JJ	O	various	amod	10	SENT_41	[p3l1253t1764r1485b1820],
10	substrates	NNS	O	substrate	dobj	8	SENT_41	[p3l1512t1764r1821b1820],
11	including	VBG	O	include	xcomp	8	SENT_41	[p3l1845t1764r2145b1837],
12	l-chloro-2	JJ	O	l-chloro-2	amod	13	SENT_41	[p3l16t1849r908b1916],
13	,4	NN	O	,4	dobj	11	SENT_41	[p3l16t1849r908b1916],
14	-	:	O	-	_	0	SENT_41	[p3l16t1849r908b1916],
15	dinitrobenzene	NN	O	dinitrobenzene	nn	18	SENT_41	[p3l16t1849r908b1916],
16	(	CD	NUMBER	(	num	18	SENT_41	[p3l931t1850r1220b1919],
17	CDNB	NN	O	cdnb	nn	18	SENT_41	[p3l931t1850r1220b1919],
18	)	NN	O	)	dep	23	SENT_41	[p3l931t1850r1220b1919],
19	,	,	O	,	_	0	SENT_41	[p3l931t1850r1220b1919],
20	ethacrynic	JJ	O	ethacrynic	amod	21	SENT_41	[p3l1244t1849r1574b1922],
21	acid	NN	O	acid	appos	18	SENT_41	[p3l1597t1849r1728b1906],
22	(	CD	NUMBER	(	num	23	SENT_41	[p3l1750t1849r2011b1919],
23	ETA	NNP	ORGANIZATION	ETA	dep	13	SENT_41	[p3l1750t1849r2011b1919],
24	)	CD	NUMBER	)	num	23	SENT_41	[p3l1750t1849r2011b1919],
25	48	CD	NUMBER	48	num	23	SENT_41	[p3l1750t1849r2011b1919],
26	and	CC	O	and	_	0	SENT_41	[p3l2034t1849r2147b1906],
27	l,3-bis	JJ	O	l,3-bis	amod	29	SENT_41	[p3l16t1936r1168b2009],
28	(	NN	O	(	nn	29	SENT_41	[p3l16t1936r1168b2009],
29	2-chloroethyl	NN	O	2-chloroethyl	conj_and	23	SENT_41	[p3l16t1936r1168b2009],
30	)	SYM	O	)	dep	13	SENT_41	[p3l16t1936r1168b2009],
31	-	:	O	-	_	0	SENT_41	[p3l16t1936r1168b2009],
32	l-nitrosourea	NN	O	l-nitrosourea	nn	34	SENT_41	[p3l16t1936r1168b2009],
33	(	CD	NUMBER	(	num	34	SENT_41	[p3l1205t1936r1554b2005],
34	BCNU	NNP	O	BCNU	nsubj	41	SENT_41	[p3l1205t1936r1554b2005],
35	)	CD	NUMBER	)	num	37	SENT_41	[p3l1205t1936r1554b2005],
36	.49	CD	NUMBER	.49	num	37	SENT_41	[p3l1205t1936r1554b2005],
37	CDNB	NN	O	cdnb	dep	34	SENT_41	[p3l1591t1936r1806b1992],
38	is	VBZ	O	be	cop	41	SENT_41	[p3l1846t1936r1895b1992],
39	a	DT	O	a	det	41	SENT_41	[p3l1934t1954r1967b1992],
40	nondrug	JJ	O	nondrug	amod	41	SENT_41	[p3l2001t1954r2144b1992, p3l9t2021r153b2094],
41	substrate	NN	O	substrate	parataxis	5	SENT_41	[p3l197t2022r495b2088],
42	,	,	O	,	_	0	SENT_41	[p3l197t2022r495b2088],
43	whilst	IN	O	whilst	mark	49	SENT_41	[p3l539t2021r734b2078],
44	ETA	NNP	ORGANIZATION	ETA	nsubj	49	SENT_41	[p3l774t2022r928b2077],
45	is	VBZ	O	be	cop	49	SENT_41	[p3l969t2021r1018b2078],
46	a	DT	O	a	det	49	SENT_41	[p3l1063t2039r1096b2078],
47	well-known	JJ	O	well-known	amod	49	SENT_41	[p3l1136t2021r1517b2078],
48	diuretic	JJ	O	diuretic	amod	49	SENT_41	[p3l1559t2021r1799b2078],
49	drug	NN	O	drug	dep	5	SENT_41	[p3l1843t2021r1986b2094],
50	that	WDT	O	that	nsubj	51	SENT_41	[p3l2028t2021r2148b2078],
51	contains	VBZ	O	contain	rcmod	49	SENT_41	[p3l9t2107r272b2163],
52	an	DT	O	a	det	55	SENT_41	[p3l299t2125r371b2163],
53	OLB-unsaturated	JJ	MISC	olb-unsaturated	amod	55	SENT_41	[p3l396t2107r888b2179],
54	ketone	NN	O	ketone	nn	55	SENT_41	[p3l910t2107r1122b2163],
55	moiety	NN	O	moiety	dobj	51	SENT_41	[p3l1146t2107r1383b2180],
56	.	.	O	.	_	0	SENT_41	[p3l1146t2107r1383b2180],

1	BCNU	NNP	O	BCNU	nsubj	6	SENT_42	[p3l1411t2107r1632b2164],
2	is	VBZ	O	be	cop	6	SENT_42	[p3l1655t2107r1705b2163],
3	an	DT	O	a	det	6	SENT_42	[p3l1732t2125r1804b2163],
4	alkylating	JJ	O	alkylating	amod	6	SENT_42	[p3l1829t2107r2145b2180],
5	anticancer	JJ	O	anticancer	amod	6	SENT_42	[p3l10t2193r338b2250],
6	agent	NN	O	agent	_	0	SENT_42	[p3l367t2202r539b2266],
7	used	VBN	O	use	partmod	6	SENT_42	[p3l566t2194r713b2250],
8	in	IN	O	in	_	0	SENT_42	[p3l742t2193r802b2249],
9	a	DT	O	a	det	10	SENT_42	[p3l834t2211r866b2250],
10	variety	NN	O	variety	prep_in	7	SENT_42	[p3l895t2193r1115b2266],
11	of	IN	O	of	_	0	SENT_42	[p3l1146t2193r1216b2250],
12	malignant	JJ	O	malignant	amod	13	SENT_42	[p3l1240t2193r1560b2266],
13	diseases	NNS	O	disease	prep_of	10	SENT_42	[p3l1589t2193r1866b2260],
14	,	,	O	,	_	0	SENT_42	[p3l1589t2193r1866b2260],
15	particularly	RB	O	particularly	advmod	7	SENT_42	[p3l1898t2193r2144b2266, p3l9t2279r153b2352],
16	in	IN	O	in	_	0	SENT_42	[p3l194t2279r254b2335],
17	the	DT	O	the	det	18	SENT_42	[p3l295t2279r390b2335],
18	treatment	NN	O	treatment	prep_in	7	SENT_42	[p3l431t2288r734b2335],
19	of	IN	O	of	_	0	SENT_42	[p3l774t2279r843b2335],
20	brain	NN	O	brain	nn	21	SENT_42	[p3l877t2279r1041b2335],
21	tumours	NNS	O	tumour	prep_of	18	SENT_42	[p3l1081t2279r1420b2335],
22	.50	CD	NUMBER	.50	tmod	7	SENT_42	[p3l1081t2279r1420b2335],
23	The	DT	O	the	det	24	SENT_42	[p3l1461t2279r1583b2335],
24	denitrosation	NN	O	denitrosation	nsubjpass	28	SENT_42	[p3l1625t2279r2041b2335],
25	of	IN	O	of	_	0	SENT_42	[p3l2083t2279r2152b2335],
26	BCNU	NNP	O	BCNU	prep_of	24	SENT_42	[p3l9t2366r229b2422],
27	is	VBZ	O	be	auxpass	28	SENT_42	[p3l264t2366r313b2422],
28	catalysed	VBN	O	catalyse	rcmod	22	SENT_42	[p3l350t2366r647b2438],
29	more	JJR	O	more	acomp	28	SENT_42	[p3l681t2383r844b2422],
30	efﬁciently	RB	O	efﬁciently	advmod	28	SENT_42	[p3l879t2366r1201b2439],
31	by	IN	O	by	_	0	SENT_42	[p3l1235t2366r1314b2438],
32	class	NN	O	class	nn	34	SENT_42	[p3l1350t2366r1501b2422],
33	Mu	NN	O	mu	nn	34	SENT_42	[p3l1538t2367r1647b2422],
34	GSTs	NNS	O	gst	agent	28	SENT_42	[p3l1683t2366r1861b2422],
35	than	IN	O	than	prep	28	SENT_42	[p3l1897t2366r2034b2422],
36	by	IN	O	by	pcomp	35	SENT_42	[p3l2067t2366r2146b2439],

1	Grant	NNP	PERSON	Grant	nn	2	SENT_43	[p3l81t2619r241b2669],
2	sponsor	NN	O	sponsor	_	0	SENT_43	[p3l278t2635r511b2683],
3	:	:	O	:	_	0	SENT_43	[p3l278t2635r511b2683],
4	International	NNP	O	International	nn	5	SENT_43	[p3l551t2619r913b2668],
5	Program	NNP	O	Program	dep	2	SENT_43	[p3l949t2620r1194b2683],
6	in	IN	O	in	_	0	SENT_43	[p3l1229t2619r1283b2668],
7	Chemical	NNP	ORGANIZATION	Chemical	nn	8	SENT_43	[p3l1319t2619r1589b2669],
8	Sciences	NNPS	ORGANIZATION	Sciences	prep_in	5	SENT_43	[p3l1627t2619r1871b2669],
9	(	CD	NUMBER	(	num	11	SENT_43	[p3l1911t2619r2144b2680],
10	IPICS	NN	O	ipic	nn	11	SENT_43	[p3l1911t2619r2144b2680],
11	)	NN	O	)	dep	8	SENT_43	[p3l1911t2619r2144b2680],
12	,	,	O	,	_	0	SENT_43	[p3l1911t2619r2144b2680],
13	Uppsala	NNP	ORGANIZATION	Uppsala	nn	14	SENT_43	[p3l8t2688r241b2753],
14	University	NNP	ORGANIZATION	University	appos	8	SENT_43	[p3l275t2688r590b2753],
15	,	,	O	,	_	0	SENT_43	[p3l275t2688r590b2753],
16	Uppsala	NNP	LOCATION	Uppsala	appos	14	SENT_43	[p3l627t2688r875b2753],
17	,	,	O	,	_	0	SENT_43	[p3l627t2688r875b2753],
18	Sweden	NNP	LOCATION	Sweden	appos	8	SENT_43	[p3l914t2688r1153b2747],
19	;	:	O	;	_	0	SENT_43	[p3l914t2688r1153b2747],
20	Grant	NNP	PERSON	Grant	nn	21	SENT_43	[p3l1192t2689r1353b2738],
21	sponsor	NN	O	sponsor	dep	8	SENT_43	[p3l1389t2704r1621b2753],
22	:	:	O	:	_	0	SENT_43	[p3l1389t2704r1621b2753],
23	Research	NNP	ORGANIZATION	Research	nn	24	SENT_43	[p3l1661t2688r1921b2738],
24	Board	NNP	ORGANIZATION	Board	dep	8	SENT_43	[p3l1956t2688r2144b2747],
25	,	,	O	,	_	0	SENT_43	[p3l1956t2688r2144b2747],
26	University	NNP	ORGANIZATION	University	appos	8	SENT_43	[p3l8t2758r307b2822],
27	of	IN	ORGANIZATION	of	_	0	SENT_43	[p3l334t2758r396b2808],
28	Zimbabwe	NNP	ORGANIZATION	Zimbabwe	prep_of	26	SENT_43	[p3l416t2758r735b2817],
29	,	,	O	,	_	0	SENT_43	[p3l416t2758r735b2817],
30	Harare	NNP	LOCATION	Harare	nn	32	SENT_43	[p3l763t2759r970b2817],
31	,	,	O	,	_	0	SENT_43	[p3l763t2759r970b2817],
32	Zimbabwe	NNP	LOCATION	Zimbabwe	appos	28	SENT_43	[p3l998t2758r1316b2808],
33	.	.	O	.	_	0	SENT_43	[p3l998t2758r1316b2808],

1	*	NN	O	*	nn	2	SENT_44	[p3l83t2973r576b3037],
2	Correspondence	NN	O	correspondence	_	0	SENT_44	[p3l83t2973r576b3037],
3	to	TO	O	to	_	0	SENT_44	[p3l606t2981r675b3023],
4	:	:	O	:	_	0	SENT_44	[p3l606t2981r675b3023],
5	Department	NNP	ORGANIZATION	Department	prep_to	2	SENT_44	[p3l709t2974r1045b3037],
6	of	IN	ORGANIZATION	of	_	0	SENT_44	[p3l1074t2973r1136b3023],
7	Biochemistry	NNP	ORGANIZATION	Biochemistry	prep_of	5	SENT_44	[p3l1160t2973r1558b3037],
8	,	,	O	,	_	0	SENT_44	[p3l1160t2973r1558b3037],
9	University	NNP	ORGANIZATION	University	appos	5	SENT_44	[p3l1590t2973r1889b3037],
10	of	IN	ORGANIZATION	of	_	0	SENT_44	[p3l1920t2973r1981b3023],
11	Zimbabwe	NNP	ORGANIZATION	Zimbabwe	prep_of	9	SENT_44	[p3l2005t2973r2144b3022, p3l7t3044r208b3103],
12	,	,	O	,	_	0	SENT_44	[p3l2005t2973r2144b3022, p3l7t3044r208b3103],
13	P.O.	NNP	O	P.O.	nn	17	SENT_44	[p3l236t3044r357b3094],
14	Box	NNP	O	Box	nn	17	SENT_44	[p3l387t3045r503b3094],
15	MP	NNP	O	MP	nn	17	SENT_44	[p3l529t3045r631b3093],
16	167	CD	NUMBER	167	num	17	SENT_44	[p3l663t3044r758b3094],
17	Mt.	NNP	O	Mt.	appos	5	SENT_44	[p3l787t3045r882b3094],
18	Pleasant	NNP	O	Pleasant	nn	22	SENT_44	[p3l911t3044r1163b3103],
19	,	,	O	,	_	0	SENT_44	[p3l911t3044r1163b3103],
20	Harare	NNP	LOCATION	Harare	appos	22	SENT_44	[p3l1191t3045r1398b3103],
21	,	,	O	,	_	0	SENT_44	[p3l1191t3045r1398b3103],
22	Zimbabwe	NNP	LOCATION	Zimbabwe	dep	17	SENT_44	[p3l1426t3044r1744b3094],
23	.	.	O	.	_	0	SENT_44	[p3l1426t3044r1744b3094],

1	Fax	NN	O	fax	_	0	SENT_45	[p3l8t3115r128b3163],
2	:	:	O	:	_	0	SENT_45	[p3l8t3115r128b3163],
3	+263	CD	NUMBER	+263	number	4	SENT_45	[p3l166t3113r635b3163],
4	—	CD	NUMBER	—	dep	1	SENT_45	[p3l166t3113r635b3163],
5	4	CD	NUMBER	4	num	6	SENT_45	[p3l166t3113r635b3163],
6	—	NN	O	—	dep	4	SENT_45	[p3l166t3113r635b3163],
7	333678	CD	NUMBER	333678	dep	4	SENT_45	[p3l166t3113r635b3163],
8	.	.	O	.	_	0	SENT_45	[p3l166t3113r635b3163],

1	E	NN	O	e	nn	3	SENT_46	[p3l664t3114r871b3163],
2	—	CD	NUMBER	—	num	3	SENT_46	[p3l664t3114r871b3163],
3	mail	NN	O	mail	_	0	SENT_46	[p3l664t3114r871b3163],
4	:	:	O	:	_	0	SENT_46	[p3l664t3114r871b3163],
5	hasler@giraffe.icon.co.zw	NN	O	hasler@giraffe.icon.co.zw	dep	3	SENT_46	[p3l901t3113r1652b3178],

1	Received	VBN	O	receive	_	0	SENT_47	[p3l79t3329r344b3378],
2	19	CD	DATE	19	dobj	1	SENT_47	[p3l369t3329r430b3379],
3	December	NNP	DATE	December	tmod	1	SENT_47	[p3l451t3329r743b3378],
4	2000	CD	DATE	2000	num	3	SENT_47	[p3l762t3329r918b3388],
5	;	:	O	;	_	0	SENT_47	[p3l762t3329r918b3388],
6	Revised	VBN	O	revise	parataxis	1	SENT_47	[p3l940t3329r1169b3378],
7	15	CD	DATE	15	dobj	6	SENT_47	[p3l1194t3329r1253b3379],
8	June	NNP	DATE	June	tmod	7	SENT_47	[p3l1275t3330r1404b3379],
9	2001	CD	DATE	2001	num	8	SENT_47	[p3l1424t3329r1581b3388],
10	;	:	O	;	_	0	SENT_47	[p3l1424t3329r1581b3388],
11	Accepted	JJ	O	accepted	amod	12	SENT_47	[p3l1603t3329r1871b3393],
12	6	CD	DATE	6	dep	7	SENT_47	[p3l1891t3329r1922b3379],
13	August	NNP	DATE	August	tmod	6	SENT_47	[p3l1942t3329r2147b3393],

1	INHIBITION	NN	O	inhibition	_	0	SENT_48	[p3l368t3692r528b3712],
2	OF	IN	O	of	dep	1	SENT_48	[p3l538t3692r575b3712],
3	RECOMBINANT	JJ	O	recombinant	amod	4	SENT_48	[p3l585t3692r798b3712],
4	GSTS	NN	O	gst	pobj	2	SENT_48	[p3l809t3692r874b3712],
5	BY	IN	O	by	dep	1	SENT_48	[p3l885t3692r924b3712],
6	ANTIIVIALARIALS	NN	O	antiivialarial	pobj	5	SENT_48	[p3l935t3692r1173b3712],
7	701	CD	NUMBER	701	num	6	SENT_48	[p3l1740t3686r1792b3712],

1	class	NN	O	class	nn	2	SENT_49	[p4l13t59r164b115],
2	Pi	NN	O	pi	nsubjpass	11	SENT_49	[p4l187t59r252b114],
3	and	CC	O	and	_	0	SENT_49	[p4l275t59r388b115],
4	Alpha	NN	O	alpha	nn	5	SENT_49	[p4l408t59r603b132],
5	GSTs	NNS	O	gst	nsubjpass	11	SENT_49	[p4l624t59r881b125],
6	,24	CD	NUMBER	,24	dep	2	SENT_49	[p4l624t59r881b125],
7	and	CC	O	and	_	0	SENT_49	[p4l904t59r1017b115],
8	it	PRP	O	it	conj_and	2	SENT_49	[p4l1038t59r1081b115],
9	has	VBZ	O	have	aux	11	SENT_49	[p4l1101t59r1204b115],
10	been	VBN	O	be	auxpass	11	SENT_49	[p4l1226t59r1377b115],
11	shown	VBN	O	show	dep	21	SENT_49	[p4l1401t59r1605b115],
12	that	IN	O	that	complm	16	SENT_49	[p4l1626t59r1745b115],
13	depletion	NN	O	depletion	nsubj	16	SENT_49	[p4l1766t59r2061b132],
14	of	IN	O	of	_	0	SENT_49	[p4l2084t59r2152b115],
15	GSH	NN	O	gsh	prep_of	13	SENT_49	[p4l14t142r171b199],
16	imposed	VBN	O	impose	ccomp	11	SENT_49	[p4l191t142r461b215],
17	on	IN	O	on	_	0	SENT_49	[p4l482t160r559b198],
18	GST	NN	O	gst	nn	20	SENT_49	[p4l581t142r729b199],
19	M-overproducing	JJ	O	m-overproducing	amod	20	SENT_49	[p4l749t142r1312b215],
20	cells	NNS	O	cell	prep_on	16	SENT_49	[p4l1334t142r1476b198],
21	increased	VBD	O	increase	_	0	SENT_49	[p4l1499t142r1800b198],
22	toxicity	NN	O	toxicity	dobj	21	SENT_49	[p4l1820t142r2061b215],
23	of	IN	O	of	_	0	SENT_49	[p4l2084t142r2153b198],
24	nitrogen	NN	O	nitrogen	nn	25	SENT_49	[p4l13t226r278b299],
25	mustards	NNS	O	mustard	prep_of	22	SENT_49	[p4l306t226r666b283],
26	.51	CD	NUMBER	.51	nsubj	21	SENT_49	[p4l306t226r666b283],

1	MATERIAL	NN	O	material	_	0	SENT_50	[p4l641t433r985b479],
2	AND	CC	O	and	rcmod	1	SENT_50	[p4l1019t433r1161b479],
3	METHODS	NNS	O	method	dep	1	SENT_50	[p4l1197t433r1515b479],

1	Most	JJS	O	most	amod	2	SENT_51	[p4l92t558r257b612],
2	chemicals	NNS	O	chemical	nsubjpass	12	SENT_51	[p4l296t556r631b623],
3	,	,	O	,	_	0	SENT_51	[p4l296t556r631b623],
4	including	VBG	O	include	_	0	SENT_51	[p4l673t556r973b629],
5	ethacrynic	JJ	O	ethacrynic	amod	6	SENT_51	[p4l1014t556r1344b629],
6	acid	NN	O	acid	prep_including	12	SENT_51	[p4l1387t556r1517b612],
7	(	CD	NUMBER	(	num	8	SENT_51	[p4l1559t557r1780b625],
8	ETA	NNP	ORGANIZATION	ETA	dep	6	SENT_51	[p4l1559t557r1780b625],
9	)	CD	NUMBER	)	num	8	SENT_51	[p4l1559t557r1780b625],
10	,	,	O	,	_	0	SENT_51	[p4l1559t557r1780b625],
11	were	VBD	O	be	auxpass	12	SENT_51	[p4l1823t574r1976b613],
12	purchased	VBN	O	purchase	dep	27	SENT_51	[p4l2015t574r2145b629, p4l13t640r229b697],
13	from	IN	O	from	_	0	SENT_51	[p4l252t640r406b696],
14	Sigma	NNP	O	Sigma	nn	17	SENT_51	[p4l431t640r632b713],
15	(	CD	NUMBER	(	num	17	SENT_51	[p4l657t641r761b710],
16	St.	NNP	LOCATION	St.	nn	17	SENT_51	[p4l657t641r761b710],
17	Louis	NNP	LOCATION	Louis	prep_from	12	SENT_51	[p4l789t640r986b707],
18	,	,	O	,	_	0	SENT_51	[p4l789t640r986b707],
19	MO	NNP	DURATION	MO	nn	20	SENT_51	[p4l1012t641r1164b710],
20	)	NNP	O	)	conj_and	17	SENT_51	[p4l1012t641r1164b710],
21	and	CC	O	and	_	0	SENT_51	[p4l1191t640r1303b697],
22	BCNU	NNP	O	BCNU	conj_and	17	SENT_51	[p4l1326t641r1546b697],
23	(	CD	NUMBER	(	num	25	SENT_51	[p4l1572t641r1999b710],
24	BecenumTM	NNP	O	BecenumTM	nn	25	SENT_51	[p4l1572t641r1999b710],
25	)	NN	O	)	nsubjpass	27	SENT_51	[p4l1572t641r1999b710],
26	was	VBD	O	be	auxpass	27	SENT_51	[p4l2025t658r2145b697],
27	obtained	VBN	O	obtain	_	0	SENT_51	[p4l14t724r287b781],
28	from	IN	O	from	_	0	SENT_51	[p4l316t724r470b781],
29	Bristol-Myers	NNP	MISC	Bristol-Myers	nn	32	SENT_51	[p4l498t724r943b797],
30	Squib	NNP	MISC	Squib	nn	32	SENT_51	[p4l976t724r1158b797],
31	(	NNP	O	(	nn	32	SENT_51	[p4l1190t724r1576b794],
32	Stockholm	NNP	LOCATION	Stockholm	prep_from	27	SENT_51	[p4l1190t724r1576b794],
33	,	,	O	,	_	0	SENT_51	[p4l1190t724r1576b794],
34	Sweden	NNP	LOCATION	Sweden	appos	32	SENT_51	[p4l1610t724r1902b794],
35	)	CD	NUMBER	)	num	34	SENT_51	[p4l1610t724r1902b794],
36	.	.	O	.	_	0	SENT_51	[p4l1610t724r1902b794],

1	Heterologous	JJ	O	heterologous	amod	2	SENT_52	[p4l11t858r446b930],
2	expression	NN	O	expression	_	0	SENT_52	[p4l477t860r815b930],
3	and	CC	O	and	_	0	SENT_52	[p4l845t858r966b915],
4	puriﬁcation	NN	O	puriﬁcation	conj_and	2	SENT_52	[p4l984t858r1363b930],
5	of	IN	O	of	_	0	SENT_52	[p4l1393t859r1465b930],
6	recombinant	JJ	O	recombinant	amod	9	SENT_52	[p4l1484t858r1887b915],
7	human	JJ	O	human	amod	9	SENT_52	[p4l1913t858r2128b915],
8	glutathione	NN	O	glutathione	nn	9	SENT_52	[p4l12t943r375b1014],
9	transferases	NNS	O	transferase	prep_of	2	SENT_52	[p4l406t943r793b1014],

1	Glutathione	NN	O	glutathione	nn	3	SENT_53	[p4l94t1042r469b1099],
2	transferase	NN	O	transferase	nn	3	SENT_53	[p4l498t1042r843b1098],
3	A1-1	NN	O	a1-1	nsubjpass	16	SENT_53	[p4l873t1043r1052b1108],
4	,	,	O	,	_	0	SENT_53	[p4l873t1043r1052b1108],
5	A2-2	NN	O	a2-2	appos	3	SENT_53	[p4l1085t1043r1264b1108],
6	,	,	O	,	_	0	SENT_53	[p4l1085t1043r1264b1108],
7	Mlb-lb	NN	O	mlb-lb	conj_and	5	SENT_53	[p4l1297t1043r1570b1108],
8	,	,	O	,	_	0	SENT_53	[p4l1297t1043r1570b1108],
9	M2-2	NN	O	m2-2	conj_and	5	SENT_53	[p4l1603t1043r1796b1108],
10	,	,	O	,	_	0	SENT_53	[p4l1603t1043r1796b1108],
11	M3-3	NN	O	m3-3	conj_and	5	SENT_53	[p4l1828t1043r2000b1099],
12	and	CC	O	and	_	0	SENT_53	[p4l2035t1042r2148b1098],
13	P1-1	NN	O	p1-1	conj_and	5	SENT_53	[p4l13t1126r179b1192],
14	,	,	O	,	_	0	SENT_53	[p4l13t1126r179b1192],
15	were	VBD	O	be	auxpass	16	SENT_53	[p4l225t1143r378b1182],
16	expressed	VBN	O	express	_	0	SENT_53	[p4l421t1126r735b1199],
17	in	IN	O	in	_	0	SENT_53	[p4l777t1126r837b1181],
18	Escherichia	FW	LOCATION	escherichia	nn	19	SENT_53	[p4l878t1126r1259b1182],
19	coli	FW	O	coli	prep_in	16	SENT_53	[p4l1304t1126r1421b1182],
20	and	CC	O	and	_	0	SENT_53	[p4l1465t1126r1577b1182],
21	prepared	VBN	O	prepare	conj_and	16	SENT_53	[p4l1618t1126r1898b1199],
22	as	IN	O	as	_	0	SENT_53	[p4l1941t1143r2003b1182],
23	described52-55	NN	O	described52-55	prep_as	21	SENT_53	[p4l2048t1126r2145b1182, p4l15t1210r384b1266],
24	with	IN	O	with	_	0	SENT_53	[p4l417t1210r557b1266],
25	minor	JJ	O	minor	amod	26	SENT_53	[p4l586t1210r776b1266],
26	modiﬁcations	NNS	O	modiﬁcations	prep_with	21	SENT_53	[p4l805t1210r1255b1266],
27	.	.	O	.	_	0	SENT_53	[p4l805t1210r1255b1266],

1	Instead	RB	O	instead	advmod	2	SENT_54	[p4l1289t1210r1518b1266],
2	of	IN	O	of	advcl	29	SENT_54	[p4l1548t1210r1617b1266],
3	using	VBG	O	use	pcomp	2	SENT_54	[p4l1641t1210r1812b1283],
4	hexylglu	NN	O	hexylglu	nn	6	SENT_54	[p4l1842t1210r2145b1283],
5	—	NN	O	—	nn	6	SENT_54	[p4l1842t1210r2145b1283],
6	tathione	NN	O	tathione	dobj	3	SENT_54	[p4l13t1294r269b1350],
7	as	IN	O	as	_	0	SENT_54	[p4l291t1312r352b1350],
8	the	DT	O	the	det	10	SENT_54	[p4l374t1294r470b1350],
9	counter	NN	O	counter	nn	10	SENT_54	[p4l491t1303r730b1350],
10	ligand	NN	O	ligand	prep_as	6	SENT_54	[p4l749t1294r947b1367],
11	to	TO	O	to	aux	12	SENT_54	[p4l967t1302r1026b1350],
12	elute	VB	O	elute	xcomp	3	SENT_54	[p4l1048t1294r1201b1350],
13	GST	NN	O	gst	nn	14	SENT_54	[p4l1223t1294r1371b1350],
14	A1-1	NN	O	a1-1	dobj	12	SENT_54	[p4l1391t1294r1547b1349],
15	and	CC	O	and	_	0	SENT_54	[p4l1576t1294r1688b1350],
16	P1-1	NN	O	p1-1	dobj	12	SENT_54	[p4l1708t1294r1850b1349],
17	from	IN	O	from	_	0	SENT_54	[p4l1878t1294r2032b1350],
18	the	DT	O	the	det	20	SENT_54	[p4l2051t1294r2147b1350],
19	afﬁnity	NN	O	afﬁnity	nn	20	SENT_54	[p4l14t1377r241b1450],
20	column	NN	O	column	prep_from	12	SENT_54	[p4l263t1377r518b1444],
21	,	,	O	,	_	0	SENT_54	[p4l263t1377r518b1444],
22	50	CD	NUMBER	50	num	24	SENT_54	[p4l542t1377r618b1434],
23	mM	NN	O	mm	nn	24	SENT_54	[p4l639t1379r770b1433],
24	glycine	NN	O	glycine	nsubjpass	29	SENT_54	[p4l792t1377r1024b1450],
25	at	IN	O	at	_	0	SENT_54	[p4l1047t1385r1102b1433],
26	pH	NN	O	ph	prep_at	24	SENT_54	[p4l1120t1379r1217b1450],
27	10	CD	NUMBER	10	num	26	SENT_54	[p4l1245t1378r1315b1434],
28	was	VBD	O	be	auxpass	29	SENT_54	[p4l1336t1395r1456b1434],
29	used	VBN	O	use	_	0	SENT_54	[p4l1478t1377r1639b1433],
30	.	.	O	.	_	0	SENT_54	[p4l1478t1377r1639b1433],

1	This	DT	O	this	nsubj	2	SENT_55	[p4l1664t1377r1802b1433],
2	is	VBZ	O	be	_	0	SENT_55	[p4l1824t1377r1873b1433],
3	because	IN	O	because	mark	5	SENT_55	[p4l1895t1377r2147b1433],
4	S-hexylglutathione	NN	MISC	s-hexylglutathione	nsubj	25	SENT_55	[p4l15t1461r620b1534],
5	binds	VBZ	O	bind	advcl	2	SENT_55	[p4l644t1461r815b1518],
6	to	TO	O	to	_	0	SENT_55	[p4l842t1469r901b1517],
7	GSTs	NNS	O	gst	prep_to	5	SENT_55	[p4l928t1462r1105b1518],
8	with	IN	O	with	_	0	SENT_55	[p4l1133t1461r1273b1518],
9	high	JJ	O	high	amod	10	SENT_55	[p4l1297t1461r1438b1534],
10	afﬁnity	NN	O	afﬁnity	prep_with	7	SENT_55	[p4l1464t1461r1691b1534],
11	and	CC	O	and	_	0	SENT_55	[p4l1719t1461r1831b1518],
12	failure	NN	O	failure	conj_and	10	SENT_55	[p4l1856t1461r2062b1517],
13	to	TO	O	to	aux	14	SENT_55	[p4l2087t1470r2147b1517],
14	remove	VB	O	remove	xcomp	5	SENT_55	[p4l12t1563r251b1602],
15	S-hexylglutathione	NN	MISC	s-hexylglutathione	nn	16	SENT_55	[p4l277t1545r882b1618],
16	results	NNS	O	result	dobj	14	SENT_55	[p4l905t1546r1112b1602],
17	in	IN	O	in	_	0	SENT_55	[p4l1137t1545r1198b1601],
18	inhibition	NN	O	inhibition	prep_in	14	SENT_55	[p4l1221t1545r1531b1602],
19	of	IN	O	of	_	0	SENT_55	[p4l1556t1545r1624b1602],
20	the	DT	O	the	det	21	SENT_55	[p4l1643t1546r1739b1602],
21	enzyme	NN	O	enzyme	prep_of	18	SENT_55	[p4l1764t1563r2010b1618],
22	and	CC	O	and	_	0	SENT_55	[p4l2035t1546r2148b1602],
23	does	VBZ	O	do	aux	25	SENT_55	[p4l13t1630r156b1686],
24	not	RB	O	not	neg	25	SENT_55	[p4l192t1638r293b1686],
25	give	VB	O	give	conj_and	5	SENT_55	[p4l327t1630r462b1703],
26	a	DT	O	a	det	28	SENT_55	[p4l498t1647r532b1686],
27	true	JJ	O	true	amod	28	SENT_55	[p4l564t1638r687b1686],
28	reﬂection	NN	O	reﬂection	dobj	25	SENT_55	[p4l720t1630r1022b1686],
29	of	IN	O	of	_	0	SENT_55	[p4l1057t1630r1126b1686],
30	the	DT	O	the	det	32	SENT_55	[p4l1155t1630r1250b1686],
31	speciﬁc	NN	O	speciﬁc	nn	32	SENT_55	[p4l1288t1630r1526b1703],
32	activity	NN	O	activity	prep_of	28	SENT_55	[p4l1564t1630r1816b1703],
33	.	.	O	.	_	0	SENT_55	[p4l1564t1630r1816b1703],

1	For	IN	O	for	_	0	SENT_56	[p4l1854t1631r1965b1686],
2	GST	NN	O	gst	nn	3	SENT_56	[p4l1999t1630r2147b1686],
3	P1-1	NN	O	p1-1	prep_for	6	SENT_56	[p4l13t1714r155b1769],
4	the	DT	O	the	det	5	SENT_56	[p4l183t1714r279b1770],
5	procedure	NN	O	procedure	nsubj	6	SENT_56	[p4l300t1714r619b1787],
6	was	VBD	O	be	_	0	SENT_56	[p4l641t1731r762b1770],
7	as	IN	O	as	mark	8	SENT_56	[p4l787t1731r848b1770],
8	follows	VBZ	O	follow	advcl	6	SENT_56	[p4l872t1714r1126b1770],
9	.	.	O	.	_	0	SENT_56	[p4l872t1714r1126b1770],

1	Escherichia	FW	PERSON	escherichia	nn	2	SENT_57	[p4l1150t1714r1532b1770],
2	coli	FW	PERSON	coli	nsubjpass	8	SENT_57	[p4l1555t1714r1672b1770],
3	containing	VBG	O	contain	partmod	2	SENT_57	[p4l1694t1714r2029b1787],
4	the	DT	O	the	det	6	SENT_57	[p4l2052t1714r2147b1770],
5	plasmid	NN	O	plasmid	nn	6	SENT_57	[p4l12t1798r265b1871],
6	pKXHPl	NN	O	pkxhpl	dobj	3	SENT_57	[p4l290t1798r580b1871],
7	was	VBD	O	be	auxpass	8	SENT_57	[p4l614t1816r734b1854],
8	grown	VBN	O	grow	_	0	SENT_57	[p4l764t1816r965b1871],
9	in	IN	O	in	_	0	SENT_57	[p4l992t1798r1052b1853],
10	50	CD	NUMBER	50	num	11	SENT_57	[p4l1080t1798r1156b1854],
11	ml	NN	O	ml	prep_in	8	SENT_57	[p4l1183t1798r1266b1853],
12	of	IN	O	of	_	0	SENT_57	[p4l1293t1798r1363b1854],
13	2TYA	JJ	O	2tya	amod	14	SENT_57	[p4l1385t1798r1587b1853],
14	medium	NN	O	medium	prep_of	11	SENT_57	[p4l1613t1798r1875b1854],
15	for	IN	O	for	_	0	SENT_57	[p4l1900t1798r1993b1854],
16	8	CD	DURATION	8	num	17	SENT_57	[p4l2021t1798r2053b1854],
17	hr	NN	DURATION	hr	prep_for	8	SENT_57	[p4l2082t1798r2149b1853],
18	in	IN	O	in	_	0	SENT_57	[p4l13t1881r73b1937],
19	a	DT	O	a	det	20	SENT_57	[p4l116t1899r149b1937],
20	culture	NN	O	culture	prep_in	17	SENT_57	[p4l190t1881r426b1937],
21	.	.	O	.	_	0	SENT_57	[p4l190t1881r426b1937],

1	This	DT	O	this	det	2	SENT_58	[p4l472t1881r610b1937],
2	culture	NN	O	culture	nsubjpass	4	SENT_58	[p4l654t1881r873b1937],
3	was	VBD	O	be	auxpass	4	SENT_58	[p4l916t1899r1036b1937],
4	used	VBN	O	use	ccomp	63	SENT_58	[p4l1079t1881r1225b1937],
5	for	IN	O	for	_	0	SENT_58	[p4l1266t1881r1359b1937],
6	inoculation	NN	O	inoculation	prep_for	4	SENT_58	[p4l1399t1881r1757b1937],
7	of	IN	O	of	_	0	SENT_58	[p4l1800t1881r1869b1937],
8	500	CD	NUMBER	500	num	11	SENT_58	[p4l1906t1881r2023b1938],
9	ml	NN	O	ml	nn	11	SENT_58	[p4l2065t1881r2147b1937],
10	expression	NN	O	expression	nn	11	SENT_58	[p4l13t1965r353b2038],
11	medium	NN	O	medium	prep_of	6	SENT_58	[p4l376t1965r637b2021],
12	(	CD	NUMBER	(	number	13	SENT_58	[p4l662t1966r763b2035],
13	10	CD	NUMBER	10	num	15	SENT_58	[p4l662t1966r763b2035],
14	g	NN	O	g	nn	15	SENT_58	[p4l787t1983r823b2038],
15	tryptone	NN	O	tryptone	dep	11	SENT_58	[p4l847t1974r1129b2038],
16	,	,	O	,	_	0	SENT_58	[p4l847t1974r1129b2038],
17	7.5	CD	NUMBER	7.5	num	20	SENT_58	[p4l1155t1965r1249b2022],
18	g	NN	O	g	nn	20	SENT_58	[p4l1276t1983r1312b2038],
19	yeast	NN	O	yeast	nn	20	SENT_58	[p4l1335t1974r1499b2038],
20	extract	NN	O	extract	prep_of	6	SENT_58	[p4l1521t1974r1754b2032],
21	,	,	O	,	_	0	SENT_58	[p4l1521t1974r1754b2032],
22	2.5	CD	NUMBER	2.5	num	24	SENT_58	[p4l1780t1965r1873b2022],
23	g	NN	O	g	nn	24	SENT_58	[p4l1901t1983r1937b2038],
24	NaCl	NN	O	nacl	appos	20	SENT_58	[p4l1960t1965r2144b2032],
25	,	,	O	,	_	0	SENT_58	[p4l1960t1965r2144b2032],
26	5	CD	NUMBER	5	num	28	SENT_58	[p4l14t2049r47b2106],
27	g	NN	O	g	nn	28	SENT_58	[p4l80t2067r116b2122],
28	glycerol	NN	O	glycerol	appos	20	SENT_58	[p4l147t2049r406b2122],
29	and	CC	O	and	_	0	SENT_58	[p4l437t2050r549b2106],
30	25	CD	NUMBER	25	num	31	SENT_58	[p4l578t2049r651b2106],
31	mg	NN	O	mg	prep_of	6	SENT_58	[p4l684t2067r783b2122],
32	of	IN	O	of	_	0	SENT_58	[p4l814t2049r883b2106],
33	ampicillin	NN	O	ampicillin	nn	34	SENT_58	[p4l908t2049r1254b2122],
34	)	NN	O	)	prep_of	31	SENT_58	[p4l908t2049r1254b2122],
35	in	IN	O	in	_	0	SENT_58	[p4l1284t2049r1345b2105],
36	a	DT	O	a	det	40	SENT_58	[p4l1375t2067r1408b2106],
37	2	CD	NUMBER	2	number	38	SENT_58	[p4l1437t2050r1473b2105],
38	L	NN	O	l	amod	40	SENT_58	[p4l1502t2051r1549b2105],
39	Erlenmeyer	NN	MISC	erlenmeyer	nn	40	SENT_58	[p4l1577t2049r1951b2122],
40	ﬂask	NN	O	ﬂask	prep_in	4	SENT_58	[p4l1979t2049r2144b2116],
41	,	,	O	,	_	0	SENT_58	[p4l1979t2049r2144b2116],
42	which	WDT	O	which	nsubjpass	45	SENT_58	[p4l13t2134r207b2190],
43	was	VBD	O	be	auxpass	45	SENT_58	[p4l232t2151r352b2190],
44	then	RB	O	then	advmod	45	SENT_58	[p4l379t2134r515b2190],
45	placed	VBN	O	place	rcmod	40	SENT_58	[p4l538t2134r747b2207],
46	in	IN	O	in	_	0	SENT_58	[p4l771t2134r832b2189],
47	a	DT	O	a	det	49	SENT_58	[p4l858t2151r891b2190],
48	rotary	JJ	O	rotary	amod	49	SENT_58	[p4l914t2142r1103b2207],
49	shaker	NN	O	shaker	prep_in	45	SENT_58	[p4l1132t2134r1337b2190],
50	at	IN	O	at	_	0	SENT_58	[p4l1362t2142r1417b2190],
51	37	CD	NUMBER	37	number	52	SENT_58	[p4l1443t2134r1620b2190],
52	°	CD	NUMBER	°	num	53	SENT_58	[p4l1443t2134r1620b2190],
53	C.	NNP	O	C.	prep_at	49	SENT_58	[p4l1443t2134r1620b2190],
54	At	IN	O	at	_	0	SENT_58	[p4l1649t2134r1729b2190],
55	an	DT	O	a	det	56	SENT_58	[p4l1754t2151r1826b2190],
56	OD555	NN	O	od555	prep_at	53	SENT_58	[p4l1852t2134r2055b2207],
57	of	IN	O	of	_	0	SENT_58	[p4l2084t2134r2152b2190],
58	0.2-0	CD	NUMBER	0.2-0	num	59	SENT_58	[p4l13t2218r277b2284],
59	.3	NN	NUMBER	.3	prep_of	56	SENT_58	[p4l13t2218r277b2284],
60	,	,	O	,	_	0	SENT_58	[p4l13t2218r277b2284],
61	IPTG	NN	O	iptg	nsubjpass	63	SENT_58	[p4l305t2218r482b2274],
62	was	VBD	O	be	auxpass	63	SENT_58	[p4l507t2236r627b2274],
63	added	VBN	O	add	_	0	SENT_58	[p4l655t2218r844b2274],
64	to	TO	O	to	_	0	SENT_58	[p4l868t2226r927b2274],
65	a	DT	O	a	det	67	SENT_58	[p4l955t2236r988b2274],
66	ﬁnal	JJ	O	ﬁnal	amod	67	SENT_58	[p4l1013t2218r1152b2274],
67	concentration	NN	O	concentration	prep_to	63	SENT_58	[p4l1178t2218r1611b2274],
68	of	IN	O	of	_	0	SENT_58	[p4l1637t2218r1706b2274],
69	0.2	CD	NUMBER	0.2	num	70	SENT_58	[p4l1726t2218r1822b2274],
70	mM	NN	O	mm	prep_of	67	SENT_58	[p4l1848t2219r1996b2274],
71	.	.	O	.	_	0	SENT_58	[p4l1848t2219r1996b2274],

1	The	DT	O	the	det	2	SENT_59	[p4l2025t2218r2147b2274],
2	culture	NN	O	culture	nsubjpass	4	SENT_59	[p4l13t2301r233b2357],
3	was	VBD	O	be	auxpass	4	SENT_59	[p4l266t2319r386b2357],
4	grown	VBN	O	grow	_	0	SENT_59	[p4l421t2319r623b2374],
5	for	IN	O	for	_	0	SENT_59	[p4l656t2301r748b2357],
6	20	CD	DURATION	20	num	7	SENT_59	[p4l781t2301r857b2357],
7	hr	NN	DURATION	hr	prep_for	4	SENT_59	[p4l889t2301r956b2356],
8	and	CC	O	and	_	0	SENT_59	[p4l989t2301r1102b2357],
9	the	DT	O	the	det	10	SENT_59	[p4l1134t2301r1229b2357],
10	bacteria	NNS	O	bacterium	nsubjpass	24	SENT_59	[p4l1261t2301r1514b2357],
11	were	VBD	O	be	auxpass	12	SENT_59	[p4l1546t2319r1699b2357],
12	harvested	VBN	O	harvest	conj_and	4	SENT_59	[p4l1731t2301r2038b2357],
13	by	IN	O	by	_	0	SENT_59	[p4l2068t2301r2147b2374],
14	centrifugation	NN	O	centrifugation	agent	12	SENT_59	[p4l13t2384r460b2457],
15	for	IN	O	for	_	0	SENT_59	[p4l484t2384r577b2440],
16	10	CD	DURATION	10	num	17	SENT_59	[p4l607t2385r677b2441],
17	min	NN	DURATION	min	prep_for	14	SENT_59	[p4l702t2384r824b2440],
18	at	IN	O	at	_	0	SENT_59	[p4l851t2392r906b2440],
19	3,000	CD	NUMBER	3,000	num	20	SENT_59	[p4l931t2384r1165b2451],
20	>	JJR	O	>	prep_at	12	SENT_59	[p4l931t2384r1165b2451],
21	<	JJR	O	<	amod	22	SENT_59	[p4l931t2384r1165b2451],
22	g	NN	O	g	dep	20	SENT_59	[p4l1175t2403r1213b2456],
23	and	CC	O	and	_	0	SENT_59	[p4l1239t2384r1352b2440],
24	resuspended	VBN	O	resuspend	conj_and	12	SENT_59	[p4l1375t2384r1770b2457],
25	in	IN	O	in	_	0	SENT_59	[p4l1794t2384r1854b2440],
26	an	DT	O	a	det	28	SENT_59	[p4l1880t2402r1952b2440],
27	equal	JJ	O	equal	amod	28	SENT_59	[p4l1977t2384r2147b2457],
28	volume	NN	O	volume	prep_in	24	SENT_59	[p4l13t2468r251b2525],
29	of	IN	O	of	_	0	SENT_59	[p4l272t2468r341b2525],
30	lysis	NN	O	lysis	nn	31	SENT_59	[p4l355t2468r498b2541],
31	buffer	NN	O	buffer	prep_of	28	SENT_59	[p4l519t2468r715b2524],
32	containing	VBG	O	contain	xcomp	24	SENT_59	[p4l734t2468r1068b2541],
33	10	CD	NUMBER	10	num	35	SENT_59	[p4l1097t2469r1166b2525],
34	mM	NN	O	mm	nn	35	SENT_59	[p4l1187t2470r1318b2524],
35	Tris-HCl	NN	O	tris-hcl	dobj	32	SENT_59	[p4l1338t2468r1642b2535],
36	,	,	O	,	_	0	SENT_59	[p4l1338t2468r1642b2535],
37	pH	NN	O	ph	dobj	32	SENT_59	[p4l1664t2470r1760b2541],
38	7.8	CD	NUMBER	7.8	num	37	SENT_59	[p4l1781t2469r1896b2535],
39	,	,	O	,	_	0	SENT_59	[p4l1781t2469r1896b2535],
40	50	CD	NUMBER	50	num	42	SENT_59	[p4l1919t2468r1996b2525],
41	mM	NN	O	mm	nn	42	SENT_59	[p4l2016t2470r2147b2524],
42	EDTA	NN	O	edta	dobj	32	SENT_59	[p4l12t2553r241b2619],
43	,	,	O	,	_	0	SENT_59	[p4l12t2553r241b2619],
44	15	CD	PERCENT	15	num	46	SENT_59	[p4l285t2552r418b2609],
45	%	NN	PERCENT	%	nn	46	SENT_59	[p4l285t2552r418b2609],
46	glucose	NN	O	glucose	dobj	32	SENT_59	[p4l455t2552r697b2625],
47	and	CC	O	and	_	0	SENT_59	[p4l732t2553r844b2609],
48	1	CD	NUMBER	1	num	51	SENT_59	[p4l884t2553r907b2608],
49	mg/ml	NN	O	mg/ml	nn	51	SENT_59	[p4l947t2552r1154b2625],
50	chicken	NN	O	chicken	nn	51	SENT_59	[p4l1188t2552r1434b2609],
51	egg	NN	O	egg	dobj	32	SENT_59	[p4l1468t2570r1580b2625],
52	white	JJ	O	white	amod	53	SENT_59	[p4l1614t2552r1789b2609],
53	lysozyme	NN	O	lysozyme	dobj	12	SENT_59	[p4l1823t2552r2143b2625],
54	.	.	O	.	_	0	SENT_59	[p4l1823t2552r2143b2625],

1	After	IN	O	after	_	0	SENT_60	[p4l12t2637r181b2693],
2	1	CD	DURATION	1	num	4	SENT_60	[p4l210t2637r233b2692],
3	hr	NN	DURATION	hr	nn	4	SENT_60	[p4l261t2637r328b2692],
4	incubation	NN	O	incubation	prep_after	11	SENT_60	[p4l349t2637r685b2693],
5	on	IN	O	on	_	0	SENT_60	[p4l708t2654r785b2693],
6	ice	NN	O	ice	prep_on	4	SENT_60	[p4l807t2637r916b2703],
7	,	,	O	,	_	0	SENT_60	[p4l807t2637r916b2703],
8	the	DT	O	the	det	9	SENT_60	[p4l941t2637r1037b2693],
9	cells	NNS	O	cell	nsubjpass	11	SENT_60	[p4l1060t2637r1202b2693],
10	were	VBD	O	be	auxpass	11	SENT_60	[p4l1227t2654r1379b2693],
11	disrupted	VBN	O	disrupt	_	0	SENT_60	[p4l1402t2637r1698b2710],
12	by	IN	O	by	_	0	SENT_60	[p4l1719t2637r1797b2709],
13	sonication	NN	O	sonication	nn	15	SENT_60	[p4l1823t2637r2148b2693],
14	(	CD	NUMBER	(	num	15	SENT_60	[p4l15t2721r383b2794],
15	Soniprobe	NNP	O	Soniprobe	agent	11	SENT_60	[p4l15t2721r383b2794],
16	,	,	O	,	_	0	SENT_60	[p4l15t2721r383b2794],
17	Dawex	NNP	ORGANIZATION	Dawex	nn	19	SENT_60	[p4l422t2722r646b2777],
18	Instruments	NNPS	ORGANIZATION	Instruments	nn	19	SENT_60	[p4l682t2722r1056b2777],
19	Ltd	NNP	ORGANIZATION	Ltd	appos	15	SENT_60	[p4l1093t2721r1220b2787],
20	,	,	O	,	_	0	SENT_60	[p4l1093t2721r1220b2787],
21	UK	NNP	LOCATION	UK	nn	22	SENT_60	[p4l1258t2722r1414b2790],
22	)	NNP	O	)	appos	19	SENT_60	[p4l1258t2722r1414b2790],
23	.	.	O	.	_	0	SENT_60	[p4l1258t2722r1414b2790],

1	After	IN	O	after	_	0	SENT_61	[p4l1453t2721r1622b2777],
2	the	DT	O	the	det	3	SENT_61	[p4l1656t2721r1751b2777],
3	addition	NN	O	addition	prep_after	16	SENT_61	[p4l1789t2721r2048b2777],
4	of	IN	O	of	_	0	SENT_61	[p4l2084t2721r2153b2777],
5	phenylmethylsulfonyl	NN	O	phenylmethylsulfonyl	nn	6	SENT_61	[p4l12t2804r713b2877],
6	ﬂuoride	NN	O	ﬂuoride	prep_of	3	SENT_61	[p4l736t2804r982b2860],
7	to	TO	O	to	_	0	SENT_61	[p4l1003t2813r1063b2860],
8	170	CD	NUMBER	170	num	10	SENT_61	[p4l1093t2805r1203b2861],
9	p.	NN	O	p.	nn	10	SENT_61	[p4l1230t2806r1364b2876],
10	M	NN	O	m	prep_to	6	SENT_61	[p4l1230t2806r1364b2876],
11	,	,	O	,	_	0	SENT_61	[p4l1230t2806r1364b2876],
12	the	DT	O	the	det	14	SENT_61	[p4l1388t2804r1484b2860],
13	soluble	JJ	O	soluble	amod	14	SENT_61	[p4l1509t2804r1734b2860],
14	fraction	NN	O	fraction	nsubjpass	16	SENT_61	[p4l1757t2804r2004b2860],
15	was	VBD	O	be	auxpass	16	SENT_61	[p4l2025t2822r2145b2861],
16	obtained	VBN	O	obtain	_	0	SENT_61	[p4l14t2888r287b2944],
17	by	IN	O	by	_	0	SENT_61	[p4l326t2888r404b2961],
18	centrifugation	NN	O	centrifugation	agent	16	SENT_61	[p4l446t2888r893b2961],
19	at	IN	O	at	_	0	SENT_61	[p4l934t2896r989b2944],
20	100,000	CD	NUMBER	100,000	number	21	SENT_61	[p4l1036t2888r1393b2960],
21	>	JJR	O	>	amod	23	SENT_61	[p4l1036t2888r1393b2960],
22	<	JJR	O	<	amod	23	SENT_61	[p4l1036t2888r1393b2960],
23	g	NN	O	g	prep_at	16	SENT_61	[p4l1036t2888r1393b2960],
24	for	IN	O	for	_	0	SENT_61	[p4l1434t2888r1526b2944],
25	1	CD	DURATION	1	num	26	SENT_61	[p4l1573t2889r1596b2944],
26	hr	NN	DURATION	hr	prep_for	23	SENT_61	[p4l1643t2888r1724b2944],
27	.	.	O	.	_	0	SENT_61	[p4l1643t2888r1724b2944],

1	For	IN	O	for	_	0	SENT_62	[p4l1768t2890r1879b2944],
2	afﬁnity	JJ	O	afﬁnity	amod	4	SENT_62	[p4l1920t2888r2147b2961],
3	chromatography	NN	O	chromatography	nn	4	SENT_62	[p4l13t2972r535b3045],
4	puriﬁcation	NN	O	puriﬁcation	prep_for	11	SENT_62	[p4l568t2972r936b3045],
5	of	IN	O	of	_	0	SENT_62	[p4l970t2972r1039b3028],
6	GSTs	NNS	O	gst	prep_of	4	SENT_62	[p4l1068t2973r1264b3039],
7	,	,	O	,	_	0	SENT_62	[p4l1068t2973r1264b3039],
8	the	DT	O	the	det	9	SENT_62	[p4l1300t2972r1396b3028],
9	supernatant	NN	O	supernatant	nsubjpass	11	SENT_62	[p4l1432t2981r1797b3045],
10	was	VBD	O	be	auxpass	11	SENT_62	[p4l1830t2990r1950b3029],
11	combined	VBN	O	combine	_	0	SENT_62	[p4l1985t2990r2145b3029, p4l11t3056r189b3113],
12	with	IN	O	with	_	0	SENT_62	[p4l213t3056r353b3113],
13	40	CD	NUMBER	40	num	15	SENT_62	[p4l376t3057r454b3113],
14	ml	NN	O	ml	nn	15	SENT_62	[p4l478t3056r560b3112],
15	S-hexylglutathione-Sepharose	NN	O	s-hexylglutathione-sepharose	prep_with	11	SENT_62	[p4l587t3056r1548b3129],
16	6B	NN	O	6b	nn	18	SENT_62	[p4l1574t3056r1659b3113],
17	afﬁnity	NN	O	afﬁnity	nn	18	SENT_62	[p4l1689t3056r1916b3129],
18	matrix	NN	O	matrix	dep	25	SENT_62	[p4l1940t3056r2147b3113],
19	in	IN	O	in	_	0	SENT_62	[p4l12t3141r73b3196],
20	buffer	NN	O	buffer	prep_in	18	SENT_62	[p4l108t3141r304b3197],
21	A	NN	O	a	dep	25	SENT_62	[p4l339t3141r395b3196],
22	(	CD	NUMBER	(	num	21	SENT_62	[p4l434t3141r536b3210],
23	10	CD	NUMBER	10	num	25	SENT_62	[p4l434t3141r536b3210],
24	mM	NN	O	mm	nn	25	SENT_62	[p4l573t3142r704b3196],
25	Tris-HCl	NN	O	tris-hcl	dep	42	SENT_62	[p4l741t3141r1045b3207],
26	,	,	O	,	_	0	SENT_62	[p4l741t3141r1045b3207],
27	pH	NN	O	ph	appos	25	SENT_62	[p4l1083t3142r1180b3214],
28	7.8	CD	NUMBER	7.8	num	27	SENT_62	[p4l1217t3141r1332b3207],
29	,	,	O	,	_	0	SENT_62	[p4l1217t3141r1332b3207],
30	1	CD	NUMBER	1	num	32	SENT_62	[p4l1379t3141r1402b3196],
31	mM	NN	O	mm	nn	32	SENT_62	[p4l1445t3142r1576b3196],
32	EDTA	NN	O	edta	appos	25	SENT_62	[p4l1613t3141r1842b3207],
33	,	,	O	,	_	0	SENT_62	[p4l1613t3141r1842b3207],
34	0.2	CD	NUMBER	0.2	num	36	SENT_62	[p4l1882t3141r1979b3197],
35	mM	NN	O	mm	nn	36	SENT_62	[p4l2016t3142r2147b3196],
36	dithiothreitol	NN	O	dithiothreitol	appos	25	SENT_62	[p4l13t3225r446b3291],
37	,	,	O	,	_	0	SENT_62	[p4l13t3225r446b3291],
38	0.02	CD	PERCENT	0.02	num	41	SENT_62	[p4l471t3225r672b3281],
39	%	NN	PERCENT	%	nn	41	SENT_62	[p4l471t3225r672b3281],
40	w/v	NN	O	w/v	nn	41	SENT_62	[p4l697t3225r814b3281],
41	NaN3	NN	O	nan3	appos	25	SENT_62	[p4l835t3226r1058b3299],
42	)	NN	O	)	dep	15	SENT_62	[p4l835t3226r1058b3299],
43	.	.	O	.	_	0	SENT_62	[p4l835t3226r1058b3299],

1	The	DT	O	the	det	2	SENT_63	[p4l1083t3225r1206b3281],
2	mixture	NN	O	mixture	nsubjpass	4	SENT_63	[p4l1227t3225r1474b3281],
3	was	VBD	O	be	auxpass	4	SENT_63	[p4l1496t3243r1616b3281],
4	kept	VBN	O	keep	_	0	SENT_63	[p4l1638t3225r1776b3298],
5	on	IN	O	on	_	0	SENT_63	[p4l1796t3243r1874b3281],
6	ice	NN	O	ice	prep_on	4	SENT_63	[p4l1894t3225r1986b3281],
7	with	IN	O	with	_	0	SENT_63	[p4l2008t3225r2148b3281],
8	gentle	JJ	O	gentle	amod	10	SENT_63	[p4l14t3309r206b3382],
9	periodic	JJ	O	periodic	amod	10	SENT_63	[p4l248t3309r508b3382],
10	agitation	NN	O	agitation	prep_with	4	SENT_63	[p4l554t3309r830b3382],
11	for	IN	O	for	_	0	SENT_63	[p4l873t3309r965b3365],
12	1	CD	DURATION	1	num	13	SENT_63	[p4l1014t3309r1037b3364],
13	hr	NN	DURATION	hr	prep_for	10	SENT_63	[p4l1086t3309r1167b3365],
14	.	.	O	.	_	0	SENT_63	[p4l1086t3309r1167b3365],

1	The	DT	O	the	det	2	SENT_64	[p4l1214t3309r1336b3365],
2	gel	NN	O	gel	nsubjpass	9	SENT_64	[p4l1379t3309r1474b3382],
3	was	VBD	O	be	auxpass	4	SENT_64	[p4l1517t3327r1637b3365],
4	packed	VBN	O	pack	_	0	SENT_64	[p4l1681t3309r1907b3382],
5	into	IN	O	into	_	0	SENT_64	[p4l1949t3309r2071b3365],
6	a	DT	O	a	det	7	SENT_64	[p4l2116t3327r2149b3365],
7	column	NN	O	column	prep_into	4	SENT_64	[p4l13t3392r251b3448],
8	and	CC	O	and	_	0	SENT_64	[p4l276t3392r389b3448],
9	washed	VBN	O	wash	conj_and	4	SENT_64	[p4l412t3392r650b3449],
10	with	IN	O	with	_	0	SENT_64	[p4l674t3392r814b3449],
11	buffer	NN	O	buffer	nn	12	SENT_64	[p4l837t3392r1033b3448],
12	A	NN	O	a	prep_with	9	SENT_64	[p4l1055t3393r1111b3448],
13	and	CC	O	and	_	0	SENT_64	[p4l1136t3392r1248b3448],
14	then	RB	O	then	advmod	9	SENT_64	[p4l1271t3392r1407b3448],
15	buffer	NN	O	buffer	dobj	17	SENT_64	[p4l1430t3392r1626b3448],
16	A	DT	O	a	dep	15	SENT_64	[p4l1648t3393r1704b3448],
17	fortiﬁed	VBN	O	fortiﬁed	conj_and	4	SENT_64	[p4l1728t3392r1984b3448],
18	with	IN	O	with	prep	17	SENT_64	[p4l2008t3392r2148b3448],

1	0.2	CD	NUMBER	0.2	num	3	SENT_65	[p5l13t21r110b77],
2	M	NN	O	m	nn	3	SENT_65	[p5l147t22r215b76],
3	NaCl	NN	O	nacl	_	0	SENT_65	[p5l252t20r419b77],
4	(	CD	NUMBER	(	num	7	SENT_65	[p5l458t20r677b90],
5	buffer	NN	O	buffer	nn	7	SENT_65	[p5l458t20r677b90],
6	B	NN	O	b	nn	7	SENT_65	[p5l712t21r806b90],
7	)	NN	O	)	dep	3	SENT_65	[p5l712t21r806b90],
8	.	.	O	.	_	0	SENT_65	[p5l712t21r806b90],

1	GST	NN	O	gst	nsubjpass	3	SENT_66	[p5l847t21r995b77],
2	was	VBD	O	be	auxpass	3	SENT_66	[p5l1032t38r1152b77],
3	eluted	VBN	O	elute	_	0	SENT_66	[p5l1191t20r1384b76],
4	with	IN	O	with	_	0	SENT_66	[p5l1420t20r1560b77],
5	buffer	NN	O	buffer	nn	6	SENT_66	[p5l1595t20r1791b76],
6	B	NN	O	b	prep_with	3	SENT_66	[p5l1826t22r1873b76],
7	supplemented	VBN	O	supplement	partmod	6	SENT_66	[p5l1917t20r2145b93, p5l13t105r247b161],
8	with	IN	O	with	_	0	SENT_66	[p5l285t104r425b161],
9	5	CD	NUMBER	5	num	11	SENT_66	[p5l463t104r496b161],
10	mM	NN	O	mm	nn	11	SENT_66	[p5l537t106r668b160],
11	S-hexylglutathione	NN	O	s-hexylglutathione	prep_with	7	SENT_66	[p5l708t104r1330b177],
12	.	.	O	.	_	0	SENT_66	[p5l708t104r1330b177],

1	The	DT	O	the	nsubjpass	5	SENT_67	[p5l1371t104r1493b161],
2	eluted	VBN	O	elute	partmod	1	SENT_67	[p5l1532t105r1726b161],
3	protein	NN	O	protein	dobj	2	SENT_67	[p5l1762t104r1988b177],
4	was	VBD	O	be	auxpass	5	SENT_67	[p5l2026t122r2146b161],
5	concentrated	VBN	O	concentrate	_	0	SENT_67	[p5l13t189r420b245],
6	using	VBG	O	use	xcomp	5	SENT_67	[p5l444t189r615b262],
7	a	DT	O	a	det	10	SENT_67	[p5l642t206r675b245],
8	PLGC	NN	O	plgc	nn	10	SENT_67	[p5l698t189r899b245],
9	membrane	NN	O	membrane	nn	10	SENT_67	[p5l925t189r1261b245],
10	NMLW	NN	O	nmlw	dobj	6	SENT_67	[p5l1286t190r1538b245],
11	10000	CD	NUMBER	10000	number	12	SENT_67	[p5l1570t189r1760b245],
12	(	CD	NUMBER	(	dep	10	SENT_67	[p5l1787t189r2149b258],
13	Pharmacia	NNP	ORGANIZATION	Pharmacia	nn	18	SENT_67	[p5l1787t189r2149b258],
14	Biotech	NNP	ORGANIZATION	Biotech	nn	18	SENT_67	[p5l13t273r277b339],
15	,	,	O	,	_	0	SENT_67	[p5l13t273r277b339],
16	Uppsala	NNP	LOCATION	Uppsala	appos	18	SENT_67	[p5l301t273r579b346],
17	,	,	O	,	_	0	SENT_67	[p5l301t273r579b346],
18	Sweden	NNP	LOCATION	Sweden	dep	12	SENT_67	[p5l605t273r896b342],
19	)	CD	NUMBER	)	num	18	SENT_67	[p5l605t273r896b342],
20	.	.	O	.	_	0	SENT_67	[p5l605t273r896b342],

1	The	DT	O	the	det	3	SENT_68	[p5l921t273r1044b329],
2	concentrated	JJ	O	concentrated	amod	3	SENT_68	[p5l1066t273r1473b329],
3	protein	NN	O	protein	nsubjpass	5	SENT_68	[p5l1492t273r1718b346],
4	was	VBD	O	be	auxpass	5	SENT_68	[p5l1740t291r1860b329],
5	dialysed	VBN	O	dialyse	_	0	SENT_68	[p5l1883t273r2148b346],
6	against	IN	O	against	_	0	SENT_68	[p5l14t356r239b429],
7	buffer	NN	O	buffer	nn	8	SENT_68	[p5l259t356r456b412],
8	A.	NN	O	a.	prep_against	5	SENT_68	[p5l477t357r548b412],
9	The	NNP	O	The	nn	11	SENT_68	[p5l575t356r697b412],
10	protein	NN	O	protein	nn	11	SENT_68	[p5l719t356r945b429],
11	concentration	NN	O	concentration	nsubjpass	13	SENT_68	[p5l968t356r1402b412],
12	was	VBD	O	be	auxpass	13	SENT_68	[p5l1425t374r1545b413],
13	determined	VBN	O	determine	rcmod	8	SENT_68	[p5l1571t356r1929b412],
14	by	IN	O	by	_	0	SENT_68	[p5l1950t356r2028b429],
15	the	DT	O	the	det	16	SENT_68	[p5l2051t356r2147b412],
16	method	NN	O	method	agent	13	SENT_68	[p5l13t440r252b496],
17	of	IN	O	of	_	0	SENT_68	[p5l281t440r350b496],
18	Lowry	NNP	PERSON	Lowry	prep_of	16	SENT_68	[p5l373t442r584b513],
19	et	FW	O	et	nn	20	SENT_68	[p5l615t451r672b496],
20	al.	FW	O	al.	tmod	13	SENT_68	[p5l698t440r835b496],
21	56	CD	NUMBER	56	dep	20	SENT_68	[p5l698t440r835b496],

1	Sodium	NN	O	sodium	nn	2	SENT_69	[p5l13t574r251b631],
2	dodecyl	NN	O	dodecyl	_	0	SENT_69	[p5l279t574r528b646],
3	sulphate-polyacrylamide	JJ	O	sulphate-polyacrylamide	amod	5	SENT_69	[p5l556t574r1349b646],
4	gel	NN	O	gel	nn	5	SENT_69	[p5l1378t574r1476b646],
5	electrophoresis	NN	O	electrophoresis	dep	2	SENT_69	[p5l1504t574r1995b646],
6	and	CC	O	and	_	0	SENT_69	[p5l2024t574r2146b630],
7	isoelectric	JJ	O	isoelectric	conj_and	2	SENT_69	[p5l15t658r344b714],
8	focusing	VBG	O	focus	partmod	7	SENT_69	[p5l360t658r642b730],

1	Sodium	NN	O	sodium	nn	2	SENT_70	[p5l95t758r341b815],
2	dodecyl	NN	O	dodecyl	nsubjpass	10	SENT_70	[p5l388t758r638b831],
3	sulphate-polyacrylamide	JJ	O	sulphate-polyacrylamide	amod	8	SENT_70	[p5l688t758r1475b831],
4	gel	NN	O	gel	nn	8	SENT_70	[p5l1523t758r1618b831],
5	electrophoresis	NN	O	electrophoresis	nn	8	SENT_70	[p5l1665t758r2146b831],
6	(	CD	NUMBER	(	num	8	SENT_70	[p5l15t843r444b912],
7	SDS-PAGE	NN	O	sds-page	nn	8	SENT_70	[p5l15t843r444b912],
8	)	NN	O	)	dep	2	SENT_70	[p5l15t843r444b912],
9	was	VBD	O	be	auxpass	10	SENT_70	[p5l468t860r588b899],
10	carried	VBN	O	carry	_	0	SENT_70	[p5l612t842r832b899],
11	out	RP	O	out	prt	10	SENT_70	[p5l853t851r954b898],
12	using	VBG	O	use	xcomp	10	SENT_70	[p5l973t842r1144b915],
13	puriﬁed	JJ	O	puriﬁed	amod	15	SENT_70	[p5l1165t842r1414b915],
14	GST	NN	O	gst	nn	15	SENT_70	[p5l1435t843r1584b899],
15	fractions	NNS	O	fraction	dobj	12	SENT_70	[p5l1605t842r1881b899],
16	on	IN	O	on	_	0	SENT_70	[p5l1905t860r1981b898],
17	15	CD	PERCENT	15	number	18	SENT_70	[p5l2010t842r2144b899],
18	%	NN	PERCENT	%	amod	20	SENT_70	[p5l2010t842r2144b899],
19	slab	NN	O	slab	nn	20	SENT_70	[p5l15t926r138b983],
20	gels	NNS	O	gel	prep_on	12	SENT_70	[p5l174t927r298b999],
21	as	IN	O	as	mark	22	SENT_70	[p5l336t944r397b983],
22	described	VBN	O	describe	advcl	12	SENT_70	[p5l433t926r738b983],
23	by	IN	O	by	_	0	SENT_70	[p5l770t927r849b999],
24	Laemmli57	NN	O	laemmli57	prep_by	22	SENT_70	[p5l883t926r1226b983],
25	using	VBG	O	use	partmod	24	SENT_70	[p5l1261t926r1432b999],
26	a	DT	O	a	det	32	SENT_70	[p5l1469t944r1502b983],
27	Hoefer	NNP	O	Hoefer	nn	32	SENT_70	[p5l1534t926r1756b983],
28	SE	NN	O	se	nn	32	SENT_70	[p5l1791t927r1880b983],
29	Mighty	NNP	O	Mighty	nn	32	SENT_70	[p5l1913t926r2147b999],
30	Small	NNP	O	Small	nn	32	SENT_70	[p5l15t1011r197b1067],
31	electrophoresis	NN	O	electrophoresis	nn	32	SENT_70	[p5l239t1011r719b1084],
32	system	NN	O	system	dobj	25	SENT_70	[p5l763t1019r982b1083],
33	or	CC	O	or	_	0	SENT_70	[p5l1022t1028r1087b1067],
34	Biorad	NNP	O	Biorad	nn	37	SENT_70	[p5l1126t1011r1342b1067],
35	Protean	NNP	O	Protean	nn	37	SENT_70	[p5l1382t1012r1625b1067],
36	electrophoresis	NN	O	electrophoresis	nn	37	SENT_70	[p5l1666t1011r2146b1084],
37	system	NN	O	system	dobj	25	SENT_70	[p5l15t1104r249b1168],
38	.	.	O	.	_	0	SENT_70	[p5l15t1104r249b1168],

1	Protein	NN	O	protein	nn	2	SENT_71	[p5l282t1095r512b1151],
2	bands	NNS	O	band	nsubjpass	4	SENT_71	[p5l540t1095r724b1151],
3	were	VBD	O	be	auxpass	4	SENT_71	[p5l756t1113r909b1151],
4	stained	VBN	O	stain	_	0	SENT_71	[p5l941t1095r1164b1151],
5	with	IN	O	with	_	0	SENT_71	[p5l1193t1095r1334b1151],
6	Coomassie	NNP	PERSON	Coomassie	nn	7	SENT_71	[p5l1364t1095r1712b1151],
7	Blue-G	NNP	O	Blue-G	prep_with	4	SENT_71	[p5l1742t1095r1991b1151],
8	.	.	O	.	_	0	SENT_71	[p5l1742t1095r1991b1151],

1	Analytical	NNP	MISC	Analytical	nsubjpass	5	SENT_72	[p5l2025t1095r2145b1150, p5l14t1179r246b1252],
2	isoelectric	JJ	O	isoelectric	amod	1	SENT_72	[p5l280t1179r606b1235],
3	focusing	VBG	O	focus	dep	2	SENT_72	[p5l641t1179r914b1252],
4	was	VBD	O	be	auxpass	5	SENT_72	[p5l950t1197r1070b1235],
5	carried	VBN	O	carry	dep	10	SENT_72	[p5l1106t1179r1326b1235],
6	out	RP	O	out	prt	5	SENT_72	[p5l1360t1187r1461b1235],
7	on	IN	O	on	_	0	SENT_72	[p5l1495t1197r1572b1235],
8	precast	JJ	O	precast	amod	9	SENT_72	[p5l1605t1188r1832b1252],
9	gels	NNS	O	gel	prep_on	5	SENT_72	[p5l1865t1179r1989b1252],
10	(	VBP	O	(	_	0	SENT_72	[p5l2028t1180r2147b1252],
11	pH	NN	O	ph	nn	13	SENT_72	[p5l2028t1180r2147b1252],
12	3-10	CD	NUMBER	3-10	num	13	SENT_72	[p5l15t1262r195b1332],
13	)	NN	O	)	dobj	10	SENT_72	[p5l15t1262r195b1332],
14	following	VBG	O	follow	_	0	SENT_72	[p5l229t1262r537b1335],
15	the	DT	O	the	det	16	SENT_72	[p5l569t1262r665b1318],
16	manufacturer	NN	O	manufacturer	poss	18	SENT_72	[p5l696t1262r1177b1318],
17	’s	POS	O	’s	_	0	SENT_72	[p5l696t1262r1177b1318],
18	instructions	NNS	O	instruction	prep_following	10	SENT_72	[p5l1211t1262r1580b1318],
19	(	CD	NUMBER	(	num	22	SENT_72	[p5l1616t1262r1977b1332],
20	Pharmacia	NNP	ORGANIZATION	Pharmacia	nn	22	SENT_72	[p5l1616t1262r1977b1332],
21	Biotech	NNP	ORGANIZATION	Biotech	nn	22	SENT_72	[p5l2007t1262r2145b1318, p5l12t1346r187b1415],
22	)	NN	O	)	nsubj	10	SENT_72	[p5l2007t1262r2145b1318, p5l12t1346r187b1415],
23	.	.	O	.	_	0	SENT_72	[p5l2007t1262r2145b1318, p5l12t1346r187b1415],

1	Assay	NN	O	assay	_	0	SENT_73	[p5l7t1481r197b1552],
2	of	IN	O	of	_	0	SENT_73	[p5l227t1481r300b1552],
3	GST	NN	O	gst	nn	4	SENT_73	[p5l318t1481r463b1537],
4	activity	NN	O	activity	prep_of	1	SENT_73	[p5l484t1482r718b1552],
5	and	CC	O	and	_	0	SENT_73	[p5l747t1480r868b1537],
6	inhibition	NN	O	inhibition	prep_of	1	SENT_73	[p5l897t1480r1202b1537],
7	by	IN	O	by	_	0	SENT_73	[p5l1232t1480r1305b1552],
8	antimalarials	NNS	O	antimalarial	prep_by	1	SENT_73	[p5l1334t1480r1763b1537],

1	Enzyme	NN	O	enzyme	nn	2	SENT_74	[p5l92t1582r353b1653],
2	activity	NN	O	activity	nsubjpass	4	SENT_74	[p5l395t1580r631b1653],
3	was	VBD	O	be	auxpass	4	SENT_74	[p5l672t1598r793b1637],
4	assessed	VBN	O	assess	_	0	SENT_74	[p5l837t1580r1105b1637],
5	by	IN	O	by	_	0	SENT_74	[p5l1143t1580r1222b1653],
6	measuring	VBG	O	measure	agent	4	SENT_74	[p5l1263t1580r1594b1653],
7	the	DT	O	the	det	9	SENT_74	[p5l1635t1580r1730b1637],
8	conjugating	VBG	O	conjugate	amod	9	SENT_74	[p5l1772t1580r2146b1653],
9	activity	NN	O	activity	dobj	6	SENT_74	[p5l14t1664r250b1737],
10	with	IN	O	with	_	0	SENT_74	[p5l288t1664r428b1721],
11	CDNB	NN	O	cdnb	prep_with	9	SENT_74	[p5l464t1665r701b1731],
12	,	,	O	,	_	0	SENT_74	[p5l464t1665r701b1731],
13	ETA48	NN	O	eta48	conj_and	11	SENT_74	[p5l740t1665r950b1720],
14	and	CC	O	and	_	0	SENT_74	[p5l989t1665r1102b1721],
15	denitrosation	NN	O	denitrosation	conj_and	11	SENT_74	[p5l1138t1664r1554b1721],
16	of	IN	O	of	_	0	SENT_74	[p5l1591t1664r1660b1721],
17	BCNU	NNP	O	BCNU	prep_of	9	SENT_74	[p5l1690t1665r1988b1721],
18	.49	CD	NUMBER	.49	num	17	SENT_74	[p5l1690t1665r1988b1721],
19	The	DT	O	the	det	20	SENT_74	[p5l2025t1665r2147b1721],
20	assay	NN	O	assay	nsubjpass	24	SENT_74	[p5l14t1766r183b1821],
21	with	IN	O	with	_	0	SENT_74	[p5l215t1749r355b1805],
22	CDNB	NN	ORGANIZATION	cdnb	prep_with	20	SENT_74	[p5l386t1749r601b1805],
23	was	VBD	O	be	auxpass	24	SENT_74	[p5l637t1766r757b1805],
24	adapted	VBN	O	adapt	parataxis	4	SENT_74	[p5l791t1749r1037b1822],
25	so	RB	O	so	advmod	29	SENT_74	[p5l1070t1766r1135b1805],
26	that	IN	O	that	dep	29	SENT_74	[p5l1167t1749r1286b1805],
27	absorbance	NN	O	absorbance	nsubjpass	29	SENT_74	[p5l1317t1749r1673b1805],
28	was	VBD	O	be	auxpass	29	SENT_74	[p5l1704t1766r1824b1805],
29	read	VBN	O	read	advcl	24	SENT_74	[p5l1856t1749r1993b1805],
30	in	IN	O	in	_	0	SENT_74	[p5l2023t1749r2084b1804],
31	a	DT	O	a	det	36	SENT_74	[p5l2115t1766r2149b1805],
32	SpectraMax	NN	O	spectramax	nn	36	SENT_74	[p5l15t1833r397b1906],
33	340	CD	NUMBER	340	num	36	SENT_74	[p5l435t1833r551b1889],
34	ELISA	NN	O	elisa	nn	36	SENT_74	[p5l586t1833r811b1889],
35	plate	NN	O	plate	nn	36	SENT_74	[p5l845t1833r1000b1905],
36	reader	NN	O	reader	prep_in	29	SENT_74	[p5l1034t1833r1235b1889],
37	(	CD	NUMBER	(	num	39	SENT_74	[p5l1271t1833r1624b1902],
38	Molecular	JJ	ORGANIZATION	molecular	amod	39	SENT_74	[p5l1271t1833r1624b1902],
39	Devices	NNPS	ORGANIZATION	Devices	dep	36	SENT_74	[p5l1658t1833r1912b1889],
40	Corp.	NNP	ORGANIZATION	Corp.	dep	45	SENT_74	[p5l1950t1833r2144b1906],
41	,	,	O	,	_	0	SENT_74	[p5l1950t1833r2144b1906],
42	Sunnyvale	NNP	LOCATION	Sunnyvale	dep	40	SENT_74	[p5l15t1917r366b1990],
43	,	,	O	,	_	0	SENT_74	[p5l15t1917r366b1990],
44	CA	NNP	LOCATION	CA	nn	45	SENT_74	[p5l393t1917r545b1986],
45	)	NNP	O	)	dep	39	SENT_74	[p5l393t1917r545b1986],
46	,	,	O	,	_	0	SENT_74	[p5l393t1917r545b1986],
47	whilst	IN	O	whilst	mark	52	SENT_74	[p5l572t1917r767b1973],
48	activity	NN	O	activity	nsubjpass	52	SENT_74	[p5l791t1917r1026b1990],
49	with	IN	O	with	_	0	SENT_74	[p5l1051t1917r1191b1973],
50	ETA	NNP	ORGANIZATION	ETA	prep_with	48	SENT_74	[p5l1214t1917r1368b1972],
51	was	VBD	O	be	auxpass	52	SENT_74	[p5l1392t1935r1512b1973],
52	determined	VBN	O	determine	dep	4	SENT_74	[p5l1538t1917r1896b1973],
53	using	VBG	O	use	xcomp	52	SENT_74	[p5l1919t1917r2089b1990],
54	a	DT	O	a	det	57	SENT_74	[p5l2115t1935r2149b1973],
55	Shimadzu	NNP	ORGANIZATION	Shimadzu	nn	57	SENT_74	[p5l15t2000r331b2057],
56	UV	NN	O	uv	nn	57	SENT_74	[p5l375t2002r489b2057],
57	spectrophotometer	NN	O	spectrophotometer	dobj	53	SENT_74	[p5l536t2000r1145b2073],
58	,	,	O	,	_	0	SENT_74	[p5l536t2000r1145b2073],
59	UV1601	NN	O	uv1601	nn	61	SENT_74	[p5l1192t2000r1459b2057],
60	(	CD	NUMBER	(	num	61	SENT_74	[p5l1513t2000r1873b2069],
61	Shimadzu	NNP	ORGANIZATION	Shimadzu	appos	57	SENT_74	[p5l1513t2000r1873b2069],
62	,	,	O	,	_	0	SENT_74	[p5l1513t2000r1873b2069],
63	Tokyo	NNP	LOCATION	Tokyo	appos	57	SENT_74	[p5l1920t2000r2144b2073],
64	,	,	O	,	_	0	SENT_74	[p5l1920t2000r2144b2073],
65	Japan	NNP	LOCATION	Japan	appos	57	SENT_74	[p5l12t2085r236b2157],
66	)	CD	NUMBER	)	num	65	SENT_74	[p5l12t2085r236b2157],
67	.	.	O	.	_	0	SENT_74	[p5l12t2085r236b2157],

1	For	IN	O	for	_	0	SENT_75	[p5l270t2086r381b2141],
2	the	DT	O	the	det	3	SENT_75	[p5l409t2084r505b2140],
3	determination	NN	O	determination	prep_for	26	SENT_75	[p5l536t2084r978b2141],
4	of	IN	O	of	_	0	SENT_75	[p5l1009t2084r1078b2141],
5	the	DT	O	the	det	6	SENT_75	[p5l1103t2084r1198b2141],
6	concentration	NN	O	concentration	prep_of	3	SENT_75	[p5l1230t2084r1663b2141],
7	of	IN	O	of	_	0	SENT_75	[p5l1694t2084r1763b2140],
8	inhibitor	NN	O	inhibitor	prep_of	6	SENT_75	[p5l1788t2084r2063b2141],
9	at	IN	O	at	_	0	SENT_75	[p5l2093t2093r2149b2141],
10	which	WDT	O	which	rel	18	SENT_75	[p5l13t2168r207b2225],
11	50	CD	PERCENT	50	number	12	SENT_75	[p5l233t2168r373b2225],
12	%	NN	PERCENT	%	amod	13	SENT_75	[p5l233t2168r373b2225],
13	inhibition	NN	O	inhibition	nsubjpass	18	SENT_75	[p5l402t2168r712b2225],
14	of	IN	O	of	_	0	SENT_75	[p5l739t2168r807b2225],
15	enzyme	NN	O	enzyme	nn	16	SENT_75	[p5l829t2186r1075b2241],
16	activity	NN	O	activity	prep_of	13	SENT_75	[p5l1103t2168r1338b2241],
17	was	VBD	O	be	auxpass	18	SENT_75	[p5l1365t2186r1485b2225],
18	obtained	VBN	O	obtain	rcmod	3	SENT_75	[p5l1514t2168r1787b2225],
19	(	JJ	O	(	amod	21	SENT_75	[p5l1815t2169r2023b2242],
20	IC50	NN	O	ic50	nn	21	SENT_75	[p5l1815t2169r2023b2242],
21	)	NN	O	)	dobj	18	SENT_75	[p5l1815t2169r2023b2242],
22	,	,	O	,	_	0	SENT_75	[p5l1815t2169r2023b2242],
23	the	DT	O	the	det	25	SENT_75	[p5l2051t2169r2147b2225],
24	reaction	NN	O	reaction	nn	25	SENT_75	[p5l12t2252r269b2309],
25	mixture	NN	O	mixture	nsubj	26	SENT_75	[p5l303t2252r550b2309],
26	contained	VBD	O	contain	_	0	SENT_75	[p5l585t2252r895b2309],
27	15	CD	NUMBER	15	num	28	SENT_75	[p5l936t2252r1003b2309],
28	ul	NN	O	ul	dobj	26	SENT_75	[p5l1046t2253r1114b2325],
29	of	IN	O	of	_	0	SENT_75	[p5l1150t2252r1218b2309],
30	antimalarial	JJ	O	antimalarial	amod	46	SENT_75	[p5l1249t2252r1628b2309],
31	in	IN	O	in	_	0	SENT_75	[p5l1663t2252r1723b2308],
32	either	CC	O	either	advmod	34	SENT_75	[p5l1758t2252r1939b2309],
33	phosphate	NN	O	phosphate	nn	34	SENT_75	[p5l1970t2253r2145b2325, p5l12t2337r184b2410],
34	buffer	NN	O	buffer	prep_in	30	SENT_75	[p5l220t2337r416b2393],
35	(	CD	NUMBER	(	number	36	SENT_75	[p5l455t2337r570b2406],
36	0.1	CD	NUMBER	0.1	dep	37	SENT_75	[p5l455t2337r570b2406],
37	M	NN	O	m	dep	34	SENT_75	[p5l614t2338r700b2403],
38	,	,	O	,	_	0	SENT_75	[p5l614t2338r700b2403],
39	1	CD	NUMBER	1	num	41	SENT_75	[p5l748t2337r771b2392],
40	mM	NN	O	mm	nn	41	SENT_75	[p5l815t2338r946b2392],
41	EDTA	NN	O	edta	appos	34	SENT_75	[p5l984t2337r1220b2406],
42	)	CD	NUMBER	)	num	45	SENT_75	[p5l984t2337r1220b2406],
43	or	CC	O	or	_	0	SENT_75	[p5l1260t2354r1325b2393],
44	95	CD	PERCENT	95	num	45	SENT_75	[p5l1362t2336r1503b2394],
45	%	NN	PERCENT	%	dep	41	SENT_75	[p5l1362t2336r1503b2394],
46	ethanol	NN	O	ethanol	prep_of	28	SENT_75	[p5l1544t2337r1793b2393],
47	.	.	O	.	_	0	SENT_75	[p5l1544t2337r1793b2393],

1	The	DT	O	the	det	4	SENT_76	[p5l1834t2337r1956b2393],
2	ETA	NNP	O	ETA	nn	4	SENT_76	[p5l1994t2337r2148b2392],
3	conjugation	NN	O	conjugation	nn	4	SENT_76	[p5l13t2421r389b2494],
4	reaction	NN	O	reaction	nsubjpass	6	SENT_76	[p5l422t2421r680b2477],
5	was	VBD	O	be	auxpass	6	SENT_76	[p5l715t2439r835b2477],
6	initiated	VBN	O	initiate	_	0	SENT_76	[p5l871t2421r1132b2477],
7	by	IN	O	by	_	0	SENT_76	[p5l1165t2421r1244b2494],
8	addition	NN	O	addition	agent	6	SENT_76	[p5l1281t2421r1540b2477],
9	of	IN	O	of	_	0	SENT_76	[p5l1575t2421r1644b2477],
10	25	CD	NUMBER	25	num	12	SENT_76	[p5l1674t2421r1748b2477],
11	Ml	NN	O	ml	nn	12	SENT_76	[p5l1792t2421r1859b2493],
12	ETA	NNP	ORGANIZATION	ETA	prep_of	8	SENT_76	[p5l1894t2421r2048b2476],
13	(	CD	NUMBER	(	number	14	SENT_76	[p5l2085t2421r2144b2490],
14	8	CD	NUMBER	8	num	15	SENT_76	[p5l2085t2421r2144b2490],
15	mM	NN	O	mm	dep	8	SENT_76	[p5l8t2506r140b2560],
16	in	IN	O	in	_	0	SENT_76	[p5l169t2505r230b2560],
17	ethanolic	JJ	O	ethanolic	amod	19	SENT_76	[p5l259t2505r549b2561],
18	solution	NN	O	solution	nn	19	SENT_76	[p5l582t2505r860b2574],
19	)	NN	O	)	prep_in	15	SENT_76	[p5l582t2505r860b2574],
20	and	CC	O	and	_	0	SENT_76	[p5l893t2505r1005b2561],
21	50	CD	NUMBER	50	num	23	SENT_76	[p5l1035t2505r1111b2561],
22	pl	NN	O	pl	nn	23	SENT_76	[p5l1146t2505r1214b2577],
23	GSH	NN	O	gsh	conj_and	8	SENT_76	[p5l1245t2505r1401b2561],
24	(	CD	NUMBER	(	number	25	SENT_76	[p5l1433t2505r1492b2574],
25	5	CD	NUMBER	5	num	26	SENT_76	[p5l1433t2505r1492b2574],
26	mM	NN	O	mm	dep	23	SENT_76	[p5l1524t2506r1655b2560],
27	in	IN	O	in	_	0	SENT_76	[p5l1684t2505r1745b2560],
28	buffer	NN	O	buffer	nn	29	SENT_76	[p5l1773t2505r1992b2574],
29	)	NN	O	)	prep_in	6	SENT_76	[p5l1773t2505r1992b2574],
30	in	IN	O	in	_	0	SENT_76	[p5l2023t2505r2084b2560],
31	a	DT	O	a	det	34	SENT_76	[p5l2114t2523r2147b2561],
32	1,000	CD	NUMBER	1,000	num	34	SENT_76	[p5l16t2588r186b2655],
33	p.l	NN	O	p.l	nn	34	SENT_76	[p5l217t2588r284b2660],
34	mixture	NN	O	mixture	prep_in	29	SENT_76	[p5l310t2588r573b2644],
35	.	.	O	.	_	0	SENT_76	[p5l310t2588r573b2644],

1	The	DT	O	the	det	3	SENT_77	[p5l602t2588r724b2644],
2	ﬁnal	JJ	O	ﬁnal	amod	3	SENT_77	[p5l749t2588r889b2644],
3	concentration	NN	O	concentration	nsubj	10	SENT_77	[p5l914t2588r1348b2644],
4	of	IN	O	of	_	0	SENT_77	[p5l1374t2588r1443b2644],
5	ethanol	NN	O	ethanol	prep_of	3	SENT_77	[p5l1463t2588r1696b2644],
6	was	VBD	O	be	cop	10	SENT_77	[p5l1721t2606r1841b2645],
7	less	JJR	O	less	mwe	8	SENT_77	[p5l1868t2588r1984b2644],
8	than	IN	O	than	quantmod	9	SENT_77	[p5l2010t2588r2147b2644],
9	5	CD	PERCENT	5	num	10	SENT_77	[p5l10t2672r129b2729],
10	%	NN	PERCENT	%	_	0	SENT_77	[p5l10t2672r129b2729],
11	.	.	O	.	_	0	SENT_77	[p5l10t2672r129b2729],

1	The	DT	O	the	det	2	SENT_78	[p5l169t2672r291b2728],
2	blanks	NNS	O	blank	nsubj	3	SENT_78	[p5l326t2672r532b2729],
3	contained	VBD	O	contain	_	0	SENT_78	[p5l570t2672r880b2729],
4	all	DT	O	all	det	5	SENT_78	[p5l916t2672r992b2729],
5	components	NNS	O	component	dobj	3	SENT_78	[p5l1029t2681r1412b2745],
6	except	IN	O	except	_	0	SENT_78	[p5l1450t2681r1658b2745],
7	for	IN	O	for	prepc_except_for	3	SENT_78	[p5l1692t2672r1785b2729],
8	GST	NN	O	gst	pobj	3	SENT_78	[p5l1820t2673r1984b2729],
9	.	.	O	.	_	0	SENT_78	[p5l1820t2673r1984b2729],

1	The	DT	O	the	det	3	SENT_79	[p5l2024t2672r2146b2728],
2	IC50	NN	O	ic50	nn	3	SENT_79	[p5l9t2757r149b2830],
3	values	NNS	O	value	nsubjpass	5	SENT_79	[p5l173t2757r373b2813],
4	were	VBD	O	be	auxpass	5	SENT_79	[p5l399t2774r553b2813],
5	determined	VBN	O	determine	_	0	SENT_79	[p5l577t2756r936b2813],
6	from	IN	O	from	_	0	SENT_79	[p5l959t2756r1113b2813],
7	plots	NNS	O	plot	prep_from	5	SENT_79	[p5l1135t2757r1288b2829],
8	of	IN	O	of	_	0	SENT_79	[p5l1314t2756r1383b2813],
9	percent	NN	O	percent	nn	11	SENT_79	[p5l1401t2765r1637b2829],
10	control	NN	O	control	nn	11	SENT_79	[p5l1660t2756r1884b2813],
11	activity	NN	O	activity	prep_of	7	SENT_79	[p5l1909t2756r2146b2829],
12	vs.	CC	O	vs.	_	0	SENT_79	[p5l9t2860r85b2897],
13	log	NN	O	log	nn	19	SENT_79	[p5l122t2841r221b2913],
14	inhibitor	NN	O	inhibitor	nn	19	SENT_79	[p5l251t2840r527b2897],
15	concentration	NN	O	concentration	nn	19	SENT_79	[p5l555t2840r989b2897],
16	(	CD	NUMBER	(	num	19	SENT_79	[p5l1020t2840r1658b2910],
17	GraFitTM-Erithacus	NNP	O	GraFitTM-Erithacus	nn	19	SENT_79	[p5l1020t2840r1658b2910],
18	Software	NNP	O	Software	nn	19	SENT_79	[p5l1691t2840r2019b2910],
19	)	NN	O	)	conj_vs.	11	SENT_79	[p5l1691t2840r2019b2910],
20	.	.	O	.	_	0	SENT_79	[p5l1691t2840r2019b2910],

1	Inactivation	NN	O	inactivation	_	0	SENT_80	[p5l7t2976r393b3030],
2	of	IN	O	of	_	0	SENT_80	[p5l424t2974r496b3045],
3	the	DT	O	the	det	5	SENT_80	[p5l514t2973r606b3030],
4	anticancer	JJ	O	anticancer	amod	5	SENT_80	[p5l637t2976r981b3030],
5	drug	NN	O	drug	prep_of	1	SENT_80	[p5l1006t2973r1155b3045],
6	BCN	NNP	O	BCN	nn	7	SENT_80	[p5l1183t2975r1345b3030],
7	U	NNP	O	U	dep	1	SENT_80	[p5l1348t2976r1402b3030],
8	by	IN	O	by	_	0	SENT_80	[p5l1426t2973r1499b3045],
9	GST	NN	O	gst	nn	10	SENT_80	[p5l1531t2975r1676b3030],
10	MI-I	NN	O	mi-i	prep_by	7	SENT_80	[p5l1695t2974r1863b3029],

1	The	DT	O	the	det	2	SENT_81	[p5l89t3073r211b3130],
2	formation	NN	O	formation	nsubjpass	6	SENT_81	[p5l242t3073r556b3130],
3	of	IN	O	of	_	0	SENT_81	[p5l588t3073r657b3130],
4	nitrite	NN	O	nitrite	prep_of	2	SENT_81	[p5l682t3073r871b3130],
5	was	VBD	O	be	auxpass	6	SENT_81	[p5l903t3091r1023b3130],
6	used	VBN	O	use	_	0	SENT_81	[p5l1055t3074r1201b3130],
7	as	IN	O	as	_	0	SENT_81	[p5l1233t3091r1293b3130],
8	an	DT	O	a	det	9	SENT_81	[p5l1328t3091r1400b3130],
9	index	NN	O	index	prep_as	6	SENT_81	[p5l1430t3073r1606b3130],
10	of	IN	O	of	_	0	SENT_81	[p5l1638t3073r1707b3130],
11	BCNU	NN	O	bcnu	nn	12	SENT_81	[p5l1732t3074r1953b3130],
12	denitrosation	NN	O	denitrosation	prep_of	9	SENT_81	[p5l1984t3073r2144b3130, p6l8t21r303b77],
13	.	.	O	.	_	0	SENT_81	[p5l1984t3073r2144b3130, p6l8t21r303b77],

1	The	DT	O	the	det	2	SENT_82	[p6l338t21r461b77],
2	effect	NN	O	effect	nsubjpass	18	SENT_82	[p6l493t21r674b77],
3	of	IN	O	of	_	0	SENT_82	[p6l704t21r773b77],
4	increasing	VBG	O	increase	prepc_of	2	SENT_82	[p6l799t21r1125b94],
5	the	DT	O	the	det	6	SENT_82	[p6l1157t21r1253b77],
6	concentration	NN	O	concentration	dobj	4	SENT_82	[p6l1285t21r1719b77],
7	of	IN	O	of	_	0	SENT_82	[p6l1751t21r1820b77],
8	quinidine	NN	O	quinidine	nn	11	SENT_82	[p6l1846t21r2146b94],
9	(	CD	NUMBER	(	num	11	SENT_82	[p6l11t105r231b175],
10	QND	NN	O	qnd	nn	11	SENT_82	[p6l11t105r231b175],
11	)	NN	O	)	prep_of	6	SENT_82	[p6l11t105r231b175],
12	and	CC	O	and	_	0	SENT_82	[p6l265t105r377b161],
13	quinine	NN	O	quinine	dobj	4	SENT_82	[p6l406t105r644b178],
14	on	IN	O	on	_	0	SENT_82	[p6l674t123r752b161],
15	GST	NN	MISC	gst	nn	16	SENT_82	[p6l782t105r930b161],
16	M1-1	NN	MISC	m1-1	prep_on	13	SENT_82	[p6l959t105r1128b160],
17	was	VBD	O	be	auxpass	18	SENT_82	[p6l1165t123r1286b161],
18	investigated	VBN	O	investigate	_	0	SENT_82	[p6l1316t105r1718b178],
19	.	.	O	.	_	0	SENT_82	[p6l1316t105r1718b178],

1	The	DT	O	the	det	2	SENT_83	[p6l1752t105r1874b161],
2	antimalarials	NNS	O	antimalarial	nsubjpass	4	SENT_83	[p6l1905t105r2144b161, p6l9t188r201b244],
3	were	VBD	O	be	auxpass	4	SENT_83	[p6l236t206r389b244],
4	added	VBN	O	add	_	0	SENT_83	[p6l424t188r613b244],
5	at	IN	O	at	_	0	SENT_83	[p6l648t196r703b244],
6	ﬁnal	JJ	O	ﬁnal	amod	7	SENT_83	[p6l736t188r875b244],
7	concentrations	NNS	O	concentration	prep_at	4	SENT_83	[p6l910t188r1373b244],
8	of	IN	O	of	_	0	SENT_83	[p6l1409t188r1478b244],
9	25	CD	NUMBER	25	prep_of	7	SENT_83	[p6l1508t188r1601b254],
10	,	,	O	,	_	0	SENT_83	[p6l1508t188r1601b254],
11	50	CD	NUMBER	50	prep_of	7	SENT_83	[p6l1639t188r1733b254],
12	,	,	O	,	_	0	SENT_83	[p6l1639t188r1733b254],
13	75	CD	NUMBER	75	prep_of	7	SENT_83	[p6l1770t188r1844b244],
14	and	CC	O	and	_	0	SENT_83	[p6l1883t188r1996b244],
15	100	CD	NUMBER	100	num	17	SENT_83	[p6l2036t188r2146b244],
16	p.M.	NNP	O	p.M.	nn	17	SENT_83	[p6l14t273r147b343],
17	Blanks	NNPS	O	Blanks	conj_and	9	SENT_83	[p6l172t271r391b327],
18	containing	VBG	O	contain	ccomp	4	SENT_83	[p6l414t271r749b344],
19	no	DT	O	no	det	20	SENT_83	[p6l771t289r848b327],
20	enzyme	NN	O	enzyme	dobj	18	SENT_83	[p6l870t289r1117b344],
21	but	CC	O	but	_	0	SENT_83	[p6l1137t271r1240b327],
22	including	VBG	O	include	ccomp	4	SENT_83	[p6l1259t271r1559b344],
23	the	DT	O	the	det	24	SENT_83	[p6l1581t271r1676b327],
24	inhibitor	NN	O	inhibitor	nsubjpass	26	SENT_83	[p6l1697t271r1973b327],
25	were	VBD	O	be	auxpass	26	SENT_83	[p6l1993t289r2146b328],
26	run	VBN	O	run	ccomp	22	SENT_83	[p6l8t373r113b412],
27	in	IN	O	in	_	0	SENT_83	[p6l141t355r201b411],
28	parallel	NN	O	parallel	prep_in	26	SENT_83	[p6l227t356r483b428],
29	.	.	O	.	_	0	SENT_83	[p6l227t356r483b428],

1	Conditions	NNS	O	condition	nsubjpass	6	SENT_84	[p6l515t355r863b412],
2	for	IN	O	for	_	0	SENT_84	[p6l892t355r985b412],
3	assay	NN	O	assay	prep_for	1	SENT_84	[p6l1012t373r1182b428],
4	were	VBD	O	be	auxpass	6	SENT_84	[p6l1210t373r1363b412],
5	as	IN	O	as	advmod	6	SENT_84	[p6l1392t373r1454b412],
6	described	VBN	O	describe	dep	15	SENT_84	[p6l1484t355r1789b412],
7	by	IN	O	by	_	0	SENT_84	[p6l1815t355r1893b428],
8	T	NN	O	t	nn	9	SENT_84	[p6l1921t357r1968b411],
9	alcott	NN	O	alcott	agent	6	SENT_84	[p6l1972t356r2148b412],
10	and	CC	O	and	_	0	SENT_84	[p6l10t439r123b496],
11	Levin	NNP	PERSON	Levin	nn	13	SENT_84	[p6l150t439r412b496],
12	.58	CD	NUMBER	.58	num	13	SENT_84	[p6l150t439r412b496],
13	Incubations	NNS	O	incubation	conj_and	9	SENT_84	[p6l441t439r812b496],
14	were	VBD	O	be	auxpass	15	SENT_84	[p6l842t457r996b496],
15	carried	VBN	O	carry	_	0	SENT_84	[p6l1024t439r1245b496],
16	out	RP	O	out	prt	15	SENT_84	[p6l1274t448r1374b496],
17	in	IN	O	in	_	0	SENT_84	[p6l1401t439r1462b495],
18	duplicate	VB	O	duplicate	prepc_in	15	SENT_84	[p6l1491t439r1782b512],
19	at	IN	O	at	advmod	18	SENT_84	[p6l1812t448r1867b496],
20	37	CD	NUMBER	37	number	21	SENT_84	[p6l1896t440r2056b496],
21	°	CD	NUMBER	°	num	22	SENT_84	[p6l1896t440r2056b496],
22	C	NN	O	c	pobj	19	SENT_84	[p6l1896t440r2056b496],
23	in	IN	O	in	_	0	SENT_84	[p6l2086t439r2147b495],
24	50	CD	NUMBER	50	num	27	SENT_84	[p6l10t523r86b580],
25	ml	NN	O	ml	nn	27	SENT_84	[p6l108t524r190b579],
26	Erlenmeyer	NN	O	erlenmeyer	nn	27	SENT_84	[p6l212t524r586b597],
27	ﬂasks	NNS	O	ﬂasks	prep_in	18	SENT_84	[p6l607t524r785b580],
28	using	VBG	O	use	partmod	27	SENT_84	[p6l808t524r980b597],
29	5	CD	NUMBER	5	num	30	SENT_84	[p6l1003t523r1036b580],
30	ml	NN	O	ml	dobj	28	SENT_84	[p6l1062t524r1144b579],
31	of	IN	O	of	_	0	SENT_84	[p6l1167t524r1236b580],
32	0.1	CD	NUMBER	0.1	number	33	SENT_84	[p6l1253t524r1343b580],
33	M	NN	O	m	amod	37	SENT_84	[p6l1372t525r1441b579],
34	phosphate	NN	O	phosphate	nn	37	SENT_84	[p6l1462t524r1786b597],
35	buffer	NN	O	buffer	nn	37	SENT_84	[p6l1807t524r2003b580],
36	(	NN	O	(	nn	37	SENT_84	[p6l2026t524r2146b597],
37	pH	NN	O	ph	prep_of	30	SENT_84	[p6l2026t524r2146b597],
38	7.4	CD	NUMBER	7.4	num	39	SENT_84	[p6l9t608r150b677],
39	)	NN	O	)	nsubjpass	15	SENT_84	[p6l9t608r150b677],
40	,	,	O	,	_	0	SENT_84	[p6l9t608r150b677],
41	5	CD	NUMBER	5	num	43	SENT_84	[p6l182t608r215b664],
42	mM	NN	O	mm	nn	43	SENT_84	[p6l245t609r377b663],
43	GSH	NN	O	gsh	appos	39	SENT_84	[p6l406t608r563b664],
44	and	CC	O	and	_	0	SENT_84	[p6l592t608r704b664],
45	150-600	CD	NUMBER	150-600	num	48	SENT_84	[p6l739t608r1029b664],
46	p.	NN	O	p.	nn	48	SENT_84	[p6l1062t608r1255b681],
47	g/ml	NN	O	g/ml	nn	48	SENT_84	[p6l1062t608r1255b681],
48	GST	NN	O	gst	conj_and	43	SENT_84	[p6l1283t608r1447b664],
49	.	.	O	.	_	0	SENT_84	[p6l1283t608r1447b664],

1	Samples	NNS	O	sample	nsubjpass	3	SENT_85	[p6l1481t608r1747b681],
2	were	VBD	O	be	auxpass	3	SENT_85	[p6l1776t626r1929b664],
3	preincubated	VBN	O	preincubate	dep	15	SENT_85	[p6l1956t608r2144b681, p6l9t691r256b747],
4	at	IN	O	at	_	0	SENT_85	[p6l286t700r342b747],
5	37	CD	NUMBER	37	number	6	SENT_85	[p6l372t691r531b748],
6	°	CD	NUMBER	°	num	7	SENT_85	[p6l372t691r531b748],
7	C	NN	O	c	prep_at	3	SENT_85	[p6l372t691r531b748],
8	for	IN	O	for	_	0	SENT_85	[p6l562t691r655b747],
9	30	CD	DURATION	30	num	10	SENT_85	[p6l684t691r760b748],
10	sec	NN	DURATION	sec	prep_for	7	SENT_85	[p6l792t709r888b747],
11	and	CC	O	and	_	0	SENT_85	[p6l920t691r1033b747],
12	the	DT	O	the	det	13	SENT_85	[p6l1061t691r1156b747],
13	substrate	NN	O	substrate	conj_and	10	SENT_85	[p6l1189t691r1468b747],
14	was	VBD	O	be	auxpass	15	SENT_85	[p6l1498t709r1618b747],
15	added	VBN	O	add	_	0	SENT_85	[p6l1651t691r1840b747],
16	prepared	VBN	O	prepare	dep	15	SENT_85	[p6l1867t691r2147b764],
17	from	IN	O	from	_	0	SENT_85	[p6l9t775r163b831],
18	a	DT	O	a	det	21	SENT_85	[p6l197t793r230b832],
19	freshly	RB	O	freshly	advmod	21	SENT_85	[p6l262t775r482b848],
20	prepared	JJ	O	prepared	amod	21	SENT_85	[p6l515t775r795b848],
21	stock	NN	O	stock	prep_from	16	SENT_85	[p6l831t775r997b831],
22	in	IN	O	in	_	0	SENT_85	[p6l1028t775r1089b831],
23	99.5	CD	PERCENT	99.5	num	24	SENT_85	[p6l1123t775r1323b832],
24	%	NN	PERCENT	%	prep_in	21	SENT_85	[p6l1123t775r1323b832],
25	ethanol	NN	O	ethanol	nn	30	SENT_85	[p6l1360t775r1594b832],
26	solution	NN	O	solution	nn	30	SENT_85	[p6l1630t775r1884b832],
27	(	NN	O	(	nn	30	SENT_85	[p6l1919t776r1981b845],
28	2	CD	NUMBER	2	num	30	SENT_85	[p6l1919t776r1981b845],
29	mM	NN	O	mm	nn	30	SENT_85	[p6l2015t777r2146b831],
30	BCNU	NN	O	bcnu	nsubjpass	15	SENT_85	[p6l8t860r246b926],
31	,	,	O	,	_	0	SENT_85	[p6l8t860r246b926],
32	ﬁnal	JJ	O	ﬁnal	amod	34	SENT_85	[p6l283t859r422b916],
33	concentration	NN	O	concentration	nn	34	SENT_85	[p6l455t859r932b929],
34	)	NN	O	)	appos	30	SENT_85	[p6l455t859r932b929],
35	.	.	O	.	_	0	SENT_85	[p6l455t859r932b929],

1	A	DT	O	a	det	2	SENT_86	[p6l968t860r1024b915],
2	control	NN	O	control	nsubjpass	9	SENT_86	[p6l1057t859r1281b916],
3	that	WDT	O	that	nsubj	6	SENT_86	[p6l1314t860r1433b916],
4	did	VBD	O	do	aux	6	SENT_86	[p6l1465t859r1566b916],
5	not	RB	O	not	neg	6	SENT_86	[p6l1598t868r1699b916],
6	contain	VB	O	contain	rcmod	2	SENT_86	[p6l1731t859r1965b916],
7	GST	NN	O	gst	dobj	6	SENT_86	[p6l1998t860r2146b916],
8	was	VBD	O	be	auxpass	9	SENT_86	[p6l9t961r129b1000],
9	run	VBN	O	run	_	0	SENT_86	[p6l152t961r258b1000],
10	in	IN	O	in	_	0	SENT_86	[p6l280t944r341b999],
11	parallel	NN	O	parallel	prep_in	9	SENT_86	[p6l361t944r617b1017],
12	.	.	O	.	_	0	SENT_86	[p6l361t944r617b1017],

1	Aliquots	NNP	O	Aliquots	nsubjpass	9	SENT_87	[p6l643t944r915b1017],
2	(	CD	NUMBER	(	num	1	SENT_87	[p6l942t944r997b1013],
3	1	CD	NUMBER	1	num	5	SENT_87	[p6l942t944r997b1013],
4	ml	NN	O	ml	nn	5	SENT_87	[p6l1026t944r1133b1013],
5	)	NN	O	)	dep	1	SENT_87	[p6l1026t944r1133b1013],
6	were	VBD	O	be	auxpass	7	SENT_87	[p6l1158t961r1311b1000],
7	withdrawn	VBN	O	withdraw	_	0	SENT_87	[p6l1334t944r1675b1000],
8	and	CC	O	and	_	0	SENT_87	[p6l1698t944r1811b1000],
9	processed	VBN	O	process	conj_and	7	SENT_87	[p6l1831t944r2147b1017],
10	as	IN	O	as	_	0	SENT_87	[p6l10t1045r71b1084],
11	described	VBN	O	describe	prepc_as	7	SENT_87	[p6l106t1028r411b1084],
12	below	IN	O	below	dep	11	SENT_87	[p6l442t1028r636b1084],
13	for	IN	O	for	_	0	SENT_87	[p6l669t1028r762b1084],
14	the	DT	O	the	det	15	SENT_87	[p6l793t1028r888b1084],
15	determination	NN	O	determination	prep_for	11	SENT_87	[p6l922t1028r1365b1084],
16	of	IN	O	of	_	0	SENT_87	[p6l1398t1028r1466b1084],
17	nitrite	JJ	O	nitrite	amod	18	SENT_87	[p6l1493t1028r1683b1084],
18	formation	NN	O	formation	prep_of	15	SENT_87	[p6l1715t1028r2045b1084],
19	.	.	O	.	_	0	SENT_87	[p6l1715t1028r2045b1084],

1	In	IN	O	in	_	0	SENT_88	[p6l2082t1029r2147b1083],
2	the	DT	O	the	det	4	SENT_88	[p6l8t1112r104b1168],
3	preliminary	JJ	O	preliminary	amod	4	SENT_88	[p6l130t1112r502b1185],
4	experiment	NN	O	experiment	prep_in	9	SENT_88	[p6l530t1112r905b1185],
5	,	,	O	,	_	0	SENT_88	[p6l530t1112r905b1185],
6	BCNU	NN	O	bcnu	nn	7	SENT_88	[p6l935t1112r1156b1168],
7	denitrosation	NN	O	denitrosation	nsubjpass	9	SENT_88	[p6l1183t1112r1599b1168],
8	was	VBD	O	be	auxpass	9	SENT_88	[p6l1626t1130r1746b1168],
9	found	VBN	O	find	_	0	SENT_88	[p6l1774t1112r1960b1168],
10	to	TO	O	to	aux	12	SENT_88	[p6l1986t1120r2045b1168],
11	be	VB	O	be	cop	12	SENT_88	[p6l2072t1112r2146b1168],
12	linear	JJ	O	linear	xcomp	9	SENT_88	[p6l9t1195r190b1251],
13	with	IN	O	with	_	0	SENT_88	[p6l219t1195r359b1251],
14	respect	NN	O	respect	prep_with	12	SENT_88	[p6l387t1203r614b1268],
15	to	TO	O	to	_	0	SENT_88	[p6l642t1203r702b1251],
16	incubation	NN	O	incubation	nn	17	SENT_88	[p6l732t1195r1069b1251],
17	time	NN	O	time	prep_to	12	SENT_88	[p6l1098t1195r1238b1251],
18	(	CD	NUMBER	(	num	17	SENT_88	[p6l1270t1196r1372b1268],
19	up	RP	DURATION	up	prep	12	SENT_88	[p6l1270t1196r1372b1268],
20	to	TO	DURATION	to	_	0	SENT_88	[p6l1402t1203r1461b1251],
21	40	CD	DURATION	40	num	23	SENT_88	[p6l1492t1195r1569b1252],
22	min	NN	DURATION	min	nn	23	SENT_88	[p6l1599t1195r1746b1264],
23	)	NN	O	)	prep_to	19	SENT_88	[p6l1599t1195r1746b1264],
24	and	CC	O	and	_	0	SENT_88	[p6l1780t1195r1892b1251],
25	protein	NN	O	protein	nn	26	SENT_88	[p6l1920t1195r2147b1268],
26	concentration	NN	O	concentration	conj_and	23	SENT_88	[p6l9t1279r459b1336],
27	.	.	O	.	_	0	SENT_88	[p6l9t1279r459b1336],

1	Aliquots	NNS	O	aliquot	nsubjpass	3	SENT_89	[p6l491t1279r764b1352],
2	were	VBD	O	be	auxpass	3	SENT_89	[p6l794t1297r947b1336],
3	withdrawn	VBN	O	withdraw	_	0	SENT_89	[p6l976t1279r1317b1336],
4	from	IN	O	from	_	0	SENT_89	[p6l1345t1279r1500b1335],
5	each	DT	O	each	det	6	SENT_89	[p6l1528t1279r1672b1336],
6	ﬂask	NN	O	ﬂask	prep_from	3	SENT_89	[p6l1701t1279r1851b1335],
7	at	IN	O	at	_	0	SENT_89	[p6l1879t1288r1935b1335],
8	o	NN	O	o	prep_at	6	SENT_89	[p6l1962t1280r2017b1346],
9	,	,	O	,	_	0	SENT_89	[p6l1962t1280r2017b1346],
10	10	CD	NUMBER	10	prep_at	6	SENT_89	[p6l2056t1280r2143b1346],
11	,	,	O	,	_	0	SENT_89	[p6l2056t1280r2143b1346],
12	20	CD	NUMBER	20	prep_at	6	SENT_89	[p6l10t1364r103b1430],
13	,	,	O	,	_	0	SENT_89	[p6l10t1364r103b1430],
14	30	CD	NUMBER	30	prep_at	6	SENT_89	[p6l134t1364r209b1420],
15	and	CC	O	and	_	0	SENT_89	[p6l237t1363r349b1420],
16	40	CD	DURATION	40	num	17	SENT_89	[p6l374t1364r451b1420],
17	min	NN	DURATION	min	prep_at	6	SENT_89	[p6l477t1363r600b1419],
18	after	IN	O	after	_	0	SENT_89	[p6l627t1363r772b1420],
19	the	DT	O	the	det	20	SENT_89	[p6l795t1364r891b1420],
20	addition	NN	O	addition	prep_after	3	SENT_89	[p6l918t1363r1177b1420],
21	of	IN	O	of	_	0	SENT_89	[p6l1203t1363r1273b1420],
22	the	DT	O	the	det	23	SENT_89	[p6l1293t1363r1388b1420],
23	substrate	NN	O	substrate	prep_of	20	SENT_89	[p6l1416t1363r1712b1420],
24	.	.	O	.	_	0	SENT_89	[p6l1416t1363r1712b1420],

1	Each	DT	O	each	det	2	SENT_90	[p6l1741t1363r1901b1420],
2	aliquot	NN	O	aliquot	nsubjpass	4	SENT_90	[p6l1927t1363r2147b1436],
3	was	VBD	O	be	auxpass	4	SENT_90	[p6l9t1465r129b1504],
4	pipetted	VBN	O	pipet	_	0	SENT_90	[p6l172t1448r430b1521],
5	into	IN	O	into	_	0	SENT_90	[p6l471t1448r593b1504],
6	a	DT	O	a	det	10	SENT_90	[p6l637t1465r670b1504],
7	12	CD	NUMBER	12	num	10	SENT_90	[p6l719t1448r788b1503],
8	ml	NN	O	ml	nn	10	SENT_90	[p6l831t1448r913b1503],
9	centrifuge	NN	O	centrifuge	nn	10	SENT_90	[p6l957t1448r1278b1521],
10	tube	NN	O	tube	prep_into	4	SENT_90	[p6l1321t1448r1457b1504],
11	containing	VBG	O	contain	xcomp	4	SENT_90	[p6l1499t1448r1834b1521],
12	1	CD	NUMBER	1	num	13	SENT_90	[p6l1885t1448r1908b1503],
13	ml	NN	O	ml	dobj	11	SENT_90	[p6l1957t1448r2040b1503],
14	of	IN	O	of	_	0	SENT_90	[p6l2082t1448r2152b1504],
15	chloroform	NN	O	chloroform	prep_of	13	SENT_90	[p6l9t1532r383b1588],
16	.	.	O	.	_	0	SENT_90	[p6l9t1532r383b1588],

1	An	DT	O	a	det	6	SENT_91	[p6l414t1532r511b1587],
2	aliquot	JJ	O	aliquot	amod	6	SENT_91	[p6l539t1532r759b1605],
3	(	NN	O	(	nn	6	SENT_91	[p6l788t1532r909b1601],
4	0.6	CD	NUMBER	0.6	num	6	SENT_91	[p6l788t1532r909b1601],
5	ml	NN	O	ml	nn	6	SENT_91	[p6l938t1532r1044b1601],
6	)	NN	O	)	nsubjpass	12	SENT_91	[p6l938t1532r1044b1601],
7	of	IN	O	of	_	0	SENT_91	[p6l1075t1532r1144b1588],
8	each	DT	O	each	det	10	SENT_91	[p6l1167t1532r1311b1588],
9	aqueous	JJ	O	aqueous	amod	10	SENT_91	[p6l1340t1550r1597b1605],
10	phase	NN	O	phase	prep_of	6	SENT_91	[p6l1625t1532r1806b1605],
11	was	VBD	O	be	auxpass	12	SENT_91	[p6l1834t1550r1954b1588],
12	reextracted	VBN	O	reextract	_	0	SENT_91	[p6l1983t1550r2144b1588, p6l8t1616r225b1672],
13	with	IN	O	with	_	0	SENT_91	[p6l260t1616r400b1672],
14	1	CD	NUMBER	1	num	16	SENT_91	[p6l442t1616r465b1671],
15	ml	NN	O	ml	nn	16	SENT_91	[p6l506t1616r589b1671],
16	chloroform	NN	O	chloroform	prep_with	12	SENT_91	[p6l624t1616r984b1672],
17	to	TO	O	to	aux	18	SENT_91	[p6l1017t1624r1077b1672],
18	remove	VB	O	remove	xcomp	12	SENT_91	[p6l1111t1634r1350b1672],
19	traces	NNS	O	trace	dobj	18	SENT_91	[p6l1385t1625r1568b1672],
20	of	IN	O	of	_	0	SENT_91	[p6l1606t1616r1675b1672],
21	BCNU	NN	O	bcnu	prep_of	19	SENT_91	[p6l1704t1616r1940b1672],
22	.	.	O	.	_	0	SENT_91	[p6l1704t1616r1940b1672],

1	After	IN	O	after	_	0	SENT_92	[p6l1979t1616r2148b1672],
2	additional	JJ	O	additional	amod	3	SENT_92	[p6l10t1699r327b1755],
3	separation	NN	O	separation	prep_after	17	SENT_92	[p6l365t1699r690b1772],
4	of	IN	O	of	_	0	SENT_92	[p6l726t1699r795b1755],
5	the	DT	O	the	det	6	SENT_92	[p6l825t1699r921b1755],
6	phases	NNS	O	phase	prep_of	3	SENT_92	[p6l955t1699r1166b1772],
7	by	IN	O	by	_	0	SENT_92	[p6l1202t1699r1280b1772],
8	centrifugation	NN	O	centrifugation	prep_by	6	SENT_92	[p6l1317t1699r1781b1772],
9	,	,	O	,	_	0	SENT_92	[p6l1317t1699r1781b1772],
10	180	CD	NUMBER	180	num	11	SENT_92	[p6l1827t1699r1937b1756],
11	pl	NN	O	pl	nsubjpass	17	SENT_92	[p6l1978t1699r2046b1771],
12	of	IN	O	of	_	0	SENT_92	[p6l2082t1699r2151b1755],
13	each	DT	O	each	det	15	SENT_92	[p6l9t1783r154b1840],
14	aqueous	JJ	O	aqueous	amod	15	SENT_92	[p6l201t1801r459b1856],
15	layer	NN	O	layer	prep_of	11	SENT_92	[p6l507t1783r666b1856],
16	was	VBD	O	be	auxpass	17	SENT_92	[p6l712t1801r832b1840],
17	reextracted	VBN	O	reextract	_	0	SENT_92	[p6l879t1783r1235b1840],
18	with	IN	O	with	_	0	SENT_92	[p6l1281t1783r1422b1840],
19	1	CD	NUMBER	1	num	21	SENT_92	[p6l1476t1784r1498b1839],
20	ml	NN	O	ml	nn	21	SENT_92	[p6l1552t1783r1634b1839],
21	chloroform	NN	O	chloroform	prep_with	17	SENT_92	[p6l1682t1783r2041b1839],
22	to	TO	O	to	aux	23	SENT_92	[p6l2086t1792r2146b1839],
23	remove	VB	O	remove	xcomp	17	SENT_92	[p6l8t1885r247b1924],
24	traces	NNS	O	trace	dobj	23	SENT_92	[p6l269t1876r452b1924],
25	of	IN	O	of	_	0	SENT_92	[p6l478t1867r546b1924],
26	BCNU	NN	O	bcnu	prep_of	24	SENT_92	[p6l563t1868r800b1924],
27	.	.	O	.	_	0	SENT_92	[p6l563t1868r800b1924],

1	An	DT	O	a	det	6	SENT_93	[p6l826t1868r923b1923],
2	aliquot	JJ	O	aliquot	amod	6	SENT_93	[p6l946t1867r1167b1940],
3	(	NN	O	(	nn	6	SENT_93	[p6l1190t1868r1332b1937],
4	180	CD	NUMBER	180	num	6	SENT_93	[p6l1190t1868r1332b1937],
5	pl	NN	O	pl	nn	6	SENT_93	[p6l1360t1868r1453b1940],
6	)	NN	O	)	nsubjpass	12	SENT_93	[p6l1360t1868r1453b1940],
7	of	IN	O	of	_	0	SENT_93	[p6l1479t1867r1548b1924],
8	the	DT	O	the	det	10	SENT_93	[p6l1565t1868r1660b1924],
9	aqueous	JJ	O	aqueous	amod	10	SENT_93	[p6l1684t1885r1942b1940],
10	phase	NN	O	phase	prep_of	6	SENT_93	[p6l1965t1867r2146b1940],
11	was	VBD	O	be	auxpass	12	SENT_93	[p6l9t1969r129b2008],
12	analysed	VBN	O	analyse	_	0	SENT_93	[p6l158t1952r436b2025],
13	for	IN	O	for	_	0	SENT_93	[p6l461t1952r554b2008],
14	nitrite	JJ	O	nitrite	amod	15	SENT_93	[p6l577t1952r767b2008],
15	formation	NN	O	formation	prep_for	12	SENT_93	[p6l792t1952r1107b2008],
16	as	IN	O	as	mark	17	SENT_93	[p6l1134t1969r1195b2008],
17	follows	VBZ	O	follow	advcl	12	SENT_93	[p6l1222t1952r1477b2008],
18	.	.	O	.	_	0	SENT_93	[p6l1222t1952r1477b2008],

1	The	DT	O	the	det	3	SENT_94	[p6l1506t1952r1628b2008],
2	twice	JJ	O	twice	amod	3	SENT_94	[p6l1654t1952r2147b2008],
3	—	NN	O	—	_	0	SENT_94	[p6l1654t1952r2147b2008],
4	extracted	VBN	O	extract	partmod	3	SENT_94	[p6l1654t1952r2147b2008],
5	aqueous	JJ	O	aqueous	amod	6	SENT_94	[p6l10t2054r267b2109],
6	aliquots	NNS	O	aliquot	nsubjpass	8	SENT_94	[p6l291t2036r540b2109],
7	were	VBD	O	be	auxpass	8	SENT_94	[p6l562t2054r715b2092],
8	added	VBN	O	add	ccomp	4	SENT_94	[p6l738t2036r926b2092],
9	to	TO	O	to	_	0	SENT_94	[p6l946t2044r1005b2092],
10	glass	NN	O	glass	nn	12	SENT_94	[p6l1028t2036r1183b2109],
11	test	NN	O	test	nn	12	SENT_94	[p6l1205t2044r1316b2092],
12	tubes	NNS	O	tube	prep_to	8	SENT_94	[p6l1335t2036r1501b2092],
13	containing	VBG	O	contain	xcomp	8	SENT_94	[p6l1524t2036r1859b2109],
14	5	CD	NUMBER	5	num	15	SENT_94	[p6l1881t2036r1915b2092],
15	ml	NN	O	ml	dobj	13	SENT_94	[p6l1938t2036r2021b2091],
16	1	CD	PERCENT	1	number	17	SENT_94	[p6l2049t2036r2143b2092],
17	%	NN	PERCENT	%	amod	15	SENT_94	[p6l2049t2036r2143b2092],
18	(	CD	NUMBER	(	num	21	SENT_94	[p6l11t2119r177b2189],
19	w/V	NN	O	w/v	nn	21	SENT_94	[p6l11t2119r177b2189],
20	)	NN	O	)	nn	21	SENT_94	[p6l11t2119r177b2189],
21	sulphanilamide	NN	O	sulphanilamide	dep	26	SENT_94	[p6l222t2119r707b2192],
22	in	IN	O	in	_	0	SENT_94	[p6l747t2119r808b2175],
23	24	CD	PERCENT	24	num	24	SENT_94	[p6l848t2119r988b2176],
24	%	NN	PERCENT	%	prep_in	21	SENT_94	[p6l848t2119r988b2176],
25	(	CD	NUMBER	(	num	26	SENT_94	[p6l1034t2119r1183b2188],
26	v/v	NN	O	v/v	dep	3	SENT_94	[p6l1034t2119r1183b2188],
27	)	CD	NUMBER	)	num	28	SENT_94	[p6l1034t2119r1183b2188],
28	HCl	NN	O	hcl	dep	26	SENT_94	[p6l1225t2119r1373b2176],
29	.	.	O	.	_	0	SENT_94	[p6l1225t2119r1373b2176],

1	Five	CD	NUMBER	five	num	2	SENT_95	[p6l1416t2119r1556b2175],
2	milliliters	NNS	O	milliliter	nsubjpass	43	SENT_95	[p6l1597t2119r1905b2175],
3	of	IN	O	of	_	0	SENT_95	[p6l1947t2119r2016b2175],
4	the	DT	O	the	det	6	SENT_95	[p6l2050t2119r2146b2175],
5	coupling	NN	O	coupling	nn	6	SENT_95	[p6l9t2203r286b2276],
6	reagent	NN	O	reagent	prep_of	2	SENT_95	[p6l314t2211r566b2276],
7	,	,	O	,	_	0	SENT_95	[p6l314t2211r566b2276],
8	0.02	CD	PERCENT	0.02	num	9	SENT_95	[p6l597t2203r798b2260],
9	%	NN	PERCENT	%	appos	6	SENT_95	[p6l597t2203r798b2260],
10	(	CD	NUMBER	(	num	11	SENT_95	[p6l831t2203r998b2272],
11	w/v	NN	O	w/v	dep	31	SENT_95	[p6l831t2203r998b2272],
12	)	CD	NUMBER	)	num	13	SENT_95	[p6l831t2203r998b2272],
13	N-1-naphthylethyldiamine	NN	O	n-1-naphthylethyldiamine	dep	11	SENT_95	[p6l1027t2203r1902b2276],
14	/	:	O	/	punct	11	SENT_95	[p6l1027t2203r1902b2276],
15	HCl	NN	O	hcl	dep	11	SENT_95	[p6l1927t2203r2058b2260],
16	in	IN	O	in	_	0	SENT_95	[p6l2086t2203r2147b2259],
17	distilled	JJ	O	distilled	amod	18	SENT_95	[p6l9t2287r266b2343],
18	water	NN	O	water	prep_in	15	SENT_95	[p6l300t2296r493b2354],
19	,	,	O	,	_	0	SENT_95	[p6l300t2296r493b2354],
20	were	VBD	O	be	auxpass	21	SENT_95	[p6l530t2305r683b2344],
21	added	VBN	O	add	csubjpass	31	SENT_95	[p6l720t2287r908b2344],
22	to	TO	O	to	_	0	SENT_95	[p6l942t2296r1002b2343],
23	each	DT	O	each	det	24	SENT_95	[p6l1038t2287r1182b2344],
24	tube	NN	O	tube	prep_to	21	SENT_95	[p6l1217t2287r1352b2343],
25	with	IN	O	with	_	0	SENT_95	[p6l1387t2287r1528b2344],
26	vortexing	NN	O	vortexing	prep_with	24	SENT_95	[p6l1562t2287r1867b2360],
27	and	CC	O	and	_	0	SENT_95	[p6l1904t2287r2016b2343],
28	the	DT	O	the	det	29	SENT_95	[p6l2050t2287r2146b2343],
29	tubes	NNS	O	tube	conj_and	26	SENT_95	[p6l8t2371r174b2428],
30	were	VBD	O	be	auxpass	31	SENT_95	[p6l201t2389r354b2428],
31	incubated	VBN	O	incubate	rcmod	9	SENT_95	[p6l379t2371r690b2428],
32	for	IN	O	for	_	0	SENT_95	[p6l715t2371r807b2428],
33	20	CD	NUMBER	20	num	34	SENT_95	[p6l832t2372r908b2428],
34	n1in	NN	O	n1in	prep_for	31	SENT_95	[p6l934t2371r1057b2427],
35	at	IN	O	at	_	0	SENT_95	[p6l1083t2380r1138b2428],
36	55	CD	NUMBER	55	number	37	SENT_95	[p6l1163t2371r1342b2428],
37	°	CD	NUMBER	°	num	40	SENT_95	[p6l1163t2371r1342b2428],
38	C.	NNP	O	C.	nn	40	SENT_95	[p6l1163t2371r1342b2428],
39	The	NNP	O	The	nn	40	SENT_95	[p6l1371t2372r1493b2428],
40	solutions	NNS	O	solution	prep_at	34	SENT_95	[p6l1522t2371r1804b2428],
41	were	VBD	O	be	auxpass	43	SENT_95	[p6l1832t2389r1985b2428],
42	then	RB	O	then	advmod	43	SENT_95	[p6l2010t2371r2146b2428],
43	vortexed	VBN	O	vortex	_	0	SENT_95	[p6l9t2456r304b2522],
44	,	,	O	,	_	0	SENT_95	[p6l9t2456r304b2522],
45	the	DT	O	the	det	47	SENT_95	[p6l339t2456r435b2512],
46	A540	NN	O	a540	nn	47	SENT_95	[p6l467t2456r697b2529],
47	“	NN	O	“	dobj	43	SENT_95	[p6l467t2456r697b2529],
48	measured	VBN	O	measure	partmod	47	SENT_95	[p6l728t2456r1034b2512],
49	and	CC	O	and	_	0	SENT_95	[p6l1068t2456r1181b2512],
50	the	DT	O	the	det	52	SENT_95	[p6l1212t2456r1307b2512],
51	nitrite	JJ	O	nitrite	amod	52	SENT_95	[p6l1340t2455r1529b2512],
52	concentration	NN	O	concentration	dobj	43	SENT_95	[p6l1562t2455r1996b2512],
53	calculated	VBN	O	calculate	partmod	52	SENT_95	[p6l2029t2456r2144b2512, p6l9t2540r238b2596],
54	from	IN	O	from	_	0	SENT_95	[p6l271t2540r426b2596],
55	a	DT	O	a	det	58	SENT_95	[p6l459t2557r492b2596],
56	nitrite	JJ	O	nitrite	amod	58	SENT_95	[p6l524t2540r712b2596],
57	standard	JJ	O	standard	amod	58	SENT_95	[p6l748t2540r1016b2596],
58	curve	NN	O	curve	prep_from	53	SENT_95	[p6l1049t2557r1240b2596],
59	.	.	O	.	_	0	SENT_95	[p6l1049t2557r1240b2596],

1	Speciﬁc	JJ	O	speciﬁc	amod	2	SENT_96	[p6l1279t2540r1532b2613],
2	activities	NNS	O	activity	nsubjpass	17	SENT_96	[p6l1568t2540r1852b2596],
3	of	IN	O	of	_	0	SENT_96	[p6l1888t2540r1956b2596],
4	denitrosation	NN	O	denitrosation	prep_of	2	SENT_96	[p6l1985t2540r2144b2596, p6l8t2624r287b2680],
5	were	VBD	O	be	auxpass	6	SENT_96	[p6l327t2642r480b2680],
6	calculated	VBN	O	calculate	_	0	SENT_96	[p6l521t2624r844b2680],
7	from	IN	O	from	_	0	SENT_96	[p6l883t2624r1038b2680],
8	the	DT	O	the	det	9	SENT_96	[p6l1076t2624r1172b2680],
9	slopes	NNS	O	slope	prep_from	6	SENT_96	[p6l1215t2624r1408b2697],
10	of	IN	O	of	_	0	SENT_96	[p6l1451t2624r1520b2680],
11	the	DT	O	the	det	15	SENT_96	[p6l1554t2624r1650b2680],
12	corresponding	JJ	O	corresponding	amod	15	SENT_96	[p6l1690t2624r2146b2697],
13	reaction	NN	O	reaction	nn	15	SENT_96	[p6l8t2707r265b2763],
14	progress	NN	O	progress	nn	15	SENT_96	[p6l294t2725r562b2780],
15	curves	NNS	O	curve	prep_of	9	SENT_96	[p6l595t2725r800b2763],
16	and	CC	O	and	_	0	SENT_96	[p6l834t2707r946b2763],
17	expressed	VBN	O	express	conj_and	6	SENT_96	[p6l977t2707r1291b2780],
18	as	IN	O	as	mark	21	SENT_96	[p6l1322t2725r1383b2763],
19	nmol	NN	O	nmol	nn	20	SENT_96	[p6l1415t2707r1578b2763],
20	nitrite	NN	O	nitrite	nsubj	21	SENT_96	[p6l1608t2707r1797b2763],
21	produced	VBD	O	produce	advcl	17	SENT_96	[p6l1827t2707r2148b2780],
22	/	:	O	/	punct	23	SENT_96	[p6l1827t2707r2148b2780],
23	mirﬂmg	NN	O	mirﬂmg	dep	21	SENT_96	[p6l9t2791r255b2864],
24	protein	NN	O	protein	dep	23	SENT_96	[p6l298t2791r540b2864],
25	.	.	O	.	_	0	SENT_96	[p6l298t2791r540b2864],

1	To	TO	O	to	aux	2	SENT_97	[p6l588t2793r674b2847],
2	establish	VB	O	establish	dep	41	SENT_97	[p6l718t2791r997b2848],
3	if	IN	O	if	mark	7	SENT_97	[p6l1039t2791r1092b2847],
4	the	DT	O	the	det	5	SENT_97	[p6l1129t2791r1225b2847],
5	reaction	NN	O	reaction	nsubjpass	7	SENT_97	[p6l1267t2791r1524b2847],
6	was	VBD	O	be	auxpass	7	SENT_97	[p6l1568t2809r1688b2848],
7	mediated	VBN	O	mediate	advcl	2	SENT_97	[p6l1733t2791r2026b2847],
8	by	IN	O	by	_	0	SENT_97	[p6l2067t2791r2146b2864],
9	GSTs	NNS	O	gst	agent	7	SENT_97	[p6l10t2876r206b2942],
10	,	,	O	,	_	0	SENT_97	[p6l10t2876r206b2942],
11	the	DT	O	the	det	12	SENT_97	[p6l229t2876r325b2932],
12	effect	NN	O	effect	appos	9	SENT_97	[p6l346t2875r527b2932],
13	of	IN	O	of	_	0	SENT_97	[p6l547t2875r617b2932],
14	the	DT	O	the	det	15	SENT_97	[p6l632t2875r727b2932],
15	inhibitor	NN	O	inhibitor	prep_of	12	SENT_97	[p6l748t2875r1039b2942],
16	,	,	O	,	_	0	SENT_97	[p6l748t2875r1039b2942],
17	ethacrynic	JJ	O	ethacrynic	amod	20	SENT_97	[p6l1063t2875r1393b2948],
18	acid	NN	O	acid	nn	20	SENT_97	[p6l1417t2875r1563b2942],
19	,	,	O	,	_	0	SENT_97	[p6l1417t2875r1563b2942],
20	denitrosation	NN	O	denitrosation	nsubjpass	22	SENT_97	[p6l1587t2875r2004b2932],
21	was	VBD	O	be	auxpass	22	SENT_97	[p6l2024t2893r2145b2932],
22	investigated	VBN	O	investigate	parataxis	41	SENT_97	[p6l8t2959r395b3032],
23	at	IN	O	at	_	0	SENT_97	[p6l428t2968r483b3016],
24	concentrations	NNS	O	concentration	prep_at	22	SENT_97	[p6l516t2959r979b3016],
25	of	IN	O	of	_	0	SENT_97	[p6l1015t2959r1083b3016],
26	50	CD	NUMBER	50	prep_of	24	SENT_97	[p6l1112t2959r1206b3026],
27	,	,	O	,	_	0	SENT_97	[p6l1112t2959r1206b3026],
28	250	CD	NUMBER	250	num	26	SENT_97	[p6l1243t2959r1359b3016],
29	and	CC	O	and	_	0	SENT_97	[p6l1394t2960r1507b3016],
30	1,250	CD	NUMBER	1,250	conj_and	26	SENT_97	[p6l1547t2959r1717b3026],
31	p.M.	NNP	O	p.M.	nn	32	SENT_97	[p6l1755t2961r1889b3032],
32	Blanks	NNPS	O	Blanks	nsubjpass	41	SENT_97	[p6l1926t2960r2145b3016],
33	containing	VBG	O	contain	partmod	32	SENT_97	[p6l9t3044r344b3117],
34	no	DT	O	no	det	35	SENT_97	[p6l374t3061r451b3100],
35	enzyme	NN	O	enzyme	dobj	33	SENT_97	[p6l482t3061r728b3117],
36	but	CC	O	but	cc	33	SENT_97	[p6l756t3044r858b3100],
37	with	IN	O	with	_	0	SENT_97	[p6l886t3044r1027b3100],
38	the	DT	O	the	det	39	SENT_97	[p6l1055t3044r1151b3100],
39	inhibitor	NN	O	inhibitor	prep_with	33	SENT_97	[p6l1179t3044r1456b3100],
40	were	VBD	O	be	auxpass	41	SENT_97	[p6l1483t3061r1636b3100],
41	run	VBN	O	run	_	0	SENT_97	[p6l1664t3061r1770b3100],
42	in	IN	O	in	_	0	SENT_97	[p6l1799t3044r1859b3099],
43	parallel	NN	O	parallel	prep_in	41	SENT_97	[p6l1887t3044r2142b3117],
44	.	.	O	.	_	0	SENT_97	[p6l1887t3044r2142b3117],

1	Kinetic	JJ	O	kinetic	amod	2	SENT_98	[p6l8t3180r238b3233],
2	measurements	NNS	O	measurement	_	0	SENT_98	[p6l267t3188r724b3233],

1	Measurement	NN	O	measurement	nsubjpass	14	SENT_99	[p6l88t3278r524b3333],
2	of	IN	O	of	_	0	SENT_99	[p6l557t3277r625b3333],
3	the	DT	O	the	det	4	SENT_99	[p6l652t3277r748b3333],
4	dependence	NN	O	dependence	prep_of	1	SENT_99	[p6l780t3277r1156b3349],
5	of	IN	O	of	_	0	SENT_99	[p6l1189t3277r1259b3333],
6	initial	JJ	O	initial	amod	7	SENT_99	[p6l1285t3277r1470b3333],
7	rates	NNS	O	rate	prep_of	4	SENT_99	[p6l1501t3285r1649b3333],
8	of	IN	O	of	_	0	SENT_99	[p6l1684t3277r1753b3333],
9	reaction	NN	O	reaction	prep_of	7	SENT_99	[p6l1779t3277r2037b3333],
10	on	IN	O	on	_	0	SENT_99	[p6l2069t3294r2147b3333],
11	CDNB	JJ	ORGANIZATION	cdnb	amod	12	SENT_99	[p6l9t3361r225b3417],
12	concentration	NN	O	concentration	prep_on	9	SENT_99	[p6l268t3361r702b3417],
13	was	VBD	O	be	auxpass	14	SENT_99	[p6l740t3379r860b3417],
14	done	VBN	O	do	csubjpass	66	SENT_99	[p6l901t3361r1054b3417],
15	under	IN	O	under	_	0	SENT_99	[p6l1091t3361r1274b3417],
16	the	DT	O	the	det	18	SENT_99	[p6l1310t3361r1406b3417],
17	following	JJ	O	following	amod	18	SENT_99	[p6l1444t3361r1753b3434],
18	conditions	NNS	O	condition	prep_under	14	SENT_99	[p6l1792t3361r2141b3417],
19	:	:	O	:	_	0	SENT_99	[p6l1792t3361r2141b3417],
20	50	CD	NUMBER	50	number	21	SENT_99	[p6l10t3444r316b3511],
21	—	CD	NUMBER	—	dep	18	SENT_99	[p6l10t3444r316b3511],
22	1,500	CD	NUMBER	1,500	num	25	SENT_99	[p6l10t3444r316b3511],
23	p.M	NN	O	p.m	nn	25	SENT_99	[p6l348t3446r465b3516],
24	CDNB	NN	O	cdnb	nn	25	SENT_99	[p6l492t3444r708b3501],
25	(	NN	O	(	dep	53	SENT_99	[p6l741t3444r858b3514],
26	for	IN	O	for	_	0	SENT_99	[p6l741t3444r858b3514],
27	12	CD	NUMBER	12	num	28	SENT_99	[p6l890t3445r960b3500],
28	concentrations	NNS	O	concentration	prep_for	25	SENT_99	[p6l987t3444r1476b3513],
29	)	RB	O	)	advmod	28	SENT_99	[p6l987t3444r1476b3513],
30	in	IN	O	in	_	0	SENT_99	[p6l1505t3444r1565b3500],
31	the	DT	O	the	det	32	SENT_99	[p6l1591t3444r1687b3500],
32	presence	NN	O	presence	prep_in	28	SENT_99	[p6l1712t3462r1991b3517],
33	of	IN	O	of	_	0	SENT_99	[p6l2018t3444r2088b3500],
34	5	CD	NUMBER	5	num	36	SENT_99	[p6l2109t3444r2143b3501],
35	mM	NN	O	mm	nn	36	SENT_99	[p6l9t3530r140b3584],
36	GSH	NN	O	gsh	prep_of	32	SENT_99	[p6l193t3529r350b3585],
37	in	IN	O	in	_	0	SENT_99	[p6l401t3528r462b3584],
38	0.1	CD	NUMBER	0.1	num	41	SENT_99	[p6l513t3529r604b3585],
39	M	NN	O	m	nn	41	SENT_99	[p6l662t3530r731b3584],
40	sodium	NN	O	sodium	nn	41	SENT_99	[p6l786t3528r1018b3584],
41	phosphate	NN	O	phosphate	prep_in	36	SENT_99	[p6l1067t3528r1409b3601],
42	,	,	O	,	_	0	SENT_99	[p6l1067t3528r1409b3601],
43	pH	NN	O	ph	conj_and	41	SENT_99	[p6l1462t3530r1559b3601],
44	6.5	CD	NUMBER	6.5	num	43	SENT_99	[p6l1612t3528r1705b3585],
45	and	CC	O	and	_	0	SENT_99	[p6l1761t3528r1874b3585],
46	1	CD	NUMBER	1	num	48	SENT_99	[p6l1933t3529r1956b3584],
47	mM	NN	O	mm	nn	48	SENT_99	[p6l2015t3530r2146b3584],
48	Na2EDTA	NN	O	na2edta	conj_and	41	SENT_99	[p6l8t3613r345b3686],
49	at	IN	O	at	_	0	SENT_99	[p6l368t3621r423b3669],
50	30	CD	NUMBER	30	prep_at	48	SENT_99	[p6l445t3613r623b3669],
51	°	CD	NUMBER	°	dep	53	SENT_99	[p6l445t3613r623b3669],
52	C.	NNP	O	C.	nn	53	SENT_99	[p6l445t3613r623b3669],
53	Measurement	NNP	O	Measurement	dep	18	SENT_99	[p6l648t3614r1084b3669],
54	of	IN	O	of	_	0	SENT_99	[p6l1105t3612r1174b3669],
55	the	DT	O	the	det	56	SENT_99	[p6l1190t3613r1286b3669],
56	dependence	NN	O	dependence	prep_of	53	SENT_99	[p6l1308t3612r1683b3685],
57	of	IN	O	of	_	0	SENT_99	[p6l1706t3612r1775b3669],
58	initial	JJ	O	initial	amod	59	SENT_99	[p6l1790t3612r1975b3669],
59	rates	NNS	O	rate	prep_of	56	SENT_99	[p6l1996t3621r2145b3669],
60	of	IN	O	of	_	0	SENT_99	[p6l9t3696r79b3753],
61	reaction	NN	O	reaction	prep_of	18	SENT_99	[p6l106t3696r363b3753],
62	on	IN	O	on	_	0	SENT_99	[p6l397t3714r475b3753],
63	GSH	NN	ORGANIZATION	gsh	nn	64	SENT_99	[p6l509t3697r666b3753],
64	concentration	NN	O	concentration	prep_on	14	SENT_99	[p6l700t3696r1135b3753],
65	was	VBD	O	be	auxpass	66	SENT_99	[p6l1168t3714r1289b3753],
66	carried	VBN	O	carry	conj_but	66	SENT_99	[p6l1325t3696r1545b3753],
67	out	RP	O	out	prt	66	SENT_99	[p6l1579t3705r1679b3753],
68	under	IN	O	under	_	0	SENT_99	[p6l1711t3697r1894b3753],
69	similar	JJ	O	similar	amod	70	SENT_99	[p6l1928t3696r2148b3753],
70	conditions	NNS	O	condition	prep_under	66	SENT_99	[p7l9t21r339b77],
71	but	CC	O	but	_	0	SENT_99	[p7l383t21r485b77],
72	with	IN	O	with	_	0	SENT_99	[p7l528t21r669b77],
73	50	CD	NUMBER	50	num	74	SENT_99	[p7l713t20r1020b87],
74	—	CD	NUMBER	—	prep_with	66	SENT_99	[p7l713t20r1020b87],
75	5,000	CD	NUMBER	5,000	num	77	SENT_99	[p7l713t20r1020b87],
76	p.M	NN	O	p.m	nn	77	SENT_99	[p7l1069t22r1186b93],
77	GSH	NN	O	gsh	nsubjpass	66	SENT_99	[p7l1231t21r1388b77],
78	and	CC	O	and	_	0	SENT_99	[p7l1433t21r1546b77],
79	1.5	CD	NUMBER	1.5	num	81	SENT_99	[p7l1596t21r1683b77],
80	mM	NN	O	mm	nn	81	SENT_99	[p7l1730t22r1861b76],
81	CDNB	NN	O	cdnb	nsubjpass	66	SENT_99	[p7l1906t21r2142b77],
82	.	.	O	.	_	0	SENT_99	[p7l1906t21r2142b77],

1	Measurements	NNS	O	measurement	nsubjpass	3	SENT_100	[p7l8t106r472b161],
2	were	VBD	O	be	auxpass	3	SENT_100	[p7l509t123r662b161],
3	made	VBN	O	make	_	0	SENT_100	[p7l696t105r867b161],
4	in	IN	O	in	_	0	SENT_100	[p7l902t105r962b160],
5	triplicate	NN	O	triplicate	prep_in	3	SENT_100	[p7l996t105r1279b178],
6	in	IN	O	in	_	0	SENT_100	[p7l1313t105r1374b160],
7	microtitre	NN	O	microtitre	nn	8	SENT_100	[p7l1407t105r1721b161],
8	plates	NNS	O	plate	prep_in	5	SENT_100	[p7l1755t105r1939b178],
9	using	VBG	O	use	xcomp	3	SENT_100	[p7l1974t105r2146b178],
10	the	DT	O	the	det	14	SENT_100	[p7l8t188r104b244],
11	SpectraMax	NN	O	spectramax	nn	14	SENT_100	[p7l155t188r538b261],
12	340	CD	NUMBER	340	num	14	SENT_100	[p7l588t188r704b245],
13	plate	NN	O	plate	nn	14	SENT_100	[p7l751t188r906b261],
14	reader	NN	O	reader	dobj	9	SENT_100	[p7l953t188r1168b244],
15	.	.	O	.	_	0	SENT_100	[p7l953t188r1168b244],

1	GSTs	NNS	O	gst	nsubj	5	SENT_101	[p7l1221t188r1399b245],
2	do	VBP	O	do	aux	5	SENT_101	[p7l1450t188r1526b244],
3	not	RB	O	not	neg	5	SENT_101	[p7l1575t197r1677b244],
4	strictly	RB	O	strictly	advmod	5	SENT_101	[p7l1726t188r1944b261],
5	obey	VB	O	obey	dep	33	SENT_101	[p7l1994t188r2146b261],
6	Michaelis-Menten	NNP	MISC	Michaelis-Menten	nn	7	SENT_101	[p7l8t272r595b328],
7	kinetics	NNS	O	kinetics	nsubj	8	SENT_101	[p7l619t272r944b339],
8	,59	CD	NUMBER	,59	xcomp	5	SENT_101	[p7l619t272r944b339],
9	but	CC	O	but	prep	8	SENT_101	[p7l969t272r1071b328],
10	the	DT	O	the	det	13	SENT_101	[p7l1095t272r1190b328],
11	maximum	NN	O	maximum	nn	13	SENT_101	[p7l1216t272r1540b328],
12	velocity	NN	O	velocity	nn	13	SENT_101	[p7l1563t272r1819b345],
13	Vmax	NN	O	vmax	dep	9	SENT_101	[p7l1845t274r2008b346],
14	and	CC	O	and	_	0	SENT_101	[p7l2034t272r2147b328],
15	the	DT	O	the	det	17	SENT_101	[p7l8t356r104b413],
16	substrate	NN	O	substrate	nn	17	SENT_101	[p7l138t357r418b413],
17	concentration	NN	O	concentration	dep	9	SENT_101	[p7l451t356r885b413],
18	giving	VBG	O	give	partmod	17	SENT_101	[p7l917t356r1118b429],
19	half	NN	O	half	iobj	18	SENT_101	[p7l1149t356r1278b413],
20	maximal	JJ	O	maximal	amod	22	SENT_101	[p7l1304t356r1582b413],
21	velocity	NN	O	velocity	nn	22	SENT_101	[p7l1614t356r1870b429],
22	Km	NN	O	km	nsubjpass	25	SENT_101	[p7l1903t358r2007b430],
23	can	MD	O	can	aux	25	SENT_101	[p7l2038t374r2147b413],
24	be	VB	O	be	auxpass	25	SENT_101	[p7l7t440r82b497],
25	obtained	VBN	O	obtain	rcmod	19	SENT_101	[p7l112t440r386b497],
26	by	IN	O	by	_	0	SENT_101	[p7l412t441r491b513],
27	curve-ﬁtting	JJ	O	curve-ﬁtting	amod	28	SENT_101	[p7l521t440r993b513],
28	.60	CD	NUMBER	.60	agent	25	SENT_101	[p7l521t440r993b513],
29	The	DT	O	the	det	31	SENT_101	[p7l1022t440r1144b497],
30	kinetic	JJ	O	kinetic	amod	31	SENT_101	[p7l1172t440r1388b497],
31	data	NNS	O	datum	dobj	18	SENT_101	[p7l1419t440r1551b497],
32	were	VBD	O	be	auxpass	33	SENT_101	[p7l1579t458r1732b497],
33	analysed	VBN	O	analyse	_	0	SENT_101	[p7l1762t441r2040b513],
34	by	IN	O	by	_	0	SENT_101	[p7l2067t441r2146b513],
35	nonlinear	JJ	O	nonlinear	amod	37	SENT_101	[p7l8t525r311b581],
36	regression	NN	O	regression	nn	37	SENT_101	[p7l330t525r659b598],
37	analysis	NN	O	analysis	agent	33	SENT_101	[p7l683t525r936b597],
38	using	VBG	O	use	partmod	37	SENT_101	[p7l959t525r1130b598],
39	the	DT	O	the	det	43	SENT_101	[p7l1153t525r1249b581],
40	computer	NN	O	computer	nn	43	SENT_101	[p7l1272t533r1573b598],
41	program	NN	O	program	nn	43	SENT_101	[p7l1593t542r1865b598],
42	package	NN	O	package	nn	43	SENT_101	[p7l1885t525r2146b598],
43	ENZFITTERTM	NNP	O	ENZFITTERTM	dobj	38	SENT_101	[p7l8t610r512b665],
44	(	CD	NUMBER	(	num	46	SENT_101	[p7l554t609r1091b678],
45	Leatherbarrow	NNP	PERSON	Leatherbarrow	nn	46	SENT_101	[p7l554t609r1091b678],
46	)	NN	O	)	nsubjpass	33	SENT_101	[p7l554t609r1091b678],
47	.	.	O	.	_	0	SENT_101	[p7l554t609r1091b678],

1	The	DT	O	the	det	4	SENT_102	[p7l1134t609r1256b665],
2	inhibitor	NN	O	inhibitor	nn	4	SENT_102	[p7l1295t609r1571b665],
3	constant	JJ	O	constant	amod	4	SENT_102	[p7l1609t617r1875b665],
4	Ki	NN	PERSON	kus	nsubjpass	6	SENT_102	[p7l1913t610r1985b682],
5	was	VBD	O	be	auxpass	6	SENT_102	[p7l2024t627r2145b665],
6	determined	VBN	O	determine	_	0	SENT_102	[p7l9t692r368b748],
7	using	VBG	O	use	xcomp	6	SENT_102	[p7l395t692r567b765],
8	secondary	JJ	O	secondary	amod	9	SENT_102	[p7l599t692r919b765],
9	plots	NNS	O	plot	dobj	7	SENT_102	[p7l947t692r1100b765],
10	of	IN	O	of	_	0	SENT_102	[p7l1131t692r1201b748],
11	1N	NN	O	1n	prep_of	9	SENT_102	[p7l1232t692r1341b749],
12	vs.	CC	O	vs.	prep	11	SENT_102	[p7l1479t711r1555b749],
13	inhibitor	NN	O	inhibitor	nn	14	SENT_102	[p7l1591t692r1868b748],
14	concentration	NN	O	concentration	dep	12	SENT_102	[p7l1895t710r2144b748, p7l8t776r289b833],
15	.61	CD	NUMBER	.61	num	14	SENT_102	[p7l1895t710r2144b748, p7l8t776r289b833],

1	max	NN	O	max	_	0	SENT_103	[p7l1344t742r1449b766],

1	RESULTS	NNS	O	result	_	0	SENT_104	[p7l933t981r1218b1028],

1	Puriﬁcation	NN	O	puriﬁcation	_	0	SENT_105	[p7l7t1065r389b1137],
2	of	IN	O	of	_	0	SENT_105	[p7l419t1065r492b1136],
3	heterologously	RB	O	heterologously	advmod	4	SENT_105	[p7l508t1064r982b1136],
4	expressed	VBN	O	express	amod	5	SENT_105	[p7l1012t1064r1329b1136],
5	GSTS	NN	O	gst	prep_of	1	SENT_105	[p7l1357t1066r1525b1121],

1	Human	JJ	O	human	amod	2	SENT_106	[p7l89t1166r323b1221],
2	GSTs	NNS	O	gst	nsubj	10	SENT_106	[p7l358t1165r536b1221],
3	heterologously	RB	O	heterologously	advmod	4	SENT_106	[p7l571t1165r1046b1237],
4	expressed	VBN	O	express	partmod	2	SENT_106	[p7l1081t1164r1395b1237],
5	in	IN	O	in	_	0	SENT_106	[p7l1428t1164r1489b1220],
6	E.	FW	O	e.	nn	7	SENT_106	[p7l1521t1167r1582b1221],
7	coli	FW	O	coli	prep_in	4	SENT_106	[p7l1624t1165r1742b1221],
8	were	VBD	O	be	cop	10	SENT_106	[p7l1776t1182r1929b1221],
9	A1	NN	O	a1	nn	10	SENT_106	[p7l1963t1165r2143b1231],
10	—	NN	O	—	ccomp	19	SENT_106	[p7l1963t1165r2143b1231],
11	1	CD	NUMBER	1	num	10	SENT_106	[p7l1963t1165r2143b1231],
12	,	,	O	,	_	0	SENT_106	[p7l1963t1165r2143b1231],
13	A2-2	NN	O	a2-2	nsubj	19	SENT_106	[p7l8t1249r188b1315],
14	,	,	O	,	_	0	SENT_106	[p7l8t1249r188b1315],
15	M1-1	NN	O	m1-1	nn	16	SENT_106	[p7l211t1249r381b1304],
16	(	NN	O	(	appos	13	SENT_106	[p7l410t1249r627b1318],
17	allelic	JJ	O	allelic	amod	18	SENT_106	[p7l410t1249r627b1318],
18	variant	JJ	O	variant	amod	16	SENT_106	[p7l649t1249r871b1305],
19	b	NN	O	b	_	0	SENT_106	[p7l889t1249r972b1318],
20	)	NN	O	)	dobj	19	SENT_106	[p7l889t1249r972b1318],
21	,	,	O	,	_	0	SENT_106	[p7l889t1249r972b1318],
22	M3-3	NN	O	m3-3	conj_and	20	SENT_106	[p7l994t1249r1167b1305],
23	and	CC	O	and	_	0	SENT_106	[p7l1193t1249r1306b1305],
24	P1-1	NN	O	p1-1	conj_and	20	SENT_106	[p7l1325t1249r1491b1305],
25	.	.	O	.	_	0	SENT_106	[p7l1325t1249r1491b1305],

1	These	DT	O	these	nsubjpass	3	SENT_107	[p7l1515t1249r1704b1305],
2	were	VBD	O	be	auxpass	3	SENT_107	[p7l1725t1266r1878b1305],
3	puriﬁed	VBN	O	puriﬁed	_	0	SENT_107	[p7l1898t1249r2147b1322],
4	by	IN	O	by	_	0	SENT_107	[p7l7t1333r86b1406],
5	afﬁnity	NN	O	afﬁnity	nn	6	SENT_107	[p7l118t1333r345b1406],
6	chromatography	NN	O	chromatography	agent	3	SENT_107	[p7l377t1333r915b1406],
7	.	.	O	.	_	0	SENT_107	[p7l377t1333r915b1406],

1	The	DT	O	the	det	2	SENT_108	[p7l949t1333r1072b1389],
2	GSTs	NNS	MISC	gst	nsubjpass	4	SENT_108	[p7l1103t1333r1280b1389],
3	were	VBD	O	be	auxpass	4	SENT_108	[p7l1313t1350r1466b1389],
4	puriﬁed	VBN	O	puriﬁed	dep	16	SENT_108	[p7l1495t1333r1744b1406],
5	to	TO	O	to	_	0	SENT_108	[p7l1773t1341r1832b1389],
6	homogeneity	NN	O	homogeneity	prep_to	4	SENT_108	[p7l1862t1333r2144b1406, p7l8t1417r166b1490],
7	and	CC	O	and	_	0	SENT_108	[p7l189t1417r301b1473],
8	a	DT	O	a	det	10	SENT_108	[p7l323t1435r356b1473],
9	single	JJ	O	single	amod	10	SENT_108	[p7l378t1417r565b1490],
10	band	NN	O	band	nsubjpass	12	SENT_108	[p7l584t1417r740b1473],
11	was	VBD	O	be	auxpass	12	SENT_108	[p7l760t1435r880b1473],
12	obtained	VBN	O	obtain	conj_and	4	SENT_108	[p7l904t1417r1178b1473],
13	on	IN	O	on	_	0	SENT_108	[p7l1199t1435r1276b1473],
14	SDS-PAGE	NN	O	sds-page	nn	15	SENT_108	[p7l1298t1417r1677b1473],
15	analyses	NNS	O	analysis	prep_on	12	SENT_108	[p7l1699t1417r1966b1490],
16	(	VBP	O	(	_	0	SENT_108	[p7l1990t1417r2148b1486],
17	data	NNS	O	datum	nsubj	16	SENT_108	[p7l1990t1417r2148b1486],

1	702	CD	NUMBER	702	_	0	SENT_109	[p7l480t1565r535b1591],
2	MUKANGANYAMA	NNP	O	MUKANGANYAMA	nn	4	SENT_109	[p7l1326t1571r1588b1591],
3	ET	NNP	O	ET	nn	4	SENT_109	[p7l1598t1571r1635b1591],
4	AL.	NNP	O	AL.	dep	1	SENT_109	[p7l1640t1571r1680b1591],
5	.	.	O	.	_	0	SENT_109	[p7l1640t1571r1680b1591],

1	not	RB	O	not	nsubj	2	SENT_110	[p7l8t1703r110b1751],
2	shown	VBN	O	show	_	0	SENT_110	[p7l139t1695r387b1764],
3	)	NN	O	)	dobj	2	SENT_110	[p7l139t1695r387b1764],
4	.	.	O	.	_	0	SENT_110	[p7l139t1695r387b1764],

1	Speciﬁc	JJ	O	speciﬁc	amod	2	SENT_111	[p7l421t1695r674b1768],
2	activities	NNS	O	activity	_	0	SENT_111	[p7l704t1695r988b1751],
3	of	IN	O	of	_	0	SENT_111	[p7l1019t1695r1088b1751],
4	84	CD	NUMBER	84	prep_of	2	SENT_111	[p7l1113t1695r1205b1761],
5	,	,	O	,	_	0	SENT_111	[p7l1113t1695r1205b1761],
6	78	CD	NUMBER	78	prep_of	2	SENT_111	[p7l1236t1695r1331b1762],
7	,	,	O	,	_	0	SENT_111	[p7l1236t1695r1331b1762],
8	119	CD	NUMBER	119	conj_and	4	SENT_111	[p7l1370t1695r1497b1761],
9	,	,	O	,	_	0	SENT_111	[p7l1370t1695r1497b1761],
10	8	CD	NUMBER	8	conj_and	4	SENT_111	[p7l1531t1695r1563b1751],
11	and	CC	O	and	_	0	SENT_111	[p7l1595t1695r1708b1751],
12	129	CD	NUMBER	129	num	14	SENT_111	[p7l1742t1695r1851b1752],
13	p.	NN	O	p.	nn	14	SENT_111	[p7l1886t1695r2148b1767],
14	rnoles	NNS	O	rnole	conj_and	4	SENT_111	[p7l1886t1695r2148b1767],
15	/	:	O	/	punct	2	SENT_111	[p7l1886t1695r2148b1767],
16	min/mg	JJ	O	min/mg	amod	17	SENT_111	[p7l8t1778r255b1851],
17	protein	NN	O	protein	nsubjpass	19	SENT_111	[p7l281t1778r507b1851],
18	were	VBD	O	be	auxpass	19	SENT_111	[p7l532t1796r685b1834],
19	obtained	VBN	O	obtain	dep	2	SENT_111	[p7l712t1778r985b1834],
20	for	IN	O	for	_	0	SENT_111	[p7l1010t1778r1103b1834],
21	GSTs	NNS	O	gst	nn	22	SENT_111	[p7l1128t1778r1306b1835],
22	A1-1	NN	O	a1-1	prep_for	19	SENT_111	[p7l1332t1779r1512b1845],
23	,	,	O	,	_	0	SENT_111	[p7l1332t1779r1512b1845],
24	A2	NN	O	a2	nn	25	SENT_111	[p7l1541t1779r1721b1845],
25	—	NN	O	—	prep_for	19	SENT_111	[p7l1541t1779r1721b1845],
26	2	CD	NUMBER	2	dep	25	SENT_111	[p7l1541t1779r1721b1845],
27	,	,	O	,	_	0	SENT_111	[p7l1541t1779r1721b1845],
28	Ml-1	NN	O	ml-1	prep_for	19	SENT_111	[p7l1748t1779r1942b1845],
29	,	,	O	,	_	0	SENT_111	[p7l1748t1779r1942b1845],
30	M3-3	NN	O	m3-3	conj_and	22	SENT_111	[p7l1970t1778r2142b1835],
31	and	CC	O	and	_	0	SENT_111	[p7l10t1862r123b1919],
32	P1-1	NN	O	p1-1	conj_and	22	SENT_111	[p7l149t1863r316b1929],
33	,	,	O	,	_	0	SENT_111	[p7l149t1863r316b1929],
34	respectively	RB	O	respectively	advmod	19	SENT_111	[p7l346t1862r748b1935],
35	.	.	O	.	_	0	SENT_111	[p7l346t1862r748b1935],

1	The	DT	O	the	det	2	SENT_112	[p7l780t1862r902b1918],
2	effects	NNS	O	effect	nsubjpass	11	SENT_112	[p7l930t1862r1140b1919],
3	of	IN	O	of	_	0	SENT_112	[p7l1170t1862r1239b1919],
4	standard	NN	O	standard	nn	5	SENT_112	[p7l1264t1862r1532b1919],
5	inhibitors	NNS	O	inhibitor	prep_of	2	SENT_112	[p7l1558t1862r1862b1918],
6	on	IN	O	on	_	0	SENT_112	[p7l1892t1880r1970b1918],
7	GST	NN	O	gst	nn	8	SENT_112	[p7l1998t1863r2146b1919],
8	activity	NN	O	activity	prep_on	5	SENT_112	[p7l10t1946r246b2019],
9	were	VBD	O	be	auxpass	11	SENT_112	[p7l273t1964r427b2003],
10	also	RB	O	also	advmod	11	SENT_112	[p7l455t1946r579b2003],
11	determined	VBN	O	determine	_	0	SENT_112	[p7l607t1946r981b2003],
12	.	.	O	.	_	0	SENT_112	[p7l607t1946r981b2003],

1	The	DT	O	the	det	3	SENT_113	[p7l1011t1947r1134b2003],
2	inhibition	NN	O	inhibition	nn	3	SENT_113	[p7l1160t1946r1470b2003],
3	characteristics	NNS	O	characteristic	nsubj	4	SENT_113	[p7l1497t1946r1951b2003],
4	(	VBP	O	(	_	0	SENT_113	[p7l1982t1947r2147b2020],
5	IC50	NN	O	ic50	nn	6	SENT_113	[p7l1982t1947r2147b2020],
6	values	NNS	O	value	nsubj	24	SENT_113	[p7l9t2030r236b2100],
7	)	CD	NUMBER	)	nsubj	16	SENT_113	[p7l9t2030r236b2100],
8	of	IN	O	of	_	0	SENT_113	[p7l268t2030r337b2087],
9	recombinant	JJ	O	recombinant	amod	11	SENT_113	[p7l359t2030r760b2087],
10	GST	NN	O	gst	nn	11	SENT_113	[p7l789t2031r937b2087],
11	s	NNS	O	s	prep_of	7	SENT_113	[p7l942t2048r967b2087],
12	from	IN	O	from	_	0	SENT_113	[p7l997t2030r1152b2087],
13	E.	FW	O	e.	nn	14	SENT_113	[p7l1178t2033r1239b2087],
14	coli	FW	O	coli	prep_from	11	SENT_113	[p7l1277t2030r1394b2087],
15	were	VBD	O	be	cop	16	SENT_113	[p7l1423t2048r1576b2087],
16	comparable	JJ	O	comparable	rcmod	6	SENT_113	[p7l1605t2030r1977b2103],
17	with	IN	O	with	_	0	SENT_113	[p7l2006t2030r2147b2087],
18	those	DT	O	those	prep_with	16	SENT_113	[p7l8t2115r175b2171],
19	reported	VBN	O	report	partmod	18	SENT_113	[p7l204t2115r470b2188],
20	previously	RB	DATE	previously	advmod	19	SENT_113	[p7l497t2115r834b2188],
21	(	CD	NUMBER	(	num	22	SENT_113	[p7l866t2115r1024b2184],
22	data	NNS	O	datum	npadvmod	23	SENT_113	[p7l866t2115r1024b2184],
23	not	RB	O	not	neg	24	SENT_113	[p7l1051t2123r1153b2171],
24	shown	VBN	O	show	ccomp	4	SENT_113	[p7l1183t2115r1565b2184],
25	)	NN	O	)	nn	26	SENT_113	[p7l1183t2115r1565b2184],
26	.18	NN	NUMBER	.18	dobj	24	SENT_113	[p7l1183t2115r1565b2184],
27	=	JJ	O	=	amod	26	SENT_113	[p7l1183t2115r1565b2184],
28	2	CD	NUMBER	2	number	29	SENT_113	[p7l1183t2115r1565b2184],
29	°	CD	NUMBER	°	dep	27	SENT_113	[p7l1183t2115r1565b2184],

1	Eﬁects	NNS	O	eﬁects	_	0	SENT_114	[p7l7t2253r224b2325],
2	of	IN	O	of	_	0	SENT_114	[p7l254t2253r327b2325],
3	antimalarials	NNS	O	antimalarial	prep_of	1	SENT_114	[p7l343t2253r772b2310],

1	The	DT	O	the	det	2	SENT_115	[p7l89t2353r211b2409],
2	effect	NN	O	effect	nsubjpass	15	SENT_115	[p7l247t2353r428b2409],
3	of	IN	O	of	_	0	SENT_115	[p7l463t2353r532b2409],
4	antimalarial	JJ	O	antimalarial	amod	5	SENT_115	[p7l564t2353r943b2409],
5	drugs	NNS	O	drug	prep_of	2	SENT_115	[p7l979t2353r1153b2426],
6	on	IN	O	on	_	0	SENT_115	[p7l1191t2371r1268b2409],
7	the	DT	O	the	det	8	SENT_115	[p7l1303t2353r1399b2409],
8	activity	NN	O	activity	prep_on	5	SENT_115	[p7l1436t2353r1672b2426],
9	of	IN	O	of	_	0	SENT_115	[p7l1709t2353r1778b2409],
10	human	JJ	O	human	amod	13	SENT_115	[p7l1807t2353r2025b2409],
11	recombinant	JJ	O	recombinant	amod	13	SENT_115	[p7l2059t2371r2144b2409, p7l9t2437r346b2494],
12	GST	NN	O	gst	nn	13	SENT_115	[p7l373t2438r521b2494],
13	activity	NN	O	activity	prep_of	8	SENT_115	[p7l550t2437r786b2510],
14	was	VBD	O	be	auxpass	15	SENT_115	[p7l814t2455r934b2494],
15	assessed	VBN	O	assess	_	0	SENT_115	[p7l964t2437r1233b2494],
16	by	IN	O	by	_	0	SENT_115	[p7l1258t2437r1337b2510],
17	measuring	VBG	O	measure	agent	15	SENT_115	[p7l1364t2437r1695b2510],
18	the	DT	O	the	det	20	SENT_115	[p7l1723t2437r1818b2493],
19	conjugating	VBG	O	conjugate	amod	20	SENT_115	[p7l1846t2437r2144b2510, p7l8t2521r108b2594],
20	activity	NN	O	activity	dobj	17	SENT_115	[p7l139t2521r375b2594],
21	with	IN	O	with	_	0	SENT_115	[p7l405t2521r545b2578],
22	CDNB	NN	O	cdnb	prep_with	17	SENT_115	[p7l574t2522r811b2588],
23	,	,	O	,	_	0	SENT_115	[p7l574t2522r811b2588],
24	ETA	NNP	ORGANIZATION	ETA	conj_and	22	SENT_115	[p7l842t2522r997b2577],
25	and	CC	O	and	_	0	SENT_115	[p7l1027t2522r1139b2578],
26	BCNU	NNP	O	BCNU	conj_and	22	SENT_115	[p7l1167t2522r1388b2578],
27	for	IN	O	for	_	0	SENT_115	[p7l1417t2521r1509b2578],
28	GST	NN	O	gst	nn	29	SENT_115	[p7l1538t2522r1686b2578],
29	M1-1	NN	O	m1-1	prep_for	17	SENT_115	[p7l1714t2522r1906b2578],
30	.	.	O	.	_	0	SENT_115	[p7l1714t2522r1906b2578],

1	Figure	NNP	O	Figure	nsubj	3	SENT_116	[p7l1939t2521r2146b2594],
2	1	CD	NUMBER	1	num	1	SENT_116	[p7l16t2606r39b2661],
3	shows	VBZ	O	show	_	0	SENT_116	[p7l88t2606r282b2662],
4	a	DT	O	a	det	5	SENT_116	[p7l324t2623r357b2662],
5	plot	NN	O	plot	dobj	3	SENT_116	[p7l393t2606r518b2679],
6	used	VBN	O	use	partmod	5	SENT_116	[p7l555t2606r701b2662],
7	to	TO	O	to	aux	8	SENT_116	[p7l739t2614r799b2662],
8	determine	VB	O	determine	xcomp	6	SENT_116	[p7l839t2606r1156b2662],
9	the	DT	O	the	det	11	SENT_116	[p7l1195t2606r1291b2662],
10	IC50	NN	O	ic50	nn	11	SENT_116	[p7l1330t2606r1471b2679],
11	value	NN	O	value	dobj	8	SENT_116	[p7l1510t2606r1680b2662],
12	for	IN	O	for	_	0	SENT_116	[p7l1720t2606r1813b2662],
13	quinine	NN	O	quinine	poss	15	SENT_116	[p7l1850t2606r2144b2679],
14	’s	POS	O	’s	_	0	SENT_116	[p7l1850t2606r2144b2679],
15	inhibition	NN	O	inhibition	prep_for	8	SENT_116	[p7l8t2690r319b2746],
16	of	IN	O	of	_	0	SENT_116	[p7l340t2690r409b2746],
17	GST	NN	O	gst	nn	18	SENT_116	[p7l425t2690r573b2746],
18	P1-1	NN	O	p1-1	prep_of	15	SENT_116	[p7l593t2690r759b2756],
19	,	,	O	,	_	0	SENT_116	[p7l593t2690r759b2756],
20	and	CC	O	and	_	0	SENT_116	[p7l785t2690r897b2746],
21	Figure	NN	O	figure	nsubj	23	SENT_116	[p7l916t2690r1124b2763],
22	2	CD	NUMBER	2	num	21	SENT_116	[p7l1145t2690r1182b2745],
23	shows	VBZ	O	show	conj_and	3	SENT_116	[p7l1205t2690r1399b2746],
24	the	DT	O	the	det	26	SENT_116	[p7l1421t2690r1517b2746],
25	secondary	JJ	O	secondary	amod	26	SENT_116	[p7l1540t2690r1860b2763],
26	plots	NNS	O	plot	dobj	23	SENT_116	[p7l1880t2690r2033b2763],
27	for	IN	O	for	_	0	SENT_116	[p7l2055t2690r2148b2746],
28	determination	NN	O	determination	prep_for	26	SENT_116	[p7l9t2773r452b2829],
29	of	IN	O	of	_	0	SENT_116	[p7l479t2773r548b2829],
30	the	DT	O	the	det	31	SENT_116	[p7l569t2773r665b2829],
31	K	NN	O	k	prep_of	28	SENT_116	[p7l693t2775r765b2846],
32	,	,	O	,	_	0	SENT_116	[p7l693t2775r765b2846],
33	values	NNS	O	value	appos	31	SENT_116	[p7l791t2773r992b2829],
34	for	IN	O	for	_	0	SENT_116	[p7l1021t2773r1113b2829],
35	the	DT	O	the	det	36	SENT_116	[p7l1138t2773r1233b2829],
36	inhibitor	NN	O	inhibitor	prep_for	33	SENT_116	[p7l1260t2773r1536b2829],
37	and	CC	O	and	_	0	SENT_116	[p7l1562t2773r1675b2829],
38	enzyme	NN	O	enzyme	prep_for	33	SENT_116	[p7l1701t2791r1948b2846],
39	using	VBG	O	use	partmod	36	SENT_116	[p7l1974t2773r2145b2846],
40	Vmax	NN	MISC	vmax	nn	41	SENT_116	[p7l8t2859r172b2931],
41	values	NNS	O	value	dobj	39	SENT_116	[p7l215t2857r416b2914],
42	for	IN	O	for	_	0	SENT_116	[p7l461t2857r554b2913],
43	GSH	NN	O	gsh	prep_for	39	SENT_116	[p7l597t2858r754b2914],
44	and	CC	O	and	_	0	SENT_116	[p7l800t2857r912b2913],
45	for	IN	O	for	_	0	SENT_116	[p7l955t2857r1048b2913],
46	CDNB	NN	O	cdnb	prep_for	39	SENT_116	[p7l1091t2858r1326b2914],
47	.	.	O	.	_	0	SENT_116	[p7l1091t2858r1326b2914],

1	The	DT	O	the	det	3	SENT_117	[p7l1374t2857r1496b2913],
2	Vmax	NN	MISC	vmax	nn	3	SENT_117	[p7l1540t2859r1703b2931],
3	values	NNS	O	value	nsubjpass	5	SENT_117	[p7l1746t2857r1947b2914],
4	were	VBD	O	be	auxpass	5	SENT_117	[p7l1993t2875r2146b2914],
5	determined	VBN	O	determine	_	0	SENT_117	[p7l9t2941r368b2998],
6	3-4	CD	NUMBER	3-4	num	7	SENT_117	[p7l414t2942r539b2998],
7	times	NNS	O	time	dobj	5	SENT_117	[p7l585t2941r755b2998],
8	each	DT	O	each	dep	7	SENT_117	[p7l803t2942r947b2998],
9	for	IN	O	for	_	0	SENT_117	[p7l992t2941r1084b2998],
10	GSH	NN	O	gsh	prep_for	5	SENT_117	[p7l1129t2942r1286b2998],
11	and	CC	O	and	_	0	SENT_117	[p7l1333t2942r1446b2998],
12	for	IN	O	for	_	0	SENT_117	[p7l1490t2941r1583b2998],
13	CDNB	NN	O	cdnb	prep_for	5	SENT_117	[p7l1627t2942r1863b2998],
14	.	.	O	.	_	0	SENT_117	[p7l1627t2942r1863b2998],

1	Similar	JJ	O	similar	amod	2	SENT_118	[p7l1914t2941r2148b2998],
2	graphs	NNS	O	graph	nsubjpass	4	SENT_118	[p7l9t3026r218b3098],
3	were	VBD	O	be	auxpass	4	SENT_118	[p7l261t3043r414b3082],
4	plotted	VBN	O	plot	_	0	SENT_118	[p7l454t3025r677b3098],
5	to	TO	O	to	aux	6	SENT_118	[p7l716t3034r776b3082],
6	determine	VB	O	determine	xcomp	4	SENT_118	[p7l818t3025r1136b3082],
7	IC50	NN	O	ic50	nn	10	SENT_118	[p7l1177t3026r1317b3099],
8	and	CC	O	and	_	0	SENT_118	[p7l1359t3026r1472b3082],
9	Ki	NN	O	kus	nn	10	SENT_118	[p7l1513t3027r1585b3099],
10	values	NNS	O	value	dobj	6	SENT_118	[p7l1626t3026r1827b3082],
11	for	IN	O	for	_	0	SENT_118	[p7l1870t3025r1962b3082],
12	each	DT	O	each	det	13	SENT_118	[p7l2002t3025r2147b3082],
13	antimalarial	JJ	O	antimalarial	prep_for	6	SENT_118	[p7l10t3110r389b3166],
14	using	VBG	O	use	partmod	13	SENT_118	[p7l414t3110r585b3183],
15	GSH	NN	O	gsh	dobj	14	SENT_118	[p7l611t3110r769b3166],
16	together	RB	O	together	_	0	SENT_118	[p7l793t3110r1056b3183],
17	with	IN	O	with	_	0	SENT_118	[p7l1079t3110r1219b3166],
18	CDNB	NN	O	cdnb	prep_together_with	14	SENT_118	[p7l1245t3110r1460b3166],
19	as	IN	O	as	_	0	SENT_118	[p7l1491t3127r1552b3166],
20	substrate	NN	O	substrate	prep_as	18	SENT_118	[p7l1581t3110r1861b3166],
21	for	IN	O	for	_	0	SENT_118	[p7l1886t3110r1979b3166],
22	each	DT	O	each	prep_for	20	SENT_118	[p7l2002t3110r2147b3166],
23	of	IN	O	of	_	0	SENT_118	[p7l9t3194r79b3250],
24	the	DT	O	the	det	25	SENT_118	[p7l93t3194r189b3250],
25	GSTs	NNS	O	gst	prep_of	22	SENT_118	[p7l210t3194r405b3250],
26	.	.	O	.	_	0	SENT_118	[p7l210t3194r405b3250],

1	Results	NNS	O	result	nsubjpass	3	SENT_119	[p7l430t3194r662b3250],
2	are	VBP	O	be	auxpass	3	SENT_119	[p7l686t3212r780b3250],
3	summarised	VBN	O	summarise	_	0	SENT_119	[p7l803t3194r1186b3250],
4	in	IN	O	in	_	0	SENT_119	[p7l1205t3194r1266b3249],
5	Tables	NNS	O	table	prep_in	3	SENT_119	[p7l1286t3194r1496b3250],
6	I	PRP	O	I	dobj	3	SENT_119	[p7l1518t3195r1678b3250],
7	.	.	O	.	_	0	SENT_119	[p7l1518t3195r1678b3250],

1	—	NN	O	—	_	0	SENT_120	[p7l1518t3195r1678b3250],
2	.	.	O	.	_	0	SENT_120	[p7l1518t3195r1678b3250],

1	III	NNP	O	III	_	0	SENT_121	[p7l1518t3195r1678b3250],
2	.	.	O	.	_	0	SENT_121	[p7l1518t3195r1678b3250],

1	Table	NNP	O	Table	nsubj	3	SENT_122	[p7l1703t3194r1883b3250],
2	I	PRP	O	I	dep	1	SENT_122	[p7l1903t3195r1928b3249],
3	shows	VBZ	O	show	_	0	SENT_122	[p7l1951t3194r2145b3250],
4	ICSO	NN	O	icso	nn	5	SENT_122	[p7l8t3277r149b3351],
5	values	NNS	O	value	dobj	3	SENT_122	[p7l170t3277r371b3333],
6	indicating	VBG	O	indicate	partmod	5	SENT_122	[p7l393t3277r711b3350],
7	potent	JJ	O	potent	amod	8	SENT_122	[p7l731t3285r932b3350],
8	inhibitions	NNS	O	inhibition	dobj	6	SENT_122	[p7l952t3277r1291b3333],
9	for	IN	O	for	_	0	SENT_122	[p7l1313t3277r1406b3333],
10	artemisinin	NN	O	artemisinin	prep_for	8	SENT_122	[p7l1427t3277r1784b3333],
11	with	IN	O	with	_	0	SENT_122	[p7l1805t3277r1946b3333],
12	GSTs	NNS	O	gst	nn	13	SENT_122	[p7l1967t3277r2145b3334],
13	A1-1	NN	O	a1-1	prep_with	6	SENT_122	[p7l8t3362r164b3417],
14	and	CC	O	and	_	0	SENT_122	[p7l199t3361r312b3417],
15	P1-1	NN	O	p1-1	prep_with	6	SENT_122	[p7l338t3362r505b3428],
16	,	,	O	,	_	0	SENT_122	[p7l338t3362r505b3428],
17	pyrimethamine	NN	O	pyrimethamine	prep_with	6	SENT_122	[p7l533t3361r1018b3434],
18	with	IN	O	with	_	0	SENT_122	[p7l1045t3361r1186b3418],
19	GST	NN	O	gst	nn	20	SENT_122	[p7l1214t3362r1362b3418],
20	P1-1	NN	O	p1-1	prep_with	17	SENT_122	[p7l1388t3362r1531b3417],
21	and	CC	O	and	_	0	SENT_122	[p7l1566t3361r1679b3417],
22	quinidine	NN	O	quinidine	prep_with	17	SENT_122	[p7l1706t3361r2006b3434],
23	and	CC	O	and	_	0	SENT_122	[p7l2034t3361r2147b3418],
24	quinine	NN	O	quinine	conj_and	13	SENT_122	[p7l9t3445r247b3518],
25	with	IN	O	with	_	0	SENT_122	[p7l284t3445r425b3502],
26	GSTs	NNS	O	gst	nn	27	SENT_122	[p7l463t3446r640b3502],
27	M1-1	NN	O	m1-1	prep_with	24	SENT_122	[p7l679t3446r848b3501],
28	and	CC	O	and	_	0	SENT_122	[p7l894t3446r1007b3502],
29	P1-1	NN	O	p1-1	conj_and	27	SENT_122	[p7l1043t3446r1209b3502],
30	.	.	O	.	_	0	SENT_122	[p7l1043t3446r1209b3502],

1	Tetracycline	NN	O	tetracycline	nsubj	2	SENT_123	[p7l1250t3445r1648b3518],
2	inhibited	VBD	O	inhibit	_	0	SENT_123	[p7l1686t3445r1969b3502],
3	both	CC	O	both	prep	2	SENT_123	[p7l2005t3445r2147b3502],
4	GSTM3-3	NN	O	gstm3-3	dep	3	SENT_123	[p7l10t3530r332b3586],
5	and	CC	O	and	_	0	SENT_123	[p7l378t3529r491b3586],
6	P1-1	NN	O	p1-1	dep	3	SENT_123	[p7l530t3530r672b3585],
7	but	CC	O	but	cc	2	SENT_123	[p7l718t3530r821b3586],
8	with	IN	O	with	_	0	SENT_123	[p7l861t3529r1001b3586],
9	higher	JJR	O	higher	amod	11	SENT_123	[p7l1040t3529r1245b3602],
10	IC50	NN	O	ic50	nn	11	SENT_123	[p7l1283t3530r1424b3603],
11	values	NNS	O	value	prep_with	2	SENT_123	[p7l1464t3530r1683b3586],
12	.	.	O	.	_	0	SENT_123	[p7l1464t3530r1683b3586],

1	Chloroquine	NN	MISC	chloroquine	nsubj	8	SENT_124	[p7l1728t3529r2143b3602],
2	,	,	O	,	_	0	SENT_124	[p7l1728t3529r2143b3602],
3	primaquine	NN	O	primaquine	conj_and	1	SENT_124	[p7l7t3614r371b3687],
4	and	CC	O	and	_	0	SENT_124	[p7l400t3614r513b3670],
5	sulphadoxine	NN	O	sulphadoxine	conj_and	1	SENT_124	[p7l542t3614r965b3687],
6	did	VBD	O	do	aux	8	SENT_124	[p7l993t3614r1093b3670],
7	not	RB	O	not	neg	8	SENT_124	[p7l1120t3622r1221b3670],
8	inhibit	VB	O	inhibit	_	0	SENT_124	[p7l1247t3614r1456b3670],
9	GSTs	NNS	O	gst	dobj	8	SENT_124	[p7l1482t3614r1660b3670],
10	at	IN	O	at	_	0	SENT_124	[p7l1691t3622r1746b3670],
11	the	DT	O	the	det	12	SENT_124	[p7l1771t3614r1867b3670],
12	concentrations	NNS	O	concentration	prep_at	8	SENT_124	[p7l1895t3631r2144b3670, p7l8t3698r245b3754],
13	that	WDT	O	that	nsubjpass	15	SENT_124	[p7l276t3698r395b3754],
14	were	VBD	O	be	auxpass	15	SENT_124	[p7l423t3716r576b3754],
15	used	VBN	O	use	rcmod	12	SENT_124	[p7l605t3698r767b3754],
16	.	.	O	.	_	0	SENT_124	[p7l605t3698r767b3754],

1	The	DT	O	the	det	2	SENT_125	[p8l89t29r211b85],
2	effects	NNS	O	effect	_	0	SENT_125	[p8l241t29r450b85],
3	of	IN	O	of	_	0	SENT_125	[p8l482t29r551b85],
4	the	DT	O	the	det	6	SENT_125	[p8l575t29r670b85],
5	different	JJ	O	different	amod	6	SENT_125	[p8l700t29r975b85],
6	antimalarials	NNS	O	antimalarial	prep_of	2	SENT_125	[p8l1004t29r1413b85],
7	on	IN	O	on	_	0	SENT_125	[p8l1445t46r1522b85],
8	the	DT	O	the	det	10	SENT_125	[p8l1551t29r1647b85],
9	kinetic	JJ	O	kinetic	amod	10	SENT_125	[p8l1675t29r1891b85],
10	parameters	NNS	O	parameter	prep_on	2	SENT_125	[p8l1921t46r2144b90, p8l9t150r156b197],

1	VmaXGSH/CDNB	NN	O	vmaxgsh/cdnb	nsubjpass	7	SENT_126	[p8l205t129r680b214],
2	and	CC	O	and	_	0	SENT_126	[p8l732t141r845b197],
3	KiiiGSH/CDNB	NN	O	kiiigsh/cdnb	conj_and	1	SENT_126	[p8l892t129r1307b214],
4	of	IN	O	of	_	0	SENT_126	[p8l1358t141r1428b197],
5	GSTs	NNS	O	gst	prep_of	1	SENT_126	[p8l1470t142r1647b197],
6	were	VBD	O	be	auxpass	7	SENT_126	[p8l1697t159r1849b197],
7	studied	VBN	O	study	_	0	SENT_126	[p8l1899t141r2142b197],
8	.	.	O	.	_	0	SENT_126	[p8l1899t141r2142b197],

1	Table	NNP	O	Table	nn	2	SENT_127	[p8l9t224r188b280],
2	II	NNP	O	II	nsubj	3	SENT_127	[p8l221t226r272b280],
3	shows	VBZ	O	show	_	0	SENT_127	[p8l307t224r501b280],
4	typical	JJ	O	typical	amod	5	SENT_127	[p8l535t224r751b297],
5	results	NNS	O	result	dobj	3	SENT_127	[p8l783t224r989b280],
6	for	IN	O	for	_	0	SENT_127	[p8l1023t224r1116b280],
7	the	DT	O	the	det	8	SENT_127	[p8l1147t224r1243b280],
8	effects	NNS	O	effect	prep_for	3	SENT_127	[p8l1276t224r1485b280],
9	of	IN	O	of	_	0	SENT_127	[p8l1520t224r1589b280],
10	quinine	NN	O	quinine	prep_of	8	SENT_127	[p8l1617t224r1854b297],
11	on	IN	O	on	_	0	SENT_127	[p8l1888t242r1965b280],
12	GST	NN	MISC	gst	nn	15	SENT_127	[p8l1998t224r2147b281],
13	Pl-l	NN	MISC	pl-l	nn	15	SENT_127	[p8l8t309r151b364],
14	kinetic	JJ	O	kinetic	amod	15	SENT_127	[p8l195t308r411b365],
15	parameters	NNS	O	parameter	prep_on	10	SENT_127	[p8l449t317r815b381],
16	.	.	O	.	_	0	SENT_127	[p8l449t317r815b381],

1	The	DT	O	the	det	2	SENT_128	[p8l857t308r980b364],
2	Ki	NN	O	kus	_	0	SENT_128	[p8l1019t310r1091b381],
3	or	CC	O	or	_	0	SENT_128	[p8l1129t326r1195b365],
4	K	NN	O	k	conj_or	2	SENT_128	[p8l1233t306r1331b381],
5	'	''	O	'	_	0	SENT_128	[p8l1233t306r1331b381],
6	i	FW	O	i	conj_or	2	SENT_128	[p8l1233t306r1331b381],
7	Values	NNS	O	value	nsubj	11	SENT_128	[p8l1369t308r1569b365],
8	determined	VBN	O	determine	partmod	7	SENT_128	[p8l1610t308r1969b365],
9	with	IN	O	with	_	0	SENT_128	[p8l2006t308r2147b365],
10	CDNB	NN	ORGANIZATION	cdnb	prep_with	8	SENT_128	[p8l9t393r224b449],
11	was	VBD	O	be	rcmod	6	SENT_128	[p8l272t410r392b449],
12	generally	RB	O	generally	advmod	11	SENT_128	[p8l437t393r731b465],
13	within	IN	O	within	_	0	SENT_128	[p8l775t392r977b449],
14	the	DT	O	the	det	16	SENT_128	[p8l1019t393r1115b449],
15	same	JJ	O	same	amod	16	SENT_128	[p8l1160t410r1320b449],
16	range	NN	O	range	prep_within	11	SENT_128	[p8l1361t410r1538b465],
17	as	IN	O	as	_	0	SENT_128	[p8l1582t410r1643b449],
18	the	DT	O	the	det	19	SENT_128	[p8l1687t393r1782b449],
19	Ki	NN	O	kus	prep_as	16	SENT_128	[p8l1826t394r1897b466],
20	or	CC	O	or	_	0	SENT_128	[p8l1941t410r2006b449],
21	K	NN	O	k	conj_or	2	SENT_128	[p8l2048t390r2146b466],
22	’	CD	NUMBER	’	num	21	SENT_128	[p8l2048t390r2146b466],
23	i	FW	O	i	dep	21	SENT_128	[p8l2048t390r2146b466],
24	determined	VBN	O	determine	partmod	21	SENT_128	[p8l9t476r368b533],
25	with	IN	O	with	_	0	SENT_128	[p8l399t476r540b533],
26	GSH	NN	O	gsh	prep_with	24	SENT_128	[p8l573t477r729b533],
27	for	IN	O	for	_	0	SENT_128	[p8l761t476r854b533],
28	each	DT	O	each	det	30	SENT_128	[p8l885t476r1030b533],
29	particular	JJ	O	particular	amod	30	SENT_128	[p8l1060t476r1368b549],
30	drug	NN	O	drug	nn	34	SENT_128	[p8l1399t476r1542b549],
31	(	NNP	O	(	nn	34	SENT_128	[p8l1577t476r1782b546],
32	Table	NNP	O	Table	nn	34	SENT_128	[p8l1577t476r1782b546],
33	III	NNP	O	III	nn	34	SENT_128	[p8l1814t477r1934b546],
34	)	NN	O	)	prep_for	26	SENT_128	[p8l1814t477r1934b546],
35	.	.	O	.	_	0	SENT_128	[p8l1814t477r1934b546],

1	Similarly	RB	O	similarly	advmod	27	SENT_129	[p8l1972t476r2144b533, p8l9t561r170b633],
2	,	,	O	,	_	0	SENT_129	[p8l1972t476r2144b533, p8l9t561r170b633],
3	the	DT	O	the	det	5	SENT_129	[p8l205t561r300b617],
4	IC50	NN	O	ic50	nn	5	SENT_129	[p8l332t561r473b634],
5	Value	NN	O	value	nsubj	27	SENT_129	[p8l505t561r676b617],
6	obtained	VBN	O	obtain	partmod	5	SENT_129	[p8l709t561r983b617],
7	for	IN	O	for	_	0	SENT_129	[p8l1014t561r1107b617],
8	each	DT	O	each	det	9	SENT_129	[p8l1137t561r1282b617],
9	drug	NN	O	drug	prep_for	6	SENT_129	[p8l1314t561r1457b634],
10	with	IN	O	with	_	0	SENT_129	[p8l1490t561r1630b617],
11	CDNB	NN	ORGANIZATION	cdnb	prep_with	9	SENT_129	[p8l1662t561r1878b617],
12	as	IN	O	as	_	0	SENT_129	[p8l1915t578r1977b617],
13	substrate	NN	O	substrate	prep_as	6	SENT_129	[p8l2013t561r2144b617, p8l11t653r180b701],
14	was	VBD	O	be	cop	27	SENT_129	[p8l202t663r322b701],
15	generally	RB	O	generally	amod	27	SENT_129	[p8l346t645r640b718],
16	in	IN	O	in	_	0	SENT_129	[p8l662t645r723b700],
17	the	DT	O	the	det	19	SENT_129	[p8l744t645r839b701],
18	same	JJ	O	same	amod	19	SENT_129	[p8l864t663r1023b701],
19	range	NN	O	range	prep_in	15	SENT_129	[p8l1043t663r1220b718],
20	as	IN	O	as	_	0	SENT_129	[p8l1243t663r1305b701],
21	the	DT	O	the	det	22	SENT_129	[p8l1327t645r1423b701],
22	Ki	NN	O	kus	prep_as	19	SENT_129	[p8l1446t646r1517b718],
23	or	CC	O	or	_	0	SENT_129	[p8l1540t663r1605b701],
24	K	NN	O	k	prep_in	15	SENT_129	[p8l1625t643r1724b718],
25	’	CD	NUMBER	’	num	24	SENT_129	[p8l1625t643r1724b718],
26	i	FW	O	i	dep	24	SENT_129	[p8l1625t643r1724b718],
27	Value	NN	O	value	_	0	SENT_129	[p8l1745t645r1917b701],
28	for	IN	O	for	_	0	SENT_129	[p8l1938t645r2030b701],
29	the	DT	O	the	det	30	SENT_129	[p8l2050t645r2146b701],
30	drug	NN	O	drug	nn	34	SENT_129	[p8l9t728r153b801],
31	(	NNP	O	(	nn	34	SENT_129	[p8l197t728r401b797],
32	Table	NNP	MISC	Table	nn	34	SENT_129	[p8l197t728r401b797],
33	III	NNP	MISC	III	nn	34	SENT_129	[p8l442t729r563b797],
34	)	NN	O	)	prep_for	27	SENT_129	[p8l442t729r563b797],
35	.	.	O	.	_	0	SENT_129	[p8l442t729r563b797],

1	The	DT	O	the	det	5	SENT_130	[p8l608t728r730b784],
2	ICSO	NN	O	icso	nn	5	SENT_130	[p8l772t728r912b802],
3	and	CC	O	and	_	0	SENT_130	[p8l954t728r1067b784],
4	Ki	NN	O	kus	conj_and	2	SENT_130	[p8l1109t730r1180b801],
5	Values	NNS	O	value	nsubjpass	14	SENT_130	[p8l1221t728r1422b784],
6	obtained	VBN	O	obtain	partmod	5	SENT_130	[p8l1466t728r1740b784],
7	(	JJ	O	(	acomp	6	SENT_130	[p8l1783t729r2015b801],
8	except	IN	O	except	_	0	SENT_130	[p8l1783t729r2015b801],
9	for	IN	O	for	prepc_except_for	7	SENT_130	[p8l2055t728r2148b784],
10	pyrimethamine	NN	O	pyrimethamine	nn	11	SENT_130	[p8l8t812r516b885],
11	)	NN	O	)	pobj	7	SENT_130	[p8l8t812r516b885],
12	are	VBP	O	be	auxpass	14	SENT_130	[p8l542t830r636b869],
13	below	IN	O	below	advmod	14	SENT_130	[p8l656t812r850b869],
14	expected	VBN	O	expect	_	0	SENT_130	[p8l873t812r1156b885],
15	peak	NN	O	peak	nn	17	SENT_130	[p8l1176t812r1328b885],
16	plasma	NN	O	plasma	nn	17	SENT_130	[p8l1347t812r1575b885],
17	concentrations	NNS	O	concentration	dobj	14	SENT_130	[p8l1595t812r2058b869],
18	of	IN	O	of	_	0	SENT_130	[p8l2083t812r2152b868],
19	the	DT	O	the	det	20	SENT_130	[p8l8t896r104b953],
20	drugs	NNS	O	drug	prep_of	17	SENT_130	[p8l134t897r307b969],
21	during	IN	O	during	_	0	SENT_130	[p8l339t896r544b969],
22	therapy	NN	O	therapy	prep_during	14	SENT_130	[p8l574t896r812b969],
23	of	IN	O	of	_	0	SENT_130	[p8l842t896r912b953],
24	malaria	NN	O	malaria	nn	28	SENT_130	[p8l935t896r1175b953],
25	(	CD	NUMBER	(	num	28	SENT_130	[p8l1205t896r1410b966],
26	Table	NNP	O	Table	nn	28	SENT_130	[p8l1205t896r1410b966],
27	III	NNP	O	III	nn	28	SENT_130	[p8l1439t897r1559b966],
28	)	NN	O	)	prep_of	22	SENT_130	[p8l1439t897r1559b966],
29	.	.	O	.	_	0	SENT_130	[p8l1439t897r1559b966],

1	Using	VBG	O	use	_	0	SENT_131	[p8l88t996r277b1069],
2	ETA	NNP	O	ETA	dobj	1	SENT_131	[p8l307t997r461b1052],
3	as	IN	O	as	_	0	SENT_131	[p8l492t1014r553b1053],
4	a	DT	O	a	det	5	SENT_131	[p8l586t1014r619b1053],
5	substrate	NN	O	substrate	prep_as	2	SENT_131	[p8l650t996r947b1063],
6	,	,	O	,	_	0	SENT_131	[p8l650t996r947b1063],
7	GST	NN	O	gst	nn	9	SENT_131	[p8l980t997r1128b1053],
8	Pl-1	NN	O	pl-1	nn	9	SENT_131	[p8l1158t997r1300b1052],
9	activity	NN	O	activity	appos	5	SENT_131	[p8l1338t996r1574b1069],
10	was	VBD	O	be	auxpass	11	SENT_131	[p8l1604t1014r1725b1053],
11	inhibited	VBN	O	inhibit	aux	1	SENT_131	[p8l1756t996r2040b1053],
12	by	IN	O	by	_	0	SENT_131	[p8l2067t996r2146b1069],
13	pyrimethamine	NN	O	pyrimethamine	agent	11	SENT_131	[p8l7t1080r509b1153],
14	,	,	O	,	_	0	SENT_131	[p8l7t1080r509b1153],
15	quinidine	NN	O	quinidine	agent	11	SENT_131	[p8l539t1080r857b1153],
16	,	,	O	,	_	0	SENT_131	[p8l539t1080r857b1153],
17	quinine	NN	O	quinine	agent	11	SENT_131	[p8l887t1080r1124b1153],
18	and	CC	O	and	_	0	SENT_131	[p8l1153t1080r1265b1137],
19	tetracycline	NN	O	tetracycline	agent	11	SENT_131	[p8l1292t1080r1663b1153],
20	with	IN	O	with	_	0	SENT_131	[p8l1691t1080r1831b1137],
21	ICSO	NN	O	icso	nn	22	SENT_131	[p8l1857t1081r1997b1154],
22	Values	NNS	O	value	prep_with	11	SENT_131	[p8l2024t1081r2144b1137, p8l8t1182r111b1221],
23	of	IN	O	of	_	0	SENT_131	[p8l151t1164r220b1221],
24	18-70	CD	NUMBER	18-70	num	25	SENT_131	[p8l259t1165r459b1221],
25	p.M	NN	O	p.m	prep_of	22	SENT_131	[p8l501t1166r618b1237],
26	(	CD	NUMBER	(	num	29	SENT_131	[p8l658t1164r862b1234],
27	Table	NNP	O	Table	dep	28	SENT_131	[p8l658t1164r862b1234],
28	IV	CD	NUMBER	iv	amod	29	SENT_131	[p8l899t1165r1024b1234],
29	)	NN	O	)	nsubj	1	SENT_131	[p8l899t1165r1024b1234],
30	.	.	O	.	_	0	SENT_131	[p8l899t1165r1024b1234],

1	Results	NNS	O	result	nsubjpass	8	SENT_132	[p8l1065t1165r1297b1221],
2	obtained	VBN	O	obtain	partmod	1	SENT_132	[p8l1337t1164r1611b1221],
3	with	IN	O	with	_	0	SENT_132	[p8l1647t1164r1788b1221],
4	CDNB	NN	O	cdnb	prep_with	2	SENT_132	[p8l1825t1165r2040b1221],
5	as	IN	O	as	_	0	SENT_132	[p8l2083t1182r2144b1221],
6	substrate	NN	O	substrate	prep_as	2	SENT_132	[p8l11t1249r291b1305],
7	are	VBP	O	be	auxpass	8	SENT_132	[p8l324t1266r418b1305],
8	shown	VBN	O	show	_	0	SENT_132	[p8l452t1249r657b1305],
9	in	IN	O	in	_	0	SENT_132	[p8l687t1249r747b1304],
10	the	DT	O	the	det	11	SENT_132	[p8l778t1249r874b1305],
11	table	NN	O	table	prep_in	8	SENT_132	[p8l904t1249r1058b1305],
12	for	IN	O	for	_	0	SENT_132	[p8l1089t1249r1182b1305],
13	comparison	NN	O	comparison	prep_for	11	SENT_132	[p8l1212t1249r1599b1322],
14	.	.	O	.	_	0	SENT_132	[p8l1212t1249r1599b1322],

1	Artemisinin	NN	O	artemisinin	nsubj	2	SENT_133	[p8l1634t1249r2015b1305],
2	did	VBD	O	do	_	0	SENT_133	[p8l2047t1249r2147b1305],

1	%	NN	O	%	nn	2	SENT_134	[p8l20t2379r71b2435],
2	activity	NN	O	activity	_	0	SENT_134	[p8l20t2133r80b2350],

1	Log	VB	O	log	_	0	SENT_135	[p8l940t3285r1048b3339],
2	[	CD	NUMBER	[	dobj	1	SENT_135	[p8l1073t3283r1343b3339],
3	Quinine	NNP	O	Quinine	tmod	1	SENT_135	[p8l1073t3283r1343b3339],
4	]	CD	NUMBER	]	num	3	SENT_135	[p8l1073t3283r1343b3339],
5	(	CD	NUMBER	(	num	7	SENT_135	[p8l1367t3283r1495b3339],
6	pM	NN	O	pm	nn	7	SENT_135	[p8l1367t3283r1495b3339],
7	)	NN	O	)	nsubj	1	SENT_135	[p8l1367t3283r1495b3339],

1	FIGURE	NN	O	figure	_	0	SENT_136	[p9l80t66r299b118],
2	1	CD	NUMBER	1	number	3	SENT_136	[p9l330t65r359b117],
3	—	CD	NUMBER	—	num	4	SENT_136	[p9l382t98r420b102],
4	Inhibition	NN	O	inhibition	dep	1	SENT_136	[p9l440t65r737b118],
5	of	IN	O	of	_	0	SENT_136	[p9l765t65r830b118],
6	GST	NN	O	gst	nn	8	SENT_136	[p9l854t66r994b118],
7	P1	NN	O	p1	nn	8	SENT_136	[p9l1021t66r1155b117],
8	—	NN	O	—	prep_of	4	SENT_136	[p9l1021t66r1155b117],
9	1	CD	NUMBER	1	dep	8	SENT_136	[p9l1021t66r1155b117],
10	by	IN	O	by	_	0	SENT_136	[p9l1188t65r1262b133],
11	quinine	NN	O	quinine	prep_by	4	SENT_136	[p9l1291t65r1515b133],
12	using	VBG	O	use	partmod	1	SENT_136	[p9l1542t65r1704b133],
13	CDNB	NN	O	cdnb	dobj	12	SENT_136	[p9l1732t66r1936b118],
14	as	IN	O	as	_	0	SENT_136	[p9l1969t82r2027b118],
15	the	DT	O	the	det	16	SENT_136	[p9l2055t65r2146b118],
16	substrate	NN	O	substrate	prep_as	12	SENT_136	[p9l11t139r291b193],
17	.	.	O	.	_	0	SENT_136	[p9l11t139r291b193],

1	The	DT	O	the	det	3	SENT_137	[p9l323t139r438b193],
2	IC50	NN	O	ic50	nn	3	SENT_137	[p9l467t140r599b210],
3	value	NN	O	value	nsubj	6	SENT_137	[p9l627t139r789b193],
4	is	VBZ	O	be	cop	6	SENT_137	[p9l817t139r864b193],
5	inhibitor	NN	O	inhibitor	nn	6	SENT_137	[p9l894t139r1154b193],
6	concentration	NN	O	concentration	_	0	SENT_137	[p9l1182t139r1592b193],
7	giving	VBG	O	give	partmod	6	SENT_137	[p9l1621t139r1811b208],
8	50	CD	PERCENT	50	num	9	SENT_137	[p9l1841t139r1973b193],
9	%	NN	PERCENT	%	iobj	7	SENT_137	[p9l1841t139r1973b193],
10	inhibition	NN	O	inhibition	dobj	7	SENT_137	[p9l2005t139r2144b192, p9l7t214r183b267],
11	of	IN	O	of	_	0	SENT_137	[p9l208t214r273b266],
12	the	DT	O	the	det	14	SENT_137	[p9l292t214r382b267],
13	enzyme	NN	O	enzyme	nn	14	SENT_137	[p9l407t231r640b282],
14	activity	NN	O	activity	prep_of	10	SENT_137	[p9l666t214r889b282],
15	in	IN	O	in	_	0	SENT_137	[p9l913t214r970b266],
16	the	DT	O	the	det	19	SENT_137	[p9l994t214r1084b267],
17	standard	JJ	O	standard	amod	19	SENT_137	[p9l1111t214r1364b267],
18	assay	NN	O	assay	nn	19	SENT_137	[p9l1389t231r1549b282],
19	system	NN	O	system	prep_in	14	SENT_137	[p9l1576t222r1783b282],
20	with	IN	O	with	_	0	SENT_137	[p9l1806t214r1938b267],
21	1	CD	NUMBER	1	num	22	SENT_137	[p9l1969t215r1991b266],
22	mM	NN	O	mm	prep_with	7	SENT_137	[p9l2022t216r2146b266],
23	1	CD	NUMBER	1	num	25	SENT_137	[p9l16t288r858b350],
24	—	NN	O	—	nn	25	SENT_137	[p9l16t288r858b350],
25	chloro	NN	O	chloro	dep	22	SENT_137	[p9l16t288r858b350],
26	—	CD	NUMBER	—	number	27	SENT_137	[p9l16t288r858b350],
27	2,4	CD	NUMBER	2,4	num	29	SENT_137	[p9l16t288r858b350],
28	—	NN	O	—	nn	29	SENT_137	[p9l16t288r858b350],
29	dinitrobenzene	NN	O	dinitrobenzene	dep	25	SENT_137	[p9l16t288r858b350],
30	and	CC	O	and	_	0	SENT_137	[p9l903t288r1009b340],
31	is	VBZ	O	be	auxpass	32	SENT_137	[p9l1052t288r1098b340],
32	obtained	VBN	O	obtain	conj_and	6	SENT_137	[p9l1144t288r1403b340],
33	from	IN	O	from	_	0	SENT_137	[p9l1445t288r1591b340],
34	plots	NNS	O	plot	prep_from	32	SENT_137	[p9l1632t288r1777b356],
35	of	IN	O	of	_	0	SENT_137	[p9l1822t288r1887b340],
36	percent	NN	O	percent	nn	37	SENT_137	[p9l1924t296r2147b356],
37	activity	NN	O	activity	prep_of	34	SENT_137	[p9l10t363r233b431],
38	vs.	CC	O	vs.	prep	37	SENT_137	[p9l258t381r331b416],
39	log	NN	O	log	nn	41	SENT_137	[p9l362t363r456b431],
40	inhibitor	NN	O	inhibitor	nn	41	SENT_137	[p9l481t363r742b415],
41	concentration	NN	O	concentration	dep	38	SENT_137	[p9l765t363r1175b415],
42	(	CD	NUMBER	(	num	43	SENT_137	[p9l1202t363r1804b428],
43	GraFitTM	NN	O	grafittm	nsubjpass	32	SENT_137	[p9l1202t363r1804b428],
44	.	.	O	.	_	0	SENT_137	[p9l1202t363r1804b428],

1	—	NN	O	—	_	0	SENT_138	[p9l1202t363r1804b428],
2	.	.	O	.	_	0	SENT_138	[p9l1202t363r1804b428],

1	Erithacus	NNP	O	Erithacus	nn	2	SENT_139	[p9l1202t363r1804b428],
2	Software	NNP	O	Software	_	0	SENT_139	[p9l1832t363r2142b427],
3	)	NN	O	)	dep	2	SENT_139	[p9l1832t363r2142b427],
4	.	.	O	.	_	0	SENT_139	[p9l1832t363r2142b427],

1	not	RB	O	not	neg	34	SENT_140	[p9l8t451r110b499],
2	inhibit	VB	O	inhibit	csubj	34	SENT_140	[p9l139t443r347b499],
3	GST	NN	O	gst	nn	5	SENT_140	[p9l377t443r526b499],
4	P1-1	NN	O	p1-1	nn	5	SENT_140	[p9l556t443r698b498],
5	activity	NN	O	activity	dobj	2	SENT_140	[p9l736t443r973b516],
6	towards	IN	O	towards	_	0	SENT_140	[p9l1003t443r1254b499],
7	ETA	NNP	ORGANIZATION	ETA	prep_towards	5	SENT_140	[p9l1285t443r1439b498],
8	at	IN	O	at	_	0	SENT_140	[p9l1471t452r1526b499],
9	the	DT	O	the	det	10	SENT_140	[p9l1555t443r1650b499],
10	concentrations	NNS	O	concentration	prep_at	7	SENT_140	[p9l1681t443r2145b499],
11	that	WDT	O	that	nsubjpass	13	SENT_140	[p9l8t526r128b582],
12	were	VBD	O	be	auxpass	13	SENT_140	[p9l160t544r313b582],
13	used	VBN	O	use	rcmod	5	SENT_140	[p9l345t526r491b582],
14	in	IN	O	in	_	0	SENT_140	[p9l523t526r584b582],
15	contrast	NN	O	contrast	prep_in	13	SENT_140	[p9l617t534r869b582],
16	to	TO	O	to	_	0	SENT_140	[p9l900t534r960b582],
17	what	WP	O	what	nsubjpass	19	SENT_140	[p9l994t526r1148b583],
18	was	VBD	O	be	auxpass	19	SENT_140	[p9l1180t544r1300b583],
19	observed	VBN	O	observe	prepc_to	13	SENT_140	[p9l1336t526r1623b582],
20	with	IN	O	with	_	0	SENT_140	[p9l1656t526r1796b582],
21	CDNB	NN	O	cdnb	prep_with	19	SENT_140	[p9l1829t526r2044b583],
22	as	IN	O	as	_	0	SENT_140	[p9l2083t544r2144b582],
23	substrate	NN	O	substrate	prep_as	19	SENT_140	[p9l11t610r309b677],
24	,	,	O	,	_	0	SENT_140	[p9l11t610r309b677],
25	and	CC	O	and	_	0	SENT_140	[p9l352t610r481b677],
26	,	,	O	,	_	0	SENT_140	[p9l352t610r481b677],
27	except	IN	O	except	_	0	SENT_140	[p9l524t619r731b683],
28	for	IN	O	for	_	0	SENT_140	[p9l769t610r862b666],
29	tetracycline	NN	O	tetracycline	prep_except_for	5	SENT_140	[p9l899t610r1288b683],
30	,	,	O	,	_	0	SENT_140	[p9l899t610r1288b683],
31	IC50	NN	O	ic50	nn	32	SENT_140	[p9l1330t611r1470b684],
32	values	NNS	O	value	conj_and	5	SENT_140	[p9l1510t610r1710b667],
33	were	VBD	O	be	cop	34	SENT_140	[p9l1751t628r1904b667],
34	higher	JJR	O	higher	_	0	SENT_140	[p9l1943t610r2148b683],
35	with	IN	O	with	_	0	SENT_140	[p9l9t694r149b751],
36	ETA	NNP	ORGANIZATION	ETA	prep_with	34	SENT_140	[p9l177t695r332b750],
37	as	IN	O	as	_	0	SENT_140	[p9l362t712r423b751],
38	substrate	NN	O	substrate	prep_as	34	SENT_140	[p9l457t695r753b751],
39	.	.	O	.	_	0	SENT_140	[p9l457t695r753b751],

1	Eﬂects	NNS	O	eﬂects	_	0	SENT_141	[p9l7t824r224b896],
2	of	IN	O	of	_	0	SENT_141	[p9l254t824r327b896],
3	antimalarials	NNS	O	antimalarial	prep_of	1	SENT_141	[p9l343t824r772b880],
4	on	IN	O	on	_	0	SENT_141	[p9l803t843r879b880],
5	the	DT	O	the	det	6	SENT_141	[p9l911t824r1003b880],
6	denitrosation	NN	O	denitrosation	prep_on	3	SENT_141	[p9l1034t824r1458b880],
7	of	IN	O	of	_	0	SENT_141	[p9l1489t824r1562b896],
8	BCN	NNP	ORGANIZATION	BCN	nn	9	SENT_141	[p9l1575t825r1738b881],
9	U	NNP	O	U	prep_of	6	SENT_141	[p9l1740t826r1794b881],
10	by	IN	O	by	_	0	SENT_141	[p9l1818t824r1892b896],
11	GS	NN	O	g	nn	13	SENT_141	[p9l11t909r107b965],
12	T	NN	O	t	nn	13	SENT_141	[p9l110t910r156b963],
13	M	NN	O	m	prep_by	9	SENT_141	[p9l175t908r277b963],
14	]	SYM	O	]	dep	1	SENT_141	[p9l175t908r277b963],
15	-	:	O	-	_	0	SENT_141	[p9l287t908r343b963],
16	I	PRP	O	I	dep	1	SENT_141	[p9l287t908r343b963],

1	The	DT	O	the	det	2	SENT_142	[p9l89t1008r211b1064],
2	data	NNS	O	datum	nsubj	8	SENT_142	[p9l239t1008r371b1064],
3	using	VBG	O	use	partmod	2	SENT_142	[p9l395t1008r567b1081],
4	recombinant	JJ	O	recombinant	amod	6	SENT_142	[p9l593t1008r994b1064],
5	human	JJ	O	human	amod	6	SENT_142	[p9l1019t1008r1236b1064],
6	GSTs	NNS	O	gst	dobj	3	SENT_142	[p9l1263t1008r1441b1064],
7	has	VBZ	O	have	aux	8	SENT_142	[p9l1468t1008r1572b1064],
8	shown	VBN	O	show	_	0	SENT_142	[p9l1603t1008r1808b1064],
9	that	IN	O	that	complm	15	SENT_142	[p9l1834t1008r1954b1064],
10	quinidine	NN	O	quinidine	nsubj	15	SENT_142	[p9l1980t1008r2144b1081, p9l8t1091r166b1147],
11	and	CC	O	and	_	0	SENT_142	[p9l201t1091r313b1147],
12	quinine	NN	O	quinine	conj_and	10	SENT_142	[p9l346t1091r584b1164],
13	are	VBP	O	be	cop	15	SENT_142	[p9l618t1109r712b1147],
14	effective	JJ	O	effective	amod	15	SENT_142	[p9l745t1091r1023b1147],
15	inhibitors	NNS	O	inhibitor	ccomp	8	SENT_142	[p9l1055t1091r1359b1147],
16	of	IN	O	of	_	0	SENT_142	[p9l1394t1091r1463b1147],
17	GSTMl-l	NN	O	gstml-l	nn	20	SENT_142	[p9l1492t1091r1811b1148],
18	and	CC	O	and	_	0	SENT_142	[p9l1852t1091r1965b1147],
19	Pl-l	NN	MISC	pl-l	nn	20	SENT_142	[p9l1997t1092r2139b1147],
20	activity	NN	O	activity	prep_of	15	SENT_142	[p9l10t1175r246b1248],
21	with	IN	O	with	_	0	SENT_142	[p9l286t1175r426b1232],
22	CDNB	NN	O	cdnb	prep_with	20	SENT_142	[p9l465t1176r701b1232],
23	.	.	O	.	_	0	SENT_142	[p9l465t1176r701b1232],

1	Because	IN	O	because	_	0	SENT_143	[p9l744t1177r1008b1232],
2	of	IN	O	of	prepc_because_of	17	SENT_143	[p9l1049t1175r1118b1232],
3	the	DT	O	the	det	4	SENT_143	[p9l1151t1175r1246b1231],
4	role	NN	O	role	pobj	17	SENT_143	[p9l1284t1175r1407b1231],
5	of	IN	O	of	_	0	SENT_143	[p9l1447t1175r1516b1231],
6	GST	NN	O	gst	nn	7	SENT_143	[p9l1551t1176r1699b1232],
7	M1-1	NN	O	m1-1	prep_of	4	SENT_143	[p9l1737t1176r1906b1231],
8	in	IN	O	in	_	0	SENT_143	[p9l1952t1175r2012b1231],
9	the	DT	O	the	det	10	SENT_143	[p9l2050t1175r2146b1231],
10	denitrosation	NN	O	denitrosation	prep_in	7	SENT_143	[p9l9t1259r425b1316],
11	of	IN	O	of	_	0	SENT_143	[p9l458t1259r527b1316],
12	BCNU	NNP	O	BCNU	prep_of	10	SENT_143	[p9l554t1260r792b1326],
13	,	,	O	,	_	0	SENT_143	[p9l554t1260r792b1326],
14	further	JJ	O	further	amod	15	SENT_143	[p9l827t1259r1045b1316],
15	work	NN	O	work	nsubjpass	17	SENT_143	[p9l1076t1260r1240b1316],
16	was	VBD	O	be	auxpass	17	SENT_143	[p9l1271t1277r1391b1316],
17	performed	VBN	O	perform	_	0	SENT_143	[p9l1424t1259r1757b1332],
18	to	TO	O	to	aux	19	SENT_143	[p9l1789t1268r1848b1316],
19	evaluate	VB	O	evaluate	xcomp	17	SENT_143	[p9l1882t1260r2146b1316],
20	the	DT	O	the	det	21	SENT_143	[p9l8t1344r104b1400],
21	effect	NN	O	effect	dobj	19	SENT_143	[p9l150t1344r331b1400],
22	of	IN	O	of	_	0	SENT_143	[p9l376t1344r445b1400],
23	these	DT	O	these	det	25	SENT_143	[p9l484t1344r647b1400],
24	cinchona	NN	O	cinchona	nn	25	SENT_143	[p9l692t1344r981b1400],
25	alkaloids	NNS	O	alkaloid	prep_of	21	SENT_143	[p9l1025t1344r1310b1400],
26	on	IN	O	on	_	0	SENT_143	[p9l1357t1361r1435b1400],
27	the	DT	O	the	det	28	SENT_143	[p9l1479t1344r1575b1400],
28	denitrosation	NN	O	denitrosation	prep_on	25	SENT_143	[p9l1621t1344r2037b1400],
29	of	IN	O	of	_	0	SENT_143	[p9l2083t1344r2152b1400],
30	BCNU	NNP	O	BCNU	prep_of	28	SENT_143	[p9l8t1428r230b1484],
31	in	FW	O	in	nn	32	SENT_143	[p9l253t1430r310b1484],
32	vitro	FW	O	vitro	advmod	19	SENT_143	[p9l333t1430r498b1485],
33	.	.	O	.	_	0	SENT_143	[p9l333t1430r498b1485],

1	Spontaneous	JJ	O	spontaneous	amod	3	SENT_144	[p9l526t1428r929b1501],
2	nitrite	JJ	O	nitrite	amod	3	SENT_144	[p9l953t1428r1142b1484],
3	formation	NN	O	formation	nsubjpass	5	SENT_144	[p9l1164t1428r1478b1484],
4	was	VBD	O	be	auxpass	5	SENT_144	[p9l1500t1446r1620b1484],
5	subtracted	VBN	O	subtract	_	0	SENT_144	[p9l1646t1428r1971b1484],
6	from	IN	O	from	_	0	SENT_144	[p9l1993t1428r2148b1484],
7	experimental	JJ	O	experimental	amod	8	SENT_144	[p9l9t1512r425b1585],
8	values	NNS	O	value	prep_from	5	SENT_144	[p9l450t1512r650b1568],
9	and	CC	O	and	_	0	SENT_144	[p9l678t1512r791b1568],
10	was	VBD	O	be	cop	11	SENT_144	[p9l815t1530r935b1568],
11	equivalent	JJ	O	equivalent	conj_and	5	SENT_144	[p9l962t1512r1295b1585],
12	to	TO	O	to	_	0	SENT_144	[p9l1318t1520r1377b1568],
13	0.11	CD	NUMBER	0.11	prep_to	11	SENT_144	[p9l1403t1512r1534b1568],
14	i	FW	O	i	dobj	5	SENT_144	[p9l1573t1517r1621b1565],
15	0.02	CD	NUMBER	0.02	num	16	SENT_144	[p9l1654t1512r1791b1568],
16	nmol/min	NN	O	nmol/min	dep	14	SENT_144	[p9l1816t1512r2142b1568],
17	.	.	O	.	_	0	SENT_144	[p9l1816t1512r2142b1568],

1	Quinidine	NN	O	quinidine	nsubjpass	3	SENT_145	[p9l10t1595r327b1665],
2	was	VBD	O	be	auxpass	3	SENT_145	[p9l364t1613r484b1651],
3	shown	VBN	O	show	_	0	SENT_145	[p9l525t1595r730b1652],
4	to	TO	O	to	aux	5	SENT_145	[p9l766t1603r825b1651],
5	reduce	VB	O	reduce	xcomp	3	SENT_145	[p9l862t1595r1074b1651],
6	the	DT	O	the	det	7	SENT_145	[p9l1110t1595r1206b1651],
7	activity	NN	O	activity	dobj	5	SENT_145	[p9l1244t1595r1480b1668],
8	of	IN	O	of	_	0	SENT_145	[p9l1518t1595r1587b1651],
9	GST	NN	O	gst	nn	10	SENT_145	[p9l1619t1595r1768b1652],
10	M1-1	NN	O	m1-1	prep_of	7	SENT_145	[p9l1803t1596r1973b1651],
11	in	IN	O	in	_	0	SENT_145	[p9l2016t1595r2077b1651],
12	a	DT	O	a	det	14	SENT_145	[p9l2114t1613r2148b1651],
13	concentration-dependent	JJ	O	concentration-dependent	amod	14	SENT_145	[p9l9t1679r801b1752],
14	manner	NN	O	manner	prep_in	10	SENT_145	[p9l846t1697r1086b1735],
15	with	IN	O	with	_	0	SENT_145	[p9l1131t1679r1271b1736],
16	an	DT	O	a	det	17	SENT_145	[p9l1319t1697r1391b1735],
17	IC50	NN	O	ic50	prep_with	5	SENT_145	[p9l1437t1680r1577b1753],
18	of	IN	O	of	_	0	SENT_145	[p9l1625t1679r1694b1735],
19	112	CD	NUMBER	112	num	20	SENT_145	[p9l1742t1680r1852b1735],
20	p.M	NN	O	p.m	prep_of	17	SENT_145	[p9l1904t1681r2021b1751],
21	on	IN	O	on	_	0	SENT_145	[p9l2069t1697r2146b1735],
22	extrapolation	NN	O	extrapolation	prep_on	5	SENT_145	[p9l9t1763r430b1836],
23	of	IN	O	of	_	0	SENT_145	[p9l459t1763r528b1820],
24	the	DT	O	the	det	25	SENT_145	[p9l551t1764r647b1820],
25	data	NNS	O	datum	prep_of	22	SENT_145	[p9l676t1764r808b1820],
26	on	IN	O	on	_	0	SENT_145	[p9l836t1781r913b1820],
27	Figure	NNP	O	Figure	prep_on	25	SENT_145	[p9l941t1763r1148b1836],
28	3	CD	NUMBER	3	num	27	SENT_145	[p9l1179t1764r1231b1820],
29	.	.	O	.	_	0	SENT_145	[p9l1179t1764r1231b1820],

1	Quinidine	NNP	O	Quinidine	nsubj	16	SENT_146	[p9l1265t1763r1599b1833],
2	,	,	O	,	_	0	SENT_146	[p9l1265t1763r1599b1833],
3	thus	RB	O	thus	advmod	16	SENT_146	[p9l1630t1763r1779b1830],
4	,	,	O	,	_	0	SENT_146	[p9l1630t1763r1779b1830],
5	was	VBD	O	be	auxpass	6	SENT_146	[p9l1811t1781r1931b1820],
6	found	VBN	O	find	ccomp	16	SENT_146	[p9l1961t1763r2147b1820],
7	to	TO	O	to	aux	8	SENT_146	[p9l8t1856r68b1904],
8	have	VB	O	have	xcomp	6	SENT_146	[p9l93t1848r242b1904],
9	an	DT	O	a	det	11	SENT_146	[p9l269t1865r341b1904],
10	inhibitory	JJ	O	inhibitory	amod	11	SENT_146	[p9l366t1848r680b1921],
11	effect	NN	O	effect	dobj	8	SENT_146	[p9l705t1848r887b1904],
12	toward	IN	O	toward	_	0	SENT_146	[p9l910t1848r1131b1904],
13	GST	NN	O	gst	nn	14	SENT_146	[p9l1157t1848r1305b1904],
14	M1-1	NN	O	m1-1	prep_toward	11	SENT_146	[p9l1329t1848r1523b1914],
15	,	,	O	,	_	0	SENT_146	[p9l1329t1848r1523b1914],
16	monitored	VBD	O	monitor	_	0	SENT_146	[p9l1551t1848r1879b1904],
17	both	CC	O	both	dep	16	SENT_146	[p9l1902t1848r2044b1904],
18	by	IN	O	by	_	0	SENT_146	[p9l2067t1848r2145b1921],
19	GSH-dependent	JJ	O	gsh-dependent	amod	21	SENT_146	[p9l10t1932r525b2005],
20	CDNB	NN	O	cdnb	nn	21	SENT_146	[p9l554t1932r769b1988],
21	metabolism	NN	O	metabolism	prep_by	16	SENT_146	[p9l804t1932r1178b1988],
22	and	CC	O	and	_	0	SENT_146	[p9l1208t1932r1320b1988],
23	GSH-dependent	JJ	O	gsh-dependent	amod	24	SENT_146	[p9l1351t1932r1866b2005],
24	denitrosation	NN	O	denitrosation	prep_by	16	SENT_146	[p9l1895t1932r2144b1988, p9l11t2015r198b2071],
25	of	IN	O	of	_	0	SENT_146	[p9l228t2015r297b2071],
26	BCNU	NN	O	bcnu	prep_of	21	SENT_146	[p9l320t2015r557b2072],
27	.	.	O	.	_	0	SENT_146	[p9l320t2015r557b2072],

1	DISCUSSION	NN	O	discussion	_	0	SENT_147	[p9l881t2211r1274b2258],

1	Our	PRP$	O	we	poss	2	SENT_148	[p9l90t2336r213b2392],
2	study	NN	O	study	nsubj	4	SENT_148	[p9l244t2336r412b2408],
3	has	VBZ	O	have	aux	4	SENT_148	[p9l442t2336r546b2392],
4	shown	VBN	O	show	_	0	SENT_148	[p9l580t2335r785b2392],
5	that	IN	O	that	complm	10	SENT_148	[p9l815t2335r935b2392],
6	some	DT	O	some	det	7	SENT_148	[p9l966t2353r1130b2392],
7	antimalarials	NNS	O	antimalarial	nsubj	10	SENT_148	[p9l1162t2335r1571b2392],
8	are	VBP	O	be	cop	10	SENT_148	[p9l1604t2353r1698b2392],
9	potent	JJ	O	potent	amod	10	SENT_148	[p9l1727t2344r1928b2408],
10	inhibitors	NNS	O	inhibitor	ccomp	4	SENT_148	[p9l1957t2335r2144b2392, p9l8t2420r147b2476],
11	of	IN	O	of	_	0	SENT_148	[p9l183t2420r252b2476],
12	the	DT	O	the	det	13	SENT_148	[p9l281t2420r376b2476],
13	conjugation	NN	O	conjugation	prep_of	10	SENT_148	[p9l410t2420r787b2493],
14	of	IN	O	of	_	0	SENT_148	[p9l821t2420r890b2476],
15	CDNB	NN	O	cdnb	prep_of	13	SENT_148	[p9l919t2420r1134b2476],
16	by	IN	O	by	_	0	SENT_148	[p9l1171t2420r1249b2493],
17	human	JJ	O	human	amod	19	SENT_148	[p9l1283t2420r1500b2476],
18	recombinant	JJ	O	recombinant	amod	19	SENT_148	[p9l1532t2420r1933b2476],
19	GSTs	NNS	O	gst	prep_by	10	SENT_148	[p9l1967t2420r2144b2476],

1	A	DT	O	a	_	0	SENT_149	[p9l114t2625r198b2708],

1	2	CD	NUMBER	2	_	0	SENT_150	[p10l546t532r602b598],
2	i	FW	O	i	dep	1	SENT_150	[p10l1165t555r1192b599],
3	?	.	O	?	_	0	SENT_150	[p10l548t611r602b635],

1	0.0050	CD	NUMBER	0.0050	num	2	SENT_151	[p10l745t703r910b742],
2	n	NN	O	n	_	0	SENT_151	[p10l1037t711r1063b740],

1	F	NN	O	f	_	0	SENT_152	[p10l602t887r681b1176],
2	‘	CD	NUMBER	‘	num	3	SENT_152	[p10l602t887r681b1176],
3	0.0025	CD	NUMBER	0.0025	dep	1	SENT_152	[p10l745t908r912b986],

1	Concentration	NN	O	concentration	_	0	SENT_153	[p10l676t2844r1085b2889],
2	of	IN	O	of	_	0	SENT_153	[p10l1110t2844r1164b2889],
3	quinine	NN	O	quinine	nn	6	SENT_153	[p10l1183t2844r1388b2900],
4	(	CD	NUMBER	(	num	6	SENT_153	[p10l1409t2844r1534b2902],
5	uM	NN	O	um	nn	6	SENT_153	[p10l1409t2844r1534b2902],
6	)	NN	O	)	prep_of	1	SENT_153	[p10l1409t2844r1534b2902],

1	FIGURE	NN	O	figure	_	0	SENT_154	[p10l80t3014r299b3067],
2	2	CD	NUMBER	2	number	3	SENT_154	[p10l325t3013r360b3067],
3	—	CD	NUMBER	—	num	5	SENT_154	[p10l380t3047r419b3051],
4	Secondary	JJ	O	secondary	amod	5	SENT_154	[p10l440t3014r756b3083],
5	plot	NN	O	plot	npadvmod	1	SENT_154	[p10l780t3014r898b3083],
6	of	IN	O	of	_	0	SENT_154	[p10l924t3014r988b3067],
7	1/Vmax	NN	O	1/vmax	prep_of	1	SENT_154	[p10l1016t3014r1220b3085],
8	vs.	CC	O	vs.	prep	7	SENT_154	[p10l1246t3032r1318b3068],
9	antimalarial	JJ	O	antimalarial	amod	10	SENT_154	[p10l1352t3014r1710b3067],
10	concentration	NN	O	concentration	dep	8	SENT_154	[p10l1737t3014r2146b3067],
11	to	TO	O	to	aux	12	SENT_154	[p10l8t3098r64b3143],
12	determine	VB	O	determine	infmod	1	SENT_154	[p10l88t3090r388b3143],
13	the	DT	O	the	det	14	SENT_154	[p10l410t3090r500b3143],
14	Ki	NN	MISC	kus	dobj	12	SENT_154	[p10l524t3091r591b3160],
15	for	IN	O	for	_	0	SENT_154	[p10l613t3090r701b3143],
16	quinine	NN	O	quinine	nn	19	SENT_154	[p10l722t3090r946b3159],
17	and	CC	O	and	_	0	SENT_154	[p10l970t3090r1076b3143],
18	GST	NN	O	gst	nn	19	SENT_154	[p10l1099t3090r1239b3143],
19	P1-1	NN	O	p1-1	prep_for	14	SENT_154	[p10l1261t3090r1395b3142],
20	with	IN	O	with	_	0	SENT_154	[p10l1424t3090r1557b3143],
21	respect	NN	O	respect	prep_with	12	SENT_154	[p10l1577t3098r1792b3159],
22	to	TO	O	to	_	0	SENT_154	[p10l1813t3098r1869b3143],
23	GSH	NN	O	gsh	nn	26	SENT_154	[p10l1893t3090r2144b3156],
24	(	NN	O	(	nn	26	SENT_154	[p10l1893t3090r2144b3156],
25	A	NN	O	a	nn	26	SENT_154	[p10l1893t3090r2144b3156],
26	)	NN	O	)	prep_to	12	SENT_154	[p10l1893t3090r2144b3156],
27	and	CC	O	and	_	0	SENT_154	[p10l10t3165r116b3218],
28	CDNB	NN	O	cdnb	nn	31	SENT_154	[p10l152t3165r356b3218],
29	(	NN	O	(	nn	31	SENT_154	[p10l399t3165r510b3230],
30	B	NN	O	b	nn	31	SENT_154	[p10l399t3165r510b3230],
31	)	NN	O	)	prep_to	12	SENT_154	[p10l399t3165r510b3230],
32	.	.	O	.	_	0	SENT_154	[p10l399t3165r510b3230],

1	Each	DT	O	each	det	2	SENT_155	[p10l550t3165r700b3218],
2	point	NN	O	point	nsubj	3	SENT_155	[p10l735t3164r891b3234],
3	represents	VBZ	O	represent	_	0	SENT_155	[p10l925t3173r1229b3234],
4	the	DT	O	the	det	5	SENT_155	[p10l1267t3165r1357b3218],
5	average	NN	O	average	dobj	3	SENT_155	[p10l1395t3181r1627b3234],
6	of	IN	O	of	_	0	SENT_155	[p10l1664t3164r1730b3218],
7	3	CD	NUMBER	3	num	8	SENT_155	[p10l1762t3165r1793b3218],
8	Values	NNS	O	value	prep_of	5	SENT_155	[p10l1833t3165r2022b3218],
9	for	IN	O	for	_	0	SENT_155	[p10l2060t3164r2148b3218],
10	1/Vmax	NN	O	1/vmax	prep_for	8	SENT_155	[p10l16t3240r220b3310],
11	with	IN	O	with	_	0	SENT_155	[p10l251t3239r384b3293],
12	CDNB	NN	ORGANIZATION	cdnb	prep_with	10	SENT_155	[p10l415t3240r619b3293],
13	and	CC	O	and	_	0	SENT_155	[p10l655t3240r762b3293],
14	GSH	NN	O	gsh	conj_and	12	SENT_155	[p10l793t3240r942b3293],
15	as	IN	O	as	_	0	SENT_155	[p10l974t3256r1032b3293],
16	substrates	NNS	O	substrate	prep_as	3	SENT_155	[p10l1067t3240r1360b3293],
17	as	IN	O	as	mark	18	SENT_155	[p10l1394t3256r1452b3293],
18	described	VBN	O	describe	dep	16	SENT_155	[p10l1485t3240r1773b3293],
19	in	IN	O	in	_	0	SENT_155	[p10l1804t3239r1861b3292],
20	Material	NNP	O	Material	prep_in	18	SENT_155	[p10l1891t3240r2146b3293],
21	and	CC	O	and	_	0	SENT_155	[p10l10t3314r116b3367],
22	Methods	NNS	O	method	conj_and	20	SENT_155	[p10l150t3314r428b3367],
23	.	.	O	.	_	0	SENT_155	[p10l150t3314r428b3367],

1	r	NN	O	r	nsubj	2	SENT_156	[p10l466t3331r491b3366],
2	represents	VBZ	O	represent	_	0	SENT_156	[p10l523t3322r827b3382],
3	the	DT	O	the	det	5	SENT_156	[p10l863t3314r953b3367],
4	correlation	NN	O	correlation	nn	5	SENT_156	[p10l989t3314r1315b3367],
5	coefﬁcient	NN	O	coefﬁcient	dobj	2	SENT_156	[p10l1349t3314r1668b3367],
6	when	WRB	O	when	advmod	10	SENT_156	[p10l1701t3314r1863b3367],
7	the	DT	O	the	det	8	SENT_156	[p10l1897t3314r1987b3367],
8	data	NNS	O	datum	nsubjpass	10	SENT_156	[p10l2023t3314r2148b3367],
9	were	VBD	O	be	auxpass	10	SENT_156	[p10l9t3405r153b3441],
10	subjected	VBN	O	subject	dep	5	SENT_156	[p10l199t3388r481b3457],
11	to	TO	O	to	_	0	SENT_156	[p10l524t3396r580b3441],
12	a	DT	O	a	det	15	SENT_156	[p10l626t3405r657b3441],
13	linear	JJ	O	linear	amod	15	SENT_156	[p10l700t3388r871b3441],
14	regression	NN	O	regression	nn	15	SENT_156	[p10l913t3388r1223b3457],
15	analysis	NN	O	analysis	prep_to	10	SENT_156	[p10l1267t3388r1523b3457],
16	.	.	O	.	_	0	SENT_156	[p10l1267t3388r1523b3457],

1	Vmax	NN	O	vmax	nn	2	SENT_157	[p10l1570t3390r1723b3459],
2	Values	NNS	O	value	nsubjpass	4	SENT_157	[p10l1766t3388r1956b3442],
3	were	VBD	O	be	auxpass	4	SENT_157	[p10l2001t3405r2146b3442],
4	determined	VBN	O	determine	_	0	SENT_157	[p10l9t3463r348b3515],
5	for	IN	O	for	_	0	SENT_157	[p10l369t3463r457b3515],
6	the	DT	O	the	det	9	SENT_157	[p10l477t3463r567b3515],
7	2	CD	NUMBER	2	num	9	SENT_157	[p10l590t3463r624b3515],
8	substrates	NNS	O	substrate	nn	9	SENT_157	[p10l649t3463r942b3515],
9	GSH	NN	O	gsh	prep_for	4	SENT_157	[p10l966t3463r1115b3516],
10	and	CC	O	and	_	0	SENT_157	[p10l1138t3463r1244b3515],
11	CDNB	NN	O	cdnb	prep_for	4	SENT_157	[p10l1266t3463r1470b3516],
12	from	IN	O	from	_	0	SENT_157	[p10l1496t3463r1642b3515],
13	kinetic	JJ	O	kinetic	amod	14	SENT_157	[p10l1662t3463r1865b3515],
14	data	NNS	O	datum	prep_from	4	SENT_157	[p10l1889t3463r2014b3515],
15	that	WDT	O	that	nsubjpass	17	SENT_157	[p10l2034t3463r2147b3515],
16	were	VBD	O	be	auxpass	17	SENT_157	[p10l9t3555r153b3591],
17	analysed	VBN	O	analyse	rcmod	14	SENT_157	[p10l182t3539r445b3606],
18	as	IN	O	as	mark	19	SENT_157	[p10l473t3555r530b3591],
19	described	VBN	O	describe	advcl	17	SENT_157	[p10l560t3539r849b3591],
20	in	IN	O	in	_	0	SENT_157	[p10l875t3539r933b3590],
21	the	DT	O	the	det	22	SENT_157	[p10l959t3539r1049b3591],
22	Material	NNP	O	Material	prep_in	19	SENT_157	[p10l1077t3539r1332b3591],
23	and	CC	O	and	_	0	SENT_157	[p10l1361t3539r1467b3591],
24	Methods	NNS	O	method	conj_and	22	SENT_157	[p10l1493t3539r1772b3591],
25	.	.	O	.	_	0	SENT_157	[p10l1493t3539r1772b3591],

1	INHIBITION	NN	O	inhibition	_	0	SENT_158	[p10l676t3687r836b3707],
2	OF	IN	O	of	dep	1	SENT_158	[p10l847t3687r883b3707],
3	RECOMBINANT	JJ	O	recombinant	amod	4	SENT_158	[p10l893t3687r1107b3707],
4	GSTS	NN	O	gst	pobj	2	SENT_158	[p10l1118t3687r1182b3707],
5	BY	IN	O	by	dep	1	SENT_158	[p10l1193t3687r1233b3707],
6	ANTHVIALARIALS	NN	O	anthvialarial	pobj	5	SENT_158	[p10l1244t3687r1481b3707],
7	703	CD	NUMBER	703	num	6	SENT_158	[p10l2049t3681r2102b3707],

1	TABLE	NN	O	table	_	0	SENT_159	[p10l196t3757r287b3776],
2	I	NN	O	i	dep	1	SENT_159	[p10l301t3757r386b3782],
3	.	.	O	.	_	0	SENT_159	[p10l301t3757r386b3782],

1	—	NN	O	—	_	0	SENT_160	[p10l301t3757r386b3782],
2	.	.	O	.	_	0	SENT_160	[p10l301t3757r386b3782],

1	IC50	NN	O	ic50	nn	2	SENT_161	[p10l301t3757r386b3782],
2	VALUES	NNS	O	value	_	0	SENT_161	[p10l400t3757r505b3776],
3	FOR	IN	O	for	_	0	SENT_161	[p10l520t3757r573b3776],
4	HUMAN	JJ	O	human	amod	7	SENT_161	[p10l587t3757r688b3776],
5	RECOMBINANT	JJ	O	recombinant	amod	7	SENT_161	[p10l702t3757r901b3776],
6	GLUTATHIONE	NN	O	glutathione	nn	7	SENT_161	[p10l915t3757r1107b3776],
7	S-TRANSFERASES	NN	O	s-transferase	prep_for	2	SENT_161	[p10l1121t3757r1348b3776],
8	WITH	IN	O	with	dep	2	SENT_161	[p10l1363t3757r1433b3776],
9	SELECTED	VBN	O	select	pcomp	8	SENT_161	[p10l1448t3757r1582b3776],
10	ANTIMALARIALS	NN	O	antimalarial	nn	11	SENT_161	[p10l1596t3757r1817b3776],
11	IC50	NN	O	ic50	nsubj	15	SENT_161	[p10l1832t3757r1880b3782],
12	(	CD	NUMBER	(	num	15	SENT_161	[p10l1895t3751r1962b3781],
13	p.	NN	O	p.	nn	15	SENT_161	[p10l1895t3751r1962b3781],
14	M	NN	O	m	nn	15	SENT_161	[p10l1895t3751r1962b3781],
15	)	NN	O	)	xcomp	9	SENT_161	[p10l1895t3751r1962b3781],
16	1	CD	NUMBER	1	dep	15	SENT_161	[p10l1895t3751r1962b3781],

1	GST	NN	O	gst	nn	2	SENT_162	[p11l1200t18r1251b37],
2	isoform	NN	O	isoform	_	0	SENT_162	[p11l1260t18r1344b37],

1	Antimalarial	JJ	O	antimalarial	_	0	SENT_163	[p11l134t41r270b60],

1	A1-1	NN	O	a1-1	nn	3	SENT_164	[p11l575t64r628b83],
2	A2-2	NN	O	a2-2	nn	3	SENT_164	[p11l951t64r1005b83],
3	M1-1	NN	O	m1-1	_	0	SENT_164	[p11l1317t64r1375b83],
4	M3-3	NN	O	m3-3	nn	6	SENT_164	[p11l1711t64r1770b83],
5	P1	NN	O	p1	nn	6	SENT_164	[p11l2016t64r2064b83],
6	—	NN	O	—	dep	3	SENT_164	[p11l2016t64r2064b83],
7	1	CD	NUMBER	1	dep	3	SENT_164	[p11l2016t64r2064b83],

1	Artemisinin	NN	O	artemisinin	nn	4	SENT_165	[p11l92t142r260b167],
2	6	CD	NUMBER	6	num	4	SENT_165	[p11l478t142r494b167],
3	N13	NN	O	n13	nn	4	SENT_165	[p11l893t136r942b167],
4	N1	NN	O	n1	_	0	SENT_165	[p11l1228t143r1265b167],
5	NI	NN	O	nus	dep	4	SENT_165	[p11l1631t143r1668b167],
6	2	CD	NUMBER	2	num	7	SENT_165	[p11l2017t142r2033b167],
7	Chloroquine	NN	ORGANIZATION	chloroquine	dep	5	SENT_165	[p11l92t177r268b209],
8	60	CD	PERCENT	60	num	9	SENT_165	[p11l478t177r540b202],
9	%	NN	PERCENT	%	dep	4	SENT_165	[p11l478t177r540b202],
10	at	IN	O	at	_	0	SENT_165	[p11l555t181r579b202],
11	100	CD	NUMBER	100	num	14	SENT_165	[p11l595t177r643b202],
12	p.	NN	O	p.	nn	14	SENT_165	[p11l658t171r724b209],
13	M2	NN	O	m2	nn	14	SENT_165	[p11l658t171r724b209],
14	N1	NN	O	n1	prep_at	9	SENT_165	[p11l893t178r930b202],
15	57	CD	PERCENT	57	num	16	SENT_165	[p11l1229t177r1291b202],
16	%	NN	PERCENT	%	dep	4	SENT_165	[p11l1229t177r1291b202],
17	at	IN	O	at	_	0	SENT_165	[p11l1306t181r1330b202],
18	100	CD	NUMBER	100	num	19	SENT_165	[p11l1346t177r1395b202],
19	p.M	NN	O	p.m	prep_at	16	SENT_165	[p11l1410t178r1461b209],
20	N1	NN	O	n1	nn	22	SENT_165	[p11l1631t178r1668b202],
21	N1	NN	O	n1	nn	22	SENT_165	[p11l2016t178r2053b202],
22	Primaquine	NN	O	primaquine	dep	4	SENT_165	[p11l92t219r254b251],
23	60	CD	PERCENT	60	number	24	SENT_165	[p11l478t219r540b244],
24	%	NN	PERCENT	%	amod	22	SENT_165	[p11l478t219r540b244],
25	at	IN	O	at	advmod	22	SENT_165	[p11l555t223r579b244],
26	100	CD	NUMBER	100	num	27	SENT_165	[p11l595t219r643b244],
27	p.M	NN	O	p.m	pobj	25	SENT_165	[p11l658t219r710b251],
28	N1	NN	O	n1	nn	32	SENT_165	[p11l893t219r930b244],
29	N1	NN	O	n1	nn	32	SENT_165	[p11l1228t219r1265b244],
30	N1	NN	O	n1	nn	32	SENT_165	[p11l1631t219r1668b244],
31	N1	NN	O	n1	nn	32	SENT_165	[p11l2016t219r2053b244],
32	Pyrimethamine	NN	O	pyrimethamine	dep	22	SENT_165	[p11l92t261r308b293],
33	60	CD	PERCENT	60	num	34	SENT_165	[p11l478t261r540b286],
34	%	NN	PERCENT	%	dep	4	SENT_165	[p11l478t261r540b286],
35	at	IN	O	at	_	0	SENT_165	[p11l555t265r579b286],
36	20	CD	NUMBER	20	num	37	SENT_165	[p11l592t261r626b286],
37	}	NN	O	}	prep_at	34	SENT_165	[p11l641t261r692b293],
38	.	.	O	.	_	0	SENT_165	[p11l641t261r692b293],

1	LM	NNP	ORGANIZATION	LM	nn	6	SENT_166	[p11l641t261r692b293],
2	NI	NNP	ORGANIZATION	NI	nn	6	SENT_166	[p11l893t261r930b286],
3	NI	NNP	ORGANIZATION	NI	nn	6	SENT_166	[p11l1228t261r1265b286],
4	NI	NNP	ORGANIZATION	NI	nn	6	SENT_166	[p11l1631t261r1668b286],
5	1	CD	NUMBER	1	num	6	SENT_166	[p11l2020t261r2030b285],
6	Quinidine	NNP	O	Quinidine	dep	21	SENT_166	[p11l93t302r233b333],
7	70	CD	PERCENT	70	number	8	SENT_166	[p11l478t302r540b327],
8	%	NN	PERCENT	%	amod	6	SENT_166	[p11l478t302r540b327],
9	at	IN	O	at	advmod	6	SENT_166	[p11l555t306r579b327],
10	2	CD	PERCENT	2	num	12	SENT_166	[p11l592t302r608b327],
11	p.M	NN	PERCENT	p.m	nn	12	SENT_166	[p11l623t303r675b334],
12	N1	NN	PERCENT	n1	pobj	9	SENT_166	[p11l893t303r930b327],
13	12	CD	PERCENT	12	number	14	SENT_166	[p11l1232t302r1263b327],
14	60	CD	PERCENT	60	num	15	SENT_166	[p11l1632t302r1694b327],
15	%	NN	PERCENT	%	dep	6	SENT_166	[p11l1632t302r1694b327],
16	at	IN	O	at	_	0	SENT_166	[p11l1709t306r1733b327],
17	50	CD	NUMBER	50	prep_at	6	SENT_166	[p11l1746t302r1780b327],
18	p.M	NN	O	p.m	dep	21	SENT_166	[p11l1795t303r1847b334],
19	1	CD	NUMBER	1	num	18	SENT_166	[p11l2020t303r2030b327],
20	Quinine	NNP	O	Quinine	nn	21	SENT_166	[p11l93t344r205b375],
21	NI	NNP	O	NI	dep	28	SENT_166	[p11l477t345r514b369],
22	N1	NN	O	n1	dep	21	SENT_166	[p11l893t345r930b369],
23	17	CD	NUMBER	17	num	22	SENT_166	[p11l1232t344r1262b369],
24	NI	NNP	O	NI	nn	28	SENT_166	[p11l1631t345r1668b369],
25	Sulphadoxine	NNP	O	Sulphadoxine	nn	28	SENT_166	[p11l93t386r286b418],
26	NI	NNP	O	NI	nn	28	SENT_166	[p11l477t387r514b411],
27	N1	NN	O	n1	nn	28	SENT_166	[p11l893t387r930b411],
28	N1	NN	O	n1	dep	30	SENT_166	[p11l1228t387r1265b411],
29	60	CD	PERCENT	60	num	30	SENT_166	[p11l1632t386r1694b411],
30	%	NN	PERCENT	%	dep	37	SENT_166	[p11l1632t386r1694b411],
31	at	IN	O	at	_	0	SENT_166	[p11l1709t390r1733b411],
32	50	CD	NUMBER	50	num	35	SENT_166	[p11l1746t386r1780b411],
33	p.M	NN	O	p.m	nn	35	SENT_166	[p11l1795t387r1847b418],
34	NI	NNP	ORGANIZATION	NI	nn	35	SENT_166	[p11l2016t387r2053b411],
35	Tetracycline	NNP	ORGANIZATION	Tetracycline	prep_at	30	SENT_166	[p11l92t428r268b460],
36	70	CD	PERCENT	70	num	37	SENT_166	[p11l477t428r540b453],
37	%	NN	PERCENT	%	dep	50	SENT_166	[p11l477t428r540b453],
38	at	IN	O	at	_	0	SENT_166	[p11l555t432r579b453],
39	100	CD	NUMBER	100	num	42	SENT_166	[p11l595t428r643b453],
40	p.M	NN	O	p.m	nn	42	SENT_166	[p11l658t429r710b460],
41	N1	NN	O	n1	nn	42	SENT_166	[p11l893t429r930b453],
42	N1	NN	O	n1	prep_at	37	SENT_166	[p11l1228t429r1265b453],
43	47	CD	NUMBER	47	number	44	SENT_166	[p11l1631t428r1665b453],
44	13	CD	NUMBER	13	num	47	SENT_166	[p11l2020t428r2049b453],
45	1The	NN	O	1the	nn	47	SENT_166	[p11l93t484r158b515],
46	IC50	NN	O	ic50	nn	47	SENT_166	[p11l175t490r237b523],
47	values	NNS	O	value	nsubj	50	SENT_166	[p11l255t490r343b515],
48	are	VBP	O	be	cop	50	SENT_166	[p11l362t498r404b515],
49	inhibitor	NN	O	inhibitor	nn	50	SENT_166	[p11l422t490r543b515],
50	concentrations	NNS	O	concentration	_	0	SENT_166	[p11l561t490r765b515],
51	giving	VBG	O	give	partmod	50	SENT_166	[p11l784t490r873b522],
52	50	CD	PERCENT	50	num	53	SENT_166	[p11l891t490r953b515],
53	%	NN	PERCENT	%	iobj	51	SENT_166	[p11l891t490r953b515],
54	inhibition	NN	O	inhibition	dobj	51	SENT_166	[p11l972t490r1109b515],
55	of	IN	O	of	_	0	SENT_166	[p11l1127t490r1158b515],
56	the	DT	O	the	det	58	SENT_166	[p11l1173t490r1215b515],
57	enzyme	NN	O	enzyme	nn	58	SENT_166	[p11l1233t498r1342b522],
58	activity	NN	O	activity	prep_of	54	SENT_166	[p11l1360t490r1465b522],
59	in	IN	O	in	_	0	SENT_166	[p11l1483t490r1509b515],
60	the	DT	O	the	det	63	SENT_166	[p11l1527t490r1569b515],
61	standard	JJ	O	standard	amod	63	SENT_166	[p11l1588t490r1706b515],
62	assay	NN	O	assay	nn	63	SENT_166	[p11l1724t498r1799b522],
63	system	NN	O	system	prep_in	58	SENT_166	[p11l1818t494r1915b522],
64	with	IN	O	with	_	0	SENT_166	[p11l1932t490r1994b515],
65	1	CD	NUMBER	1	num	67	SENT_166	[p11l2015t490r2025b515],
66	mM	NN	O	mm	nn	67	SENT_166	[p11l2046t491r2104b515],
67	1-chloro	NN	O	1-chloro	prep_with	51	SENT_166	[p11l58t526r452b555],
68	—	CD	NUMBER	—	number	69	SENT_166	[p11l58t526r452b555],
69	2,4	CD	NUMBER	2,4	num	74	SENT_166	[p11l58t526r452b555],
70	—	NN	O	—	nn	74	SENT_166	[p11l58t526r452b555],
71	dinitrobenzene	NN	O	dinitrobenzene	nn	74	SENT_166	[p11l58t526r452b555],
72	(	CD	NUMBER	(	num	74	SENT_166	[p11l464t520r679b556],
73	CDNB	NN	O	cdnb	nn	74	SENT_166	[p11l464t520r679b556],
74	)	NN	O	)	dep	67	SENT_166	[p11l464t520r679b556],
75	.	.	O	.	_	0	SENT_166	[p11l464t520r679b556],

1	.	.	O	.	_	0	SENT_167	[p11l464t520r679b556],

1	—	NN	O	—	_	0	SENT_168	[p11l464t520r679b556],
2	.	.	O	.	_	0	SENT_168	[p11l464t520r679b556],

1	2The	JJ	O	2the	amod	2	SENT_169	[p11l464t520r679b556],
2	ﬁgures	NNS	O	ﬁgures	nsubj	5	SENT_169	[p11l691t526r785b558],
3	with	IN	O	with	_	0	SENT_169	[p11l798t526r860b551],
4	percentages	NNS	O	percentage	prep_with	2	SENT_169	[p11l870t530r1036b558],
5	indicate	VBP	O	indicate	_	0	SENT_169	[p11l1048t526r1159b551],
6	the	DT	O	the	det	8	SENT_169	[p11l1171t526r1213b551],
7	residual	JJ	O	residual	amod	8	SENT_169	[p11l1224t526r1335b551],
8	activity	NN	O	activity	dobj	5	SENT_169	[p11l1347t526r1452b558],
9	at	IN	O	at	_	0	SENT_169	[p11l1464t529r1488b551],
10	that	DT	O	that	det	11	SENT_169	[p11l1499t526r1551b551],
11	concentration	NN	O	concentration	prep_at	5	SENT_169	[p11l1562t526r1762b555],
12	,	,	O	,	_	0	SENT_169	[p11l1562t526r1762b555],
13	since	IN	O	since	mark	26	SENT_169	[p11l1775t526r1846b551],
14	in	IN	O	in	_	0	SENT_169	[p11l1857t526r1884b550],
15	these	DT	O	these	det	16	SENT_169	[p11l1895t526r1967b551],
16	cases	NNS	O	case	prep_in	26	SENT_169	[p11l1978t534r2059b555],
17	,	,	O	,	_	0	SENT_169	[p11l1978t534r2059b555],
18	an	DT	O	a	det	19	SENT_169	[p11l2073t534r2104b551],
19	increase	NN	O	increase	nsubj	26	SENT_169	[p11l55t561r170b586],
20	in	IN	O	in	_	0	SENT_169	[p11l187t561r214b586],
21	the	DT	O	the	det	23	SENT_169	[p11l231t561r273b586],
22	antimalarial	JJ	O	antimalarial	amod	23	SENT_169	[p11l291t561r458b596],
23	concentration	NN	O	concentration	prep_in	19	SENT_169	[p11l476t561r668b586],
24	did	VBD	O	do	aux	26	SENT_169	[p11l685t561r730b586],
25	not	RB	O	not	neg	26	SENT_169	[p11l747t565r791b586],
26	cause	VB	O	cause	advcl	5	SENT_169	[p11l808t569r886b586],
27	a	DT	O	a	det	28	SENT_169	[p11l904t569r918b586],
28	decrease	NN	O	decrease	dobj	26	SENT_169	[p11l935t561r1056b586],
29	to	TO	O	to	_	0	SENT_169	[p11l1073t565r1099b586],
30	below	IN	O	below	advmod	34	SENT_169	[p11l1117t561r1202b586],
31	50	CD	PERCENT	50	num	32	SENT_169	[p11l1220t561r1282b586],
32	%	NN	PERCENT	%	pobj	30	SENT_169	[p11l1220t561r1282b586],
33	original	JJ	O	original	amod	34	SENT_169	[p11l1302t561r1410b593],
34	activity	NN	O	activity	prep_to	26	SENT_169	[p11l1428t561r1540b593],
35	.	.	O	.	_	0	SENT_169	[p11l1428t561r1540b593],

1	The	DT	O	the	det	2	SENT_170	[p11l1559t561r1613b586],
2	ﬁgures	NNS	O	ﬁgures	nsubj	3	SENT_170	[p11l1631t561r1725b593],
3	represent	VBP	O	represent	_	0	SENT_170	[p11l1743t565r1873b594],
4	the	DT	O	the	det	5	SENT_170	[p11l1889t561r1931b586],
5	mean	NN	O	mean	dobj	3	SENT_170	[p11l1949t569r2025b586],
6	of	IN	O	of	_	0	SENT_170	[p11l2042t561r2073b586],
7	4	CD	NUMBER	4	num	8	SENT_170	[p11l2087t561r2104b586],
8	determinations	NNS	O	determination	prep_of	5	SENT_170	[p11l55t597r342b623],
9	.	.	O	.	_	0	SENT_170	[p11l55t597r342b623],

1	.	.	O	.	_	0	SENT_171	[p11l55t597r342b623],

1	—	NN	O	—	_	0	SENT_172	[p11l55t597r342b623],
2	.	.	O	.	_	0	SENT_172	[p11l55t597r342b623],

1	’N	NN	O	’n	nsubj	3	SENT_173	[p11l55t597r342b623],
2	I	CD	NUMBER	i	num	1	SENT_173	[p11l55t597r342b623],
3	indicates	VBZ	O	indicate	_	0	SENT_173	[p11l354t598r479b623],
4	that	IN	O	that	complm	6	SENT_173	[p11l492t598r545b623],
5	there	EX	O	there	expl	6	SENT_173	[p11l557t598r627b623],
6	was	VBD	O	be	ccomp	3	SENT_173	[p11l640t606r693b623],
7	no	DT	O	no	det	8	SENT_173	[p11l706t606r741b623],
8	inhibition	NN	O	inhibition	nsubj	6	SENT_173	[p11l754t598r891b623],
9	with	IN	O	with	_	0	SENT_173	[p11l904t598r966b623],
10	the	DT	O	the	det	12	SENT_173	[p11l978t598r1020b623],
11	particular	JJ	O	particular	amod	12	SENT_173	[p11l1033t598r1169b630],
12	inhibitor	NN	O	inhibitor	prep_with	8	SENT_173	[p11l1181t598r1303b623],
13	at	IN	O	at	_	0	SENT_173	[p11l1315t602r1340b623],
14	100	CD	NUMBER	100	num	16	SENT_173	[p11l1355t598r1404b623],
15	p.M	NN	O	p.m	nn	16	SENT_173	[p11l1419t598r1471b630],
16	concentration	NN	O	concentration	prep_at	12	SENT_173	[p11l1484t598r1683b623],
17	.	.	O	.	_	0	SENT_173	[p11l1484t598r1683b623],

1	TABLE	NN	O	table	_	0	SENT_174	[p11l85t705r176b725],
2	II	CD	NUMBER	ii	dep	1	SENT_174	[p11l191t705r291b725],
3	.	.	O	.	_	0	SENT_174	[p11l191t705r291b725],

1	—	NN	O	—	_	0	SENT_175	[p11l191t705r291b725],
2	.	.	O	.	_	0	SENT_175	[p11l191t705r291b725],

1	THE	DT	O	the	det	2	SENT_176	[p11l191t705r291b725],
2	EFFECTS	NNS	O	effect	_	0	SENT_176	[p11l305t705r416b725],
3	OF	IN	O	of	_	0	SENT_176	[p11l432t705r466b725],
4	QUININE	NNP	O	QUININE	nn	7	SENT_176	[p11l480t705r592b729],
5	ON	NNP	O	ON	nn	7	SENT_176	[p11l606t705r644b725],
6	KINETIC	NNP	O	KINETIC	nn	7	SENT_176	[p11l659t705r765b725],
7	PROPERTIES	NNPS	O	PROPERTIES	prep_of	2	SENT_176	[p11l780t705r938b725],
8	OF	IN	O	of	_	0	SENT_176	[p11l954t705r988b725],
9	GST	NN	O	gst	nn	10	SENT_176	[p11l1002t705r1052b725],
10	P1-1	NN	O	p1-1	prep_of	2	SENT_176	[p11l1066t705r1114b725],
11	WITH	IN	O	with	_	0	SENT_176	[p11l1131t706r1201b725],
12	1	CD	NUMBER	1	prep_with	2	SENT_176	[p11l1218t705r1635b728],
13	.	.	O	.	_	0	SENT_176	[p11l1218t705r1635b728],

1	—	NN	O	—	_	0	SENT_177	[p11l1218t705r1635b728],
2	.	.	O	.	_	0	SENT_177	[p11l1218t705r1635b728],

1	CHLORO	NNP	O	CHLORO	_	0	SENT_178	[p11l1218t705r1635b728],
2	.	.	O	.	_	0	SENT_178	[p11l1218t705r1635b728],

1	—	NN	O	—	_	0	SENT_179	[p11l1218t705r1635b728],
2	.	.	O	.	_	0	SENT_179	[p11l1218t705r1635b728],

1	2,4	CD	NUMBER	2,4	_	0	SENT_180	[p11l1218t705r1635b728],
2	.	.	O	.	_	0	SENT_180	[p11l1218t705r1635b728],

1	—	NN	O	—	_	0	SENT_181	[p11l1218t705r1635b728],
2	.	.	O	.	_	0	SENT_181	[p11l1218t705r1635b728],

1	DINITROBENZENE	NNP	O	DINITROBENZENE	nn	4	SENT_182	[p11l1218t705r1635b728],
2	AS	NNP	O	AS	nn	4	SENT_182	[p11l1649t705r1682b725],
3	ELECTROPHILIC	NNP	O	ELECTROPHILIC	nn	4	SENT_182	[p11l1697t705r1905b725],
4	SUBSTRATE	NNP	O	SUBSTRATE	_	0	SENT_182	[p11l1921t705r2074b725],

1	‘	NN	O	‘	_	0	SENT_183	[p11l94t760r247b812],
2	f	SYM	O	f	dep	1	SENT_183	[p11l94t760r247b812],
3	,	,	O	,	_	0	SENT_183	[p11l94t760r247b812],
4	‘	CD	NUMBER	‘	number	5	SENT_183	[p11l94t760r247b812],
5	§	CD	NUMBER	§	appos	2	SENT_183	[p11l94t760r247b812],
6	‘	NN	O	‘	dep	5	SENT_183	[p11l94t760r247b812],
7	1	CD	NUMBER	1	num	6	SENT_183	[p11l94t760r247b812],
8	§	NN	O	§	dep	1	SENT_183	[p11l94t760r247b812],
9	f	FW	O	f	nn	8	SENT_183	[p11l94t760r247b812],
10	§	FW	O	§	nn	8	SENT_183	[p11l94t760r247b812],
11	“	FW	O	“	nn	8	SENT_183	[p11l94t760r247b812],
12	{	FW	O	{	dep	8	SENT_183	[p11l94t760r247b812],
13	,	,	O	,	_	0	SENT_183	[p11l94t760r247b812],
14	j	FW	O	j	nn	20	SENT_183	[p11l94t760r247b812],
15	§	FW	O	§	nn	20	SENT_183	[p11l94t760r247b812],
16	{	FW	O	{	nn	20	SENT_183	[p11l94t760r247b812],
17	}	FW	O	}	nn	20	SENT_183	[p11l94t760r247b812],
18	’	FW	O	’	nn	20	SENT_183	[p11l94t760r247b812],
19	§	FW	O	§	nn	20	SENT_183	[p11l94t760r247b812],
20	‘	FW	O	‘	appos	8	SENT_183	[p11l94t760r247b812],
21	KcatGSH	NN	O	kcatgsh	dep	1	SENT_183	[p11l336t768r489b799],
22	(	CD	NUMBER	(	num	21	SENT_183	[p11l336t768r489b799],
23	S71	NN	O	s71	nn	25	SENT_183	[p11l336t768r489b799],
24	)	CD	NUMBER	)	num	25	SENT_183	[p11l336t768r489b799],
25	K.	NNP	O	K.	dep	21	SENT_183	[p11l596t768r696b799],
26	.	.	O	.	_	0	SENT_183	[p11l596t768r696b799],

1	.	.	O	.	_	0	SENT_184	[p11l596t768r696b799],

1	CD	NNP	O	CD	_	0	SENT_185	[p11l596t768r696b799],
2	“	CD	NUMBER	“	num	5	SENT_185	[p11l596t768r696b799],
3	"	``	O	"	punct	5	SENT_185	[p11l596t768r696b799],
4	(	NN	O	(	nn	5	SENT_185	[p11l707t768r766b797],
5	s	NNS	O	s	dep	1	SENT_185	[p11l707t768r766b797],
6	"	``	O	"	punct	5	SENT_185	[p11l707t768r766b797],
7	>	JJR	O	>	dep	5	SENT_185	[p11l707t768r766b797],
8	K.	NNP	O	K.	dep	5	SENT_185	[p11l875t768r952b799],
9	.	.	O	.	_	0	SENT_185	[p11l875t768r952b799],

1	“	NN	O	“	_	0	SENT_186	[p11l875t768r952b799],
2	S	NN	O	s	nn	4	SENT_186	[p11l875t768r952b799],
3	“	CD	NUMBER	“	num	4	SENT_186	[p11l875t768r952b799],
4	K.	NNP	O	K.	dep	1	SENT_186	[p11l1418t768r1546b799],
5	.	.	O	.	_	0	SENT_186	[p11l1418t768r1546b799],

1	.	.	O	.	_	0	SENT_187	[p11l1418t768r1546b799],

1	/	:	O	/	punct	2	SENT_188	[p11l1418t768r1546b799],
2	I	PRP	O	I	_	0	SENT_188	[p11l1418t768r1546b799],
3	<	JJR	O	<	dep	2	SENT_188	[p11l1418t768r1546b799],
4	...	:	O	...	_	0	SENT_188	[p11l1418t768r1546b799],
5	“	NN	O	“	nn	6	SENT_188	[p11l1418t768r1546b799],
6	S	NN	O	s	dep	3	SENT_188	[p11l1418t768r1546b799],
7	“	CD	NUMBER	“	num	9	SENT_188	[p11l1418t768r1546b799],
8	(	NN	O	(	nn	9	SENT_188	[p11l1556t768r1604b797],
9	s	NNS	O	s	dep	6	SENT_188	[p11l1556t768r1604b797],
10	"	``	O	"	punct	9	SENT_188	[p11l1556t768r1604b797],
11	mM	NN	O	mm	nn	12	SENT_188	[p11l1616t768r1697b797],
12	*	NN	O	*	dep	9	SENT_188	[p11l1616t768r1697b797],
13	‘	CD	NUMBER	‘	num	14	SENT_188	[p11l1616t768r1697b797],
14	>	JJR	O	>	dep	9	SENT_188	[p11l1616t768r1697b797],
15	K.	NNP	O	K.	dep	14	SENT_188	[p11l1769t768r1912b799],
16	.	.	O	.	_	0	SENT_188	[p11l1769t768r1912b799],

1	.	.	O	.	_	0	SENT_189	[p11l1769t768r1912b799],

1	/	:	O	/	punct	2	SENT_190	[p11l1769t768r1912b799],
2	K.	NNP	O	K.	_	0	SENT_190	[p11l1769t768r1912b799],
3	.	.	O	.	_	0	SENT_190	[p11l1769t768r1912b799],

1	°	RB	O	°	advmod	8	SENT_191	[p11l1769t768r1912b799],
2	"	``	O	"	punct	3	SENT_191	[p11l1769t768r1912b799],
3	”‘	CD	NUMBER	”‘	nn	8	SENT_191	[p11l1769t768r1912b799],
4	*	CD	NUMBER	*	num	7	SENT_191	[p11l1769t768r1912b799],
5	(	NN	O	(	nn	7	SENT_191	[p11l1924t768r1972b797],
6	S71	NN	O	s71	nn	7	SENT_191	[p11l1924t768r1972b797],
7	mM	NN	O	mm	dep	3	SENT_191	[p11l1984t768r2064b797],
8	’	NN	O	’	_	0	SENT_191	[p11l1984t768r2064b797],
9	1	CD	NUMBER	1	num	10	SENT_191	[p11l1984t768r2064b797],
10	)	NN	O	)	dep	8	SENT_191	[p11l1984t768r2064b797],

1	o	NN	O	o	dep	12	SENT_192	[p11l92t843r109b869],
2	92.56	CD	NUMBER	92.56	num	1	SENT_192	[p11l319t843r397b869],
3	i	FW	O	i	dep	1	SENT_192	[p11l411t845r432b867],
4	4.09	CD	NUMBER	4.09	number	5	SENT_192	[p11l445t843r506b869],
5	119.06	CD	NUMBER	119.06	dep	3	SENT_192	[p11l582t843r674b869],
6	i	FW	O	i	dep	3	SENT_192	[p11l688t845r709b867],
7	2.60	CD	NUMBER	2.60	number	8	SENT_192	[p11l723t843r784b869],
8	0.321	CD	NUMBER	0.321	dep	6	SENT_192	[p11l856t843r931b869],
9	t	NN	O	t	dep	12	SENT_192	[p11l948t845r969b867],
10	0.05	CD	NUMBER	0.05	num	9	SENT_192	[p11l983t843r1042b869],
11	0.645	CD	NUMBER	0.645	num	12	SENT_192	[p11l1128t843r1205b869],
12	t	NN	O	t	dep	15	SENT_192	[p11l1220t845r1241b867],
13	0.03	CD	NUMBER	0.03	num	14	SENT_192	[p11l1255t843r1314b869],
14	290.47	CD	NUMBER	290.47	dep	12	SENT_192	[p11l1446t843r1541b869],
15	i	FW	O	i	dep	20	SENT_192	[p11l1555t845r1577b867],
16	29	CD	NUMBER	29	number	17	SENT_192	[p11l1591t843r1624b869],
17	184.5	CD	NUMBER	184.5	dep	15	SENT_192	[p11l1835t843r1909b869],
18	i	FW	O	i	dep	17	SENT_192	[p11l1924t845r1945b867],
19	3.66	CD	NUMBER	3.66	num	20	SENT_192	[p11l1959t843r2019b869],
20	2.5	CD	NUMBER	2.5	dep	24	SENT_192	[p11l93t879r134b905],
21	63.74	CD	NUMBER	63.74	num	22	SENT_192	[p11l319t879r397b905],
22	t	NN	O	t	dep	20	SENT_192	[p11l411t881r432b903],
23	0.20	CD	NUMBER	0.20	num	24	SENT_192	[p11l446t879r506b905],
24	59.80	CD	NUMBER	59.80	dep	28	SENT_192	[p11l596t879r674b905],
25	i	FW	O	i	dep	24	SENT_192	[p11l688t881r709b903],
26	7.00	CD	NUMBER	7.00	number	27	SENT_192	[p11l723t879r784b905],
27	0.263	CD	NUMBER	0.263	dep	25	SENT_192	[p11l856t879r932b905],
28	t	NN	O	t	dep	31	SENT_192	[p11l948t881r969b903],
29	0.02	CD	NUMBER	0.02	num	28	SENT_192	[p11l983t879r1043b905],
30	0.165	CD	NUMBER	0.165	num	31	SENT_192	[p11l1128t879r1205b905],
31	t	NN	O	t	dep	33	SENT_192	[p11l1220t881r1241b903],
32	0.03	CD	NUMBER	0.03	num	33	SENT_192	[p11l1255t879r1314b905],
33	242.56	CD	NUMBER	242.56	dep	76	SENT_192	[p11l1446t879r1542b905],
34	i	FW	O	i	dep	33	SENT_192	[p11l1555t881r1577b903],
35	13.27	CD	NUMBER	13.27	number	36	SENT_192	[p11l1594t879r1668b905],
36	365.90	CD	NUMBER	365.90	dep	34	SENT_192	[p11l1815t879r1910b905],
37	:	:	O	:	_	0	SENT_192	[p11l1924t881r1945b903],
38	37	CD	NUMBER	37	number	39	SENT_192	[p11l1959t879r1992b905],
39	5	CD	NUMBER	5	dep	34	SENT_192	[p11l93t922r107b948],
40	59.28	CD	NUMBER	59.28	dep	39	SENT_192	[p11l319t922r396b948],
41	:	:	O	:	_	0	SENT_192	[p11l411t924r432b946],
42	2.34	CD	NUMBER	2.34	number	43	SENT_192	[p11l446t922r506b948],
43	66.82	CD	NUMBER	66.82	dep	34	SENT_192	[p11l596t922r674b948],
44	:	:	O	:	_	0	SENT_192	[p11l688t924r709b946],
45	3.91	CD	NUMBER	3.91	number	46	SENT_192	[p11l724t922r781b948],
46	0.247	CD	NUMBER	0.247	dep	43	SENT_192	[p11l856t922r933b948],
47	:	:	O	:	_	0	SENT_192	[p11l948t924r969b946],
48	0.02	CD	NUMBER	0.02	num	49	SENT_192	[p11l983t922r1043b948],
49	0.549	CD	NUMBER	0.549	dep	46	SENT_192	[p11l1128t922r1206b948],
50	:	:	O	:	_	0	SENT_192	[p11l1220t924r1241b946],
51	0.024	CD	NUMBER	0.024	number	52	SENT_192	[p11l1255t922r1333b948],
52	244.61	CD	NUMBER	244.61	dep	49	SENT_192	[p11l1446t922r1539b948],
53	:	:	O	:	_	0	SENT_192	[p11l1555t924r1577b946],
54	17.83	CD	NUMBER	17.83	number	55	SENT_192	[p11l1594t922r1667b948],
55	121.80	CD	NUMBER	121.80	dep	34	SENT_192	[p11l1817t922r1910b948],
56	:	:	O	:	_	0	SENT_192	[p11l1924t924r1945b946],
57	5.18	CD	NUMBER	5.18	number	58	SENT_192	[p11l1959t922r2018b948],
58	10	CD	NUMBER	10	dep	55	SENT_192	[p11l96t964r127b989],
59	36.62	CD	NUMBER	36.62	dep	58	SENT_192	[p11l319t964r397b989],
60	:	:	O	:	_	0	SENT_192	[p11l411t966r432b988],
61	2.7	CD	NUMBER	2.7	number	62	SENT_192	[p11l446t964r488b989],
62	41.73	CD	NUMBER	41.73	dep	34	SENT_192	[p11l596t964r673b989],
63	:	:	O	:	_	0	SENT_192	[p11l688t966r709b988],
64	1.56	CD	NUMBER	1.56	num	65	SENT_192	[p11l726t964r783b989],
65	0.164	CD	NUMBER	0.164	dep	62	SENT_192	[p11l856t964r934b989],
66	:	:	O	:	_	0	SENT_192	[p11l948t966r969b988],
67	0.03	CD	NUMBER	0.03	num	68	SENT_192	[p11l983t964r1042b989],
68	0.193	CD	NUMBER	0.193	dep	65	SENT_192	[p11l1128t964r1205b989],
69	:	:	O	:	_	0	SENT_192	[p11l1220t966r1241b988],
70	0.03	CD	NUMBER	0.03	num	71	SENT_192	[p11l1255t964r1314b989],
71	225.33	CD	NUMBER	225.33	dep	34	SENT_192	[p11l1446t964r1540b989],
72	:	:	O	:	_	0	SENT_192	[p11l1555t966r1577b988],
73	19.24	CD	NUMBER	19.24	number	74	SENT_192	[p11l1594t964r1669b989],
74	219.01	CD	NUMBER	219.01	dep	71	SENT_192	[p11l1815t964r1907b989],
75	:	:	O	:	_	0	SENT_192	[p11l1924t966r1945b988],
76	26	CD	NUMBER	26	_	0	SENT_192	[p11l1959t964r1993b989],

1	TABLE	NN	O	table	_	0	SENT_193	[p11l116t1076r206b1095],
2	I_II	NN	O	i_ii	dep	1	SENT_193	[p11l221t1076r305b1102],
3	.	.	O	.	_	0	SENT_193	[p11l221t1076r305b1102],

1	—	NN	O	—	_	0	SENT_194	[p11l221t1076r305b1102],
2	.	.	O	.	_	0	SENT_194	[p11l221t1076r305b1102],

1	Ki	NN	PERSON	kus	nn	4	SENT_195	[p11l221t1076r305b1102],
2	AND	CC	O	and	_	0	SENT_195	[p11l320t1077r377b1095],
3	IC50	NN	O	ic50	conj_and	1	SENT_195	[p11l392t1077r439b1102],
4	VALUES	NNS	O	value	_	0	SENT_195	[p11l453t1076r558b1096],
5	FOR	IN	O	for	_	0	SENT_195	[p11l573t1077r626b1096],
6	INHIBITION	NN	O	inhibition	prep_for	4	SENT_195	[p11l640t1077r788b1096],
7	OF	IN	O	of	_	0	SENT_195	[p11l803t1076r836b1096],
8	THE	DT	O	the	det	9	SENT_195	[p11l850t1077r902b1095],
9	CONJUGATION	NN	O	conjugation	prep_of	6	SENT_195	[p11l917t1076r1107b1096],
10	OF	IN	O	of	_	0	SENT_195	[p11l1121t1077r1155b1096],
11	1-CHLORO-2	NN	O	1-chloro-2	prep_of	9	SENT_195	[p11l1172t1076r1345b1099],
12	,4	CD	NUMBER	,4	num	11	SENT_195	[p11l1172t1076r1345b1099],
13	DINITROBENZENE	NN	O	dinitrobenzene	nn	16	SENT_195	[p11l1359t1077r1594b1096],
14	(	CD	NUMBER	(	num	16	SENT_195	[p11l1609t1077r1700b1100],
15	CDNB	NN	O	cdnb	nn	16	SENT_195	[p11l1609t1077r1700b1100],
16	)	NN	O	)	dep	4	SENT_195	[p11l1609t1077r1700b1100],
17	TO	TO	O	to	infmod	16	SENT_195	[p11l1715t1077r1750b1096],
18	GLUTATHIONE	NNP	O	GLUTATHIONE	nn	20	SENT_195	[p11l1765t1077r1956b1096],
19	BY	NNP	O	BY	nn	20	SENT_195	[p11l1970t1077r2007b1095],
20	E.	NNP	O	E.	dobj	17	SENT_195	[p11l2021t1077r2042b1096],

1	COLI-EXPRESSED	JJ	O	coli-expressed	amod	4	SENT_196	[p11l576t1104r797b1123],
2	HUMAN	NNP	O	HUMAN	nn	4	SENT_196	[p11l811t1104r913b1123],
3	RECOMBINANT	NNP	O	RECOMBINANT	nn	4	SENT_196	[p11l927t1104r1125b1123],
4	GLUTATHIONE	NNP	O	GLUTATHIONE	_	0	SENT_196	[p11l1140t1104r1331b1123],
5	S-TRANSFERASESI	NN	O	s-transferasesus	dep	4	SENT_196	[p11l1346t1098r1581b1123],

1	Type	NN	O	type	dep	11	SENT_197	[p11l1464t1161r1519b1186],
2	of	IN	O	of	_	0	SENT_197	[p11l1529t1161r1553b1180],
3	inhibition	NN	O	inhibition	nn	5	SENT_197	[p11l1561t1161r1665b1180],
4	Peak	JJ	O	peak	amod	5	SENT_197	[p11l1922t1159r1975b1178],
5	plasma	NN	O	plasma	prep_of	1	SENT_197	[p11l1984t1159r2061b1184],
6	Isoform/compound	NNP	O	Isoform/compound	nn	7	SENT_197	[p11l116t1186r323b1211],
7	KiC	NNP	O	KiC	poss	5	SENT_197	[p11l484t1180r549b1211],
8	'	POS	O	'	_	0	SENT_197	[p11l484t1180r549b1211],
9	SH	NN	O	sh	dep	11	SENT_197	[p11l484t1180r549b1211],
10	(	CD	NUMBER	(	num	9	SENT_197	[p11l560t1185r610b1211],
11	K	NNP	O	K	dep	17	SENT_197	[p11l560t1185r610b1211],
12	’	CD	NUMBER	’	num	11	SENT_197	[p11l560t1185r610b1211],
13	i	FW	O	i	nn	15	SENT_197	[p11l560t1185r610b1211],
14	)	FW	O	)	nn	15	SENT_197	[p11l560t1185r610b1211],
15	KiCDNB	NN	O	kicdnb	dep	11	SENT_197	[p11l783t1180r864b1211],
16	(	CD	NUMBER	(	num	17	SENT_197	[p11l876t1185r926b1211],
17	K	NNP	O	K	dep	24	SENT_197	[p11l876t1185r926b1211],
18	’	CD	NUMBER	’	num	17	SENT_197	[p11l876t1185r926b1211],
19	i	FW	O	i	nn	23	SENT_197	[p11l876t1185r926b1211],
20	)	FW	O	)	nn	23	SENT_197	[p11l876t1185r926b1211],
21	(	FW	O	(	nn	23	SENT_197	[p11l937t1180r1006b1211],
22	p.	NN	O	p.	nn	23	SENT_197	[p11l937t1180r1006b1211],
23	M	NN	O	m	dep	17	SENT_197	[p11l937t1180r1006b1211],
24	)	NN	O	)	_	0	SENT_197	[p11l937t1180r1006b1211],
25	2	CD	NUMBER	2	num	24	SENT_197	[p11l937t1180r1006b1211],
26	IC50	NN	O	ic50	nn	33	SENT_197	[p11l1165t1186r1212b1211],
27	concentration	NN	O	concentration	nn	33	SENT_197	[p11l1918t1186r2065b1205],
28	GSH	NN	O	gsh	nn	33	SENT_197	[p11l1370t1211r1423b1230],
29	CDNB	NN	O	cdnb	nn	33	SENT_197	[p11l1651t1211r1723b1230],
30	(	CD	NUMBER	(	num	33	SENT_197	[p11l1962t1214r2020b1238],
31	p.	NN	O	p.	nn	33	SENT_197	[p11l1962t1214r2020b1238],
32	M	NN	O	m	nn	33	SENT_197	[p11l1962t1214r2020b1238],
33	)	NN	O	)	dep	24	SENT_197	[p11l1962t1214r2020b1238],

1	GST	NN	O	gst	nn	3	SENT_198	[p11l93t1266r158b1291],
2	Mlb-lb	NN	O	mlb-lb	nn	3	SENT_198	[p11l171t1266r284b1291],
3	Quinidine	NN	O	quinidine	_	0	SENT_198	[p11l128t1301r268b1332],
4	4.0	CD	NUMBER	4.0	number	5	SENT_198	[p11l534t1301r577b1327],
5	4.3	CD	NUMBER	4.3	dep	3	SENT_198	[p11l881t1301r923b1327],
6	12	CD	NUMBER	12	num	8	SENT_198	[p11l1174t1301r1205b1326],
7	Uncomp	NN	O	uncomp	nn	8	SENT_198	[p11l1334t1302r1455b1334],
8	Uncomp3	NN	O	uncomp3	dep	5	SENT_198	[p11l1579t1295r1713b1334],
9	30	CD	NUMBER	30	dep	3	SENT_198	[p11l1962t1301r1995b1327],
10	Quinine	NNP	O	Quinine	nn	15	SENT_198	[p11l128t1337r240b1368],
11	5.0	CD	NUMBER	5.0	num	15	SENT_198	[p11l535t1337r577b1362],
12	8.5	CD	NUMBER	8.5	num	15	SENT_198	[p11l883t1337r923b1362],
13	17	CD	NUMBER	17	num	15	SENT_198	[p11l1174t1337r1204b1362],
14	Uncomp	NNP	O	Uncomp	nn	15	SENT_198	[p11l1334t1338r1455b1369],
15	Part	NNP	O	Part	dep	9	SENT_198	[p11l1579t1338r1643b1362],
16	.	.	O	.	_	0	SENT_198	[p11l1579t1338r1643b1362],

1	Uncomp4	NN	O	uncomp4	nn	4	SENT_199	[p11l1657t1331r1792b1369],
2	30	CD	NUMBER	30	num	4	SENT_199	[p11l1962t1337r1995b1362],
3	GST	NN	O	gst	nn	4	SENT_199	[p11l93t1372r158b1397],
4	A1-1	NN	O	a1-1	dep	19	SENT_199	[p11l171t1372r239b1396],
5	Arte1r1isinin	NN	O	arte1r1isinin	dep	4	SENT_199	[p11l128t1407r296b1432],
6	38	CD	NUMBER	38	num	5	SENT_199	[p11l491t1407r523b1432],
7	(	CD	NUMBER	(	number	8	SENT_199	[p11l547t1407r603b1438],
8	57	CD	NUMBER	57	num	9	SENT_199	[p11l547t1407r603b1438],
9	)	NN	O	)	dep	5	SENT_199	[p11l547t1407r603b1438],
10	8.0	CD	NUMBER	8.0	number	11	SENT_199	[p11l834t1407r876b1432],
11	(	CD	NUMBER	(	num	9	SENT_199	[p11l899t1407r955b1438],
12	75	CD	NUMBER	75	num	13	SENT_199	[p11l899t1407r955b1438],
13	)	NN	O	)	dep	19	SENT_199	[p11l899t1407r955b1438],
14	6	CD	NUMBER	6	num	19	SENT_199	[p11l1189t1407r1205b1432],
15	Mixed	NNP	O	Mixed	nn	19	SENT_199	[p11l1334t1407r1426b1432],
16	Mixed	NNP	O	Mixed	nn	19	SENT_199	[p11l1579t1407r1671b1432],
17	10	CD	NUMBER	10	num	19	SENT_199	[p11l1964t1407r1995b1432],
18	GST	NN	O	gst	nn	19	SENT_199	[p11l93t1442r158b1467],
19	M3-3	NN	O	m3-3	dep	26	SENT_199	[p11l171t1442r247b1467],
20	Tetracycline	NN	O	tetracycline	nn	25	SENT_199	[p11l127t1477r303b1509],
21	36.0	CD	NUMBER	36.0	num	25	SENT_199	[p11l517t1477r577b1502],
22	41.0	CD	NUMBER	41.0	num	25	SENT_199	[p11l864t1477r925b1502],
23	47	CD	NUMBER	47	num	25	SENT_199	[p11l1171t1477r1204b1502],
24	Mixed	NNP	O	Mixed	nn	25	SENT_199	[p11l1334t1477r1426b1502],
25	Mixed	NNP	O	Mixed	dep	19	SENT_199	[p11l1579t1477r1671b1502],
26	l2	NN	O	l2	dep	31	SENT_199	[p11l1951t1477r2034b1502],
27	—	CD	NUMBER	—	num	26	SENT_199	[p11l1951t1477r2034b1502],
28	45	CD	NUMBER	45	num	31	SENT_199	[p11l1951t1477r2034b1502],
29	GST	NN	O	gst	nn	31	SENT_199	[p11l93t1512r158b1537],
30	P1-1	NN	O	p1-1	nn	31	SENT_199	[p11l171t1512r234b1537],
31	Arterr1isinin	NN	O	arterr1isinin	dep	37	SENT_199	[p11l127t1547r296b1572],
32	2.4	CD	NUMBER	2.4	num	33	SENT_199	[p11l486t1547r528b1572],
33	(	NN	O	(	dep	31	SENT_199	[p11l551t1547r607b1578],
34	17	CD	NUMBER	17	number	35	SENT_199	[p11l551t1547r607b1578],
35	)	CD	NUMBER	)	num	36	SENT_199	[p11l551t1547r607b1578],
36	33	CD	NUMBER	33	dep	33	SENT_199	[p11l838t1547r870b1572],
37	(	NN	O	(	dep	39	SENT_199	[p11l895t1547r951b1578],
38	17	CD	NUMBER	17	num	37	SENT_199	[p11l895t1547r951b1578],
39	)	NN	O	)	dep	42	SENT_199	[p11l895t1547r951b1578],
40	2	CD	NUMBER	2	num	39	SENT_199	[p11l1189t1547r1205b1572],
41	Mixed	NNP	O	Mixed	nn	42	SENT_199	[p11l1334t1547r1426b1572],
42	Mixed	NNP	O	Mixed	dep	50	SENT_199	[p11l1579t1547r1671b1572],
43	10	CD	NUMBER	10	num	44	SENT_199	[p11l1964t1547r1995b1572],
44	Pyrimethamine	NN	O	pyrimethamine	dep	42	SENT_199	[p11l128t1582r343b1614],
45	0.9	CD	NUMBER	0.9	number	46	SENT_199	[p11l534t1582r577b1607],
46	1	CD	NUMBER	1	num	47	SENT_199	[p11l885t1582r895b1606],
47	.7	NN	NUMBER	.7	dep	44	SENT_199	[p11l901t1583r924b1607],
48	1	CD	NUMBER	1	num	50	SENT_199	[p11l1192t1582r1202b1606],
49	Uncomp	NNP	O	Uncomp	nn	50	SENT_199	[p11l1334t1582r1455b1614],
50	Uncomp	NNP	O	Uncomp	dep	59	SENT_199	[p11l1579t1582r1700b1614],
51	0.6	CD	NUMBER	0.6	num	50	SENT_199	[p11l1979t1582r2021b1607],
52	Quinine	NNP	O	Quinine	nn	57	SENT_199	[p11l128t1617r241b1649],
53	5.5	CD	NUMBER	5.5	num	57	SENT_199	[p11l535t1617r576b1643],
54	7.2	CD	NUMBER	7.2	num	57	SENT_199	[p11l882t1617r925b1643],
55	4	CD	NUMBER	4	num	57	SENT_199	[p11l1188t1617r1205b1642],
56	Uncomp	NNP	ORGANIZATION	Uncomp	nn	57	SENT_199	[p11l1334t1618r1455b1650],
57	Uncomp	NNP	ORGANIZATION	Uncomp	dep	50	SENT_199	[p11l1579t1618r1700b1650],
58	30	CD	NUMBER	30	num	59	SENT_199	[p11l1962t1617r1995b1643],
59	Quinidine	NNP	O	Quinidine	dep	79	SENT_199	[p11l128t1652r268b1684],
60	6.0	CD	NUMBER	6.0	num	59	SENT_199	[p11l535t1652r577b1678],
61	9.2	CD	NUMBER	9.2	num	62	SENT_199	[p11l882t1652r925b1678],
62	l	NN	O	l	dep	59	SENT_199	[p11l1192t1652r1202b1677],
63	Uncomp	NNP	O	Uncomp	nn	77	SENT_199	[p11l1334t1653r1455b1685],
64	Uncomp	NNP	O	Uncomp	nn	77	SENT_199	[p11l1579t1653r1700b1685],
65	30	CD	NUMBER	30	num	77	SENT_199	[p11l1962t1652r1995b1678],
66	Tetracycline	NNP	O	Tetracycline	nn	77	SENT_199	[p11l127t1687r303b1719],
67	0.4	CD	NUMBER	0.4	num	77	SENT_199	[p11l486t1687r528b1712],
68	7	CD	NUMBER	7	num	77	SENT_199	[p11l580t1687r607b1718],
69	)	NN	O	)	nn	77	SENT_199	[p11l580t1687r607b1718],
70	4.0	CD	NUMBER	4.0	num	77	SENT_199	[p11l833t1687r876b1712],
71	(	NN	O	(	nn	77	SENT_199	[p11l899t1687r955b1718],
72	18	CD	NUMBER	18	num	77	SENT_199	[p11l899t1687r955b1718],
73	)	CD	NUMBER	)	num	77	SENT_199	[p11l899t1687r955b1718],
74	13	CD	NUMBER	13	num	77	SENT_199	[p11l1174t1687r1204b1712],
75	Uncomp	NNP	O	Uncomp	nn	77	SENT_199	[p11l1334t1688r1455b1719],
76	Uncomp	NNP	O	Uncomp	nn	77	SENT_199	[p11l1579t1688r1700b1719],
77	l2	NN	O	l2	rcmod	62	SENT_199	[p11l1951t1687r2034b1712],
78	—	CD	NUMBER	—	num	79	SENT_199	[p11l1951t1687r2034b1712],
79	45	CD	NUMBER	45	_	0	SENT_199	[p11l1951t1687r2034b1712],

1	‘	NN	O	‘	nn	2	SENT_200	[p11l93t1768r200b1799],
2	Values	NNS	O	value	nsubjpass	14	SENT_200	[p11l93t1768r200b1799],
3	for	IN	O	for	_	0	SENT_200	[p11l217t1774r258b1799],
4	plasma	NN	O	plasma	nn	6	SENT_200	[p11l272t1774r373b1806],
5	antimalarial	JJ	O	antimalarial	amod	6	SENT_200	[p11l389t1774r556b1799],
6	concentrations	NNS	O	concentration	prep_for	2	SENT_200	[p11l572t1774r777b1799],
7	obtained	VBN	O	obtain	partmod	6	SENT_200	[p11l794t1774r915b1799],
8	during	IN	O	during	_	0	SENT_200	[p11l930t1774r1021b1806],
9	treatment	NN	O	treatment	prep_during	7	SENT_200	[p11l1037t1778r1171b1799],
10	with	IN	O	with	_	0	SENT_200	[p11l1186t1774r1248b1799],
11	the	DT	O	the	det	12	SENT_200	[p11l1264t1774r1306b1799],
12	drugs	NNS	O	drug	prep_with	7	SENT_200	[p11l1322t1774r1399b1806],
13	were	VBD	O	be	auxpass	14	SENT_200	[p11l1415t1782r1483b1799],
14	obtained	VBN	O	obtain	_	0	SENT_200	[p11l1499t1774r1620b1799],
15	from	IN	O	from	_	0	SENT_200	[p11l1636t1774r1704b1799],
16	Berqgvist	NNP	LOCATION	Berqgvist	prep_from	14	SENT_200	[p11l1719t1774r1857b1806],
17	and	CC	O	and	_	0	SENT_200	[p11l1872t1774r1922b1799],
18	Churchill	NNP	PERSON	Churchill	conj_and	16	SENT_200	[p11l1938t1774r2103b1803],
19	,	,	O	,	_	0	SENT_200	[p11l1938t1774r2103b1803],
20	“	CD	NUMBER	“	num	21	SENT_200	[p11l1938t1774r2103b1803],
21	Edwards56s67	NN	O	edwards56s67	conj_and	16	SENT_200	[p11l54t1809r233b1834],
22	and	CC	O	and	_	0	SENT_200	[p11l251t1809r300b1834],
23	Goodman	NNP	PERSON	Goodman	conj_and	16	SENT_200	[p11l317t1809r456b1834],
24	and	CC	O	and	_	0	SENT_200	[p11l472t1809r522b1834],
25	Gillman	NNP	PERSON	Gillman	conj_and	23	SENT_200	[p11l539t1803r773b1834],
26	.63	CD	NUMBER	.63	number	27	SENT_200	[p11l539t1803r773b1834],
27	—	CD	NUMBER	—	num	29	SENT_200	[p11l539t1803r773b1834],
28	2The	NN	O	2the	nn	29	SENT_200	[p11l539t1803r773b1834],
29	Ki	NN	O	kus	dobj	14	SENT_200	[p11l790t1810r821b1842],
30	(	CD	NUMBER	(	num	31	SENT_200	[p11l839t1808r905b1842],
31	K	NNP	O	K	nsubjpass	37	SENT_200	[p11l839t1808r905b1842],
32	’	CD	NUMBER	’	num	31	SENT_200	[p11l839t1808r905b1842],
33	i	FW	O	i	nn	35	SENT_200	[p11l839t1808r905b1842],
34	)	FW	O	)	nn	35	SENT_200	[p11l839t1808r905b1842],
35	values	NNS	O	value	dep	31	SENT_200	[p11l922t1809r1011b1834],
36	were	VBD	O	be	auxpass	37	SENT_200	[p11l1028t1817r1096b1834],
37	determined	VBN	O	determine	rcmod	29	SENT_200	[p11l1112t1809r1271b1834],
38	for	IN	O	for	_	0	SENT_200	[p11l1287t1809r1328b1834],
39	triplicate	NN	O	triplicate	nn	41	SENT_200	[p11l1343t1809r1468b1842],
40	1/Vmax	NN	O	1/vmax	nn	41	SENT_200	[p11l1488t1809r1583b1842],
41	values	NNS	O	value	prep_for	37	SENT_200	[p11l1600t1809r1689b1834],
42	for	IN	O	for	_	0	SENT_200	[p11l1706t1809r1747b1834],
43	each	DT	O	each	det	44	SENT_200	[p11l1762t1809r1826b1834],
44	[	NN	O	[	prep_for	37	SENT_200	[p11l1845t1810r1884b1840],
45	I	PRP	O	I	nsubj	46	SENT_200	[p11l1845t1810r1884b1840],
46	]	VBP	O	]	rcmod	44	SENT_200	[p11l1845t1810r1884b1840],
47	.	.	O	.	_	0	SENT_200	[p11l1845t1810r1884b1840],

1	The	DT	O	the	det	2	SENT_201	[p11l1902t1809r1956b1834],
2	IC50	NN	O	ic50	nsubjpass	4	SENT_201	[p11l1972t1809r2034b1843],
3	was	VBD	O	be	auxpass	4	SENT_201	[p11l2051t1817r2104b1834],
4	determined	VBN	O	determine	_	0	SENT_201	[p11l55t1845r213b1870],
5	in	IN	O	in	_	0	SENT_201	[p11l226t1845r252b1870],
6	quadruplicate	NN	O	quadruplicate	prep_in	4	SENT_201	[p11l265t1845r457b1877],
7	for	IN	O	for	_	0	SENT_201	[p11l470t1845r511b1870],
8	each	DT	O	each	det	9	SENT_201	[p11l523t1845r587b1870],
9	inhibitor	NN	O	inhibitor	prep_for	6	SENT_201	[p11l600t1839r890b1877],
10	.	.	O	.	_	0	SENT_201	[p11l600t1839r890b1877],

1	.	.	O	.	_	0	SENT_202	[p11l600t1839r890b1877],

1	—	NN	O	—	_	0	SENT_203	[p11l600t1839r890b1877],
2	.	.	O	.	_	0	SENT_203	[p11l600t1839r890b1877],

1	3Uncomp	NN	O	3uncomp	_	0	SENT_204	[p11l600t1839r890b1877],
2	,	,	O	,	_	0	SENT_204	[p11l600t1839r890b1877],
3	uncompetitive	JJ	O	uncompetitive	amod	4	SENT_204	[p11l904t1845r1106b1877],
4	inhibition	NN	O	inhibition	appos	1	SENT_204	[p11l1119t1839r1360b1870],
5	.	.	O	.	_	0	SENT_204	[p11l1119t1839r1360b1870],

1	.	.	O	.	_	0	SENT_205	[p11l1119t1839r1360b1870],

1	—	NN	O	—	_	0	SENT_206	[p11l1119t1839r1360b1870],
2	.	.	O	.	_	0	SENT_206	[p11l1119t1839r1360b1870],

1	4Part	NN	O	4part	_	0	SENT_207	[p11l1119t1839r1360b1870],
2	.	.	O	.	_	0	SENT_207	[p11l1119t1839r1360b1870],

1	Uncomp	NNP	O	Uncomp	_	0	SENT_208	[p11l1375t1845r1503b1877],
2	,	,	O	,	_	0	SENT_208	[p11l1375t1845r1503b1877],
3	partial	JJ	O	partial	amod	5	SENT_208	[p11l1517t1845r1606b1877],
4	uncompetitive	JJ	O	uncompetitive	amod	5	SENT_208	[p11l1619t1845r1821b1877],
5	inhibition	NN	O	inhibition	appos	1	SENT_208	[p11l1834t1845r1978b1870],
6	.	.	O	.	_	0	SENT_208	[p11l1834t1845r1978b1870],

1	with	IN	O	with	mark	18	SENT_209	[p11l8t2015r149b2071],
2	IC50	NN	O	ic50	nn	3	SENT_209	[p11l171t2015r312b2089],
3	values	NNS	O	value	nsubj	18	SENT_209	[p11l335t2015r537b2071],
4	from	IN	O	from	_	0	SENT_209	[p11l562t2015r717b2071],
5	1-46	CD	NUMBER	1-46	num	6	SENT_209	[p11l747t2015r906b2072],
6	p.M	NN	O	p.m	prep_from	3	SENT_209	[p11l936t2017r1053b2087],
7	and	CC	O	and	_	0	SENT_209	[p11l1078t2015r1191b2071],
8	Ki	NN	PERSON	kus	nn	9	SENT_209	[p11l1215t2017r1287b2088],
9	Values	NNS	PERSON	value	prep_from	3	SENT_209	[p11l1310t2015r1511b2071],
10	generally	RB	O	generally	advmod	6	SENT_209	[p11l1537t2015r1833b2088],
11	below	IN	O	below	_	0	SENT_209	[p11l1856t2015r2050b2071],
12	20	CD	TIME	20	num	13	SENT_209	[p11l2075t2016r2152b2072],
13	p.M.	NN	TIME	p.m.	prep_below	6	SENT_209	[p11l13t2101r147b2171],
14	Of	IN	O	of	_	0	SENT_209	[p11l189t2099r276b2156],
15	the	DT	O	the	det	17	SENT_209	[p11l307t2099r403b2155],
16	8	CD	NUMBER	8	num	17	SENT_209	[p11l444t2100r475b2156],
17	antimalarials	NNS	O	antimalarial	prep_of	18	SENT_209	[p11l517t2099r927b2156],
18	noted	VBD	O	note	advcl	36	SENT_209	[p11l966t2099r1144b2156],
19	to	TO	O	to	aux	20	SENT_209	[p11l1180t2107r1239b2155],
20	affect	VB	O	affect	xcomp	18	SENT_209	[p11l1279t2099r1459b2156],
21	activity	NN	O	activity	dobj	20	SENT_209	[p11l1497t2099r1734b2172],
22	when	WRB	O	when	advmod	23	SENT_209	[p11l1772t2099r1944b2156],
23	using	VBG	O	use	advcl	20	SENT_209	[p11l1980t2099r2152b2172],
24	CDNB	NN	O	cdnb	dobj	23	SENT_209	[p11l8t2184r224b2240],
25	as	IN	O	as	_	0	SENT_209	[p11l261t2201r323b2240],
26	a	DT	O	a	det	27	SENT_209	[p11l357t2201r390b2240],
27	substrate	NN	O	substrate	prep_as	23	SENT_209	[p11l422t2183r721b2250],
28	,	,	O	,	_	0	SENT_209	[p11l422t2183r721b2250],
29	pyrimethamine	NN	O	pyrimethamine	nsubj	36	SENT_209	[p11l754t2183r1240b2256],
30	and	CC	O	and	_	0	SENT_209	[p11l1273t2183r1386b2240],
31	quinine	NN	O	quinine	nsubj	36	SENT_209	[p11l1416t2183r1655b2256],
32	were	VBD	O	be	cop	36	SENT_209	[p11l1686t2201r1840b2240],
33	the	DT	O	the	det	36	SENT_209	[p11l1871t2183r1967b2240],
34	most	RBS	O	most	advmod	35	SENT_209	[p11l1998t2192r2154b2240],
35	potent	JJ	O	potent	amod	36	SENT_209	[p11l6t2276r208b2341],
36	inhibitors	NNS	O	inhibitor	_	0	SENT_209	[p11l238t2268r560b2324],
37	.	.	O	.	_	0	SENT_209	[p11l238t2268r560b2324],

1	GST	NN	O	gst	nn	2	SENT_210	[p11l597t2268r746b2324],
2	P1-1	NN	O	p1-1	nsubj	5	SENT_210	[p11l777t2268r920b2323],
3	was	VBD	O	be	cop	5	SENT_210	[p11l959t2285r1079b2324],
4	the	DT	O	the	det	5	SENT_210	[p11l1113t2268r1208b2324],
5	enzyme	NN	O	enzyme	_	0	SENT_210	[p11l1241t2285r1488b2340],
6	most	RBS	O	most	advmod	7	SENT_210	[p11l1519t2276r1675b2324],
7	susceptible	JJ	O	susceptible	amod	5	SENT_210	[p11l1708t2268r2061b2341],
8	to	TO	O	to	_	0	SENT_210	[p11l2092t2276r2152b2324],
9	inhibition	NN	O	inhibition	prep_to	5	SENT_210	[p11l7t2352r335b2408],
10	.	.	O	.	_	0	SENT_210	[p11l7t2352r335b2408],

1	The	DT	O	the	det	2	SENT_211	[p11l363t2352r486b2408],
2	Ki	NN	O	kus	nsubj	11	SENT_211	[p11l512t2353r584b2425],
3	for	IN	O	for	_	0	SENT_211	[p11l608t2352r701b2408],
4	artemisinin	NN	O	artemisinin	prep_for	2	SENT_211	[p11l726t2352r1085b2408],
5	using	VBG	O	use	partmod	4	SENT_211	[p11l1108t2352r1280b2425],
6	CDNB	NN	O	cdnb	dobj	5	SENT_211	[p11l1307t2352r1523b2408],
7	for	IN	O	for	_	0	SENT_211	[p11l1552t2352r1645b2408],
8	GST	NN	O	gst	nn	9	SENT_211	[p11l1669t2352r1817b2408],
9	A1-1	NN	O	a1-1	prep_for	6	SENT_211	[p11l1842t2352r1998b2407],
10	was	VBD	O	be	cop	11	SENT_211	[p11l2030t2369r2151b2408],
11	lower	JJR	O	lower	_	0	SENT_211	[p11l8t2436r190b2492],
12	than	IN	O	than	_	0	SENT_211	[p11l217t2436r354b2492],
13	the	DT	O	the	det	15	SENT_211	[p11l382t2436r478b2492],
14	plasma	NN	O	plasma	nn	15	SENT_211	[p11l506t2436r735b2509],
15	concentration	NN	O	concentration	prep_than	11	SENT_211	[p11l763t2436r1198b2492],
16	of	IN	O	of	_	0	SENT_211	[p11l1227t2436r1297b2492],
17	the	DT	O	the	det	18	SENT_211	[p11l1320t2436r1416b2492],
18	drug	NN	O	drug	prep_of	15	SENT_211	[p11l1446t2436r1590b2509],
19	so	IN	O	so	mark	24	SENT_211	[p11l1622t2454r1687b2492],
20	that	IN	O	that	dep	24	SENT_211	[p11l1717t2436r1837b2492],
21	this	DT	O	this	det	22	SENT_211	[p11l1864t2436r1977b2492],
22	drug	NN	O	drug	nsubj	24	SENT_211	[p11l2008t2436r2152b2509],
23	would	MD	O	would	aux	24	SENT_211	[p11l8t2519r207b2575],
24	bind	VB	O	bind	advcl	11	SENT_211	[p11l231t2519r374b2575],
25	to	TO	O	to	_	0	SENT_211	[p11l399t2528r458b2575],
26	isoform	NN	O	isoform	prep_to	24	SENT_211	[p11l485t2519r734b2575],
27	with	IN	O	with	_	0	SENT_211	[p11l759t2519r900b2575],
28	a	DT	O	a	det	30	SENT_211	[p11l927t2537r960b2575],
29	higher	JJR	O	higher	amod	30	SENT_211	[p11l984t2519r1190b2592],
30	afﬁnity	NN	O	afﬁnity	prep_with	24	SENT_211	[p11l1216t2519r1444b2592],
31	to	TO	O	to	aux	40	SENT_211	[p11l1470t2527r1529b2575],
32	the	DT	O	the	det	40	SENT_211	[p11l1556t2519r1652b2575],
33	H-site	JJ	O	h-site	amod	40	SENT_211	[p11l1678t2519r1872b2575],
34	(	CD	NUMBER	(	num	40	SENT_211	[p11l1901t2520r1998b2592],
35	Ki	NN	O	kus	nn	40	SENT_211	[p11l1901t2520r1998b2592],
36	=	JJ	O	=	amod	40	SENT_211	[p11l2033t2539r2081b2558],
37	8	CD	NUMBER	8	num	40	SENT_211	[p11l2117t2520r2150b2576],
38	p.	NN	O	p.	nn	40	SENT_211	[p11l13t2604r155b2675],
39	M	NN	O	m	nn	40	SENT_211	[p11l13t2604r155b2675],
40	)	NN	O	)	xcomp	24	SENT_211	[p11l13t2604r155b2675],
41	compared	VBN	O	compare	_	0	SENT_211	[p11l187t2603r502b2676],
42	to	TO	O	to	prepc_compared_to	40	SENT_211	[p11l531t2612r590b2659],
43	the	DT	O	the	det	46	SENT_211	[p11l620t2603r716b2659],
44	G-site	JJ	O	g-site	amod	46	SENT_211	[p11l746t2603r939b2660],
45	(	CD	NUMBER	(	num	46	SENT_211	[p11l971t2604r1069b2676],
46	Ki	NN	O	kus	nn	50	SENT_211	[p11l971t2604r1069b2676],
47	=	JJ	O	=	amod	50	SENT_211	[p11l1106t2623r1154b2642],
48	38	CD	NUMBER	38	tmod	47	SENT_211	[p11l1194t2604r1267b2660],
49	pLM	NN	O	plm	nn	50	SENT_211	[p11l1304t2604r1465b2675],
50	)	NN	O	)	pobj	40	SENT_211	[p11l1304t2604r1465b2675],
51	.	.	O	.	_	0	SENT_211	[p11l1304t2604r1465b2675],

1	Considering	VBG	O	consider	_	0	SENT_212	[p11l89t2703r479b2776],
2	the	DT	O	the	det	6	SENT_212	[p11l525t2703r621b2759],
3	IC50	NN	O	ic50	nn	6	SENT_212	[p11l668t2704r809b2777],
4	or	CC	O	or	_	0	SENT_212	[p11l856t2721r921b2759],
5	Ki	NN	MISC	kus	conj_or	3	SENT_212	[p11l967t2705r1039b2776],
6	values	NNS	O	value	prep_considering	36	SENT_212	[p11l1085t2703r1287b2759],
7	relative	JJ	O	relative	advmod	6	SENT_212	[p11l1334t2703r1573b2759],
8	to	TO	O	to	_	0	SENT_212	[p11l1620t2711r1679b2759],
9	the	DT	O	the	det	12	SENT_212	[p11l1726t2703r1822b2759],
10	expected	VBN	O	expect	amod	12	SENT_212	[p11l1869t2703r2153b2776],
11	plasma	NN	O	plasma	nn	12	SENT_212	[p11l7t2787r235b2860],
12	concentration	NN	O	concentration	prep_to	7	SENT_212	[p11l260t2787r695b2844],
13	of	IN	O	of	_	0	SENT_212	[p11l722t2787r791b2843],
14	the	DT	O	the	det	15	SENT_212	[p11l811t2787r907b2843],
15	drugs	NNS	O	drug	prep_of	12	SENT_212	[p11l934t2787r1108b2860],
16	in	IN	O	in	_	0	SENT_212	[p11l1136t2787r1196b2843],
17	the	DT	O	the	det	18	SENT_212	[p11l1222t2787r1318b2843],
18	body	NN	O	body	prep_in	15	SENT_212	[p11l1343t2787r1502b2860],
19	during	IN	O	during	_	0	SENT_212	[p11l1529t2787r1736b2860],
20	therapy	NN	O	therapy	prep_during	18	SENT_212	[p11l1762t2787r2019b2860],
21	,	,	O	,	_	0	SENT_212	[p11l1762t2787r2019b2860],
22	our	PRP$	O	we	poss	23	SENT_212	[p11l2049t2805r2154b2844],
23	results	NNS	O	result	nsubj	36	SENT_212	[p11l7t2871r213b2928],
24	with	IN	O	with	_	0	SENT_212	[p11l252t2871r393b2928],
25	CDNB	NN	ORGANIZATION	cdnb	prep_with	23	SENT_212	[p11l429t2872r646b2928],
26	as	IN	O	as	_	0	SENT_212	[p11l688t2889r749b2928],
27	a	DT	O	a	det	29	SENT_212	[p11l789t2889r822b2928],
28	substrate	JJ	O	substrate	amod	29	SENT_212	[p11l859t2872r1141b2928],
29	show	NN	O	show	prep_as	25	SENT_212	[p11l1179t2872r1344b2928],
30	that	IN	O	that	_	0	SENT_212	[p11l1381t2872r1500b2928],
31	some	DT	O	some	det	32	SENT_212	[p11l1538t2889r1702b2928],
32	antimalarials	NNS	O	antimalarial	prep_that	29	SENT_212	[p11l1741t2871r2151b2928],
33	may	MD	O	may	aux	36	SENT_212	[p11l7t2973r143b3028],
34	be	VB	O	be	cop	36	SENT_212	[p11l163t2956r237b3012],
35	effective	JJ	O	effective	amod	36	SENT_212	[p11l258t2956r537b3012],
36	inhibitors	NNS	O	inhibitor	_	0	SENT_212	[p11l557t2956r862b3012],
37	of	IN	O	of	_	0	SENT_212	[p11l884t2956r954b3012],
38	GSTs	NNS	O	gst	prep_of	36	SENT_212	[p11l970t2956r1147b3012],
39	in	IN	O	in	_	0	SENT_212	[p11l1172t2958r1229b3012],
40	viva	FW	O	viva	prep_in	38	SENT_212	[p11l1250t2958r1397b3012],
41	.	.	O	.	_	0	SENT_212	[p11l1250t2958r1397b3012],

1	Quinine	NNP	O	Quinine	nsubj	25	SENT_213	[p11l1423t2956r1679b3025],
2	and	CC	O	and	_	0	SENT_213	[p11l1701t2956r1814b3012],
3	Quinidine	NNP	O	Quinidine	nsubj	25	SENT_213	[p11l1834t2956r2152b3025],
4	as	IN	O	as	_	0	SENT_213	[p11l9t3057r70b3096],
5	inhibitors	NNS	O	inhibitor	prep_as	1	SENT_213	[p11l97t3040r401b3096],
6	for	IN	O	for	_	0	SENT_213	[p11l428t3040r521b3096],
7	GSTS	NN	O	gst	nn	8	SENT_213	[p11l545t3040r723b3096],
8	M1-1	NN	O	m1-1	prep_for	5	SENT_213	[p11l749t3040r919b3095],
9	and	CC	O	and	_	0	SENT_213	[p11l952t3040r1065b3096],
10	P1-1	NN	O	p1-1	prep_for	5	SENT_213	[p11l1089t3040r1256b3107],
11	,	,	O	,	_	0	SENT_213	[p11l1089t3040r1256b3107],
12	artemisinin	NN	O	artemisinin	conj_and	5	SENT_213	[p11l1285t3040r1644b3096],
13	for	IN	O	for	_	0	SENT_213	[p11l1668t3040r1761b3096],
14	GSTs	NNS	O	gst	nn	15	SENT_213	[p11l1785t3040r1963b3096],
15	A1-1	NN	O	a1-1	prep_for	12	SENT_213	[p11l1989t3040r2146b3095],
16	and	CC	O	and	_	0	SENT_213	[p11l9t3124r122b3180],
17	Pl-1	NN	O	pl-1	prep_as	1	SENT_213	[p11l147t3124r290b3179],
18	and	CC	O	and	_	0	SENT_213	[p11l325t3124r438b3180],
19	tetracycline	NN	O	tetracycline	conj_and	5	SENT_213	[p11l463t3124r836b3197],
20	for	IN	O	for	_	0	SENT_213	[p11l862t3124r955b3180],
21	GST	NN	O	gst	nn	22	SENT_213	[p11l981t3124r1130b3180],
22	M3-3	NN	O	m3-3	prep_for	17	SENT_213	[p11l1155t3124r1328b3180],
23	may	MD	O	may	aux	25	SENT_213	[p11l1358t3142r1494b3197],
24	be	VB	O	be	cop	25	SENT_213	[p11l1519t3124r1594b3180],
25	worthy	JJ	O	worthy	_	0	SENT_213	[p11l1620t3124r1845b3197],
26	of	IN	O	of	_	0	SENT_213	[p11l1873t3124r1942b3180],
27	future	JJ	DATE	future	amod	28	SENT_213	[p11l1963t3124r2152b3180],
28	investigations	NNS	O	investigation	prep_of	25	SENT_213	[p11l7t3207r451b3280],
29	in	IN	O	in	_	0	SENT_213	[p11l474t3207r535b3263],
30	cell	NN	O	cell	nn	31	SENT_213	[p11l557t3207r671b3263],
31	lines	NNS	O	line	prep_in	28	SENT_213	[p11l693t3207r840b3263],
32	with	IN	O	with	_	0	SENT_213	[p11l864t3207r1005b3263],
33	a	DT	O	a	det	34	SENT_213	[p11l1028t3225r1061b3263],
34	view	NN	O	view	prep_with	25	SENT_213	[p11l1082t3207r1235b3264],
35	to	TO	O	to	_	0	SENT_213	[p11l1258t3216r1318b3263],
36	their	PRP$	O	they	poss	39	SENT_213	[p11l1340t3207r1487b3263],
37	possible	JJ	O	possible	amod	39	SENT_213	[p11l1507t3207r1769b3280],
38	clinical	JJ	O	clinical	amod	39	SENT_213	[p11l1792t3207r2025b3263],
39	use	NN	O	use	prep_to	25	SENT_213	[p11l2047t3225r2152b3263],
40	in	IN	O	in	_	0	SENT_213	[p11l8t3291r68b3347],
41	Chemomodulation	NNP	LOCATION	Chemomodulation	prep_in	39	SENT_213	[p11l97t3291r692b3348],
42	.	.	O	.	_	0	SENT_213	[p11l97t3291r692b3348],

1	Chemomodulation	NN	O	chemomodulation	nsubj	5	SENT_214	[p11l89t3391r685b3448],
2	during	IN	O	during	_	0	SENT_214	[p11l707t3391r913b3464],
3	chemotherapy	NN	O	chemotherapy	prep_during	1	SENT_214	[p11l936t3391r1389b3464],
4	could	MD	O	could	aux	5	SENT_214	[p11l1411t3391r1588b3447],
5	involve	VB	O	involve	_	0	SENT_214	[p11l1608t3391r1847b3447],
6	targeting	VBG	O	target	xcomp	5	SENT_214	[p11l1868t3391r2152b3464],
7	GSTs	NNS	O	gst	nsubj	8	SENT_214	[p11l9t3476r187b3532],
8	responsible	JJ	O	responsible	xcomp	6	SENT_214	[p11l215t3475r581b3548],
9	for	IN	O	for	_	0	SENT_214	[p11l609t3475r702b3531],
10	the	DT	O	the	det	11	SENT_214	[p11l728t3475r824b3531],
11	breakdown	NN	O	breakdown	prep_for	8	SENT_214	[p11l851t3475r1207b3532],
12	of	IN	O	of	_	0	SENT_214	[p11l1236t3475r1305b3531],
13	several	JJ	O	several	amod	15	SENT_214	[p11l1331t3475r1553b3532],
14	alkylating	JJ	O	alkylating	amod	15	SENT_214	[p11l1583t3475r1900b3548],
15	agents	NNS	O	agent	prep_of	11	SENT_214	[p11l1931t3484r2149b3548],
16	.	.	O	.	_	0	SENT_214	[p11l1931t3484r2149b3548],

1	Quinine	NNP	O	Quinine	nsubjpass	5	SENT_215	[p11l9t3559r265b3629],
2	has	VBZ	O	have	aux	5	SENT_215	[p11l302t3559r406b3616],
3	already	RB	O	already	advmod	5	SENT_215	[p11l446t3559r679b3632],
4	been	VBN	O	be	auxpass	5	SENT_215	[p11l716t3560r867b3616],
5	demonstrated	VBN	O	demonstrate	_	0	SENT_215	[p11l905t3560r1337b3616],
6	to	TO	O	to	aux	7	SENT_215	[p11l1373t3568r1433b3616],
7	reverse	VB	O	reverse	conj_and	7	SENT_215	[p11l1471t3577r1701b3616],
8	resistance	NN	O	resistance	dobj	7	SENT_215	[p11l1738t3559r2054b3616],
9	to	TO	O	to	_	0	SENT_215	[p11l2092t3568r2152b3616],
10	doxorubicin	NN	O	doxorubicin	prep_to	7	SENT_215	[p11l8t3644r395b3700],
11	in	IN	O	in	_	0	SENT_215	[p11l420t3644r481b3699],
12	leukaemia	NN	O	leukaemia	nn	14	SENT_215	[p11l506t3644r836b3700],
13	cell	NN	O	cell	nn	14	SENT_215	[p11l861t3644r974b3700],
14	lines45	NN	O	lines45	prep_in	10	SENT_215	[p11l1000t3644r1205b3700],
15	and	CC	O	and	_	0	SENT_215	[p11l1235t3644r1348b3700],
16	as	IN	O	as	_	0	SENT_215	[p11l1375t3661r1436b3700],
17	a	DT	O	a	det	18	SENT_215	[p11l1466t3661r1499b3700],
18	chemomodulator	NN	O	chemomodulator	prep_as	7	SENT_215	[p11l1524t3643r2068b3700],
19	in	IN	O	in	_	0	SENT_215	[p11l2092t3643r2153b3699],
20	breast	NN	O	breast	nn	22	SENT_215	[p12l6t21r198b77],
21	cancer	NN	O	cancer	nn	22	SENT_215	[p12l227t38r436b77],
22	patients	NNS	O	patient	prep_in	18	SENT_215	[p12l462t21r709b93],
23	who	WP	O	who	nsubj	24	SENT_215	[p12l740t21r875b77],
24	failed	VBD	O	fail	rcmod	18	SENT_215	[p12l905t21r1086b77],
25	to	TO	O	to	aux	26	SENT_215	[p12l1115t29r1174b77],
26	respond	VB	O	respond	xcomp	24	SENT_215	[p12l1203t21r1457b94],
27	to	TO	O	to	_	0	SENT_215	[p12l1485t29r1544b77],
28	combination	NN	O	combination	nn	29	SENT_215	[p12l1575t21r1975b77],
29	therapy	NN	O	therapy	prep_to	26	SENT_215	[p12l2003t21r2151b77, p12l9t123r121b178],
30	of	IN	O	of	_	0	SENT_215	[p12l152t105r221b161],
31	cyclophosphamide	NN	O	cyclophosphamide	prep_of	29	SENT_215	[p12l245t105r863b178],
32	,	,	O	,	_	0	SENT_215	[p12l245t105r863b178],
33	vincristine	NN	O	vincristine	prep_of	29	SENT_215	[p12l896t105r1250b171],
34	,	,	O	,	_	0	SENT_215	[p12l896t105r1250b171],
35	adriamycin	NN	O	adriamycin	prep_of	29	SENT_215	[p12l1284t105r1643b178],
36	and	CC	O	and	_	0	SENT_215	[p12l1673t105r1787b161],
37	deXamethTABLE	NN	O	dexamethtable	prep_of	29	SENT_215	[p12l1816t105r2150b161, p12l74t339r268b380],

1	IV	CD	NUMBER	iv	number	2	SENT_216	[p12l299t340r362b381],
2	—	CD	NUMBER	—	num	3	SENT_216	[p12l377t365r407b368],
3	KM	NNS	O	km	_	0	SENT_216	[p12l423t341r502b394],
4	AND	CC	O	and	_	0	SENT_216	[p12l533t340r656b381],
5	IC50	NN	O	ic50	nn	6	SENT_216	[p12l688t340r789b394],
6	VALUES	NNS	O	value	conj_and	3	SENT_216	[p12l820t340r1045b381],
7	FOR	IN	O	for	_	0	SENT_216	[p12l1077t340r1190b381],
8	ANTIMALARIALS	NNS	O	antimalarial	prep_for	3	SENT_216	[p12l1220t340r1694b381],
9	FOR	IN	O	for	_	0	SENT_216	[p12l1727t340r1840b381],
10	HUMAN	NN	O	human	prep_for	8	SENT_216	[p12l1869t340r2088b381],

1	RECOMBINANT	JJ	O	recombinant	amod	4	SENT_217	[p12l164t398r589b439],
2	GST	NN	O	gst	nn	4	SENT_217	[p12l620t398r728b439],
3	P1	NN	O	p1	nn	4	SENT_217	[p12l758t399r861b438],
4	—	NN	O	—	_	0	SENT_217	[p12l758t399r861b438],
5	1	CD	NUMBER	1	num	6	SENT_217	[p12l758t399r861b438],
6	ACTIVITY	NN	O	activity	dep	4	SENT_217	[p12l897t398r1170b439],
7	TOWARDS	IN	O	towards	dep	8	SENT_217	[p12l1201t398r1484b439],
8	CDNB	JJ	O	cdnb	amod	6	SENT_217	[p12l1518t398r1674b439],
9	AND	CC	O	and	_	0	SENT_217	[p12l1707t399r1831b439],
10	ETA1	NN	O	eta1	conj_and	6	SENT_217	[p12l1862t386r1992b438],

1	Parameter	NN	O	parameter	_	0	SENT_218	[p12l207t516r442b555],
2	CDNB	JJ	O	cdnb	amod	3	SENT_218	[p12l1144t515r1300b556],
3	ETA	NNP	O	ETA	dep	1	SENT_218	[p12l1923t515r2035b555],

1	(	NN	O	(	nn	2	SENT_219	[p12l1508t623r1701b705],
2	u	NN	O	u	_	0	SENT_219	[p12l1508t623r1701b705],
3	«	CD	NUMBER	«	num	5	SENT_219	[p12l1508t623r1701b705],
4	M	NN	O	m	nn	5	SENT_219	[p12l1508t623r1701b705],
5	)	NN	O	)	dep	2	SENT_219	[p12l1508t623r1701b705],
6	2	CD	NUMBER	2	dep	5	SENT_219	[p12l1508t623r1701b705],

1	Km	NN	O	km	_	0	SENT_220	[p12l89t712r187b781],
2	1,200	CD	NUMBER	1,200	number	3	SENT_220	[p12l1146t711r1307b774],
3	29	CD	NUMBER	29	dep	1	SENT_220	[p12l1994t711r2065b765],
4	Icso	NN	O	icso	dep	3	SENT_220	[p12l88t787r220b858],

1	Artemisinin	NN	O	artemisinin	dep	8	SENT_221	[p12l164t862r526b916],
2	2	CD	NUMBER	2	num	3	SENT_221	[p12l1273t863r1307b915],
3	>	JJR	O	>	dep	1	SENT_221	[p12l1897t868r1948b912],
4	100	CD	NUMBER	100	num	5	SENT_221	[p12l1963t863r2067b916],
5	Quinidine	NN	O	quinidine	dep	8	SENT_221	[p12l165t938r466b1005],
6	1	CD	NUMBER	1	num	8	SENT_221	[p12l1279t939r1301b991],
7	70	CD	NUMBER	70	num	8	SENT_221	[p12l1994t939r2067b992],
8	Quinine	NN	O	quinine	dep	11	SENT_221	[p12l165t1014r407b1081],
9	4	CD	NUMBER	4	num	10	SENT_221	[p12l1271t1015r1307b1067],
10	27	CD	NUMBER	27	dep	8	SENT_221	[p12l1994t1015r2065b1068],
11	Tetracycline	NN	O	tetracycline	dep	14	SENT_221	[p12l164t1090r542b1159],
12	13	CD	NUMBER	13	num	11	SENT_221	[p12l1241t1091r1304b1144],
13	18	CD	NUMBER	18	num	14	SENT_221	[p12l2000t1091r2064b1144],
14	Pyrimethamine	NN	O	pyrimethamine	dep	16	SENT_221	[p12l164t1166r626b1235],
15	1	CD	NUMBER	1	num	16	SENT_221	[p12l1279t1166r1301b1219],
16	45	CD	NUMBER	45	_	0	SENT_221	[p12l1993t1166r2064b1220],

1	1Km	NN	O	1km	nn	2	SENT_222	[p12l89t1333r211b1416],
2	values	NNS	O	value	nsubjpass	11	SENT_222	[p12l236t1346r427b1399],
3	for	IN	O	for	_	0	SENT_222	[p12l454t1346r542b1399],
4	CDNB	NN	ORGANIZATION	cdnb	prep_for	2	SENT_222	[p12l566t1346r771b1399],
5	and	CC	O	and	_	0	SENT_222	[p12l802t1346r909b1399],
6	ETA	NNP	ORGANIZATION	ETA	conj_and	2	SENT_222	[p12l933t1346r1079b1398],
7	for	IN	O	for	_	0	SENT_222	[p12l1105t1346r1192b1399],
8	GST	NN	O	gst	nn	9	SENT_222	[p12l1218t1346r1358b1399],
9	P1-1	NN	O	p1-1	prep_for	6	SENT_222	[p12l1383t1346r1518b1398],
10	were	VBD	O	be	auxpass	11	SENT_222	[p12l1551t1363r1696b1399],
11	obtained	VBN	O	obtain	_	0	SENT_222	[p12l1722t1346r1982b1399],
12	from	IN	O	from	_	0	SENT_222	[p12l2007t1346r2154b1399],
13	Johansson	NNP	PERSON	Johansson	prep_from	11	SENT_222	[p12l7t1422r318b1475],
14	et	FW	O	et	nn	15	SENT_222	[p12l351t1432r406b1475],
15	al.	FW	O	al.	nsubj	23	SENT_222	[p12l435t1409r750b1475],
16	59	CD	NUMBER	59	number	17	SENT_222	[p12l435t1409r750b1475],
17	—	CD	NUMBER	—	dep	15	SENT_222	[p12l435t1409r750b1475],
18	2The	NN	O	2the	nn	20	SENT_222	[p12l435t1409r750b1475],
19	IC50	NN	O	ic50	nn	20	SENT_222	[p12l783t1422r915b1493],
20	value	NN	O	value	dep	15	SENT_222	[p12l948t1422r1110b1475],
21	is	VBZ	O	be	cop	23	SENT_222	[p12l1143t1422r1189b1475],
22	inhibitor	NN	O	inhibitor	nn	23	SENT_222	[p12l1223t1422r1485b1475],
23	concentration	NN	O	concentration	rcmod	13	SENT_222	[p12l1516t1422r1928b1475],
24	giving	VBG	O	give	partmod	23	SENT_222	[p12l1961t1422r2151b1491],
25	50	CD	PERCENT	50	num	26	SENT_222	[p12l9t1497r141b1551],
26	%	NN	PERCENT	%	iobj	24	SENT_222	[p12l9t1497r141b1551],
27	inhibition	NN	O	inhibition	dobj	24	SENT_222	[p12l174t1497r468b1551],
28	of	IN	O	of	_	0	SENT_222	[p12l499t1497r564b1551],
29	the	DT	O	the	det	31	SENT_222	[p12l589t1498r679b1551],
30	enzyme	NN	O	enzyme	nn	31	SENT_222	[p12l710t1514r943b1567],
31	activity	NN	O	activity	prep_of	27	SENT_222	[p12l975t1497r1199b1567],
32	in	IN	O	in	_	0	SENT_222	[p12l1229t1497r1286b1550],
33	the	DT	O	the	det	36	SENT_222	[p12l1316t1498r1406b1551],
34	standard	JJ	O	standard	amod	36	SENT_222	[p12l1439t1497r1692b1551],
35	assay	NN	O	assay	nn	36	SENT_222	[p12l1723t1514r1883b1567],
36	systems	NNS	O	system	prep_in	24	SENT_222	[p12l1916t1506r2151b1567],
37	with	IN	O	with	_	0	SENT_222	[p12l8t1573r141b1626],
38	1	CD	NUMBER	1	num	39	SENT_222	[p12l177t1573r199b1625],
39	mM	NN	O	mm	prep_with	36	SENT_222	[p12l235t1574r359b1625],
40	1	CD	NUMBER	1	number	41	SENT_222	[p12l397t1572r1242b1636],
41	—	CD	NUMBER	—	num	42	SENT_222	[p12l397t1572r1242b1636],
42	ch1oro	NN	O	ch1oro	dep	13	SENT_222	[p12l397t1572r1242b1636],
43	—	CD	NUMBER	—	number	44	SENT_222	[p12l397t1572r1242b1636],
44	2,4	CD	NUMBER	2,4	num	46	SENT_222	[p12l397t1572r1242b1636],
45	—	NN	O	—	nn	46	SENT_222	[p12l397t1572r1242b1636],
46	dinitrobenzene	NN	O	dinitrobenzene	dep	13	SENT_222	[p12l397t1572r1242b1636],
47	and	CC	O	and	_	0	SENT_222	[p12l1274t1573r1380b1626],
48	ethacrynic	JJ	O	ethacrynic	amod	49	SENT_222	[p12l1410t1573r1723b1642],
49	acid	NN	O	acid	conj_and	13	SENT_222	[p12l1755t1572r1879b1626],
50	was	VBD	O	be	auxpass	51	SENT_222	[p12l1908t1589r2022b1626],
51	obtained	VBN	O	obtain	rcmod	49	SENT_222	[p12l2054t1573r2150b1626, p12l7t1648r192b1702],
52	from	IN	O	from	_	0	SENT_222	[p12l224t1648r371b1702],
53	plots	NNS	O	plot	prep_from	51	SENT_222	[p12l401t1648r546b1717],
54	of	IN	O	of	_	0	SENT_222	[p12l582t1648r647b1702],
55	percent	NN	O	percent	nn	56	SENT_222	[p12l674t1656r898b1717],
56	activity	NN	O	activity	prep_of	53	SENT_222	[p12l931t1648r1155b1717],
57	vs.	CC	O	vs.	prep	56	SENT_222	[p12l1189t1666r1261b1702],
58	log	NN	O	log	nn	60	SENT_222	[p12l1301t1648r1395b1717],
59	inhibitor	NN	O	inhibitor	nn	60	SENT_222	[p12l1429t1648r1690b1702],
60	concentration	NN	O	concentration	dep	57	SENT_222	[p12l1722t1648r2148b1702],
61	.	.	O	.	_	0	SENT_222	[p12l1722t1648r2148b1702],

1	Activities	NNS	O	activity	nsubjpass	3	SENT_223	[p12l7t1724r299b1778],
2	were	VBD	O	be	auxpass	3	SENT_223	[p12l325t1741r470b1778],
3	determined	VBN	O	determine	_	0	SENT_223	[p12l495t1724r835b1777],
4	with	IN	O	with	_	0	SENT_223	[p12l859t1724r992b1778],
5	CDNB	NN	ORGANIZATION	cdnb	prep_with	3	SENT_223	[p12l1016t1724r1220b1778],
6	in	IN	O	in	_	0	SENT_223	[p12l1248t1724r1305b1777],
7	quadruplicate	NN	O	quadruplicate	prep_in	5	SENT_223	[p12l1330t1724r1741b1793],
8	in	IN	O	in	_	0	SENT_223	[p12l1765t1724r1822b1777],
9	a	DT	O	a	det	13	SENT_223	[p12l1847t1741r1879b1777],
10	SpectraMax	NN	O	spectramax	nn	13	SENT_223	[p12l1903t1724r2151b1793, p12l7t1801r145b1853],
11	340	CD	NUMBER	340	num	13	SENT_223	[p12l182t1800r291b1854],
12	ELISA	NN	O	elisa	nn	13	SENT_223	[p12l327t1800r541b1854],
13	reader	NN	O	reader	prep_in	3	SENT_223	[p12l575t1800r765b1853],
14	equipped	VBN	O	equip	partmod	13	SENT_223	[p12l799t1800r1076b1869],
15	with	IN	O	with	_	0	SENT_223	[p12l1111t1800r1244b1853],
16	the	DT	O	the	det	18	SENT_223	[p12l1279t1800r1369b1853],
17	kinetics	NNS	O	kinetics	nn	18	SENT_223	[p12l1404t1800r1638b1853],
18	mode	NN	O	mode	prep_with	14	SENT_223	[p12l1674t1800r1841b1853],
19	and	CC	O	and	_	0	SENT_223	[p12l1878t1800r1984b1853],
20	with	IN	O	with	_	0	SENT_223	[p12l2020t1800r2153b1853],
21	ETA	NNP	ORGANIZATION	ETA	conj_and	18	SENT_223	[p12l7t1877r153b1929],
22	in	IN	O	in	_	0	SENT_223	[p12l181t1877r238b1929],
23	a	DT	O	a	det	25	SENT_223	[p12l267t1893r298b1930],
24	Shimadzu	NNP	ORGANIZATION	Shimadzu	nn	25	SENT_223	[p12l326t1877r626b1930],
25	UV	NN	O	uv	prep_in	21	SENT_223	[p12l653t1878r761b1930],
26	1601	CD	DATE	1601	num	27	SENT_223	[p12l796t1877r932b1930],
27	spectrophotometer	NN	O	spectrophotometer	dep	14	SENT_223	[p12l969t1877r1545b1946],
28	.	.	O	.	_	0	SENT_223	[p12l969t1877r1545b1946],

1	704	CD	NUMBER	704	_	0	SENT_224	[p12l480t2021r535b2047],
2	MUKANGANYAMA	NNP	O	MUKANGANYAMA	nn	4	SENT_224	[p12l1326t2027r1588b2047],
3	ET	NNP	O	ET	nn	4	SENT_224	[p12l1598t2027r1635b2047],
4	AL.	NNP	O	AL.	dep	1	SENT_224	[p12l1640t2027r1680b2047],
5	.	.	O	.	_	0	SENT_224	[p12l1640t2027r1680b2047],

1	%	NN	O	%	nn	2	SENT_225	[p12l9t3014r67b3072],
2	Activity	NN	O	activity	_	0	SENT_225	[p12l9t2733r80b2991],

1	[	NN	O	[	nn	2	SENT_226	[p13l989t48r1370b114],
2	Quinidine	NN	O	quinidine	_	0	SENT_226	[p13l989t48r1370b114],
3	]	CD	NUMBER	]	num	4	SENT_226	[p13l989t48r1370b114],
4	pM	NN	O	pm	dep	2	SENT_226	[p13l1399t48r1496b114],

1	FIGURE	NN	O	figure	_	0	SENT_227	[p13l78t227r298b280],
2	3	CD	NUMBER	3	num	4	SENT_227	[p13l328t226r363b280],
3	—	NN	O	—	nn	4	SENT_227	[p13l384t259r423b264],
4	Effects	NNS	O	effect	dep	1	SENT_227	[p13l442t226r653b280],
5	of	IN	O	of	_	0	SENT_227	[p13l687t226r752b280],
6	quinidine	NN	O	quinidine	prep_of	4	SENT_227	[p13l778t226r1062b295],
7	on	IN	O	on	_	0	SENT_227	[p13l1094t243r1167b280],
8	the	DT	O	the	det	9	SENT_227	[p13l1197t226r1287b280],
9	denitrosation	NN	O	denitrosation	prep_on	6	SENT_227	[p13l1319t226r1713b280],
10	of	IN	O	of	_	0	SENT_227	[p13l1744t226r1810b280],
11	BCNU	NN	O	bcnu	prep_of	9	SENT_227	[p13l1835t227r2044b280],
12	by	IN	O	by	prep	6	SENT_227	[p13l2074t226r2148b295],

1	GST	NN	O	gst	nn	2	SENT_228	[p13l7t304r148b357],
2	Ml	NN	O	ml	_	0	SENT_228	[p13l175t304r357b357],
3	—	CD	NUMBER	—	num	4	SENT_228	[p13l175t304r357b357],
4	l.	NN	O	l.	dep	2	SENT_228	[p13l175t304r357b357],

1	asone	NN	O	asone	nsubj	12	SENT_229	[p13l8t536r187b575],
2	(	CD	NUMBER	(	num	3	SENT_229	[p13l232t519r587b588],
3	CAVD	NN	O	cavd	dep	1	SENT_229	[p13l232t519r587b588],
4	)	CD	NUMBER	)	number	5	SENT_229	[p13l232t519r587b588],
5	.40	CD	NUMBER	.40	num	6	SENT_229	[p13l232t519r587b588],
6	Quinine	NNP	O	Quinine	dep	1	SENT_229	[p13l630t518r885b588],
7	as	IN	O	as	_	0	SENT_229	[p13l930t536r990b575],
8	a	DT	O	a	det	10	SENT_229	[p13l1036t536r1070b575],
9	nontoxic	JJ	O	nontoxic	amod	10	SENT_229	[p13l1110t518r1388b575],
10	chemomodulator	NN	O	chemomodulator	prep_as	6	SENT_229	[p13l1432t518r1976b575],
11	thus	RB	O	thus	advmod	12	SENT_229	[p13l2016t518r2147b575],
12	enhanced	VBD	O	enhance	_	0	SENT_229	[p13l7t603r308b659],
13	the	DT	O	the	det	15	SENT_229	[p13l338t603r434b659],
14	clinical	JJ	O	clinical	amod	15	SENT_229	[p13l465t603r699b659],
15	activity	NN	O	activity	dobj	12	SENT_229	[p13l730t603r967b675],
16	of	IN	O	of	_	0	SENT_229	[p13l999t603r1068b659],
17	anticancer	JJ	O	anticancer	amod	18	SENT_229	[p13l1095t603r1423b659],
18	drugs	NNS	O	drug	prep_of	15	SENT_229	[p13l1452t603r1626b676],
19	in	IN	O	in	_	0	SENT_229	[p13l1658t603r1719b658],
20	combination	NN	O	combination	nn	21	SENT_229	[p13l1750t603r2149b659],
21	therapy	NN	O	therapy	prep_in	12	SENT_229	[p13l6t687r261b760],
22	.	.	O	.	_	0	SENT_229	[p13l6t687r261b760],

1	The	DT	O	the	det	2	SENT_230	[p13l87t787r209b843],
2	mechanism	NN	O	mechanism	nsubj	14	SENT_230	[p13l246t787r612b843],
3	by	IN	O	by	_	0	SENT_230	[p13l647t787r725b859],
4	which	WDT	O	which	agent	7	SENT_230	[p13l763t787r957b843],
5	quinine	NN	O	quinine	nsubjpass	7	SENT_230	[p13l995t787r1233b860],
6	is	VBZ	O	be	auxpass	7	SENT_230	[p13l1270t787r1319b843],
7	thought	VBN	O	think	rcmod	2	SENT_230	[p13l1358t787r1603b860],
8	to	TO	O	to	aux	9	SENT_230	[p13l1639t795r1698b843],
9	reverse	VB	O	reverse	xcomp	7	SENT_230	[p13l1735t804r1966b843],
10	drug	NN	O	drug	nn	11	SENT_230	[p13l2004t787r2147b860],
11	resistance	NN	O	resistance	dobj	9	SENT_230	[p13l6t871r321b927],
12	in	IN	O	in	_	0	SENT_230	[p13l352t871r412b926],
13	MDR	NN	O	mdr	prep_in	9	SENT_230	[p13l443t872r625b926],
14	is	VBZ	O	be	_	0	SENT_230	[p13l655t871r704b927],
15	by	IN	O	by	_	0	SENT_230	[p13l736t871r814b944],
16	inhibiting	VBG	O	inhibit	prepc_by	14	SENT_230	[p13l846t871r1156b944],
17	the	DT	O	the	det	18	SENT_230	[p13l1187t871r1283b927],
18	function	NN	O	function	dobj	16	SENT_230	[p13l1315t871r1580b927],
19	of	IN	O	of	_	0	SENT_230	[p13l1612t871r1681b927],
20	the	DT	O	the	det	23	SENT_230	[p13l1706t871r1802b927],
21	P-glycop	JJ	O	p-glycop	amod	23	SENT_230	[p13l1833t871r2146b944],
22	—	NN	O	—	nn	23	SENT_230	[p13l1833t871r2146b944],
23	rotein	NN	O	rotein	prep_of	18	SENT_230	[p13l6t955r192b1011],
24	by	IN	O	by	_	0	SENT_230	[p13l231t955r310b1028],
25	serving	VBG	O	serve	prepc_by	16	SENT_230	[p13l354t955r585b1028],
26	as	IN	O	as	_	0	SENT_230	[p13l629t973r690b1011],
27	a	DT	O	a	det	29	SENT_230	[p13l734t973r767b1011],
28	competing	VBG	O	compete	amod	29	SENT_230	[p13l807t955r1143b1028],
29	substrate	NN	O	substrate	prep_as	25	SENT_230	[p13l1188t955r1468b1011],
30	or	CC	O	or	_	0	SENT_230	[p13l1510t973r1575b1011],
31	by	IN	O	by	_	0	SENT_230	[p13l1614t955r1692b1028],
32	acting	VBG	O	act	prepc_by	25	SENT_230	[p13l1736t955r1927b1028],
33	as	IN	O	as	_	0	SENT_230	[p13l1971t973r2032b1011],
34	an	DT	O	a	det	36	SENT_230	[p13l2076t973r2148b1011],
35	allosteric	JJ	O	allosteric	amod	36	SENT_230	[p13l8t1038r298b1094],
36	modulator	NN	O	modulator	prep_as	32	SENT_230	[p13l323t1038r652b1094],
37	of	IN	O	of	_	0	SENT_230	[p13l676t1038r745b1094],
38	the	DT	O	the	det	39	SENT_230	[p13l763t1038r859b1094],
39	protein	NN	O	protein	prep_of	36	SENT_230	[p13l882t1038r1257b1111],
40	.62	CD	NUMBER	.62	num	41	SENT_230	[p13l882t1038r1257b1111],
41	a63	NN	O	a63	dobj	32	SENT_230	[p13l882t1038r1257b1111],
42	The	DT	O	the	det	43	SENT_230	[p13l1283t1038r1405b1094],
43	results	NNS	O	result	nsubj	62	SENT_230	[p13l1428t1038r1635b1094],
44	obtained	VBN	O	obtain	partmod	43	SENT_230	[p13l1662t1038r1936b1094],
45	in	IN	O	in	_	0	SENT_230	[p13l1959t1038r2020b1094],
46	our	PRP$	O	we	poss	47	SENT_230	[p13l2045t1056r2150b1094],
47	study	NN	O	study	prep_in	44	SENT_230	[p13l9t1122r195b1195],
48	,	,	O	,	_	0	SENT_230	[p13l9t1122r195b1195],
49	showing	VBG	O	show	partmod	62	SENT_230	[p13l229t1122r496b1195],
50	that	IN	O	that	complm	55	SENT_230	[p13l525t1122r644b1178],
51	quinine	NN	O	quinine	nsubj	55	SENT_230	[p13l671t1122r910b1195],
52	is	VBZ	O	be	cop	55	SENT_230	[p13l938t1122r987b1179],
53	an	DT	O	a	det	55	SENT_230	[p13l1019t1140r1091b1178],
54	effective	JJ	O	effective	amod	55	SENT_230	[p13l1119t1122r1397b1179],
55	inhibitor	NN	O	inhibitor	ccomp	49	SENT_230	[p13l1426t1122r1702b1178],
56	of	IN	O	of	_	0	SENT_230	[p13l1729t1122r1798b1179],
57	GST	NN	MISC	gst	nn	58	SENT_230	[p13l1823t1123r1971b1179],
58	Pl-l	NN	MISC	pl-l	prep_of	55	SENT_230	[p13l1998t1123r2141b1178],
59	in	FW	O	in	nn	60	SENT_230	[p13l9t1209r66b1263],
60	vitro	FW	O	vitro	advmod	55	SENT_230	[p13l90t1209r257b1273],
61	,	,	O	,	_	0	SENT_230	[p13l90t1209r257b1273],
62	suggest	VBP	O	suggest	rcmod	41	SENT_230	[p13l285t1215r523b1279],
63	that	IN	O	that	complm	72	SENT_230	[p13l544t1206r664b1263],
64	inhibition	NN	O	inhibition	nsubj	72	SENT_230	[p13l686t1206r997b1263],
65	of	IN	O	of	_	0	SENT_230	[p13l1020t1206r1090b1263],
66	GST	NN	MISC	gst	nn	67	SENT_230	[p13l1109t1207r1257b1263],
67	Pl-l	NN	MISC	pl-l	prep_of	64	SENT_230	[p13l1280t1207r1422b1262],
68	in	FW	O	in	prep	67	SENT_230	[p13l1455t1209r1512b1263],
69	vivo	FW	O	vivo	pobj	68	SENT_230	[p13l1536t1209r1666b1263],
70	may	MD	O	may	aux	72	SENT_230	[p13l1691t1224r1826b1279],
71	be	VB	O	be	cop	72	SENT_230	[p13l1849t1207r1923b1263],
72	one	CD	NUMBER	one	ccomp	62	SENT_230	[p13l1947t1224r2060b1263],
73	of	IN	O	of	_	0	SENT_230	[p13l2084t1206r2153b1263],
74	the	DT	O	the	det	75	SENT_230	[p13l6t1291r102b1347],
75	mechanisms	NNS	O	mechanism	prep_of	72	SENT_230	[p13l125t1291r518b1347],
76	to	TO	O	to	aux	77	SENT_230	[p13l542t1299r602b1347],
77	explain	VB	O	explain	infmod	72	SENT_230	[p13l626t1291r860b1364],
78	the	DT	O	the	det	79	SENT_230	[p13l882t1291r978b1347],
79	effects	NNS	O	effect	dobj	77	SENT_230	[p13l1001t1291r1211b1347],
80	of	IN	O	of	_	0	SENT_230	[p13l1236t1291r1305b1347],
81	quinine	NN	O	quinine	prep_of	79	SENT_230	[p13l1322t1291r1561b1364],
82	as	IN	O	as	_	0	SENT_230	[p13l1585t1308r1646b1347],
83	a	DT	O	a	det	86	SENT_230	[p13l1672t1308r1705b1347],
84	chemomodu	NN	O	chemomodu	nn	86	SENT_230	[p13l1727t1291r2146b1347],
85	—	NN	O	—	nn	86	SENT_230	[p13l1727t1291r2146b1347],
86	lator	NN	O	lator	prep_as	77	SENT_230	[p13l7t1379r153b1435],
87	in	IN	O	in	_	0	SENT_230	[p13l180t1379r241b1434],
88	clinical	JJ	O	clinical	amod	89	SENT_230	[p13l269t1379r503b1435],
89	studies	NNS	O	study	prep_in	86	SENT_230	[p13l534t1379r769b1435],
90	.	.	O	.	_	0	SENT_230	[p13l534t1379r769b1435],

1	Studies	NNS	O	study	nsubj	3	SENT_231	[p13l803t1379r1034b1435],
2	have	VBP	O	have	aux	3	SENT_231	[p13l1064t1379r1213b1435],
3	demonstrated	VBN	O	demonstrate	ccomp	41	SENT_231	[p13l1243t1379r1674b1435],
4	that	IN	O	that	complm	6	SENT_231	[p13l1701t1379r1821b1435],
5	there	EX	O	there	expl	6	SENT_231	[p13l1848t1379r2006b1435],
6	is	VBZ	O	be	ccomp	3	SENT_231	[p13l2035t1379r2085b1435],
7	a	DT	O	a	det	8	SENT_231	[p13l2116t1397r2150b1435],
8	tendency	NN	O	tendency	nsubj	6	SENT_231	[p13l6t1467r294b1539],
9	for	IN	O	for	_	0	SENT_231	[p13l325t1467r418b1523],
10	simultaneous	JJ	O	simultaneous	amod	11	SENT_231	[p13l449t1467r866b1523],
11	expression	NN	O	expression	prep_for	8	SENT_231	[p13l899t1467r1240b1540],
12	of	IN	O	of	_	0	SENT_231	[p13l1271t1467r1340b1523],
13	P-170	NN	O	p-170	nn	16	SENT_231	[p13l1365t1467r1554b1523],
14	and	CC	O	and	_	0	SENT_231	[p13l1586t1467r1699b1523],
15	GST	NN	O	gst	nn	16	SENT_231	[p13l1730t1467r1879b1523],
16	Pl-1	NN	O	pl-1	prep_of	11	SENT_231	[p13l1908t1467r2051b1522],
17	in	IN	O	in	_	0	SENT_231	[p13l2088t1467r2149b1522],
18	some	DT	O	some	det	19	SENT_231	[p13l9t1572r173b1611],
19	cancer	NN	O	cancer	prep_in	8	SENT_231	[p13l220t1572r429b1611],
20	types	NNS	O	type	nsubj	29	SENT_231	[p13l473t1554r760b1627],
21	.6	CD	NUMBER	.6	number	22	SENT_231	[p13l473t1554r760b1627],
22	’25	CD	NUMBER	’25	num	20	SENT_231	[p13l473t1554r760b1627],
23	Since	IN	O	since	_	0	SENT_231	[p13l810t1554r984b1611],
24	resistance	NN	O	resistance	prep_since	20	SENT_231	[p13l1029t1554r1345b1611],
25	in	IN	O	in	_	0	SENT_231	[p13l1390t1554r1451b1610],
26	cancer	NN	O	cancer	nn	27	SENT_231	[p13l1497t1572r1706b1611],
27	treatment	NN	O	treatment	prep_in	24	SENT_231	[p13l1750t1563r2052b1611],
28	is	VBZ	O	be	cop	29	SENT_231	[p13l2097t1554r2147b1611],
29	multifactorial	JJ	O	multifactorial	rcmod	19	SENT_231	[p13l6t1642r459b1708],
30	,	,	O	,	_	0	SENT_231	[p13l6t1642r459b1708],
31	the	DT	O	the	det	32	SENT_231	[p13l494t1642r590b1698],
32	use	NN	O	use	nsubj	41	SENT_231	[p13l622t1660r727b1698],
33	of	IN	O	of	_	0	SENT_231	[p13l761t1642r830b1698],
34	a	DT	O	a	det	35	SENT_231	[p13l859t1660r892b1698],
35	chemomodulator	NN	O	chemomodulator	prep_of	32	SENT_231	[p13l923t1642r1467b1698],
36	with	IN	O	with	_	0	SENT_231	[p13l1498t1642r1639b1698],
37	more	JJR	O	more	mwe	38	SENT_231	[p13l1671t1660r1833b1698],
38	than	IN	O	than	quantmod	39	SENT_231	[p13l1866t1642r2002b1698],
39	one	CD	NUMBER	one	num	40	SENT_231	[p13l2036t1660r2148b1698],
40	target	NN	O	target	prep_with	35	SENT_231	[p13l6t1738r188b1803],
41	is	VBZ	O	be	_	0	SENT_231	[p13l216t1730r266b1786],
42	likely	JJ	O	likely	acomp	41	SENT_231	[p13l297t1730r477b1803],
43	to	TO	O	to	aux	44	SENT_231	[p13l506t1738r566b1786],
44	be	VB	O	be	xcomp	42	SENT_231	[p13l595t1730r669b1786],
45	of	IN	O	of	_	0	SENT_231	[p13l699t1730r768b1786],
46	great	JJ	O	great	amod	48	SENT_231	[p13l793t1738r952b1803],
47	therapeutic	JJ	O	therapeutic	amod	48	SENT_231	[p13l979t1730r1333b1803],
48	advantage	NN	O	advantage	prep_of	44	SENT_231	[p13l1365t1730r1703b1803],
49	.	.	O	.	_	0	SENT_231	[p13l1365t1730r1703b1803],

1	Glutathione	NN	O	glutathione	nn	2	SENT_232	[p13l88t1829r464b1886],
2	transferases	NNS	O	transferase	nsubjpass	5	SENT_232	[p13l500t1829r875b1886],
3	have	VBP	O	have	aux	5	SENT_232	[p13l912t1829r1062b1886],
4	been	VBN	O	be	auxpass	5	SENT_232	[p13l1096t1829r1247b1885],
5	suggested	VBN	O	suggest	_	0	SENT_232	[p13l1285t1829r1598b1902],
6	to	TO	O	to	aux	8	SENT_232	[p13l1633t1838r1692b1886],
7	be	VB	O	be	cop	8	SENT_232	[p13l1728t1829r1802b1885],
8	necessary	JJ	O	necessary	xcomp	5	SENT_232	[p13l1838t1847r2148b1902],
9	for	IN	O	for	_	0	SENT_232	[p13l7t1917r99b1973],
10	the	DT	O	the	det	11	SENT_232	[p13l126t1917r221b1973],
11	efﬂux	NN	O	efﬂux	prep_for	8	SENT_232	[p13l250t1917r435b1973],
12	of	IN	O	of	_	0	SENT_232	[p13l464t1917r533b1973],
13	anticancer	JJ	O	anticancer	amod	14	SENT_232	[p13l557t1917r885b1973],
14	drugs	NNS	O	drug	prep_of	11	SENT_232	[p13l912t1917r1086b1990],
15	from	IN	O	from	_	0	SENT_232	[p13l1116t1917r1271b1973],
16	tumour	NN	O	tumour	nn	17	SENT_232	[p13l1297t1926r1529b1973],
17	cells	NNS	O	cell	prep_from	14	SENT_232	[p13l1556t1917r1779b1973],
18	.64	CD	NUMBER	.64	num	19	SENT_232	[p13l1556t1917r1779b1973],
19	Resistance	NN	O	resistance	tmod	8	SENT_232	[p13l1807t1917r2148b1973],
20	to	TO	O	to	_	0	SENT_232	[p13l6t2014r66b2062],
21	chlorambucil	NN	O	chlorambucil	prep_to	19	SENT_232	[p13l87t2006r509b2062],
22	in	IN	O	in	_	0	SENT_232	[p13l529t2006r590b2061],
23	MCF7	NN	O	mcf7	nn	24	SENT_232	[p13l609t2006r814b2062],
24	breast	NN	O	breast	prep_in	21	SENT_232	[p13l837t2006r1028b2062],
25	carcinoma	NN	O	carcinoma	nn	26	SENT_232	[p13l1048t2006r1381b2062],
26	cells	NNS	O	cell	nsubj	27	SENT_232	[p13l1401t2006r1543b2062],
27	showed	VBD	O	show	ccomp	8	SENT_232	[p13l1568t2006r1809b2062],
28	that	IN	O	that	complm	59	SENT_232	[p13l1829t2006r1948b2062],
29	GSTs	NNS	O	gst	nsubj	59	SENT_232	[p13l1969t2006r2147b2062],
30	(	CD	NUMBER	(	num	34	SENT_232	[p13l9t2094r146b2163],
31	Al	NNP	PERSON	Al	nn	34	SENT_232	[p13l9t2094r146b2163],
32	,	,	O	,	_	0	SENT_232	[p13l9t2094r146b2163],
33	P1	NN	O	p1	conj_and	34	SENT_232	[p13l187t2094r294b2163],
34	)	NN	O	)	nsubj	37	SENT_232	[p13l187t2094r294b2163],
35	and	CC	O	and	_	0	SENT_232	[p13l335t2093r448b2150],
36	MRPI	NN	O	mrpus	conj_and	34	SENT_232	[p13l484t2094r686b2149],
37	acted	VBD	O	act	rcmod	29	SENT_232	[p13l731t2094r898b2150],
38	in	IN	O	in	_	0	SENT_232	[p13l935t2093r995b2149],
39	synergy	NN	O	synergy	prep_in	37	SENT_232	[p13l1035t2111r1284b2166],
40	to	TO	O	to	aux	41	SENT_232	[p13l1322t2102r1381b2150],
41	protect	VB	O	protect	xcomp	37	SENT_232	[p13l1419t2102r1642b2166],
42	cells	NNS	O	cell	dobj	41	SENT_232	[p13l1679t2094r1822b2150],
43	from	IN	O	from	_	0	SENT_232	[p13l1861t2093r2016b2150],
44	the	DT	O	the	det	45	SENT_232	[p13l2052t2094r2148b2150],
45	cytotoxicity	NN	O	cytotoxicity	prep_from	41	SENT_232	[p13l7t2181r388b2254],
46	of	IN	O	of	_	0	SENT_232	[p13l412t2181r481b2237],
47	chlorambucil	NN	O	chlorambucil	prep_of	45	SENT_232	[p13l500t2181r921b2238],
48	and	CC	O	and	_	0	SENT_232	[p13l946t2181r1059b2238],
49	ethacrynic	JJ	O	ethacrynic	amod	50	SENT_232	[p13l1082t2181r1412b2254],
50	acid	NN	O	acid	prep_from	41	SENT_232	[p13l1438t2181r1585b2248],
51	,	,	O	,	_	0	SENT_232	[p13l1438t2181r1585b2248],
52	respectively	RB	O	respectively	advmod	45	SENT_232	[p13l1611t2181r2147b2254],
53	.23	CD	NUMBER	.23	dep	45	SENT_232	[p13l1611t2181r2147b2254],
54	»	CD	NUMBER	»	number	55	SENT_232	[p13l1611t2181r2147b2254],
55	28	CD	NUMBER	28	num	57	SENT_232	[p13l1611t2181r2147b2254],
56	These	DT	O	these	det	57	SENT_232	[p13l6t2270r196b2326],
57	proteins	NNS	O	protein	dep	53	SENT_232	[p13l239t2270r495b2343],
58	may	MD	O	may	aux	59	SENT_232	[p13l541t2288r677b2343],
59	present	VB	DATE	present	ccomp	27	SENT_232	[p13l721t2278r953b2343],
60	the	DT	O	the	det	62	SENT_232	[p13l996t2270r1092b2326],
61	hydrophobic	JJ	O	hydrophobic	amod	62	SENT_232	[p13l1135t2270r1539b2343],
62	ligands	NNS	O	ligand	nsubj	64	SENT_232	[p13l1585t2270r1812b2343],
63	to	TO	O	to	aux	64	SENT_232	[p13l1858t2278r1918b2326],
64	efﬂux	VB	O	efﬂux	xcomp	59	SENT_232	[p13l1964t2270r2148b2326],
65	pumps	NNS	O	pump	dobj	64	SENT_232	[p13l6t2375r216b2430],
66	either	CC	O	either	dep	5	SENT_232	[p13l248t2357r430b2414],
67	conjugated	VBN	O	conjugate	conj	5	SENT_232	[p13l458t2357r808b2430],
68	to	TO	O	to	_	0	SENT_232	[p13l837t2366r896b2414],
69	GSH	NN	O	gsh	prep_to	67	SENT_232	[p13l927t2358r1084b2414],
70	or	CC	O	or	_	0	SENT_232	[p13l1115t2375r1180b2414],
71	nonconjugated	JJ	O	nonconjugated	conj_or	69	SENT_232	[p13l1207t2357r1752b2430],
72	.	.	O	.	_	0	SENT_232	[p13l1207t2357r1752b2430],

1	“	NN	O	“	_	0	SENT_233	[p13l1207t2357r1752b2430],

1	Although	IN	O	although	mark	13	SENT_234	[p13l86t2458r389b2531],
2	most	JJS	O	most	amod	3	SENT_234	[p13l430t2466r586b2514],
3	studies	NNS	O	study	nsubj	13	SENT_234	[p13l630t2458r847b2514],
4	of	IN	O	of	_	0	SENT_234	[p13l892t2458r961b2514],
5	GST	NN	MISC	gst	nn	7	SENT_234	[p13l999t2458r1148b2514],
6	Pl-l	NN	MISC	pl-l	nn	7	SENT_234	[p13l1190t2458r1333b2513],
7	activity	NN	O	activity	prep_of	3	SENT_234	[p13l1384t2458r1620b2531],
8	in	IN	O	in	_	0	SENT_234	[p13l1663t2458r1724b2513],
9	normal	JJ	O	normal	amod	12	SENT_234	[p13l1766t2458r1992b2514],
10	and	CC	O	and	_	0	SENT_234	[p13l2036t2458r2149b2514],
11	tumour	NN	O	tumour	conj_and	9	SENT_234	[p13l6t2554r238b2602],
12	samples	NNS	O	sample	prep_in	7	SENT_234	[p13l276t2545r528b2618],
13	use	VBP	O	use	advcl	23	SENT_234	[p13l566t2563r672b2602],
14	the	DT	O	the	det	17	SENT_234	[p13l708t2546r804b2602],
15	electrophilic	JJ	O	electrophilic	amod	17	SENT_234	[p13l842t2545r1240b2618],
16	substrate	NN	O	substrate	nn	17	SENT_234	[p13l1280t2546r1561b2602],
17	CDNB	NN	O	cdnb	dobj	13	SENT_234	[p13l1599t2546r1836b2612],
18	,	,	O	,	_	0	SENT_234	[p13l1599t2546r1836b2612],
19	this	DT	O	this	nsubj	23	SENT_234	[p13l1876t2545r1988b2602],
20	is	VBZ	O	be	cop	23	SENT_234	[p13l2026t2545r2076b2602],
21	a	DT	O	a	det	23	SENT_234	[p13l2116t2563r2150b2602],
22	nondrug	JJ	O	nondrug	amod	23	SENT_234	[p13l6t2633r271b2706],
23	substrate	NN	O	substrate	_	0	SENT_234	[p13l300t2633r581b2689],
24	and	CC	O	and	_	0	SENT_234	[p13l608t2633r721b2689],
25	the	DT	O	the	det	26	SENT_234	[p13l746t2633r842b2689],
26	question	NN	O	question	nsubj	27	SENT_234	[p13l868t2633r1138b2706],
27	remains	VBZ	O	remain	conj_and	23	SENT_234	[p13l1162t2633r1414b2689],
28	as	IN	O	as	_	0	SENT_234	[p13l1443t2651r1504b2689],
29	to	TO	O	to	prepc_as_to	27	SENT_234	[p13l1531t2641r1591b2689],
30	the	DT	O	the	det	31	SENT_234	[p13l1617t2633r1713b2689],
31	suitability	NN	O	suitability	pobj	27	SENT_234	[p13l1741t2633r2058b2706],
32	of	IN	O	of	_	0	SENT_234	[p13l2085t2633r2154b2689],
33	this	DT	O	this	det	34	SENT_234	[p13l6t2722r119b2778],
34	substrate	NN	O	substrate	prep_of	31	SENT_234	[p13l145t2722r426b2778],
35	for	IN	O	for	_	0	SENT_234	[p13l448t2722r541b2778],
36	extrapolation	NN	O	extrapolation	prep_for	34	SENT_234	[p13l562t2722r984b2795],
37	to	TO	O	to	_	0	SENT_234	[p13l1006t2731r1065b2778],
38	other	JJ	O	other	amod	39	SENT_234	[p13l1089t2722r1253b2778],
39	substrates	NNS	O	substrate	prep_to	27	SENT_234	[p13l1276t2722r1604b2778],
40	.	.	O	.	_	0	SENT_234	[p13l1276t2722r1604b2778],

1	Whilst	IN	O	whilst	mark	3	SENT_235	[p13l1630t2722r1844b2778],
2	artemisinin	NN	O	artemisinin	nsubj	3	SENT_235	[p13l1867t2722r2146b2778, p13l6t2809r107b2865],
3	inhibited	VBD	O	inhibit	dep	15	SENT_235	[p13l140t2809r424b2866],
4	GST	NN	O	gst	nn	5	SENT_235	[p13l457t2810r606b2866],
5	activity	NN	O	activity	dobj	3	SENT_235	[p13l640t2809r877b2882],
6	with	IN	O	with	_	0	SENT_235	[p13l911t2809r1051b2866],
7	CDNB	NN	ORGANIZATION	cdnb	prep_with	3	SENT_235	[p13l1084t2810r1300b2866],
8	as	IN	O	as	_	0	SENT_235	[p13l1339t2827r1401b2866],
9	a	DT	O	a	det	10	SENT_235	[p13l1437t2827r1470b2866],
10	substrate	NN	O	substrate	prep_as	3	SENT_235	[p13l1504t2809r1802b2876],
11	,	,	O	,	_	0	SENT_235	[p13l1504t2809r1802b2876],
12	inhibition	NN	O	inhibition	nsubjpass	15	SENT_235	[p13l1838t2809r2149b2866],
13	was	VBD	O	be	auxpass	15	SENT_235	[p13l7t2915r127b2954],
14	not	RB	O	not	neg	15	SENT_235	[p13l161t2906r263b2954],
15	observed	VBN	O	observe	_	0	SENT_235	[p13l294t2897r582b2954],
16	with	IN	O	with	_	0	SENT_235	[p13l613t2897r754b2954],
17	ETA	NNP	ORGANIZATION	ETA	prep_with	15	SENT_235	[p13l785t2898r940b2953],
18	as	IN	O	as	_	0	SENT_235	[p13l973t2915r1034b2954],
19	a	DT	O	a	det	20	SENT_235	[p13l1069t2915r1103b2954],
20	substrate	NN	O	substrate	prep_as	15	SENT_235	[p13l1136t2897r1432b2954],
21	.	.	O	.	_	0	SENT_235	[p13l1136t2897r1432b2954],

1	ETA	NNP	ORGANIZATION	ETA	nsubj	4	SENT_236	[p13l1468t2898r1623b2953],
2	is	VBZ	O	be	cop	4	SENT_236	[p13l1654t2897r1704b2954],
3	the	DT	O	the	det	4	SENT_236	[p13l1737t2897r1833b2954],
4	substrate	NN	O	substrate	_	0	SENT_236	[p13l1868t2897r2148b2954],
5	that	WDT	O	that	nsubjpass	8	SENT_236	[p13l6t2986r126b3042],
6	is	VBZ	O	be	auxpass	8	SENT_236	[p13l156t2986r205b3042],
7	conventionally	RB	O	conventionally	advmod	8	SENT_236	[p13l239t2986r713b3059],
8	used	VBN	O	use	rcmod	4	SENT_236	[p13l744t2986r891b3042],
9	to	TO	O	to	aux	10	SENT_236	[p13l921t2994r980b3042],
10	discriminate	VB	O	discriminate	xcomp	8	SENT_236	[p13l1013t2986r1407b3042],
11	GST	NN	O	gst	nn	12	SENT_236	[p13l1440t2986r1588b3042],
12	Pl-l	NN	O	pl-l	dobj	10	SENT_236	[p13l1619t2986r1762b3041],
13	from	IN	O	from	_	0	SENT_236	[p13l1800t2986r1956b3042],
14	other	JJ	O	other	amod	15	SENT_236	[p13l1987t2986r2150b3042],
15	isoforms	NNS	O	isoform	prep_from	10	SENT_236	[p13l6t3073r301b3130],
16	.	.	O	.	_	0	SENT_236	[p13l6t3073r301b3130],

1	It	PRP	O	it	nsubj	3	SENT_237	[p13l336t3075r384b3130],
2	is	VBZ	O	be	cop	3	SENT_237	[p13l413t3073r463b3130],
3	interesting	JJ	O	interesting	_	0	SENT_237	[p13l495t3073r831b3146],
4	to	TO	O	to	aux	5	SENT_237	[p13l862t3082r922b3130],
5	note	VB	O	note	xcomp	3	SENT_237	[p13l953t3082r1089b3130],
6	that	IN	O	that	complm	25	SENT_237	[p13l1119t3073r1239b3130],
7	with	IN	O	with	_	0	SENT_237	[p13l1268t3073r1409b3130],
8	ETA	NNP	ORGANIZATION	ETA	prep_with	25	SENT_237	[p13l1439t3074r1593b3129],
9	as	IN	O	as	_	0	SENT_237	[p13l1625t3091r1686b3130],
10	substrate	NN	O	substrate	prep_as	8	SENT_237	[p13l1721t3074r2019b3140],
11	,	,	O	,	_	0	SENT_237	[p13l1721t3074r2019b3140],
12	the	DT	O	the	det	14	SENT_237	[p13l2052t3074r2148b3130],
13	IC50	NN	O	ic50	nn	14	SENT_237	[p13l6t3162r147b3235],
14	values	NNS	O	value	nsubj	25	SENT_237	[p13l190t3161r392b3218],
15	for	IN	O	for	_	0	SENT_237	[p13l437t3161r529b3217],
16	all	PDT	O	all	predet	18	SENT_237	[p13l573t3161r649b3217],
17	the	DT	O	the	det	18	SENT_237	[p13l692t3161r788b3217],
18	antimalarials	NNS	O	antimalarial	prep_for	14	SENT_237	[p13l833t3161r1262b3228],
19	,	,	O	,	_	0	SENT_237	[p13l833t3161r1262b3228],
20	except	IN	O	except	_	0	SENT_237	[p13l1308t3170r1517b3234],
21	tetracycline	NN	O	tetracycline	prep_except	14	SENT_237	[p13l1559t3161r1948b3234],
22	,	,	O	,	_	0	SENT_237	[p13l1559t3161r1948b3234],
23	were	VBD	O	be	cop	25	SENT_237	[p13l1995t3179r2148b3218],
24	considerably	RB	O	considerably	advmod	25	SENT_237	[p13l7t3250r414b3323],
25	higher	JJR	O	higher	ccomp	5	SENT_237	[p13l442t3250r647b3323],
26	than	IN	O	than	_	0	SENT_237	[p13l674t3250r810b3306],
27	those	DT	O	those	prep_than	25	SENT_237	[p13l838t3250r1005b3306],
28	obtained	VBN	O	obtain	partmod	27	SENT_237	[p13l1034t3250r1308b3306],
29	with	IN	O	with	_	0	SENT_237	[p13l1335t3250r1476b3306],
30	CDNB	NN	ORGANIZATION	cdnb	prep_with	28	SENT_237	[p13l1504t3250r1720b3306],
31	as	IN	O	as	_	0	SENT_237	[p13l1754t3268r1815b3306],
32	substrate	NN	O	substrate	prep_as	28	SENT_237	[p13l1847t3250r2144b3306],
33	.	.	O	.	_	0	SENT_237	[p13l1847t3250r2144b3306],

1	In	IN	O	in	_	0	SENT_238	[p13l7t3339r71b3393],
2	this	DT	O	this	det	3	SENT_238	[p13l103t3337r215b3394],
3	respect	NN	O	respect	prep_in	8	SENT_238	[p13l248t3346r492b3410],
4	,	,	O	,	_	0	SENT_238	[p13l248t3346r492b3410],
5	it	PRP	O	it	nsubjpass	8	SENT_238	[p13l527t3337r571b3394],
6	was	VBD	O	be	auxpass	8	SENT_238	[p13l602t3355r722b3394],
7	also	RB	O	also	advmod	8	SENT_238	[p13l758t3338r883b3394],
8	noted	VBN	O	note	_	0	SENT_238	[p13l916t3338r1093b3394],
9	that	IN	O	that	complm	29	SENT_238	[p13l1124t3337r1244b3394],
10	although	IN	O	although	mark	15	SENT_238	[p13l1276t3338r1554b3410],
11	quinidine	NN	O	quinidine	nsubj	15	SENT_238	[p13l1587t3337r1887b3410],
12	was	VBD	O	be	cop	15	SENT_238	[p13l1920t3355r2041b3394],
13	an	DT	O	a	det	15	SENT_238	[p13l2076t3355r2149b3394],
14	effective	JJ	O	effective	amod	15	SENT_238	[p13l7t3425r285b3482],
15	inhibitor	NN	O	inhibitor	advcl	29	SENT_238	[p13l311t3425r587b3481],
16	of	IN	O	of	_	0	SENT_238	[p13l612t3425r681b3481],
17	GST	NN	MISC	gst	nn	18	SENT_238	[p13l702t3426r850b3482],
18	Ml-l	NN	MISC	ml-l	prep_of	15	SENT_238	[p13l875t3426r1045b3481],
19	using	VBG	O	use	partmod	18	SENT_238	[p13l1077t3425r1248b3498],
20	CDNB	NNP	O	CDNB	dobj	19	SENT_238	[p13l1276t3426r1513b3492],
21	,	,	O	,	_	0	SENT_238	[p13l1276t3426r1513b3492],
22	the	DT	O	the	det	24	SENT_238	[p13l1541t3425r1637b3481],
23	IC50	NN	O	ic50	nn	24	SENT_238	[p13l1662t3426r1803b3499],
24	value	NN	O	value	nsubj	29	SENT_238	[p13l1828t3425r2000b3482],
25	was	VBD	O	be	cop	29	SENT_238	[p13l2026t3443r2147b3482],
26	greater	JJR	O	greater	mwe	27	SENT_238	[p13l7t3522r229b3587],
27	than	IN	O	than	quantmod	28	SENT_238	[p13l257t3514r394b3570],
28	100	CD	NUMBER	100	num	29	SENT_238	[p13l431t3514r541b3570],
29	p.M	NN	O	p.m	ccomp	8	SENT_238	[p13l576t3515r693b3586],
30	when	WRB	O	when	advmod	31	SENT_238	[p13l724t3514r896b3570],
31	using	VBG	O	use	dep	29	SENT_238	[p13l925t3514r1096b3587],
32	BCNU	NNP	O	BCNU	dobj	31	SENT_238	[p13l1127t3514r1348b3570],
33	as	IN	O	as	_	0	SENT_238	[p13l1380t3532r1441b3570],
34	a	DT	O	a	det	35	SENT_238	[p13l1474t3532r1507b3570],
35	substrate	NN	O	substrate	prep_as	32	SENT_238	[p13l1539t3514r1835b3570],
36	.	.	O	.	_	0	SENT_238	[p13l1539t3514r1835b3570],

1	Extrapolation	NN	O	extrapolation	nsubj	15	SENT_239	[p13l1869t3515r2146b3587, p13l7t3601r188b3658],
2	of	IN	O	of	_	0	SENT_239	[p13l235t3601r304b3658],
3	results	NNS	O	result	prep_of	1	SENT_239	[p13l344t3602r551b3658],
4	from	IN	O	from	_	0	SENT_239	[p13l599t3601r754b3658],
5	inhibition	NN	O	inhibition	nn	6	SENT_239	[p13l799t3601r1110b3658],
6	studies	NNS	O	study	prep_from	3	SENT_239	[p13l1159t3601r1376b3658],
7	with	IN	O	with	_	0	SENT_239	[p13l1424t3601r1565b3658],
8	CDNB	NN	O	cdnb	prep_with	6	SENT_239	[p13l1612t3602r1828b3658],
9	to	TO	O	to	_	0	SENT_239	[p13l1878t3610r1938b3658],
10	other	JJ	O	other	amod	11	SENT_239	[p13l1986t3602r2150b3658],
11	substrates	NNS	O	substrate	prep_to	8	SENT_239	[p14l9t22r319b79],
12	may	MD	O	may	aux	15	SENT_239	[p14l350t40r485b95],
13	not	RB	O	not	neg	15	SENT_239	[p14l514t31r616b79],
14	be	VB	O	be	cop	15	SENT_239	[p14l641t22r716b78],
15	valid	JJ	O	valid	_	0	SENT_239	[p14l745t22r903b79],
16	as	IN	O	as	_	0	SENT_239	[p14l933t40r994b78],
17	exempliﬁed	JJ	O	exempliﬁed	prep_as	15	SENT_239	[p14l1025t22r1402b95],
18	well	RB	O	well	advmod	15	SENT_239	[p14l1430t22r1566b79],
19	here	RB	O	here	advmod	15	SENT_239	[p14l1593t22r1730b78],
20	by	IN	O	by	_	0	SENT_239	[p14l1757t22r1836b95],
21	artemisinin	NN	O	artemisinin	prep_by	15	SENT_239	[p14l1867t22r2146b78, p14l6t111r124b177],
22	,	,	O	,	_	0	SENT_239	[p14l1867t22r2146b78, p14l6t111r124b177],
23	which	WDT	O	which	nsubj	24	SENT_239	[p14l152t111r346b167],
24	inhibited	VBD	O	inhibit	rcmod	21	SENT_239	[p14l369t111r654b167],
25	CDNB	NN	O	cdnb	nn	26	SENT_239	[p14l678t111r894b167],
26	conjugation	NN	O	conjugation	dobj	24	SENT_239	[p14l923t111r1300b184],
27	but	CC	O	but	_	0	SENT_239	[p14l1322t111r1425b167],
28	not	RB	O	not	_	0	SENT_239	[p14l1448t119r1550b167],
29	ETA	NNP	O	ETA	nn	30	SENT_239	[p14l1572t111r1727b166],
30	conjugation	NN	O	conjugation	conj_negcc	26	SENT_239	[p14l1751t111r2144b184],
31	.	.	O	.	_	0	SENT_239	[p14l1751t111r2144b184],

1	The	DT	O	the	det	4	SENT_240	[p14l6t199r129b255],
2	most	RBS	O	most	advmod	3	SENT_240	[p14l170t207r325b255],
3	appropriate	JJ	O	appropriate	amod	4	SENT_240	[p14l365t199r728b272],
4	substrate	NN	O	substrate	nsubj	14	SENT_240	[p14l771t199r1051b255],
5	for	IN	O	for	_	0	SENT_240	[p14l1092t199r1185b255],
6	GSTS	NNS	O	gst	prep_for	4	SENT_240	[p14l1225t199r1403b255],
7	for	IN	O	for	_	0	SENT_240	[p14l1445t199r1538b255],
8	inhibition	NN	O	inhibition	nn	9	SENT_240	[p14l1576t199r1887b255],
9	studies	NNS	O	study	prep_for	6	SENT_240	[p14l1930t199r2147b255],
10	would	MD	O	would	aux	14	SENT_240	[p14l7t286r206b343],
11	be	VB	O	be	cop	14	SENT_240	[p14l239t286r314b343],
12	the	DT	O	the	det	14	SENT_240	[p14l349t286r445b343],
13	anticancer	JJ	O	anticancer	amod	14	SENT_240	[p14l482t286r809b343],
14	drug	NN	O	drug	_	0	SENT_240	[p14l844t286r987b359],
15	that	WDT	O	that	nsubj	18	SENT_240	[p14l1023t286r1142b343],
16	is	VBZ	O	be	cop	18	SENT_240	[p14l1176t286r1226b342],
17	a	DT	O	a	det	18	SENT_240	[p14l1264t304r1298b343],
18	substrate	NN	O	substrate	rcmod	14	SENT_240	[p14l1334t286r1614b343],
19	of	IN	O	of	_	0	SENT_240	[p14l1651t286r1720b342],
20	the	DT	O	the	det	21	SENT_240	[p14l1750t286r1845b343],
21	enzyme	NN	O	enzyme	prep_of	18	SENT_240	[p14l1881t304r2144b359],
22	.	.	O	.	_	0	SENT_240	[p14l1881t304r2144b359],

1	Most	JJS	O	most	amod	2	SENT_241	[p14l6t376r171b431],
2	investigators	NNS	O	investigator	nsubj	4	SENT_241	[p14l199t375r605b448],
3	routinely	RB	O	routinely	advmod	4	SENT_241	[p14l635t375r924b448],
4	use	VBP	O	use	_	0	SENT_241	[p14l953t393r1058b431],
5	only	RB	O	only	advmod	6	SENT_241	[p14l1088t375r1227b448],
6	CDNB	JJ	O	cdnb	dobj	4	SENT_241	[p14l1258t375r1473b431],
7	as	IN	O	as	_	0	SENT_241	[p14l1509t393r1570b431],
8	the	DT	O	the	det	9	SENT_241	[p14l1601t375r1696b431],
9	substrate	NN	O	substrate	prep_as	4	SENT_241	[p14l1728t375r2025b431],
10	.	.	O	.	_	0	SENT_241	[p14l1728t375r2025b431],

1	Further	JJ	O	further	amod	2	SENT_242	[p14l86t474r323b531],
2	work	NN	O	work	nsubjpass	4	SENT_242	[p14l353t474r517b531],
3	is	VBZ	O	be	auxpass	4	SENT_242	[p14l547t474r597b531],
4	needed	VBN	O	need	_	0	SENT_242	[p14l630t474r856b531],
5	to	TO	O	to	aux	6	SENT_242	[p14l887t483r946b531],
6	determine	VB	O	determine	xcomp	4	SENT_242	[p14l979t474r1297b531],
7	whether	IN	O	whether	complm	9	SENT_242	[p14l1329t474r1587b531],
8	antimalarials	NNS	O	antimalarial	nsubj	9	SENT_242	[p14l1619t474r2028b531],
9	inhibit	VBP	O	inhibit	ccomp	6	SENT_242	[p14l2062t474r2146b530, p14l6t563r153b619],

1	other	JJ	O	other	amod	3	SENT_243	[p14l182t563r345b619],
2	resistance-related	JJ	O	resistance-related	amod	3	SENT_243	[p14l371t563r933b619],
3	proteins	NNS	O	protein	_	0	SENT_243	[p14l960t563r1216b636],
4	like	IN	O	like	_	0	SENT_243	[p14l1247t563r1365b619],
5	glutathione	NN	O	glutathione	nn	6	SENT_243	[p14l1395t563r1753b636],
6	peroxidase	NN	O	peroxidase	prep_like	3	SENT_243	[p14l1782t563r2146b636],
7	,	,	O	,	_	0	SENT_243	[p14l1782t563r2146b636],
8	topoisomerase	NN	O	topoisomerase	prep_like	3	SENT_243	[p14l6t651r468b724],
9	II	CD	NUMBER	ii	num	8	SENT_243	[p14l498t652r549b706],
10	and	CC	O	and	_	0	SENT_243	[p14l579t651r692b707],
11	DNA	NN	O	dna	nn	13	SENT_243	[p14l721t651r893b707],
12	repair	NN	O	repair	nn	13	SENT_243	[p14l920t651r1108b724],
13	enzymes	NNS	O	enzyme	prep_like	3	SENT_243	[p14l1137t668r1431b723],
14	.	.	O	.	_	0	SENT_243	[p14l1137t668r1431b723],

1	REFERENCES	NNS	O	reference	_	0	SENT_244	[p14l983t786r1177b808],

1	Robert	NNP	PERSON	Robert	nn	3	SENT_245	[p14l149t892r343b941],
2	J.	NNP	PERSON	J.	nn	3	SENT_245	[p14l378t893r418b941],
3	Proposals	NNP	PERSON	Proposals	_	0	SENT_245	[p14l457t892r732b956],
4	for	IN	O	for	_	0	SENT_245	[p14l770t891r853b941],
5	concomitant	JJ	O	concomitant	amod	6	SENT_245	[p14l888t892r1240b941],
6	use	NN	O	use	prep_for	3	SENT_245	[p14l1274t907r1368b941],
7	of	IN	O	of	_	0	SENT_245	[p14l1405t891r1467b941],
8	several	JJ	O	several	amod	9	SENT_245	[p14l1501t892r1699b941],
9	modulators	NNS	O	modulator	prep_of	3	SENT_245	[p14l1735t892r2053b941],
10	of	IN	O	of	_	0	SENT_245	[p14l2092t891r2153b941],
11	multidrug	JJ	O	multidrug	amod	12	SENT_245	[p14l149t964r428b1029],
12	resistance	NN	O	resistance	prep_of	9	SENT_245	[p14l454t965r734b1014],
13	in	IN	O	in	_	0	SENT_245	[p14l760t965r814b1013],
14	clinics	NNS	O	clinic	prep_in	3	SENT_245	[p14l841t964r1038b1014],
15	.	.	O	.	_	0	SENT_245	[p14l841t964r1038b1014],

1	Anticancer	JJ	O	anticancer	amod	2	SENT_246	[p14l1068t964r1381b1014],
2	Res	NNP	O	Res	_	0	SENT_246	[p14l1405t966r1509b1014],
3	1994	CD	DATE	1994	dep	2	SENT_246	[p14l1543t965r2026b1023],
4	;	:	O	;	_	0	SENT_246	[p14l1543t965r2026b1023],
5	14:2371	CD	NUMBER	14:2371	number	6	SENT_246	[p14l1543t965r2026b1023],
6	—	CD	NUMBER	—	dep	2	SENT_246	[p14l1543t965r2026b1023],
7	4	CD	NUMBER	4	dep	6	SENT_246	[p14l1543t965r2026b1023],
8	.	.	O	.	_	0	SENT_246	[p14l1543t965r2026b1023],

1	Ringborg	NN	PERSON	ringborg	nn	8	SENT_247	[p14l149t1038r417b1102],
2	U	NN	PERSON	u	nn	8	SENT_247	[p14l456t1039r521b1096],
3	,	,	O	,	_	0	SENT_247	[p14l456t1039r521b1096],
4	Platz	NNP	ORGANIZATION	Platz	dep	8	SENT_247	[p14l562t1038r703b1087],
5	A.	NNP	ORGANIZATION	A.	nn	8	SENT_247	[p14l742t1038r806b1087],
6	Chemotherapy	NNP	ORGANIZATION	Chemotherapy	nn	8	SENT_247	[p14l849t1038r1267b1102],
7	resistance	NN	O	resistance	nn	8	SENT_247	[p14l1305t1038r1586b1087],
8	mechanisms	NNS	O	mechanism	_	0	SENT_247	[p14l1625t1037r1975b1087],
9	Acta	NNP	O	Acta	nn	10	SENT_247	[p14l2015t1038r2149b1087],
10	Oncol	NNP	O	Oncol	dep	8	SENT_247	[p14l151t1110r322b1161],
11	1996	CD	DATE	1996	num	10	SENT_247	[p14l354t1110r813b1169],
12	;	:	O	;	_	0	SENT_247	[p14l354t1110r813b1169],
13	S5	CD	NUMBER	s5	number	14	SENT_247	[p14l354t1110r813b1169],
14	:76	CD	NUMBER	:76	dep	8	SENT_247	[p14l354t1110r813b1169],
15	—	NN	O	—	dep	14	SENT_247	[p14l354t1110r813b1169],
16	80	CD	NUMBER	80	num	15	SENT_247	[p14l354t1110r813b1169],
17	.	.	O	.	_	0	SENT_247	[p14l354t1110r813b1169],

1	Gottesman	NNP	PERSON	Gottesman	nn	2	SENT_248	[p14l150t1184r457b1233],
2	MM	NN	O	mm	_	0	SENT_248	[p14l486t1185r627b1242],
3	,	,	O	,	_	0	SENT_248	[p14l486t1185r627b1242],
4	Pastan	NNP	PERSON	Pastan	appos	2	SENT_248	[p14l659t1185r844b1233],
5	1	CD	NUMBER	1	num	4	SENT_248	[p14l874t1185r910b1233],
6	.	.	O	.	_	0	SENT_248	[p14l874t1185r910b1233],

1	Biochemistry	NNP	O	Biochemistry	nsubj	6	SENT_249	[p14l943t1183r1326b1248],
2	of	IN	O	of	_	0	SENT_249	[p14l1357t1183r1419b1233],
3	the	DT	O	the	det	5	SENT_249	[p14l1443t1183r1528b1233],
4	multidrug	JJ	O	multidrug	amod	5	SENT_249	[p14l1559t1183r1838b1248],
5	resistance	NN	O	resistance	prep_of	1	SENT_249	[p14l1868t1183r2148b1233],
6	mediated	VBN	O	mediate	_	0	SENT_249	[p14l149t1256r410b1306],
7	by	IN	O	by	_	0	SENT_249	[p14l434t1256r504b1321],
8	multidrug	JJ	O	multidrug	amod	9	SENT_249	[p14l530t1256r809b1321],
9	transporter	NN	O	transporter	prep_by	6	SENT_249	[p14l835t1264r1157b1321],
10	.	.	O	.	_	0	SENT_249	[p14l835t1264r1157b1321],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_250	[p14l1186t1257r1308b1305],
2	Rev	NN	PERSON	rev	nn	3	SENT_250	[p14l1333t1258r1446b1306],
3	Biochem	NNP	O	Biochem	_	0	SENT_250	[p14l1471t1256r1729b1306],
4	1993	CD	DATE	1993	num	6	SENT_250	[p14l1760t1256r2149b1315, p14l148t1328r269b1378],
5	;	:	O	;	_	0	SENT_250	[p14l1760t1256r2149b1315, p14l148t1328r269b1378],
6	62:385427	CD	NUMBER	62:385427	dep	3	SENT_250	[p14l1760t1256r2149b1315, p14l148t1328r269b1378],
7	.	.	O	.	_	0	SENT_250	[p14l1760t1256r2149b1315, p14l148t1328r269b1378],

1	Williams	NNP	PERSON	Williams	nn	2	SENT_251	[p14l148t1401r408b1451],
2	JB	NNP	O	JB	_	0	SENT_251	[p14l428t1402r516b1451],
3	.	.	O	.	_	0	SENT_251	[p14l428t1402r516b1451],

1	Drug	NN	O	drug	nn	2	SENT_252	[p14l539t1402r683b1466],
2	efﬂux	NN	O	efﬂux	_	0	SENT_252	[p14l704t1401r868b1451],
3	as	IN	O	as	_	0	SENT_252	[p14l889t1417r944b1451],
4	a	DT	O	a	det	5	SENT_252	[p14l966t1417r995b1451],
5	mechanism	NN	O	mechanism	prep_as	2	SENT_252	[p14l1013t1401r1338b1451],
6	of	IN	O	of	_	0	SENT_252	[p14l1357t1401r1419b1451],
7	resistance	NN	O	resistance	prep_of	2	SENT_252	[p14l1432t1401r1727b1451],
8	.	.	O	.	_	0	SENT_252	[p14l1432t1401r1727b1451],

1	Brit	NN	O	brit	nn	4	SENT_253	[p14l1750t1401r1861b1451],
2	J	NN	O	j	nn	4	SENT_253	[p14l1878t1402r1905b1451],
3	Biomed	NNP	O	Biomed	nn	4	SENT_253	[p14l1924t1401r2149b1451],
4	Sci	NNP	O	Sci	_	0	SENT_253	[p14l151t1474r238b1525],
5	1996	CD	DATE	1996	num	4	SENT_253	[p14l271t1474r718b1533],
6	;	:	O	;	_	0	SENT_253	[p14l271t1474r718b1533],
7	53:290	CD	NUMBER	53:290	number	8	SENT_253	[p14l271t1474r718b1533],
8	—	CD	NUMBER	—	dep	4	SENT_253	[p14l271t1474r718b1533],
9	3	CD	NUMBER	3	dep	8	SENT_253	[p14l271t1474r718b1533],
10	.	.	O	.	_	0	SENT_253	[p14l271t1474r718b1533],

1	Bates	NNP	PERSON	Bates	nn	2	SENT_254	[p14l149t1548r304b1596],
2	SE	NN	O	se	_	0	SENT_254	[p14l334t1547r428b1606],
3	,	,	O	,	_	0	SENT_254	[p14l334t1547r428b1606],
4	Regis	NNP	PERSON	Regis	nn	5	SENT_254	[p14l456t1547r615b1611],
5	JI	NNP	PERSON	JI	appos	2	SENT_254	[p14l642t1548r707b1606],
6	,	,	O	,	_	0	SENT_254	[p14l642t1548r707b1606],
7	Robey	NNP	PERSON	Robey	nn	8	SENT_254	[p14l736t1547r919b1611],
8	RW	NNP	O	RW	appos	2	SENT_254	[p14l946t1548r1074b1606],
9	,	,	O	,	_	0	SENT_254	[p14l946t1548r1074b1606],
10	et	FW	O	et	nn	11	SENT_254	[p14l1102t1555r1153b1596],
11	al.	FW	O	al.	appos	2	SENT_254	[p14l1178t1547r1241b1597],
12	.	.	O	.	_	0	SENT_254	[p14l1178t1547r1241b1597],

1	Chemoresistance	NNP	O	Chemoresistance	_	0	SENT_255	[p14l1271t1547r1756b1597],
2	in	IN	O	in	_	0	SENT_255	[p14l1782t1547r1836b1596],
3	the	DT	O	the	det	4	SENT_255	[p14l1860t1547r1945b1596],
4	clinic	NN	O	clinic	prep_in	1	SENT_255	[p14l1972t1547r2143b1597],
5	:	:	O	:	_	0	SENT_255	[p14l1972t1547r2143b1597],
6	overview	NN	O	overview	dep	1	SENT_255	[p14l150t1620r412b1670],
7	1994	CD	DATE	1994	dep	6	SENT_255	[p14l446t1620r594b1671],
8	.	.	O	.	_	0	SENT_255	[p14l446t1620r594b1671],

1	Bull	NNP	O	Bull	nn	2	SENT_256	[p14l623t1620r744b1670],
2	Cancer	NNP	O	Cancer	_	0	SENT_256	[p14l771t1620r972b1670],
3	1994	CD	DATE	1994	num	2	SENT_256	[p14l1004t1620r1538b1681],
4	;	:	O	;	_	0	SENT_256	[p14l1004t1620r1538b1681],
5	9	CD	NUMBER	9	num	7	SENT_256	[p14l1004t1620r1538b1681],
6	(	NN	O	(	nn	7	SENT_256	[p14l1004t1620r1538b1681],
7	S2	NN	O	s2	dep	2	SENT_256	[p14l1004t1620r1538b1681],
8	)	CD	NUMBER	)	number	9	SENT_256	[p14l1004t1620r1538b1681],
9	:55	CD	NUMBER	:55	dep	7	SENT_256	[p14l1004t1620r1538b1681],
10	—	NN	O	—	dep	9	SENT_256	[p14l1004t1620r1538b1681],
11	61	CD	NUMBER	61	num	10	SENT_256	[p14l1004t1620r1538b1681],
12	.	.	O	.	_	0	SENT_256	[p14l1004t1620r1538b1681],

1	Sauerbrey	NNP	PERSON	Sauerbrey	nn	2	SENT_257	[p14l151t1693r436b1757],
2	A	NNP	O	A	_	0	SENT_257	[p14l469t1693r533b1752],
3	,	,	O	,	_	0	SENT_257	[p14l469t1693r533b1752],
4	Zintil	NNP	O	Zintil	nn	5	SENT_257	[p14l567t1693r724b1742],
5	F	NN	O	f	conj_and	2	SENT_257	[p14l756t1694r810b1752],
6	,	,	O	,	_	0	SENT_257	[p14l756t1694r810b1752],
7	Volm	NNP	PERSON	Volm	nn	9	SENT_257	[p14l844t1693r1006b1743],
8	M.	NNP	PERSON	M.	nn	9	SENT_257	[p14l1036t1694r1112b1743],
9	P-glycoprotein	NN	PERSON	p-glycoprotein	conj_and	2	SENT_257	[p14l1147t1693r1571b1757],
10	and	CC	O	and	_	0	SENT_257	[p14l1604t1693r1704b1742],
11	glutathione	NN	O	glutathione	nn	13	SENT_257	[p14l1736t1693r2055b1757],
12	Stransferase	NN	PERSON	stransferase	nn	13	SENT_257	[p14l2089t1693r2146b1743, p14l149t1766r456b1815],
13	p	NN	O	p	conj_and	2	SENT_257	[p14l496t1782r530b1830],
14	in	IN	O	in	_	0	SENT_257	[p14l571t1766r625b1815],
15	childhood	NN	O	childhood	nn	18	SENT_257	[p14l666t1766r950b1815],
16	acute	JJ	O	acute	amod	18	SENT_257	[p14l991t1773r1138b1815],
17	lymphoblastic	JJ	O	lymphoblastic	amod	18	SENT_257	[p14l1179t1766r1581b1830],
18	leukaemia	NN	O	leukaemia	prep_in	13	SENT_257	[p14l1622t1766r1928b1816],
19	.	.	O	.	_	0	SENT_257	[p14l1622t1766r1928b1816],

1	Brit	NN	O	brit	nn	3	SENT_258	[p14l1973t1766r2083b1815],
2	J	NN	O	j	nn	3	SENT_258	[p14l2122t1767r2148b1816],
3	Cancer	NN	O	cancer	_	0	SENT_258	[p14l150t1839r351b1889],
4	1994	CD	DATE	1994	dep	3	SENT_258	[p14l382t1839r865b1898],
5	;	:	O	;	_	0	SENT_258	[p14l382t1839r865b1898],
6	70:1144	CD	NUMBER	70:1144	number	7	SENT_258	[p14l382t1839r865b1898],
7	—	CD	NUMBER	—	dep	3	SENT_258	[p14l382t1839r865b1898],
8	9	CD	NUMBER	9	dep	7	SENT_258	[p14l382t1839r865b1898],
9	.	.	O	.	_	0	SENT_258	[p14l382t1839r865b1898],

1	Koomagi	NNP	PERSON	Koomagi	nn	2	SENT_259	[p14l150t1912r413b1977],
2	R	NNP	PERSON	R	_	0	SENT_259	[p14l431t1914r493b1972],
3	,	,	O	,	_	0	SENT_259	[p14l431t1914r493b1972],
4	Stammler	NNP	PERSON	Stammler	nn	5	SENT_259	[p14l515t1913r791b1962],
5	G	NNP	PERSON	G	appos	2	SENT_259	[p14l809t1913r872b1971],
6	,	,	O	,	_	0	SENT_259	[p14l809t1913r872b1971],
7	Manegold	NNP	ORGANIZATION	Manegold	nn	8	SENT_259	[p14l893t1913r1182b1977],
8	C	NNP	ORGANIZATION	C	appos	2	SENT_259	[p14l1200t1913r1260b1971],
9	,	,	O	,	_	0	SENT_259	[p14l1200t1913r1260b1971],
10	et	FW	O	et	nn	11	SENT_259	[p14l1282t1920r1332b1962],
11	al.	FW	O	al.	appos	2	SENT_259	[p14l1351t1912r1413b1962],
12	.	.	O	.	_	0	SENT_259	[p14l1351t1912r1413b1962],

1	Expression	NN	O	expression	_	0	SENT_260	[p14l1435t1913r1751b1977],
2	of	IN	O	of	_	0	SENT_260	[p14l1770t1912r1831b1962],
3	resistancerelated	JJ	O	resistancerelated	amod	4	SENT_260	[p14l1844t1913r2146b1962, p14l148t1986r342b2035],
4	proteins	NNS	O	protein	prep_of	1	SENT_260	[p14l372t1985r599b2050],
5	in	IN	O	in	_	0	SENT_260	[p14l632t1986r686b2034],
6	tumoral	JJ	O	tumoral	amod	9	SENT_260	[p14l717t1986r937b2035],
7	and	CC	O	and	_	0	SENT_260	[p14l970t1985r1070b2035],
8	peritumoral	JJ	O	peritumoral	amod	9	SENT_260	[p14l1100t1986r1432b2050],
9	tissues	NNS	O	tissue	prep_in	1	SENT_260	[p14l1463t1986r1650b2035],
10	of	IN	O	of	_	0	SENT_260	[p14l1684t1985r1745b2035],
11	patients	NNS	O	patient	prep_of	1	SENT_260	[p14l1770t1986r1990b2050],
12	with	IN	O	with	_	0	SENT_260	[p14l2023t1986r2149b2035],
13	lung	NN	O	lung	nn	14	SENT_260	[p14l149t2058r274b2123],
14	cancer	NN	O	cancer	prep_with	11	SENT_260	[p14l301t2074r499b2108],
15	.	.	O	.	_	0	SENT_260	[p14l301t2074r499b2108],

1	Cancer	NNP	O	Cancer	nn	2	SENT_261	[p14l529t2059r730b2108],
2	Lett	NNP	O	Lett	_	0	SENT_261	[p14l754t2060r868b2108],
3	1996	CD	DATE	1996	num	2	SENT_261	[p14l900t2058r1418b2117],
4	;	:	O	;	_	0	SENT_261	[p14l900t2058r1418b2117],
5	110:129	CD	NUMBER	110:129	number	6	SENT_261	[p14l900t2058r1418b2117],
6	—	CD	NUMBER	—	dep	2	SENT_261	[p14l900t2058r1418b2117],
7	36	CD	NUMBER	36	dep	6	SENT_261	[p14l900t2058r1418b2117],
8	.	.	O	.	_	0	SENT_261	[p14l900t2058r1418b2117],

1	Volm	NNP	O	Volm	nn	3	SENT_262	[p14l149t2131r311b2181],
2	M.	NNP	O	M.	nn	3	SENT_262	[p14l333t2132r408b2181],
3	Multidrug	NNP	O	Multidrug	_	0	SENT_262	[p14l435t2131r722b2196],
4	resistance	NN	O	resistance	dep	3	SENT_262	[p14l744t2131r1025b2181],
5	and	CC	O	and	_	0	SENT_262	[p14l1050t2131r1150b2181],
6	its	PRP$	O	its	poss	7	SENT_262	[p14l1172t2131r1236b2181],
7	reversal	NN	O	reversal	dep	3	SENT_262	[p14l1259t2131r1499b2181],
8	.	.	O	.	_	0	SENT_262	[p14l1259t2131r1499b2181],

1	Anticancer	JJ	O	anticancer	amod	2	SENT_263	[p14l1525t2131r1838b2181],
2	Res	NNP	O	Res	_	0	SENT_263	[p14l1859t2132r1963b2181],
3	1998	CD	DATE	1998	dep	2	SENT_263	[p14l1994t2132r2146b2190],
4	;	:	O	;	_	0	SENT_263	[p14l1994t2132r2146b2190],
5	18:2905	CD	NUMBER	18:2905	number	6	SENT_263	[p14l156t2203r503b2253],
6	—	CD	NUMBER	—	dep	2	SENT_263	[p14l156t2203r503b2253],
7	18	CD	NUMBER	18	dep	6	SENT_263	[p14l156t2203r503b2253],
8	.	.	O	.	_	0	SENT_263	[p14l156t2203r503b2253],

1	Stammler	NNP	PERSON	Stammler	nn	2	SENT_264	[p14l151t2276r426b2326],
2	G	NNP	PERSON	G	_	0	SENT_264	[p14l449t2276r513b2335],
3	,	,	O	,	_	0	SENT_264	[p14l449t2276r513b2335],
4	Koomagi	NNP	PERSON	Koomagi	nn	5	SENT_264	[p14l539t2276r801b2340],
5	R	NNP	PERSON	R	appos	2	SENT_264	[p14l824t2277r885b2335],
6	,	,	O	,	_	0	SENT_264	[p14l824t2277r885b2335],
7	Mattem	NNP	O	Mattem	nn	8	SENT_264	[p14l910t2277r1135b2325],
8	J	NNP	O	J	appos	2	SENT_264	[p14l1157t2277r1183b2326],
9	,	,	O	,	_	0	SENT_264	[p14l1188t2317r1198b2335],
10	et	FW	O	et	nn	11	SENT_264	[p14l1224t2283r1274b2325],
11	al.	FW	O	al.	appos	2	SENT_264	[p14l1297t2276r1360b2325],
12	.	.	O	.	_	0	SENT_264	[p14l1297t2276r1360b2325],

1	Comparison	NN	O	comparison	nsubj	8	SENT_265	[p14l1386t2276r1733b2340],
2	of	IN	O	of	_	0	SENT_265	[p14l1757t2276r1818b2325],
3	the	DT	O	the	det	5	SENT_265	[p14l1836t2276r1921b2325],
4	mRNA	NN	O	mrna	nn	5	SENT_265	[p14l1944t2276r2149b2326],
5	expression	NN	O	expression	prep_of	1	SENT_265	[p14l150t2349r453b2413],
6	of	IN	O	of	_	0	SENT_265	[p14l482t2349r543b2398],
7	factors	NNS	O	factor	prep_of	5	SENT_265	[p14l566t2349r757b2398],
8	related	VBN	O	relate	_	0	SENT_265	[p14l785t2349r979b2398],
9	to	TO	O	to	_	0	SENT_265	[p14l1007t2356r1060b2398],
10	drug	NN	O	drug	nn	11	SENT_265	[p14l1089t2349r1216b2413],
11	resistance	NN	O	resistance	prep_to	8	SENT_265	[p14l1244t2349r1524b2398],
12	in	IN	O	in	_	0	SENT_265	[p14l1553t2349r1606b2398],
13	lung	NN	O	lung	nn	14	SENT_265	[p14l1634t2349r1759b2413],
14	tumours	NNS	O	tumour	prep_in	11	SENT_265	[p14l1787t2356r2018b2398],
15	and	CC	O	and	_	0	SENT_265	[p14l2049t2349r2149b2398],
16	adjacent	JJ	O	adjacent	amod	18	SENT_265	[p14l151t2423r387b2487],
17	normal	JJ	O	normal	amod	18	SENT_265	[p14l411t2423r612b2472],
18	tissue	NN	O	tissue	prep_in	11	SENT_265	[p14l637t2423r812b2472],
19	.	.	O	.	_	0	SENT_265	[p14l637t2423r812b2472],

1	Int	NN	O	int	nn	3	SENT_266	[p14l842t2424r920b2472],
2	J	NN	O	j	nn	3	SENT_266	[p14l945t2424r971b2472],
3	Oncol	NN	O	oncol	_	0	SENT_266	[p14l998t2423r1169b2472],
4	1996	CD	DATE	1996	dep	3	SENT_266	[p14l1202t2422r1648b2481],
5	;	:	O	;	_	0	SENT_266	[p14l1202t2422r1648b2481],
6	8:537	CD	NUMBER	8:537	number	7	SENT_266	[p14l1202t2422r1648b2481],
7	—	CD	NUMBER	—	dep	3	SENT_266	[p14l1202t2422r1648b2481],
8	42	CD	NUMBER	42	dep	7	SENT_266	[p14l1202t2422r1648b2481],
9	.	.	O	.	_	0	SENT_266	[p14l1202t2422r1648b2481],

1	Draper	NNP	PERSON	Draper	nn	2	SENT_267	[p14l149t2497r347b2560],
2	MP	NNP	O	MP	_	0	SENT_267	[p14l366t2497r483b2554],
3	,	,	O	,	_	0	SENT_267	[p14l366t2497r483b2554],
4	Martell	NNP	ORGANIZATION	Martell	nn	5	SENT_267	[p14l505t2495r715b2545],
5	RL	NNP	ORGANIZATION	RL	appos	2	SENT_267	[p14l735t2497r840b2554],
6	,	,	O	,	_	0	SENT_267	[p14l735t2497r840b2554],
7	Levy	NNP	ORGANIZATION	Levy	nn	8	SENT_267	[p14l863t2497r1008b2560],
8	SB	NN	ORGANIZATION	sb	appos	5	SENT_267	[p14l1031t2496r1129b2545],
9	.	.	O	.	_	0	SENT_267	[p14l1031t2496r1129b2545],

1	Indomethacin	NN	LOCATION	indomethacin	nsubj	2	SENT_268	[p14l1153t2495r1544b2545],
2	mediated	VBD	O	mediate	_	0	SENT_268	[p14l1564t2495r1826b2545],
3	reversal	NN	O	reversal	dobj	2	SENT_268	[p14l1844t2495r2070b2545],
4	of	IN	O	of	_	0	SENT_268	[p14l2092t2495r2153b2545],
5	multidrug	JJ	O	multidrug	amod	6	SENT_268	[p14l149t2568r428b2633],
6	resistance	NN	O	resistance	prep_of	3	SENT_268	[p14l469t2568r749b2618],
7	and	CC	O	and	_	0	SENT_268	[p14l791t2568r892b2618],
8	drug	NN	O	drug	nn	9	SENT_268	[p14l932t2568r1060b2633],
9	efﬂux	NN	O	efﬂux	prep_of	3	SENT_268	[p14l1101t2568r1266b2618],
10	in	IN	O	in	_	0	SENT_268	[p14l1305t2568r1360b2617],
11	human	JJ	O	human	amod	14	SENT_268	[p14l1399t2568r1593b2618],
12	and	CC	O	and	_	0	SENT_268	[p14l1634t2568r1735b2618],
13	murine	JJ	O	murine	conj_and	11	SENT_268	[p14l1774t2568r1974b2618],
14	lines	NNS	O	line	prep_in	2	SENT_268	[p14l2015t2568r2147b2618],
15	expressing	VBG	O	express	partmod	14	SENT_268	[p14l150t2641r452b2706],
16	MRP	NN	ORGANIZATION	mrp	dobj	15	SENT_268	[p14l537t2642r687b2690],
17	but	CC	O	but	_	0	SENT_268	[p14l770t2641r861b2691],
18	not	RB	O	not	_	0	SENT_268	[p14l945t2649r1035b2691],
19	P	NN	O	p	nn	21	SENT_268	[p14l1118t2641r1556b2706],
20	—	CD	NUMBER	—	num	21	SENT_268	[p14l1118t2641r1556b2706],
21	glycoprotein	NN	O	glycoprotein	dobj	15	SENT_268	[p14l1118t2641r1556b2706],
22	.	.	O	.	_	0	SENT_268	[p14l1118t2641r1556b2706],

1	Brit	NN	O	brit	nn	3	SENT_269	[p14l1644t2641r1754b2691],
2	J	NN	O	j	nn	3	SENT_269	[p14l1837t2642r1864b2691],
3	Cancer	NN	O	cancer	_	0	SENT_269	[p14l1949t2641r2150b2691],
4	1997	CD	DATE	1997	dep	3	SENT_269	[p14l156t2714r603b2773],
5	;	:	O	;	_	0	SENT_269	[p14l156t2714r603b2773],
6	75:810	CD	NUMBER	75:810	number	7	SENT_269	[p14l156t2714r603b2773],
7	—	CD	NUMBER	—	dep	3	SENT_269	[p14l156t2714r603b2773],
8	5	CD	NUMBER	5	dep	7	SENT_269	[p14l156t2714r603b2773],
9	.	.	O	.	_	0	SENT_269	[p14l156t2714r603b2773],

1	Zaman	NNP	PERSON	Zaman	nn	2	SENT_270	[p14l148t2788r346b2836],
2	GJR	NNP	O	GJR	_	0	SENT_270	[p14l366t2787r505b2846],
3	,	,	O	,	_	0	SENT_270	[p14l366t2787r505b2846],
4	Lankema	NNP	PERSON	Lankema	nn	5	SENT_270	[p14l527t2787r792b2836],
5	J	NNP	PERSON	J	appos	2	SENT_270	[p14l810t2788r836b2837],
6	,	,	O	,	_	0	SENT_270	[p14l841t2828r851b2846],
7	van	NNP	PERSON	van	nn	9	SENT_270	[p14l873t2803r974b2836],
8	Tellingen	NNP	PERSON	Tellingen	nn	9	SENT_270	[p14l993t2787r1266b2851],
9	O	NNP	O	O	appos	2	SENT_270	[p14l1286t2787r1349b2845],
10	,	,	O	,	_	0	SENT_270	[p14l1286t2787r1349b2845],
11	et	FW	O	et	nn	12	SENT_270	[p14l1372t2794r1422b2836],
12	al.	FW	O	al.	appos	2	SENT_270	[p14l1441t2787r1504b2836],
13	.	.	O	.	_	0	SENT_270	[p14l1441t2787r1504b2836],

1	Role	NN	O	role	_	0	SENT_271	[p14l1527t2787r1659b2836],
2	of	IN	O	of	_	0	SENT_271	[p14l1680t2787r1741b2836],
3	glutathione	NN	O	glutathione	prep_of	1	SENT_271	[p14l1756t2787r2075b2851],
4	in	IN	O	in	_	0	SENT_271	[p14l2095t2787r2149b2836],
5	the	DT	O	the	det	6	SENT_271	[p14l149t2860r234b2909],
6	export	NN	O	export	prep_in	3	SENT_271	[p14l276t2867r457b2924],
7	of	IN	O	of	_	0	SENT_271	[p14l499t2860r560b2909],
8	compounds	NNS	O	compound	prep_of	6	SENT_271	[p14l597t2860r922b2924],
9	from	IN	O	from	_	0	SENT_271	[p14l965t2860r1103b2909],
10	cells	NNS	O	cell	prep_from	8	SENT_271	[p14l1144t2860r1271b2909],
11	by	IN	O	by	_	0	SENT_271	[p14l1312t2860r1382b2924],
12	the	DT	O	the	det	19	SENT_271	[p14l1424t2860r1509b2909],
13	multidrug-associated	JJ	O	multidrug-associated	amod	19	SENT_271	[p14l1551t2860r2149b2924],
14	protein	NN	O	protein	nn	19	SENT_271	[p14l148t2933r350b2998],
15	Proc	NNP	ORGANIZATION	Proc	nn	19	SENT_271	[p14l375t2935r503b2983],
16	Natl	NNP	ORGANIZATION	Natl	nn	19	SENT_271	[p14l530t2934r651b2983],
17	Acad	NNP	ORGANIZATION	Acad	nn	19	SENT_271	[p14l677t2934r826b2983],
18	Sci	NNP	ORGANIZATION	Sci	nn	19	SENT_271	[p14l854t2934r941b2983],
19	USA	NNP	ORGANIZATION	USA	prep_by	10	SENT_271	[p14l966t2934r1108b2983],
20	1995	CD	DATE	1995	num	19	SENT_271	[p14l1140t2933r1631b2992],
21	;	:	O	;	_	0	SENT_271	[p14l1140t2933r1631b2992],
22	92:7690	CD	NUMBER	92:7690	number	23	SENT_271	[p14l1140t2933r1631b2992],
23	—	CD	NUMBER	—	dep	1	SENT_271	[p14l1140t2933r1631b2992],
24	4	CD	NUMBER	4	dep	23	SENT_271	[p14l1140t2933r1631b2992],
25	.	.	O	.	_	0	SENT_271	[p14l1140t2933r1631b2992],

1	Dolan	NNP	PERSON	Dolan	nn	2	SENT_272	[p14l149t3005r322b3056],
2	ME	NNP	O	ME	_	0	SENT_272	[p14l347t3007r467b3065],
3	,	,	O	,	_	0	SENT_272	[p14l347t3007r467b3065],
4	Roy	NNP	PERSON	Roy	nn	5	SENT_272	[p14l495t3007r612b3071],
5	SK	NNP	PERSON	SK	appos	2	SENT_272	[p14l639t3006r742b3065],
6	,	,	O	,	_	0	SENT_272	[p14l639t3006r742b3065],
7	Garbiras	NNP	ORGANIZATION	Garbiras	nn	8	SENT_272	[p14l770t3005r1012b3056],
8	BJ	NNP	ORGANIZATION	BJ	appos	2	SENT_272	[p14l1038t3007r1127b3065],
9	,	,	O	,	_	0	SENT_272	[p14l1038t3007r1127b3065],
10	et	FW	O	et	nn	11	SENT_272	[p14l1155t3013r1206b3056],
11	al.	FW	O	al.	appos	2	SENT_272	[p14l1231t3005r1293b3056],
12	.	.	O	.	_	0	SENT_272	[p14l1231t3005r1293b3056],

1	O6	NN	O	o6	_	0	SENT_273	[p14l1323t3005r1979b3101],
2	.	.	O	.	_	0	SENT_273	[p14l1323t3005r1979b3101],

1	—	NN	O	—	_	0	SENT_274	[p14l1323t3005r1979b3101],
2	.	.	O	.	_	0	SENT_274	[p14l1323t3005r1979b3101],

1	alkyl6guanine	NN	O	alkyl6guanine	_	0	SENT_275	[p14l1323t3005r1979b3101],
2	.	.	O	.	_	0	SENT_275	[p14l1323t3005r1979b3101],

1	—	NN	O	—	_	0	SENT_276	[p14l1323t3005r1979b3101],
2	.	.	O	.	_	0	SENT_276	[p14l1323t3005r1979b3101],

1	DNA	NN	O	dna	nn	3	SENT_277	[p14l1323t3005r1979b3101],
2	alkyltransferase	NN	O	alkyltransferase	nn	3	SENT_277	[p14l2005t3005r2147b3071, p14l149t3079r477b3130],
3	inactivation	NN	O	inactivation	_	0	SENT_277	[p14l508t3079r843b3130],
4	by	IN	O	by	_	0	SENT_277	[p14l873t3079r943b3144],
5	ester	NN	O	ester	nn	6	SENT_277	[p14l975t3087r1109b3130],
6	prodrugs	NNS	O	prodrug	prep_by	3	SENT_277	[p14l1138t3079r1389b3145],
7	of	IN	O	of	_	0	SENT_277	[p14l1423t3079r1484b3130],
8	O	NN	O	o	nn	11	SENT_277	[p14l1512t3080r1559b3130],
9	—	CD	NUMBER	—	num	11	SENT_277	[p14l1591t3079r2028b3145],
10	benzylguanine	NN	O	benzylguanine	nn	11	SENT_277	[p14l1591t3079r2028b3145],
11	derivatives	NNS	O	derivative	prep_of	6	SENT_277	[p14l2060t3079r2146b3130, p14l148t3153r392b3203],
12	and	CC	O	and	_	0	SENT_277	[p14l423t3153r524b3202],
13	their	PRP$	O	they	poss	14	SENT_277	[p14l552t3153r682b3202],
14	rate	NN	O	rate	prep_by	3	SENT_277	[p14l709t3161r814b3202],
15	of	IN	O	of	_	0	SENT_277	[p14l844t3153r906b3202],
16	hydrolysis	NN	O	hydrolysis	prep_of	14	SENT_277	[p14l929t3153r1224b3217],
17	by	IN	O	by	_	0	SENT_277	[p14l1253t3153r1323b3217],
18	cellular	JJ	O	cellular	amod	19	SENT_277	[p14l1353t3153r1567b3202],
19	esterases	NNS	O	esterase	prep_by	3	SENT_277	[p14l1594t3160r1860b3203],
20	.	.	O	.	_	0	SENT_277	[p14l1594t3160r1860b3203],

1	Biochem	NNP	O	Biochem	nn	2	SENT_278	[p14l1892t3153r2149b3202],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_278	[p14l149t3226r453b3276],
3	1998	CD	DATE	1998	num	2	SENT_278	[p14l485t3226r959b3285],
4	;	:	O	;	_	0	SENT_278	[p14l485t3226r959b3285],
5	55:1701	CD	NUMBER	55:1701	number	6	SENT_278	[p14l485t3226r959b3285],
6	—	CD	NUMBER	—	dep	2	SENT_278	[p14l485t3226r959b3285],
7	9	CD	NUMBER	9	dep	6	SENT_278	[p14l485t3226r959b3285],
8	.	.	O	.	_	0	SENT_278	[p14l485t3226r959b3285],

1	Chen	NNP	PERSON	Chen	nn	2	SENT_279	[p14l150t3299r298b3349],
2	G	NNP	PERSON	G	_	0	SENT_279	[p14l331t3299r395b3357],
3	,	,	O	,	_	0	SENT_279	[p14l331t3299r395b3357],
4	Waxman	NNP	PERSON	Waxman	nn	5	SENT_279	[p14l429t3300r686b3348],
5	DJ	NNP	O	DJ	appos	2	SENT_279	[p14l717t3300r809b3349],
6	.	.	O	.	_	0	SENT_279	[p14l717t3300r809b3349],

1	Role	NN	O	role	nsubj	7	SENT_280	[p14l845t3299r977b3348],
2	of	IN	O	of	_	0	SENT_280	[p14l1010t3299r1072b3348],
3	cellular	JJ	O	cellular	amod	4	SENT_280	[p14l1100t3299r1313b3348],
4	glutathione	NN	O	glutathione	prep_of	1	SENT_280	[p14l1345t3299r1663b3363],
5	and	CC	O	and	_	0	SENT_280	[p14l1696t3299r1797b3348],
6	glutathione	NN	O	glutathione	prep_of	1	SENT_280	[p14l1829t3299r2148b3363],
7	S	NN	O	s	_	0	SENT_280	[p14l151t3372r520b3422],
8	—	CD	NUMBER	—	num	9	SENT_280	[p14l151t3372r520b3422],
9	transferase	NN	O	transferase	dobj	7	SENT_280	[p14l151t3372r520b3422],
10	in	IN	O	in	_	0	SENT_280	[p14l557t3373r612b3421],
11	the	DT	O	the	det	12	SENT_280	[p14l648t3373r733b3422],
12	expression	NN	O	expression	prep_in	9	SENT_280	[p14l771t3373r1075b3437],
13	of	IN	O	of	_	0	SENT_280	[p14l1113t3372r1174b3422],
14	alkylating	VBG	O	alkylate	prepc_of	12	SENT_280	[p14l1208t3372r1490b3437],
15	agent	NN	O	agent	nn	16	SENT_280	[p14l1529t3380r1682b3437],
16	cytotoxicity	NN	O	cytotoxicity	dobj	14	SENT_280	[p14l1719t3373r2057b3437],
17	in	IN	O	in	_	0	SENT_280	[p14l2094t3373r2148b3421],
18	human	JJ	O	human	amod	20	SENT_280	[p14l149t3445r342b3496],
19	cancer	NN	O	cancer	nn	20	SENT_280	[p14l368t3461r553b3496],
20	cells	NNS	O	cell	prep_in	14	SENT_280	[p14l578t3445r721b3496],
21	.	.	O	.	_	0	SENT_280	[p14l578t3445r721b3496],

1	Biochem	NNP	O	Biochem	nn	2	SENT_281	[p14l750t3445r1007b3496],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_281	[p14l1032t3445r1335b3496],
3	1994	CD	DATE	1994	num	2	SENT_281	[p14l1368t3446r1895b3503],
4	;	:	O	;	_	0	SENT_281	[p14l1368t3446r1895b3503],
5	47:1079	CD	NUMBER	47:1079	number	6	SENT_281	[p14l1368t3446r1895b3503],
6	—	CD	NUMBER	—	dep	2	SENT_281	[p14l1368t3446r1895b3503],
7	87	CD	NUMBER	87	dep	6	SENT_281	[p14l1368t3446r1895b3503],
8	.	.	O	.	_	0	SENT_281	[p14l1368t3446r1895b3503],

1	Mannervik	NN	O	mannervik	nn	2	SENT_282	[p14l149t3519r462b3569],
2	B	NN	O	b	_	0	SENT_282	[p14l483t3520r544b3578],
3	,	,	O	,	_	0	SENT_282	[p14l483t3520r544b3578],
4	Awasthi	NNP	PERSON	Awasthi	nn	5	SENT_282	[p14l568t3519r804b3569],
5	YC	NNP	O	YC	appos	2	SENT_282	[p14l827t3519r939b3577],
6	,	,	O	,	_	0	SENT_282	[p14l827t3519r939b3577],
7	Board	NNP	ORGANIZATION	Board	nn	8	SENT_282	[p14l964t3519r1138b3569],
8	PG	NNP	ORGANIZATION	PG	appos	2	SENT_282	[p14l1159t3519r1264b3578],
9	,	,	O	,	_	0	SENT_282	[p14l1159t3519r1264b3578],
10	et	FW	O	et	nn	11	SENT_282	[p14l1289t3526r1339b3569],
11	al.	FW	O	al.	appos	2	SENT_282	[p14l1362t3519r1424b3569],
12	.	.	O	.	_	0	SENT_282	[p14l1362t3519r1424b3569],

1	Nomenclature	NNP	O	Nomenclature	_	0	SENT_283	[p14l1450t3519r1852b3569],
2	of	IN	O	of	_	0	SENT_283	[p14l1876t3518r1938b3569],
3	human	JJ	O	human	amod	5	SENT_283	[p14l1954t3519r2148b3569],
4	glutathione	NN	O	glutathione	nn	5	SENT_283	[p14l150t3591r468b3656],
5	transferases	NNS	O	transferase	prep_of	1	SENT_283	[p14l494t3591r844b3641],
6	.	.	O	.	_	0	SENT_283	[p14l494t3591r844b3641],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	2	SENT_284	[p14l873t3592r1130b3641],
2	J	NNP	O	J	_	0	SENT_284	[p14l1154t3593r1180b3641],
3	1992	CD	DATE	1992	num	2	SENT_284	[p14l1213t3591r1695b3650],
4	;	:	O	;	_	0	SENT_284	[p14l1213t3591r1695b3650],
5	282:305	CD	NUMBER	282:305	number	6	SENT_284	[p14l1213t3591r1695b3650],
6	—	CD	NUMBER	—	dep	2	SENT_284	[p14l1213t3591r1695b3650],
7	6	CD	NUMBER	6	dep	6	SENT_284	[p14l1213t3591r1695b3650],
8	.	.	O	.	_	0	SENT_284	[p14l1213t3591r1695b3650],

1	Hayes	NNP	PERSON	Hayes	nn	2	SENT_285	[p14l149t3666r324b3729],
2	JD	NNP	O	JD	_	0	SENT_285	[p14l365t3666r458b3723],
3	,	,	O	,	_	0	SENT_285	[p14l365t3666r458b3723],
4	Pulford	NNP	PERSON	Pulford	nn	5	SENT_285	[p14l501t3664r714b3714],
5	DJ	NNP	O	DJ	appos	2	SENT_285	[p14l753t3666r845b3714],
6	.	.	O	.	_	0	SENT_285	[p14l753t3666r845b3714],

1	The	DT	O	the	det	2	SENT_286	[p14l889t3665r997b3714],
2	glutathione	NN	O	glutathione	nsubj	3	SENT_286	[p14l1039t3665r1357b3729],
3	S	NN	O	s	_	0	SENT_286	[p14l1399t3664r1794b3714],
4	—	CD	NUMBER	—	num	5	SENT_286	[p14l1399t3664r1794b3714],
5	transferases	NNS	O	transferase	dobj	3	SENT_286	[p14l1399t3664r1794b3714],
6	super	JJ	O	super	amod	9	SENT_286	[p14l1839t3680r2147b3729],
7	—	NN	O	—	nn	9	SENT_286	[p14l1839t3680r2147b3729],
8	gene	NN	O	gene	nn	9	SENT_286	[p14l1839t3680r2147b3729],
9	family	NN	O	family	dep	5	SENT_286	[p14l149t3737r349b3802],
10	:	:	O	:	_	0	SENT_286	[p14l149t3737r349b3802],
11	regulation	NN	O	regulation	dep	5	SENT_286	[p14l378t3737r667b3802],
12	of	IN	O	of	_	0	SENT_286	[p14l693t3737r754b3787],
13	GST	NN	O	gst	prep_of	11	SENT_286	[p14l776t3738r908b3787],
14	and	CC	O	and	_	0	SENT_286	[p14l935t3737r1035b3787],
15	the	DT	O	the	det	16	SENT_286	[p14l1060t3737r1145b3787],
16	contribution	NN	O	contribution	conj_and	5	SENT_286	[p14l1171t3737r1518b3787],
17	of	IN	O	of	_	0	SENT_286	[p14l1544t3737r1606b3787],
18	the	DT	O	the	det	19	SENT_286	[p14l1626t3737r1711b3787],
19	isoenzymes	NNS	O	isoenzyme	prep_of	16	SENT_286	[p14l1736t3737r2066b3802],
20	to	TO	O	to	_	0	SENT_286	[p14l2093t3745r2147b3787],
21	cancer	NN	O	cancer	nn	22	SENT_286	[p15l150t27r335b61],
22	chemoprotection	NN	O	chemoprotection	prep_to	3	SENT_286	[p15l360t11r839b76],
23	and	CC	O	and	_	0	SENT_286	[p15l866t11r967b61],
24	drug	NN	O	drug	nn	25	SENT_286	[p15l993t11r1121b76],
25	resistance	NN	O	resistance	prep_to	3	SENT_286	[p15l1147t11r1442b61],
26	.	.	O	.	_	0	SENT_286	[p15l1147t11r1442b61],

1	Crit	NNP	O	Crit	nn	5	SENT_287	[p15l1473t11r1582b61],
2	Rev	NN	O	rev	nn	5	SENT_287	[p15l1608t13r1721b61],
3	Biochem	NNP	O	Biochem	nn	5	SENT_287	[p15l1747t11r2004b61],
4	Mol	NNP	O	Mol	nn	5	SENT_287	[p15l2030t11r2147b61],
5	Biol	NNP	O	Biol	_	0	SENT_287	[p15l149t84r270b134],
6	1995	CD	DATE	1995	num	5	SENT_287	[p15l303t84r821b143],
7	;	:	O	;	_	0	SENT_287	[p15l303t84r821b143],
8	30:445	CD	NUMBER	30:445	number	9	SENT_287	[p15l303t84r821b143],
9	-600	CD	NUMBER	-600	dep	5	SENT_287	[p15l303t84r821b143],
10	.	.	O	.	_	0	SENT_287	[p15l303t84r821b143],

1	Eaton	NNP	ORGANIZATION	Eaton	nn	2	SENT_288	[p15l148t159r314b207],
2	DL	NNP	ORGANIZATION	DL	_	0	SENT_288	[p15l340t159r449b216],
3	,	,	O	,	_	0	SENT_288	[p15l340t159r449b216],
4	Bammler	NNP	O	Bammler	nn	5	SENT_288	[p15l478t157r744b207],
5	TK	NN	O	tk	appos	2	SENT_288	[p15l769t159r876b207],
6	.	.	O	.	_	0	SENT_288	[p15l769t159r876b207],

1	Concise	JJ	O	concise	amod	2	SENT_289	[p15l907t157r1134b207],
2	review	NN	O	review	nsubj	6	SENT_289	[p15l1161t157r1354b207],
3	of	IN	O	of	_	0	SENT_289	[p15l1381t157r1443b207],
4	the	DT	O	the	det	5	SENT_289	[p15l1465t157r1550b207],
5	glutathione	NN	O	glutathione	prep_of	2	SENT_289	[p15l1578t157r1896b222],
6	S	NN	O	s	_	0	SENT_289	[p15l1925t158r2145b207, p15l149t230r344b280],
7	—	CD	NUMBER	—	num	8	SENT_289	[p15l1925t158r2145b207, p15l149t230r344b280],
8	transferases	NNS	O	transferase	dobj	6	SENT_289	[p15l1925t158r2145b207, p15l149t230r344b280],
9	and	CC	O	and	_	0	SENT_289	[p15l365t230r466b280],
10	their	PRP$	O	they	poss	11	SENT_289	[p15l482t230r613b280],
11	signiﬁcance	NN	O	signiﬁcance	dobj	6	SENT_289	[p15l632t230r968b295],
12	to	TO	O	to	_	0	SENT_289	[p15l987t237r1040b280],
13	toxicology	NN	O	toxicology	prep_to	6	SENT_289	[p15l1058t230r1376b294],
14	.	.	O	.	_	0	SENT_289	[p15l1058t230r1376b294],

1	Toxicol	NNP	O	Toxicol	nn	2	SENT_290	[p15l1398t230r1618b280],
2	Sci	NNP	O	Sci	_	0	SENT_290	[p15l1639t230r1726b280],
3	1999	CD	DATE	1999	num	2	SENT_290	[p15l1751t230r2149b289, p15l150t302r233b352],
4	;	:	O	;	_	0	SENT_290	[p15l1751t230r2149b289, p15l150t302r233b352],
5	49:15664	CD	NUMBER	49:15664	dep	2	SENT_290	[p15l1751t230r2149b289, p15l150t302r233b352],
6	.	.	O	.	_	0	SENT_290	[p15l1751t230r2149b289, p15l150t302r233b352],

1	Pikula	NNP	O	Pikula	nn	2	SENT_291	[p15l149t375r331b425],
2	S	NNP	O	S	_	0	SENT_291	[p15l356t375r407b434],
3	,	,	O	,	_	0	SENT_291	[p15l356t375r407b434],
4	Bandorowicz-Pikula	NNP	PERSON	Bandorowicz-Pikula	nn	5	SENT_291	[p15l434t375r1021b425],
5	J	NNP	PERSON	J	appos	2	SENT_291	[p15l1044t376r1085b434],
6	,	,	O	,	_	0	SENT_291	[p15l1044t376r1085b434],
7	Awasthi	NNP	PERSON	Awasthi	nn	8	SENT_291	[p15l1112t375r1348b425],
8	S	NNP	O	S	appos	2	SENT_291	[p15l1375t376r1426b434],
9	,	,	O	,	_	0	SENT_291	[p15l1375t376r1426b434],
10	et	FW	O	et	nn	11	SENT_291	[p15l1453t383r1504b425],
11	al.	FW	O	al.	appos	2	SENT_291	[p15l1528t375r1591b425],
12	.	.	O	.	_	0	SENT_291	[p15l1528t375r1591b425],

1	ATP-driven	JJ	O	atp-driven	amod	2	SENT_292	[p15l1619t375r1958b425],
2	efﬂux	NN	O	efﬂux	nsubj	5	SENT_292	[p15l1983t375r2147b425],
3	of	IN	O	of	_	0	SENT_292	[p15l150t448r212b497],
4	glutathione	NN	O	glutathione	prep_of	2	SENT_292	[p15l230t448r548b512],
5	S	NN	O	s	_	0	SENT_292	[p15l574t448r954b512],
6	—	CD	NUMBER	—	num	7	SENT_292	[p15l574t448r954b512],
7	conjugates	NNS	O	conjugate	dobj	5	SENT_292	[p15l574t448r954b512],
8	,	,	O	,	_	0	SENT_292	[p15l574t448r954b512],
9	anti	JJ	O	anti	amod	12	SENT_292	[p15l981t448r1317b497],
10	—	NN	O	—	nn	12	SENT_292	[p15l981t448r1317b497],
11	tumour	NN	O	tumour	nn	12	SENT_292	[p15l981t448r1317b497],
12	drugs	NNS	O	drug	dobj	5	SENT_292	[p15l1339t448r1510b512],
13	,	,	O	,	_	0	SENT_292	[p15l1339t448r1510b512],
14	and	CC	O	and	_	0	SENT_292	[p15l1537t448r1638b497],
15	xenobiotics	NNS	O	xenobiotic	conj_and	7	SENT_292	[p15l1660t448r1986b497],
16	from	IN	O	from	_	0	SENT_292	[p15l2010t448r2148b497],
17	human	JJ	O	human	amod	18	SENT_292	[p15l148t521r341b570],
18	erythrocytes	NNS	O	erythrocyte	prep_from	5	SENT_292	[p15l368t521r732b585],
19	.	.	O	.	_	0	SENT_292	[p15l368t521r732b585],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	2	SENT_293	[p15l762t521r1019b570],
2	Arch	NNP	ORGANIZATION	Arch	_	0	SENT_293	[p15l1043t521r1185b571],
3	1996	CD	DATE	1996	num	2	SENT_293	[p15l1217t521r1691b580],
4	;	:	O	;	_	0	SENT_293	[p15l1217t521r1691b580],
5	12:261	CD	NUMBER	12:261	number	6	SENT_293	[p15l1217t521r1691b580],
6	—	CD	NUMBER	—	dep	2	SENT_293	[p15l1217t521r1691b580],
7	71	CD	NUMBER	71	dep	6	SENT_293	[p15l1217t521r1691b580],
8	.	.	O	.	_	0	SENT_293	[p15l1217t521r1691b580],

1	Awasthi	NNP	O	Awasthi	nn	2	SENT_294	[p15l149t594r384b644],
2	YC	NNP	O	YC	_	0	SENT_294	[p15l424t594r536b653],
3	,	,	O	,	_	0	SENT_294	[p15l424t594r536b653],
4	Sharma	FW	PERSON	sharma	appos	2	SENT_294	[p15l578t594r794b644],
5	R	NN	PERSON	r	dep	4	SENT_294	[p15l830t595r891b653],
6	,	,	O	,	_	0	SENT_294	[p15l830t595r891b653],
7	Singhal	NNP	PERSON	Singhal	nn	8	SENT_294	[p15l934t594r1148b658],
8	SS	NNP	O	SS	appos	2	SENT_294	[p15l1188t594r1278b644],
9	.	.	O	.	_	0	SENT_294	[p15l1188t594r1278b644],

1	Human	JJ	O	human	amod	3	SENT_295	[p15l1319t595r1528b643],
2	glutahtione	NN	O	glutahtione	nn	3	SENT_295	[p15l1567t594r1885b658],
3	S	NN	O	s	_	0	SENT_295	[p15l1925t594r2145b644, p15l149t667r332b717],
4	—	CD	NUMBER	—	num	5	SENT_295	[p15l1925t594r2145b644, p15l149t667r332b717],
5	transferase	NN	O	transferase	dep	3	SENT_295	[p15l1925t594r2145b644, p15l149t667r332b717],
6	.	.	O	.	_	0	SENT_295	[p15l1925t594r2145b644, p15l149t667r332b717],

1	Int	NN	O	int	nn	2	SENT_296	[p15l361t668r440b717],
2	J	NN	O	j	_	0	SENT_296	[p15l464t668r490b717],
3	Biochem	NNP	O	Biochem	dep	2	SENT_296	[p15l516t667r773b717],
4	1994	CD	DATE	1994	num	3	SENT_296	[p15l804t667r1314b726],
5	;	:	O	;	_	0	SENT_296	[p15l804t667r1314b726],
6	26:295	CD	NUMBER	26:295	num	7	SENT_296	[p15l804t667r1314b726],
7	-308	CD	NUMBER	-308	dep	2	SENT_296	[p15l804t667r1314b726],
8	.	.	O	.	_	0	SENT_296	[p15l804t667r1314b726],

1	Marshall	NNP	PERSON	Marshall	nn	2	SENT_297	[p15l148t740r401b789],
2	GE	NNP	O	GE	_	0	SENT_297	[p15l422t740r528b790],
3	.	.	O	.	_	0	SENT_297	[p15l422t740r528b790],

1	Antioxidant	JJ	O	antioxidant	amod	2	SENT_298	[p15l551t740r892b789],
2	enzymes	NNS	O	enzyme	_	0	SENT_298	[p15l911t756r1157b804],
3	in	IN	O	in	_	0	SENT_298	[p15l1179t740r1233b789],
4	the	DT	O	the	det	6	SENT_298	[p15l1252t740r1337b789],
5	human	JJ	O	human	amod	6	SENT_298	[p15l1357t740r1550b789],
6	iris	NN	O	iris	prep_in	2	SENT_298	[p15l1570t740r1674b789],
7	:	:	O	:	_	0	SENT_298	[p15l1570t740r1674b789],
8	an	DT	O	a	det	10	SENT_298	[p15l1700t756r1764b789],
9	immunogold	JJ	O	immunogold	amod	10	SENT_298	[p15l1784t740r2148b804],
10	study	NN	O	study	dep	2	SENT_298	[p15l151t813r316b878],
11	.	.	O	.	_	0	SENT_298	[p15l151t813r316b878],

1	Brit	NNP	O	Brit	nn	3	SENT_299	[p15l345t814r456b863],
2	J	NNP	O	J	nn	3	SENT_299	[p15l480t815r506b863],
3	Ophthamol	NNP	O	Ophthamol	_	0	SENT_299	[p15l533t814r851b878],
4	1997	CD	DATE	1997	num	3	SENT_299	[p15l884t814r1339b872],
5	;	:	O	;	_	0	SENT_299	[p15l884t814r1339b872],
6	81:314	CD	NUMBER	81:314	number	7	SENT_299	[p15l884t814r1339b872],
7	-8	CD	NUMBER	-8	dep	3	SENT_299	[p15l884t814r1339b872],
8	.	.	O	.	_	0	SENT_299	[p15l884t814r1339b872],

1	Mannervik	NN	O	mannervik	nn	2	SENT_300	[p15l148t886r463b936],
2	B	NN	O	b	_	0	SENT_300	[p15l491t888r551b945],
3	,	,	O	,	_	0	SENT_300	[p15l491t888r551b945],
4	Widersten	NNP	PERSON	Widersten	nn	8	SENT_300	[p15l583t886r876b936],
5	M.	NNP	PERSON	M.	nn	8	SENT_300	[p15l906t888r982b936],
6	Human	NNP	PERSON	Human	nn	8	SENT_300	[p15l1015t888r1224b936],
7	glutathione	NN	O	glutathione	nn	8	SENT_300	[p15l1255t886r1573b951],
8	transferases	NNS	O	transferase	appos	2	SENT_300	[p15l1603t886r1954b945],
9	,	,	O	,	_	0	SENT_300	[p15l1603t886r1954b945],
10	tissue	NN	O	tissue	nn	11	SENT_300	[p15l1986t886r2147b936],
11	distribution	NN	O	distribution	appos	2	SENT_300	[p15l150t959r492b1018],
12	,	,	O	,	_	0	SENT_300	[p15l150t959r492b1018],
13	structure	NN	O	structure	appos	2	SENT_300	[p15l533t967r778b1009],
14	and	CC	O	and	_	0	SENT_300	[p15l816t959r916b1009],
15	functional	JJ	O	functional	amod	16	SENT_300	[p15l952t959r1239b1009],
16	properties	NNS	O	property	appos	2	SENT_300	[p15l1274t959r1573b1024],
17	.	.	O	.	_	0	SENT_300	[p15l1274t959r1573b1024],

1	Advances	NNS	O	advance	_	0	SENT_301	[p15l1613t959r1891b1009],
2	in	IN	O	in	_	0	SENT_301	[p15l1928t959r1983b1008],
3	drug	NN	O	drug	nn	4	SENT_301	[p15l2019t959r2147b1024],
4	metabolism	NN	O	metabolism	prep_in	1	SENT_301	[p15l149t1032r482b1082],
5	in	IN	O	in	_	0	SENT_301	[p15l503t1032r557b1081],
6	man	NN	O	man	prep_in	1	SENT_301	[p15l578t1048r714b1082],
7	.	.	O	.	_	0	SENT_301	[p15l578t1048r714b1082],

1	In	IN	O	in	dep	4	SENT_302	[p15l740t1033r812b1082],
2	:	:	O	:	_	0	SENT_302	[p15l740t1033r812b1082],
3	Paciﬁci	NN	O	paciﬁci	nn	4	SENT_302	[p15l839t1032r1051b1082],
4	G	NN	O	g	_	0	SENT_302	[p15l1075t1032r1139b1091],
5	,	,	O	,	_	0	SENT_302	[p15l1075t1032r1139b1091],
6	Fracchia	NN	O	fracchium	nn	7	SENT_302	[p15l1163t1032r1409b1082],
7	F	NN	O	f	appos	4	SENT_302	[p15l1429t1033r1482b1091],
8	,	,	O	,	_	0	SENT_302	[p15l1429t1033r1482b1091],
9	eds	NNS	O	ed	appos	4	SENT_302	[p15l1508t1032r1615b1082],
10	.	.	O	.	_	0	SENT_302	[p15l1508t1032r1615b1082],

1	Advances	NNS	O	advance	_	0	SENT_303	[p15l1641t1032r1919b1082],
2	in	IN	O	in	_	0	SENT_303	[p15l1942t1032r1997b1081],
3	drug	NN	O	drug	nn	4	SENT_303	[p15l2019t1032r2147b1097],
4	metabolism	NN	O	metabolism	prep_in	1	SENT_303	[p15l149t1105r482b1155],
5	in	IN	O	in	_	0	SENT_303	[p15l503t1105r557b1154],
6	man	NN	O	man	prep_in	1	SENT_303	[p15l579t1121r715b1155],
7	.	.	O	.	_	0	SENT_303	[p15l579t1121r715b1155],

1	EUR15439	NN	O	eur15439	_	0	SENT_304	[p15l741t1105r1076b1164],
2	,	,	O	,	_	0	SENT_304	[p15l741t1105r1076b1164],
3	ECDGX11	NN	O	ecdgx11	appos	1	SENT_304	[p15l1101t1105r1558b1155],
4	.	.	O	.	_	0	SENT_304	[p15l1101t1105r1558b1155],

1	—	NN	O	—	_	0	SENT_305	[p15l1101t1105r1558b1155],
2	.	.	O	.	_	0	SENT_305	[p15l1101t1105r1558b1155],

1	E	NN	O	e	_	0	SENT_306	[p15l1101t1105r1558b1155],
2	.	.	O	.	_	0	SENT_306	[p15l1101t1105r1558b1155],

1	—	NN	O	—	_	0	SENT_307	[p15l1101t1105r1558b1155],
2	.	.	O	.	_	0	SENT_307	[p15l1101t1105r1558b1155],

1	4	LS	NUMBER	4	_	0	SENT_308	[p15l1101t1105r1558b1155],
2	.	.	O	.	_	0	SENT_308	[p15l1101t1105r1558b1155],

1	Brussels	NNP	LOCATION	Brussels	_	0	SENT_309	[p15l1584t1105r1839b1155],
2	:	:	O	:	_	0	SENT_309	[p15l1584t1105r1839b1155],
3	Ofﬁce	NNP	O	Ofﬁce	dep	1	SENT_309	[p15l1868t1105r2043b1155],
4	for	IN	O	for	_	0	SENT_309	[p15l2066t1105r2149b1155],
5	Ofﬁcial	NNP	ORGANIZATION	Ofﬁcial	nn	6	SENT_309	[p15l150t1178r365b1228],
6	Publications	NNP	ORGANIZATION	Publications	prep_for	3	SENT_309	[p15l391t1178r740b1227],
7	of	IN	ORGANIZATION	of	_	0	SENT_309	[p15l769t1178r830b1227],
8	the	DT	ORGANIZATION	the	det	10	SENT_309	[p15l851t1178r936b1227],
9	European	NNP	ORGANIZATION	European	nn	10	SENT_309	[p15l962t1179r1234b1242],
10	Community	NNP	ORGANIZATION	Community	prep_of	6	SENT_309	[p15l1260t1178r1614b1242],
11	,	,	O	,	_	0	SENT_309	[p15l1260t1178r1614b1242],
12	1995	CD	DATE	1995	appos	10	SENT_309	[p15l1650t1178r1798b1228],
13	.	.	O	.	_	0	SENT_309	[p15l1650t1178r1798b1228],

1	408	CD	NUMBER	408	num	2	SENT_310	[p15l1827t1178r1930b1228],
2	-59	CD	NUMBER	-59	_	0	SENT_310	[p15l1942t1178r2062b1228],
3	.	.	O	.	_	0	SENT_310	[p15l1942t1178r2062b1228],

1	Tew	NNP	PERSON	Tew	_	0	SENT_311	[p15l149t1253r273b1301],
2	KD	NN	O	kd	dep	1	SENT_311	[p15l304t1253r418b1301],
3	.	.	O	.	_	0	SENT_311	[p15l304t1253r418b1301],

1	Glutathione	NN	O	glutathione	nn	2	SENT_312	[p15l452t1252r1104b1301],
2	—	NN	O	—	nsubj	3	SENT_312	[p15l452t1252r1104b1301],
3	associated	VBN	O	associate	_	0	SENT_312	[p15l452t1252r1104b1301],
4	enzymes	NNS	O	enzyme	dobj	3	SENT_312	[p15l1133t1267r1379b1316],
5	in	IN	O	in	_	0	SENT_312	[p15l1409t1252r1463b1300],
6	anti	JJ	O	anti	amod	10	SENT_312	[p15l1494t1252r1809b1301],
7	—	NN	O	—	nn	10	SENT_312	[p15l1494t1252r1809b1301],
8	cancer	NN	O	cancer	nn	10	SENT_312	[p15l1494t1252r1809b1301],
9	drug	NN	O	drug	nn	10	SENT_312	[p15l1837t1251r1965b1316],
10	resistance	NN	O	resistance	prep_in	4	SENT_312	[p15l1993t1252r2145b1301, p15l149t1332r312b1375],
11	.	.	O	.	_	0	SENT_312	[p15l1993t1252r2145b1301, p15l149t1332r312b1375],

1	Cancer	NNP	O	Cancer	nn	2	SENT_313	[p15l342t1325r543b1375],
2	Res	NNP	O	Res	_	0	SENT_313	[p15l567t1326r671b1375],
3	1994	CD	DATE	1994	num	2	SENT_313	[p15l705t1324r1215b1383],
4	;	:	O	;	_	0	SENT_313	[p15l705t1324r1215b1383],
5	54:4313	CD	NUMBER	54:4313	number	6	SENT_313	[p15l705t1324r1215b1383],
6	—	CD	NUMBER	—	dep	2	SENT_313	[p15l705t1324r1215b1383],
7	20	CD	NUMBER	20	dep	6	SENT_313	[p15l705t1324r1215b1383],
8	.	.	O	.	_	0	SENT_313	[p15l705t1324r1215b1383],

1	Townsend	NNP	PERSON	Townsend	nn	2	SENT_314	[p15l149t1397r445b1447],
2	AJ	NNP	PERSON	AJ	_	0	SENT_314	[p15l474t1398r567b1456],
3	,	,	O	,	_	0	SENT_314	[p15l474t1398r567b1456],
4	Kiningham	NNP	ORGANIZATION	Kiningham	nn	5	SENT_314	[p15l600t1397r920b1462],
5	KK	NNP	ORGANIZATION	KK	appos	2	SENT_314	[p15l950t1399r1065b1456],
6	,	,	O	,	_	0	SENT_314	[p15l950t1399r1065b1456],
7	St	NNP	ORGANIZATION	St	nn	9	SENT_314	[p15l1100t1398r1156b1447],
8	Clair	NNP	ORGANIZATION	Clair	nn	9	SENT_314	[p15l1185t1397r1327b1447],
9	D	NNP	ORGANIZATION	D	appos	2	SENT_314	[p15l1356t1399r1420b1456],
10	,	,	O	,	_	0	SENT_314	[p15l1356t1399r1420b1456],
11	et	FW	O	et	nn	12	SENT_314	[p15l1453t1405r1503b1447],
12	al.	FW	O	al.	appos	2	SENT_314	[p15l1534t1397r1596b1447],
13	.	.	O	.	_	0	SENT_314	[p15l1534t1397r1596b1447],

1	Symposium	NNP	O	Symposium	nn	2	SENT_315	[p15l1631t1397r1970b1462],
2	overview	NN	O	overview	_	0	SENT_315	[p15l1999t1413r2145b1447, p15l149t1470r301b1520],
3	:	:	O	:	_	0	SENT_315	[p15l1999t1413r2145b1447, p15l149t1470r301b1520],
4	characterisation	NN	O	characterisation	dep	2	SENT_315	[p15l341t1470r792b1520],
5	of	IN	O	of	_	0	SENT_315	[p15l827t1470r889b1520],
6	xenobiotic	JJ	O	xenobiotic	amod	9	SENT_315	[p15l919t1470r1217b1520],
7	metabolising	JJ	O	metabolising	amod	9	SENT_315	[p15l1253t1470r1620b1535],
8	enzyme	NN	O	enzyme	nn	9	SENT_315	[p15l1656t1486r1876b1535],
9	function	NN	O	function	prep_of	4	SENT_315	[p15l1911t1470r2148b1520],
10	using	VBG	O	use	partmod	9	SENT_315	[p15l149t1543r301b1607],
11	heterologous	JJ	O	heterologous	amod	13	SENT_315	[p15l324t1543r691b1607],
12	expression	NN	O	expression	nn	13	SENT_315	[p15l716t1543r1019b1607],
13	systems	NNS	O	system	dobj	10	SENT_315	[p15l1044t1551r1280b1607],
14	.	.	O	.	_	0	SENT_315	[p15l1044t1551r1280b1607],

1	Toxicol	NNP	O	Toxicol	nn	2	SENT_316	[p15l1307t1543r1527b1592],
2	Sci	NNP	O	Sci	_	0	SENT_316	[p15l1553t1543r1639b1593],
3	1999	CD	DATE	1999	num	2	SENT_316	[p15l1670t1543r2144b1602],
4	;	:	O	;	_	0	SENT_316	[p15l1670t1543r2144b1602],
5	48:143	CD	NUMBER	48:143	number	6	SENT_316	[p15l1670t1543r2144b1602],
6	—	CD	NUMBER	—	dep	2	SENT_316	[p15l1670t1543r2144b1602],
7	50	CD	NUMBER	50	dep	6	SENT_316	[p15l1670t1543r2144b1602],
8	.	.	O	.	_	0	SENT_316	[p15l1670t1543r2144b1602],

1	Morrow	NNP	PERSON	Morrow	nn	2	SENT_317	[p15l149t1617r380b1666],
2	CS	NNP	O	CS	_	0	SENT_317	[p15l409t1616r509b1675],
3	,	,	O	,	_	0	SENT_317	[p15l409t1616r509b1675],
4	Smitherson	NNP	O	Smitherson	nn	5	SENT_317	[p15l539t1616r861b1666],
5	PK	NNP	O	PK	appos	2	SENT_317	[p15l888t1617r992b1675],
6	,	,	O	,	_	0	SENT_317	[p15l888t1617r992b1675],
7	Diah	NNP	PERSON	Diah	nn	8	SENT_317	[p15l1021t1616r1159b1666],
8	SK	NNP	O	SK	appos	2	SENT_317	[p15l1187t1616r1290b1675],
9	,	,	O	,	_	0	SENT_317	[p15l1187t1616r1290b1675],
10	et	FW	O	et	nn	11	SENT_317	[p15l1319t1623r1369b1666],
11	al.	FW	O	al.	appos	2	SENT_317	[p15l1396t1616r1459b1666],
12	.	.	O	.	_	0	SENT_317	[p15l1396t1616r1459b1666],

1	Co	NNP	O	Co	_	0	SENT_318	[p15l1490t1616r1865b1666],
2	—	CD	NUMBER	—	num	1	SENT_318	[p15l1490t1616r1865b1666],
3	ordinated	VBN	O	ordinate	partmod	1	SENT_318	[p15l1490t1616r1865b1666],
4	action	NN	O	action	dobj	3	SENT_318	[p15l1892t1616r2063b1666],
5	of	IN	O	of	_	0	SENT_318	[p15l2091t1616r2152b1666],
6	glutathione	NN	O	glutathione	nn	7	SENT_318	[p15l150t1689r468b1753],
7	S	NN	O	s	prep_of	4	SENT_318	[p15l495t1689r891b1739],
8	—	CD	NUMBER	—	num	9	SENT_318	[p15l495t1689r891b1739],
9	transferases	NNS	O	transferase	dep	20	SENT_318	[p15l495t1689r891b1739],
10	(	CD	NUMBER	(	num	11	SENT_318	[p15l920t1689r1124b1750],
11	GSTs	NNS	O	gst	dep	9	SENT_318	[p15l920t1689r1124b1750],
12	)	CD	NUMBER	)	dep	11	SENT_318	[p15l920t1689r1124b1750],
13	and	CC	O	and	_	0	SENT_318	[p15l1153t1689r1253b1738],
14	multidrug	JJ	O	multidrug	amod	16	SENT_318	[p15l1278t1689r1557b1753],
15	resistance	NN	O	resistance	nn	16	SENT_318	[p15l1582t1689r1862b1738],
16	protein	NN	O	protein	dep	11	SENT_318	[p15l1887t1689r2089b1753],
17	1	CD	NUMBER	1	number	18	SENT_318	[p15l2121t1689r2141b1738],
18	(	CD	NUMBER	(	num	20	SENT_318	[p15l151t1763r379b1824],
19	MRP1	NN	O	mrp1	nn	20	SENT_318	[p15l151t1763r379b1824],
20	)	NN	O	)	dep	1	SENT_318	[p15l151t1763r379b1824],
21	in	IN	O	in	_	0	SENT_318	[p15l403t1762r457b1811],
22	antineoplastic	JJ	O	antineoplastic	amod	24	SENT_318	[p15l480t1762r873b1827],
23	drug	NN	O	drug	nn	24	SENT_318	[p15l896t1763r1024b1827],
24	detoxiﬁcation	NN	O	detoxiﬁcation	prep_in	20	SENT_318	[p15l1047t1762r1452b1812],
25	.	.	O	.	_	0	SENT_318	[p15l1047t1762r1452b1812],

1	J	NNP	O	J	nn	3	SENT_319	[p15l1477t1764r1504b1812],
2	Biol	NNP	O	Biol	nn	3	SENT_319	[p15l1525t1762r1647b1812],
3	Chem	NNP	O	Chem	_	0	SENT_319	[p15l1670t1763r1838b1812],
4	1998	CD	DATE	1998	num	6	SENT_319	[p15l1866t1763r2142b1821],
5	;	:	O	;	_	0	SENT_319	[p15l1866t1763r2142b1821],
6	273	CD	NUMBER	273	dep	3	SENT_319	[p15l1866t1763r2142b1821],
7	:	:	O	:	_	0	SENT_319	[p15l1866t1763r2142b1821],
8	201	CD	NUMBER	201	number	9	SENT_319	[p15l150t1836r248b1885],
9	14	CD	NUMBER	14	dep	3	SENT_319	[p15l263t1836r325b1884],
10	-20	CD	NUMBER	-20	dep	9	SENT_319	[p15l335t1836r456b1885],
11	.	.	O	.	_	0	SENT_319	[p15l335t1836r456b1885],

1	Berhane	NNP	PERSON	Berhane	nn	2	SENT_320	[p15l149t1907r385b1958],
2	K	NNP	PERSON	K	_	0	SENT_320	[p15l415t1909r479b1967],
3	,	,	O	,	_	0	SENT_320	[p15l415t1909r479b1967],
4	Hao	NNP	PERSON	Hao	nn	5	SENT_320	[p15l510t1909r627b1958],
5	X	NNP	O	X	appos	2	SENT_320	[p15l656t1909r797b1967],
6	.	.	O	.	_	0	SENT_320	[p15l656t1909r797b1967],

1	—	NN	O	—	_	0	SENT_321	[p15l656t1909r797b1967],
2	.	.	O	.	_	0	SENT_321	[p15l656t1909r797b1967],

1	Y	NN	O	y	nn	5	SENT_322	[p15l656t1909r797b1967],
2	,	,	O	,	_	0	SENT_322	[p15l656t1909r797b1967],
3	Egyh2	NN	O	egyh2	dep	5	SENT_322	[p15l828t1905r1060b1973],
4	°	CD	NUMBER	°	num	5	SENT_322	[p15l828t1905r1060b1973],
5	1zi	NNS	O	1zus	_	0	SENT_322	[p15l828t1905r1060b1973],
6	S	NN	O	s	dep	5	SENT_322	[p15l1091t1908r1142b1967],
7	,	,	O	,	_	0	SENT_322	[p15l1091t1908r1142b1967],
8	et	FW	O	et	nn	9	SENT_322	[p15l1175t1915r1225b1958],
9	al.	FW	O	al.	appos	6	SENT_322	[p15l1254t1907r1316b1958],
10	.	.	O	.	_	0	SENT_322	[p15l1254t1907r1316b1958],

1	Contribution	NN	O	contribution	nsubj	5	SENT_323	[p15l1350t1907r1713b1958],
2	of	IN	O	of	_	0	SENT_323	[p15l1742t1907r1804b1958],
3	glutathione	NN	O	glutathione	nn	4	SENT_323	[p15l1828t1907r2147b1973],
4	transferase	NN	O	transferase	prep_of	1	SENT_323	[p15l149t1981r456b2031],
5	M3	NN	O	m3	_	0	SENT_323	[p15l474t1982r628b2031],
6	—	CD	NUMBER	—	number	7	SENT_323	[p15l474t1982r628b2031],
7	3	CD	NUMBER	3	dobj	5	SENT_323	[p15l474t1982r628b2031],
8	to	TO	O	to	_	0	SENT_323	[p15l650t1989r703b2031],
9	1,3	CD	NUMBER	1,3	prep_to	7	SENT_323	[p15l729t1981r1778b2045],
10	.	.	O	.	_	0	SENT_323	[p15l729t1981r1778b2045],

1	—	NN	O	—	_	0	SENT_324	[p15l729t1981r1778b2045],
2	.	.	O	.	_	0	SENT_324	[p15l729t1981r1778b2045],

1	bis	FW	O	bis	nn	2	SENT_325	[p15l729t1981r1778b2045],
2	(	FW	O	(	_	0	SENT_325	[p15l729t1981r1778b2045],
3	2	LS	NUMBER	2	dep	2	SENT_325	[p15l729t1981r1778b2045],
4	.	.	O	.	_	0	SENT_325	[p15l729t1981r1778b2045],

1	—	NN	O	—	_	0	SENT_326	[p15l729t1981r1778b2045],
2	.	.	O	.	_	0	SENT_326	[p15l729t1981r1778b2045],

1	chloroerthyl	NN	O	chloroerthyl	_	0	SENT_327	[p15l729t1981r1778b2045],
2	)	NN	O	)	dep	1	SENT_327	[p15l729t1981r1778b2045],
3	.	.	O	.	_	0	SENT_327	[p15l729t1981r1778b2045],

1	—	NN	O	—	_	0	SENT_328	[p15l729t1981r1778b2045],
2	.	.	O	.	_	0	SENT_328	[p15l729t1981r1778b2045],

1	l	NN	O	l	_	0	SENT_329	[p15l729t1981r1778b2045],
2	.	.	O	.	_	0	SENT_329	[p15l729t1981r1778b2045],

1	—	NN	O	—	_	0	SENT_330	[p15l729t1981r1778b2045],
2	.	.	O	.	_	0	SENT_330	[p15l729t1981r1778b2045],

1	nitrosourea	NN	O	nitrosourea	nn	2	SENT_331	[p15l729t1981r1778b2045],
2	resistance	NN	O	resistance	_	0	SENT_331	[p15l1795t1981r2075b2031],
3	in	IN	O	in	_	0	SENT_331	[p15l2094t1981r2148b2030],
4	a	DT	O	a	det	11	SENT_331	[p15l150t2070r180b2103],
5	human	JJ	O	human	amod	11	SENT_331	[p15l208t2054r401b2103],
6	non-small	JJ	O	non-small	amod	11	SENT_331	[p15l431t2054r715b2103],
7	cell	NN	O	cell	nn	11	SENT_331	[p15l745t2054r846b2103],
8	lung	NN	O	lung	nn	11	SENT_331	[p15l876t2054r1000b2118],
9	cancer	NN	O	cancer	nn	11	SENT_331	[p15l1032t2070r1217b2103],
10	cell	NN	O	cell	nn	11	SENT_331	[p15l1246t2054r1346b2103],
11	line	NN	O	line	prep_in	2	SENT_331	[p15l1377t2054r1496b2104],
12	.	.	O	.	_	0	SENT_331	[p15l1377t2054r1496b2104],

1	Cancer	NNP	O	Cancer	nn	3	SENT_332	[p15l1530t2054r1731b2104],
2	Res	NNP	O	Res	nn	3	SENT_332	[p15l1760t2055r1863b2103],
3	l993	NN	O	l993	_	0	SENT_332	[p15l1902t2054r2142b2113],
4	;	:	O	;	_	0	SENT_332	[p15l1902t2054r2142b2113],
5	53	CD	NUMBER	53	num	7	SENT_332	[p15l1902t2054r2142b2113],
6	:	:	O	:	_	0	SENT_332	[p15l1902t2054r2142b2113],
7	4257-61	CD	NUMBER	4257-61	dep	3	SENT_332	[p15l149t2126r420b2176],
8	.	.	O	.	_	0	SENT_332	[p15l149t2126r420b2176],

1	Volm	NN	O	volm	nn	2	SENT_333	[p15l149t2200r311b2249],
2	M	NN	O	m	_	0	SENT_333	[p15l331t2201r408b2258],
3	,	,	O	,	_	0	SENT_333	[p15l331t2201r408b2258],
4	Zintl	NN	PERSON	zintl	nn	5	SENT_333	[p15l431t2199r569b2249],
5	F	NN	PERSON	f	appos	2	SENT_333	[p15l590t2201r643b2259],
6	,	,	O	,	_	0	SENT_333	[p15l590t2201r643b2259],
7	Edler	NNP	PERSON	Edler	nn	8	SENT_333	[p15l667t2200r821b2249],
8	L	NNP	O	L	appos	2	SENT_333	[p15l841t2201r898b2258],
9	,	,	O	,	_	0	SENT_333	[p15l841t2201r898b2258],
10	et	FW	O	et	nn	11	SENT_333	[p15l923t2207r973b2249],
11	al.	FW	O	al.	appos	2	SENT_333	[p15l995t2200r1057b2249],
12	.	.	O	.	_	0	SENT_333	[p15l995t2200r1057b2249],

1	Prognostic	JJ	O	prognostic	amod	2	SENT_334	[p15l1082t2200r1385b2264],
2	value	NN	O	value	dep	17	SENT_334	[p15l1407t2200r1559b2249],
3	of	IN	O	of	_	0	SENT_334	[p15l1582t2199r1643b2249],
4	protein	NN	O	protein	nn	11	SENT_334	[p15l1659t2200r1861b2264],
5	kinase	NN	O	kinase	nn	11	SENT_334	[p15l1881t2200r2062b2249],
6	C	NN	O	c	nn	11	SENT_334	[p15l2084t2200r2145b2258],
7	,	,	O	,	_	0	SENT_334	[p15l2084t2200r2145b2258],
8	proto	NN	O	proto	dep	11	SENT_334	[p15l148t2281r595b2338],
9	—	NN	O	—	nn	11	SENT_334	[p15l148t2281r595b2338],
10	oncogene	NN	O	oncogene	nn	11	SENT_334	[p15l148t2281r595b2338],
11	products	NNS	O	product	prep_of	2	SENT_334	[p15l635t2274r878b2338],
12	and	CC	O	and	_	0	SENT_334	[p15l921t2274r1022b2323],
13	resistance	NN	O	resistance	nn	15	SENT_334	[p15l1060t2274r1340b2323],
14	related	JJ	O	related	amod	15	SENT_334	[p15l1379t2273r1573b2323],
15	proteins	NNS	O	protein	conj_and	11	SENT_334	[p15l1612t2274r1839b2338],
16	in	IN	O	in	dep	17	SENT_334	[p15l1881t2274r1935b2322],
17	newly	RB	O	newly	_	0	SENT_334	[p15l1975t2274r2147b2338],

1	INHIBITION	NN	O	inhibition	_	0	SENT_335	[p15l367t2419r527b2439],
2	OF	IN	O	of	dep	1	SENT_335	[p15l537t2419r574b2439],
3	RECOMBINANT	JJ	O	recombinant	amod	4	SENT_335	[p15l584t2419r797b2439],
4	GSTS	NN	O	gst	pobj	2	SENT_335	[p15l808t2419r873b2439],
5	BY	IN	O	by	dep	1	SENT_335	[p15l884t2419r924b2439],
6	ANTIMALARIALS	NN	O	antimalarial	pobj	5	SENT_335	[p15l934t2419r1172b2439],
7	705	CD	NUMBER	705	num	6	SENT_335	[p15l1740t2413r1793b2439],

1	diagnosed	VBN	O	diagnose	amod	2	SENT_336	[p15l150t2545r438b2610],
2	childhood	NN	O	childhood	_	0	SENT_336	[p15l472t2545r756b2595],
3	acute	JJ	O	acute	amod	5	SENT_336	[p15l790t2553r938b2595],
4	lymphoblastic	JJ	O	lymphoblastic	amod	5	SENT_336	[p15l972t2545r1374b2610],
5	leukaemia	NN	O	leukaemia	dep	2	SENT_336	[p15l1409t2545r1715b2595],
6	.	.	O	.	_	0	SENT_336	[p15l1409t2545r1715b2595],

1	Med	NNP	MISC	Med	nn	4	SENT_337	[p15l1752t2545r1882b2595],
2	Paediatr	NNP	MISC	Paediatr	nn	4	SENT_337	[p15l1916t2545r2150b2595],
3	Oncol	NNP	MISC	Oncol	nn	4	SENT_337	[p15l150t2616r322b2667],
4	l997	NN	O	l997	_	0	SENT_337	[p15l354t2616r828b2675],
5	;	:	O	;	_	0	SENT_337	[p15l354t2616r828b2675],
6	28	CD	NUMBER	28	num	8	SENT_337	[p15l354t2616r828b2675],
7	:	:	O	:	_	0	SENT_337	[p15l354t2616r828b2675],
8	ll7	CD	NUMBER	ll7	dep	4	SENT_337	[p15l354t2616r828b2675],
9	—	CD	NUMBER	—	number	10	SENT_337	[p15l354t2616r828b2675],
10	26	CD	NUMBER	26	dep	8	SENT_337	[p15l354t2616r828b2675],
11	.	.	O	.	_	0	SENT_337	[p15l354t2616r828b2675],

1	Yang	NNP	PERSON	Yang	nn	2	SENT_338	[p15l150t2687r301b2750],
2	WZ	NNP	PERSON	WZ	_	0	SENT_338	[p15l330t2687r455b2745],
3	,	,	O	,	_	0	SENT_338	[p15l330t2687r455b2745],
4	Begleiter	NNP	PERSON	Begleiter	nn	5	SENT_338	[p15l487t2686r749b2750],
5	A	NNP	O	A	appos	2	SENT_338	[p15l776t2686r841b2744],
6	,	,	O	,	_	0	SENT_338	[p15l776t2686r841b2744],
7	Johnston	NNP	PERSON	Johnston	nn	8	SENT_338	[p15l872t2686r1125b2736],
8	JB	NNP	O	JB	appos	2	SENT_338	[p15l1154t2687r1243b2745],
9	,	,	O	,	_	0	SENT_338	[p15l1154t2687r1243b2745],
10	et	FW	O	et	nn	11	SENT_338	[p15l1275t2693r1325b2735],
11	al.	FW	O	al.	appos	2	SENT_338	[p15l1355t2686r1417b2735],
12	.	.	O	.	_	0	SENT_338	[p15l1355t2686r1417b2735],

1	Role	NN	O	role	nsubj	6	SENT_339	[p15l1450t2686r1583b2735],
2	of	IN	O	of	_	0	SENT_339	[p15l1613t2686r1674b2735],
3	glutathione	NN	O	glutathione	prep_of	1	SENT_339	[p15l1699t2686r2018b2750],
4	and	CC	O	and	_	0	SENT_339	[p15l2049t2686r2149b2735],
5	glutathione	NN	O	glutathione	prep_of	1	SENT_339	[p15l150t2756r468b2821],
6	S	NN	O	s	_	0	SENT_339	[p15l493t2756r888b2806],
7	—	CD	NUMBER	—	num	8	SENT_339	[p15l493t2756r888b2806],
8	transferases	NNS	O	transferase	dobj	6	SENT_339	[p15l493t2756r888b2806],
9	in	IN	O	in	_	0	SENT_339	[p15l912t2756r966b2805],
10	chlorambucil	NN	O	chlorambucil	nn	11	SENT_339	[p15l989t2756r1363b2806],
11	resistance	NN	O	resistance	prep_in	8	SENT_339	[p15l1384t2756r1679b2806],
12	.	.	O	.	_	0	SENT_339	[p15l1384t2756r1679b2806],

1	Mol	NNP	ORGANIZATION	Mol	nn	3	SENT_340	[p15l1705t2756r1822b2806],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_340	[p15l1844t2756r2148b2806],
3	l992	NN	O	l992	_	0	SENT_340	[p15l156t2827r630b2886],
4	;	:	O	;	_	0	SENT_340	[p15l156t2827r630b2886],
5	4l	NN	O	4l	dep	3	SENT_340	[p15l156t2827r630b2886],
6	:625	CD	NUMBER	:625	num	5	SENT_340	[p15l156t2827r630b2886],
7	—	CD	NUMBER	—	number	8	SENT_340	[p15l156t2827r630b2886],
8	30	CD	NUMBER	30	dep	5	SENT_340	[p15l156t2827r630b2886],
9	.	.	O	.	_	0	SENT_340	[p15l156t2827r630b2886],

1	Kearns	NNP	PERSON	Kearns	nn	2	SENT_341	[p15l150t2898r348b2946],
2	PR	NNP	O	PR	_	0	SENT_341	[p15l371t2898r472b2955],
3	,	,	O	,	_	0	SENT_341	[p15l371t2898r472b2955],
4	Hall	NNP	ORGANIZATION	Hall	nn	5	SENT_341	[p15l496t2897r617b2946],
5	AG	NNP	ORGANIZATION	AG	appos	2	SENT_341	[p15l638t2897r754b2947],
6	.	.	O	.	_	0	SENT_341	[p15l638t2897r754b2947],

1	Glutathione	NN	O	glutathione	_	0	SENT_342	[p15l780t2897r1114b2947],
2	and	CC	O	and	_	0	SENT_342	[p15l1137t2897r1238b2946],
3	the	DT	O	the	det	4	SENT_342	[p15l1259t2897r1344b2946],
4	response	NN	O	response	conj_and	1	SENT_342	[p15l1364t2913r1613b2961],
5	of	IN	O	of	_	0	SENT_342	[p15l1635t2897r1697b2946],
6	malignant	JJ	O	malignant	amod	7	SENT_342	[p15l1714t2897r1999b2961],
7	cells	NNS	O	cell	prep_of	1	SENT_342	[p15l2020t2897r2147b2946],
8	to	TO	O	to	_	0	SENT_342	[p15l149t2975r202b3017],
9	chemotherapy	NN	O	chemotherapy	prep_to	1	SENT_342	[p15l229t2967r646b3032],
10	.	.	O	.	_	0	SENT_342	[p15l229t2967r646b3032],

1	DDT	NNP	O	DDT	_	0	SENT_343	[p15l675t2969r820b3016],
2	1998	CD	DATE	1998	num	1	SENT_343	[p15l853t2968r1290b3026],
3	;	:	O	;	_	0	SENT_343	[p15l853t2968r1290b3026],
4	3:113	CD	NUMBER	3:113	number	5	SENT_343	[p15l853t2968r1290b3026],
5	—	CD	NUMBER	—	dep	1	SENT_343	[p15l853t2968r1290b3026],
6	21	CD	NUMBER	21	dep	5	SENT_343	[p15l853t2968r1290b3026],
7	.	.	O	.	_	0	SENT_343	[p15l853t2968r1290b3026],

1	Morrow	NNP	PERSON	Morrow	nn	2	SENT_344	[p15l149t3038r381b3087],
2	CS	NNP	O	CS	_	0	SENT_344	[p15l405t3037r505b3096],
3	,	,	O	,	_	0	SENT_344	[p15l405t3037r505b3096],
4	Smitherson	NNP	O	Smitherson	nn	5	SENT_344	[p15l533t3037r855b3087],
5	PK	NNP	O	PK	appos	2	SENT_344	[p15l877t3038r982b3096],
6	,	,	O	,	_	0	SENT_344	[p15l877t3038r982b3096],
7	Townsend	NNP	PERSON	Townsend	nn	8	SENT_344	[p15l1008t3037r1304b3087],
8	AJ	NNP	O	AJ	appos	5	SENT_344	[p15l1326t3038r1418b3087],
9	.	.	O	.	_	0	SENT_344	[p15l1326t3038r1418b3087],

1	Combined	VBN	O	combine	amod	2	SENT_345	[p15l1446t3037r1742b3087],
2	expression	NN	O	expression	_	0	SENT_345	[p15l1765t3037r2068b3101],
3	of	IN	O	of	_	0	SENT_345	[p15l2092t3037r2153b3087],
4	multidrug	JJ	O	multidrug	amod	6	SENT_345	[p15l149t3107r428b3171],
5	resistance	NN	O	resistance	nn	6	SENT_345	[p15l470t3107r750b3156],
6	protein	NN	O	protein	prep_of	2	SENT_345	[p15l791t3107r993b3171],
7	(	CD	NUMBER	(	num	9	SENT_345	[p15l1037t3107r1229b3168],
8	MRP	NN	O	mrp	nn	9	SENT_345	[p15l1037t3107r1229b3168],
9	)	NN	O	)	dep	19	SENT_345	[p15l1037t3107r1229b3168],
10	and	CC	O	and	_	0	SENT_345	[p15l1275t3107r1375b3156],
11	glutathione	NN	O	glutathione	nn	13	SENT_345	[p15l1417t3107r1735b3171],
12	S-transferase	NN	O	s-transferase	nn	13	SENT_345	[p15l1779t3107r2148b3157],
13	P1	NN	O	p1	conj_and	9	SENT_345	[p15l149t3178r276b3226],
14	—	NN	O	—	dep	19	SENT_345	[p15l149t3178r276b3226],
15	1	CD	NUMBER	1	num	14	SENT_345	[p15l149t3178r276b3226],
16	(	CD	NUMBER	(	num	19	SENT_345	[p15l321t3178r476b3239],
17	GST	NN	O	gst	nn	19	SENT_345	[p15l321t3178r476b3239],
18	P1-1	NN	O	p1-1	nn	19	SENT_345	[p15l512t3178r667b3239],
19	)	NN	O	)	dep	2	SENT_345	[p15l512t3178r667b3239],
20	in	IN	O	in	_	0	SENT_345	[p15l706t3177r760b3226],
21	MCF7	NN	O	mcf7	nn	22	SENT_345	[p15l796t3178r978b3227],
22	cells	NNS	O	cell	prep_in	19	SENT_345	[p15l1018t3177r1145b3227],
23	and	CC	O	and	_	0	SENT_345	[p15l1184t3177r1285b3227],
24	high	JJ	O	high	amod	26	SENT_345	[p15l1320t3177r1447b3242],
25	level	NN	O	level	nn	26	SENT_345	[p15l1483t3177r1619b3227],
26	resistance	NN	O	resistance	conj_and	19	SENT_345	[p15l1655t3177r1936b3227],
27	to	TO	O	to	_	0	SENT_345	[p15l1972t3185r2025b3227],
28	the	DT	O	the	det	29	SENT_345	[p15l2063t3177r2148b3227],
29	cytotoxicities	NNS	O	cytotoxicity	prep_to	26	SENT_345	[p15l150t3247r530b3311],
30	of	IN	O	of	_	0	SENT_345	[p15l555t3247r616b3297],
31	ethacrynic	JJ	O	ethacrynic	amod	32	SENT_345	[p15l634t3247r928b3311],
32	acid	NN	O	acid	prep_of	2	SENT_345	[p15l952t3247r1069b3297],
33	but	CC	O	but	_	0	SENT_345	[p15l1089t3247r1181b3297],
34	not	RB	O	not	_	0	SENT_345	[p15l1201t3255r1292b3297],
35	oxazaphosphorines	NNS	O	oxazaphosphorine	conj_negcc	2	SENT_345	[p15l1313t3247r1856b3312],
36	or	CC	O	or	_	0	SENT_345	[p15l1881t3263r1939b3297],
37	cispla	JJ	O	cispla	amod	39	SENT_345	[p15l1960t3247r2146b3311],
38	—	NN	O	—	nn	39	SENT_345	[p15l1960t3247r2146b3311],
39	tin	NN	O	tin	conj_negcc	2	SENT_345	[p15l149t3318r237b3368],
40	.	.	O	.	_	0	SENT_345	[p15l149t3318r237b3368],

1	Biochem	NNP	O	Biochem	nn	3	SENT_346	[p15l266t3318r523b3368],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_346	[p15l548t3318r851b3368],
3	l998	NN	O	l998	_	0	SENT_346	[p15l885t3318r1394b3377],
4	;	:	O	;	_	0	SENT_346	[p15l885t3318r1394b3377],
5	56	CD	NUMBER	56	num	7	SENT_346	[p15l885t3318r1394b3377],
6	:	:	O	:	_	0	SENT_346	[p15l885t3318r1394b3377],
7	l013	CD	NUMBER	l013	dep	3	SENT_346	[p15l885t3318r1394b3377],
8	—	CD	NUMBER	—	number	9	SENT_346	[p15l885t3318r1394b3377],
9	22	CD	NUMBER	22	dep	7	SENT_346	[p15l885t3318r1394b3377],
10	.	.	O	.	_	0	SENT_346	[p15l885t3318r1394b3377],

1	Horton	NNP	PERSON	Horton	nn	3	SENT_347	[p15l149t3390r350b3438],
2	J	NNP	PERSON	J	nn	3	SENT_347	[p15l368t3390r395b3438],
3	K	NNP	PERSON	K	_	0	SENT_347	[p15l398t3390r462b3447],
4	,	,	O	,	_	0	SENT_347	[p15l398t3390r462b3447],
5	Roy	NNP	PERSON	Roy	nn	6	SENT_347	[p15l484t3390r601b3453],
6	G	NNP	PERSON	G	appos	3	SENT_347	[p15l621t3389r685b3447],
7	,	,	O	,	_	0	SENT_347	[p15l621t3389r685b3447],
8	Piper	NNP	ORGANIZATION	Piper	nn	10	SENT_347	[p15l707t3388r857b3453],
9	J	NNP	ORGANIZATION	J	nn	10	SENT_347	[p15l875t3390r901b3438],
10	T	NN	ORGANIZATION	t	appos	3	SENT_347	[p15l903t3390r960b3447],
11	,	,	O	,	_	0	SENT_347	[p15l903t3390r960b3447],
12	et	FW	O	et	nn	13	SENT_347	[p15l982t3396r1033b3438],
13	al.	FW	O	al.	appos	3	SENT_347	[p15l1052t3388r1115b3438],
14	.	.	O	.	_	0	SENT_347	[p15l1052t3388r1115b3438],

1	Characterisation	NN	O	characterisation	_	0	SENT_348	[p15l1139t3388r1604b3438],
2	of	IN	O	of	_	0	SENT_348	[p15l1624t3388r1686b3438],
3	a	DT	O	a	det	9	SENT_348	[p15l1702t3404r1731b3438],
4	chlorambucilresistant	JJ	O	chlorambucilresistant	amod	9	SENT_348	[p15l1750t3388r2146b3438, p15l148t3458r387b3508],
5	human	JJ	O	human	amod	9	SENT_348	[p15l408t3458r601b3508],
6	ovarian	JJ	O	ovarian	amod	9	SENT_348	[p15l625t3458r837b3508],
7	carcinoma	NN	O	carcinoma	nn	9	SENT_348	[p15l860t3458r1156b3508],
8	cell	NN	O	cell	nn	9	SENT_348	[p15l1179t3458r1279b3508],
9	line	NN	O	line	prep_of	1	SENT_348	[p15l1302t3458r1407b3508],
10	over	IN	O	over	_	0	SENT_348	[p15l1431t3458r1884b3523],
11	—	CD	NUMBER	—	prep_over	9	SENT_348	[p15l1431t3458r1884b3523],
12	expressing	VBG	O	express	partmod	1	SENT_348	[p15l1431t3458r1884b3523],
13	glutathione	NN	O	glutathione	nn	14	SENT_348	[p15l1909t3458r2146b3523, p15l150t3544r250b3577],
14	S	NN	O	s	dobj	12	SENT_348	[p15l278t3528r647b3578],
15	—	CD	NUMBER	—	num	17	SENT_348	[p15l278t3528r647b3578],
16	transferase	NN	O	transferase	nn	17	SENT_348	[p15l278t3528r647b3578],
17	p.	NN	O	p.	dep	14	SENT_348	[p15l678t3546r733b3592],
18	.	.	O	.	_	0	SENT_348	[p15l678t3546r733b3592],

1	Biochem	NNP	O	Biochem	nn	2	SENT_349	[p15l762t3528r1019b3577],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_349	[p15l1044t3528r1347b3577],
3	1999	CD	DATE	1999	num	2	SENT_349	[p15l1380t3528r1890b3587],
4	;	:	O	;	_	0	SENT_349	[p15l1380t3528r1890b3587],
5	58:693	CD	NUMBER	58:693	number	6	SENT_349	[p15l1380t3528r1890b3587],
6	-702	CD	NUMBER	-702	dep	2	SENT_349	[p15l1380t3528r1890b3587],
7	.	.	O	.	_	0	SENT_349	[p15l1380t3528r1890b3587],

1	Berhane	NNP	PERSON	Berhane	nn	2	SENT_350	[p15l149t3598r385b3648],
2	K	NNP	PERSON	K	_	0	SENT_350	[p15l424t3600r488b3657],
3	,	,	O	,	_	0	SENT_350	[p15l424t3600r488b3657],
4	Mannervik	NNP	O	Mannervik	nn	6	SENT_350	[p15l528t3598r842b3648],
5	B.	NNP	O	B.	nn	6	SENT_350	[p15l877t3600r938b3648],
6	Inactivation	NNP	O	Inactivation	appos	2	SENT_350	[p15l979t3598r1319b3648],
7	of	IN	O	of	_	0	SENT_350	[p15l1357t3598r1419b3648],
8	the	DT	O	the	det	11	SENT_350	[p15l1451t3598r1536b3648],
9	genotoxic	JJ	O	genotoxic	amod	11	SENT_350	[p15l1575t3598r1853b3663],
10	aldehyde	NN	O	aldehyde	nn	11	SENT_350	[p15l1893t3598r2148b3663],
11	acrolein	NN	O	acrolein	prep_of	6	SENT_350	[p15l151t3668r378b3718],
12	by	IN	O	by	_	0	SENT_350	[p15l403t3668r473b3732],
13	human	JJ	O	human	amod	15	SENT_350	[p15l499t3668r693b3718],
14	glutathione	NN	O	glutathione	nn	15	SENT_350	[p15l720t3668r1038b3732],
15	transferases	NNS	O	transferase	prep_by	18	SENT_350	[p15l1065t3668r1399b3718],
16	of	IN	O	of	_	0	SENT_350	[p15l1428t3668r1489b3718],
17	classes	NNS	O	class	prep_of	15	SENT_350	[p15l1512t3668r1706b3718],
18	alpha	NN	O	alpha	amod	6	SENT_350	[p15l1735t3668r1902b3732],
19	,	,	O	,	_	0	SENT_350	[p15l1735t3668r1902b3732],
20	mu	NN	O	mu	appos	6	SENT_350	[p15l1931t3684r2020b3718],
21	and	CC	O	and	_	0	SENT_350	[p15l2049t3668r2149b3718],
22	pi	NN	O	pi	conj_and	20	SENT_350	[p15l148t3738r217b3802],
23	.	.	O	.	_	0	SENT_350	[p15l148t3738r217b3802],

1	Mol	NNP	ORGANIZATION	Mol	nn	2	SENT_351	[p15l246t3738r363b3787],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_351	[p15l389t3738r693b3787],
3	1990	CD	DATE	1990	num	2	SENT_351	[p15l725t3738r1172b3797],
4	;	:	O	;	_	0	SENT_351	[p15l725t3738r1172b3797],
5	37:251	CD	NUMBER	37:251	number	6	SENT_351	[p15l725t3738r1172b3797],
6	-4	CD	NUMBER	-4	dep	2	SENT_351	[p15l725t3738r1172b3797],
7	.	.	O	.	_	0	SENT_351	[p15l725t3738r1172b3797],

1	Dirven	NNP	PERSON	Dirven	nn	2	SENT_352	[p16l149t10r346b60],
2	HAAM	NNP	PERSON	HAAM	_	0	SENT_352	[p16l371t11r603b69],
3	,	,	O	,	_	0	SENT_352	[p16l371t11r603b69],
4	Megens	NNP	ORGANIZATION	Megens	nn	5	SENT_352	[p16l630t12r853b75],
5	L	NNP	ORGANIZATION	L	appos	2	SENT_352	[p16l880t12r938b69],
6	,	,	O	,	_	0	SENT_352	[p16l880t12r938b69],
7	Oudshoorn	NNP	O	Oudshoorn	nn	8	SENT_352	[p16l966t10r1282b60],
8	MJ	NNP	O	MJ	appos	2	SENT_352	[p16l1306t12r1411b69],
9	,	,	O	,	_	0	SENT_352	[p16l1306t12r1411b69],
10	et	FW	O	et	nn	11	SENT_352	[p16l1439t18r1490b60],
11	al.	FW	O	al.	appos	2	SENT_352	[p16l1515t10r1578b60],
12	.	.	O	.	_	0	SENT_352	[p16l1515t10r1578b60],

1	Glutathione	NN	O	glutathione	nn	2	SENT_353	[p16l1608t10r1942b60],
2	conjugation	NN	O	conjugation	nsubj	14	SENT_353	[p16l1968t10r2146b75, p16l150t80r326b145],
3	of	IN	O	of	_	0	SENT_353	[p16l351t80r412b130],
4	the	DT	O	the	det	7	SENT_353	[p16l431t80r516b130],
5	cytostatic	JJ	O	cytostatic	amod	7	SENT_353	[p16l541t80r811b144],
6	drug	NN	O	drug	nn	7	SENT_353	[p16l838t80r965b145],
7	ifosfarnide	NN	O	ifosfarnide	prep_of	2	SENT_353	[p16l990t80r1293b130],
8	and	CC	O	and	_	0	SENT_353	[p16l1319t80r1420b130],
9	the	DT	O	the	det	10	SENT_353	[p16l1442t80r1528b130],
10	role	NN	O	role	prep_of	2	SENT_353	[p16l1551t80r1661b130],
11	of	IN	O	of	_	0	SENT_353	[p16l1686t80r1748b130],
12	human	JJ	O	human	amod	13	SENT_353	[p16l1766t80r1960b130],
13	glutathione	NN	O	glutathione	prep_of	10	SENT_353	[p16l1984t80r2146b145, p16l149t151r326b201],
14	S	NN	O	s	_	0	SENT_353	[p16l353t151r765b201],
15	—	CD	NUMBER	—	num	16	SENT_353	[p16l353t151r765b201],
16	transferases	NNS	O	transferase	dobj	14	SENT_353	[p16l353t151r765b201],
17	.	.	O	.	_	0	SENT_353	[p16l353t151r765b201],

1	Chem	NNP	ORGANIZATION	Chem	nn	4	SENT_354	[p16l795t151r964b201],
2	Res	NNP	ORGANIZATION	Res	nn	4	SENT_354	[p16l989t152r1092b201],
3	Toxicol	NNP	O	Toxicol	nn	4	SENT_354	[p16l1120t151r1340b201],
4	l995	NN	O	l995	_	0	SENT_354	[p16l1373t151r1828b210],
5	;	:	O	;	_	0	SENT_354	[p16l1373t151r1828b210],
6	8:979	CD	NUMBER	8:979	number	7	SENT_354	[p16l1373t151r1828b210],
7	—	CD	NUMBER	—	dep	4	SENT_354	[p16l1373t151r1828b210],
8	86	CD	NUMBER	86	dep	7	SENT_354	[p16l1373t151r1828b210],
9	.	.	O	.	_	0	SENT_354	[p16l1373t151r1828b210],

1	Sato	NNP	PERSON	Sato	nn	3	SENT_355	[p16l151t222r274b271],
2	K.	NNP	PERSON	K.	nn	3	SENT_355	[p16l317t223r379b271],
3	Glutathione	NNP	PERSON	Glutathione	_	0	SENT_355	[p16l426t221r760b271],
4	transferases	NNS	O	transferase	dep	3	SENT_355	[p16l801t221r1135b271],
5	as	IN	O	as	_	0	SENT_355	[p16l1180t237r1235b271],
6	markers	NNS	O	marker	prep_as	4	SENT_355	[p16l1277t221r1504b271],
7	of	IN	O	of	_	0	SENT_355	[p16l1548t221r1610b271],
8	preneoplasia	NN	O	preneoplasium	prep_of	6	SENT_355	[p16l1646t221r2007b286],
9	and	CC	O	and	_	0	SENT_355	[p16l2049t221r2149b271],
10	neoplasia	NN	O	neoplasium	conj_and	8	SENT_355	[p16l149t291r432b355],
11	.	.	O	.	_	0	SENT_355	[p16l149t291r432b355],

1	Adv	NNP	O	Adv	nn	3	SENT_356	[p16l460t291r582b341],
2	Cancer	NNP	O	Cancer	nn	3	SENT_356	[p16l608t292r809b341],
3	Res	NNP	O	Res	_	0	SENT_356	[p16l834t292r937b341],
4	1989	CD	DATE	1989	num	3	SENT_356	[p16l972t291r1454b350],
5	;	:	O	;	_	0	SENT_356	[p16l972t291r1454b350],
6	52:205	CD	NUMBER	52:205	number	7	SENT_356	[p16l972t291r1454b350],
7	—	CD	NUMBER	—	dep	3	SENT_356	[p16l972t291r1454b350],
8	47	CD	NUMBER	47	dep	7	SENT_356	[p16l972t291r1454b350],
9	.	.	O	.	_	0	SENT_356	[p16l972t291r1454b350],

1	Moral	JJ	O	moral	amod	2	SENT_357	[p16l149t361r322b410],
2	A	NN	O	a	_	0	SENT_357	[p16l343t361r408b419],
3	,	,	O	,	_	0	SENT_357	[p16l343t361r408b419],
4	Palou	NN	PERSON	palou	nn	5	SENT_357	[p16l432t361r594b410],
5	J	NN	PERSON	j	appos	2	SENT_357	[p16l615t362r656b420],
6	,	,	O	,	_	0	SENT_357	[p16l615t362r656b420],
7	Lafuente	NNP	PERSON	Lafuente	nn	8	SENT_357	[p16l680t361r932b410],
8	A	NNP	O	A	appos	2	SENT_357	[p16l954t361r1019b419],
9	,	,	O	,	_	0	SENT_357	[p16l954t361r1019b419],
10	et	FW	O	et	nn	11	SENT_357	[p16l1044t368r1094b410],
11	al.	FW	O	al.	appos	2	SENT_357	[p16l1116t361r1179b410],
12	.	.	O	.	_	0	SENT_357	[p16l1116t361r1179b410],

1	Immunochemical	JJ	O	immunochemical	amod	2	SENT_358	[p16l1204t361r1702b410],
2	study	NN	O	study	_	0	SENT_358	[p16l1726t361r1876b425],
3	of	IN	O	of	_	0	SENT_358	[p16l1899t361r1961b410],
4	alpha	NN	O	alpha	prep_of	2	SENT_358	[p16l1979t361r2146b425],
5	,	,	O	,	_	0	SENT_358	[p16l1979t361r2146b425],
6	mu	NN	O	mu	prep_of	2	SENT_358	[p16l149t447r238b481],
7	and	CC	O	and	_	0	SENT_358	[p16l276t431r376b481],
8	pi	NN	O	pi	conj_and	4	SENT_358	[p16l410t431r465b496],
9	class	NN	O	class	nn	14	SENT_358	[p16l501t431r636b481],
10	glutathione	NN	O	glutathione	nn	14	SENT_358	[p16l674t431r992b496],
11	S	NN	O	s	nn	14	SENT_358	[p16l1031t431r1400b481],
12	—	CD	NUMBER	—	num	14	SENT_358	[p16l1031t431r1400b481],
13	transferase	NN	O	transferase	nn	14	SENT_358	[p16l1031t431r1400b481],
14	expression	NN	O	expression	dep	2	SENT_358	[p16l1436t431r1740b496],
15	in	IN	O	in	_	0	SENT_358	[p16l1775t431r1829b480],
16	malignant	JJ	O	malignant	amod	17	SENT_358	[p16l1864t431r2149b496],
17	melanoma	NN	O	melanoma	prep_in	14	SENT_358	[p16l149t502r459b552],
18	.	.	O	.	_	0	SENT_358	[p16l149t502r459b552],

1	Brit	NNP	O	Brit	nn	3	SENT_359	[p16l488t502r599b552],
2	J	NNP	O	J	nn	3	SENT_359	[p16l623t503r649b553],
3	Dermatol	NNP	O	Dermatol	_	0	SENT_359	[p16l675t502r943b552],
4	1997	CD	DATE	1997	num	3	SENT_359	[p16l976t502r1485b561],
5	;	:	O	;	_	0	SENT_359	[p16l976t502r1485b561],
6	136:345	CD	NUMBER	136:345	number	7	SENT_359	[p16l976t502r1485b561],
7	—	CD	NUMBER	—	dep	3	SENT_359	[p16l976t502r1485b561],
8	50	CD	NUMBER	50	dep	7	SENT_359	[p16l976t502r1485b561],
9	.	.	O	.	_	0	SENT_359	[p16l976t502r1485b561],

1	Inoue	JJ	ORGANIZATION	inoue	amod	2	SENT_360	[p16l149t573r310b621],
2	T	NN	ORGANIZATION	t	_	0	SENT_360	[p16l339t573r396b630],
3	,	,	O	,	_	0	SENT_360	[p16l339t573r396b630],
4	Ishida	NNP	ORGANIZATION	Ishida	nn	5	SENT_360	[p16l429t572r603b621],
5	T	NN	ORGANIZATION	t	appos	2	SENT_360	[p16l632t573r688b631],
6	,	,	O	,	_	0	SENT_360	[p16l632t573r688b631],
7	Sugio	NNP	ORGANIZATION	Sugio	nn	8	SENT_360	[p16l723t572r885b636],
8	K	NNP	ORGANIZATION	K	appos	2	SENT_360	[p16l917t573r980b631],
9	,	,	O	,	_	0	SENT_360	[p16l917t573r980b631],
10	et	FW	O	et	nn	11	SENT_360	[p16l1013t579r1063b621],
11	al.	FW	O	al.	appos	2	SENT_360	[p16l1094t572r1156b621],
12	.	.	O	.	_	0	SENT_360	[p16l1094t572r1156b621],

1	Glutathione	NN	O	glutathione	nn	2	SENT_361	[p16l1191t572r1525b622],
2	S	NN	O	s	nsubj	9	SENT_361	[p16l1557t572r1926b622],
3	—	CD	NUMBER	—	num	5	SENT_361	[p16l1557t572r1926b622],
4	transferase	NN	O	transferase	nn	5	SENT_361	[p16l1557t572r1926b622],
5	Pi	NN	O	pi	dep	2	SENT_361	[p16l1956t572r2013b621],
6	is	VBZ	O	be	cop	9	SENT_361	[p16l2043t572r2087b621],
7	a	DT	O	a	det	9	SENT_361	[p16l2120t588r2150b621],
8	powerful	JJ	O	powerful	amod	9	SENT_361	[p16l148t642r405b707],
9	indicator	NN	O	indicator	_	0	SENT_361	[p16l440t642r694b692],
10	in	IN	O	in	_	0	SENT_361	[p16l728t642r782b691],
11	chemotherapy	NN	O	chemotherapy	prep_in	9	SENT_361	[p16l818t642r1220b707],
12	of	IN	O	of	_	0	SENT_361	[p16l1257t642r1318b692],
13	human	JJ	O	human	amod	16	SENT_361	[p16l1348t642r1542b692],
14	lung	NN	O	lung	nn	16	SENT_361	[p16l1577t642r1701b707],
15	squamous-cell	NN	O	squamous-cell	nn	16	SENT_361	[p16l1740t642r2148b707],
16	carcinoma	NN	O	carcinoma	prep_of	11	SENT_361	[p16l150t712r459b762],
17	.	.	O	.	_	0	SENT_361	[p16l150t712r459b762],

1	Respiration	NN	O	respiration	_	0	SENT_362	[p16l488t712r816b776],
2	1995	CD	DATE	1995	num	1	SENT_362	[p16l849t712r1287b771],
3	;	:	O	;	_	0	SENT_362	[p16l849t712r1287b771],
4	62:223	CD	NUMBER	62:223	num	5	SENT_362	[p16l849t712r1287b771],
5	—	NN	O	—	dep	1	SENT_362	[p16l849t712r1287b771],
6	7	CD	NUMBER	7	dep	5	SENT_362	[p16l849t712r1287b771],
7	.	.	O	.	_	0	SENT_362	[p16l849t712r1287b771],

1	Lacreat	NNP	O	Lacreat	nn	2	SENT_363	[p16l149t784r362b833],
2	FP	NN	O	fp	_	0	SENT_363	[p16l403t784r496b842],
3	,	,	O	,	_	0	SENT_363	[p16l403t784r496b842],
4	Brennan	NNP	PERSON	Brennan	nn	5	SENT_363	[p16l540t784r781b833],
5	JM	NN	O	jm	appos	2	SENT_363	[p16l822t784r927b842],
6	,	,	O	,	_	0	SENT_363	[p16l822t784r927b842],
7	Nash	NNP	PERSON	Nash	nn	8	SENT_363	[p16l971t783r1116b833],
8	SL	NNP	O	SL	appos	2	SENT_363	[p16l1159t783r1254b842],
9	,	,	O	,	_	0	SENT_363	[p16l1159t783r1254b842],
10	et	FW	O	et	nn	11	SENT_363	[p16l1299t790r1349b833],
11	al.	FW	O	al.	appos	2	SENT_363	[p16l1392t783r1454b833],
12	.	.	O	.	_	0	SENT_363	[p16l1392t783r1454b833],

1	Pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_364	[p16l1499t783r2004b833],
2	and	CC	O	and	_	0	SENT_364	[p16l2049t783r2149b833],
3	bioavailability	NN	O	bioavailability	nn	4	SENT_364	[p16l148t853r560b918],
4	study	NN	O	study	conj_and	1	SENT_364	[p16l587t853r737b918],
5	of	IN	O	of	_	0	SENT_364	[p16l763t853r825b903],
6	ethacrynic	JJ	O	ethacrynic	amod	7	SENT_364	[p16l845t853r1139b918],
7	acid	NN	O	acid	prep_of	1	SENT_364	[p16l1166t853r1283b903],
8	as	IN	O	as	_	0	SENT_364	[p16l1308t869r1362b903],
9	a	DT	O	a	det	10	SENT_364	[p16l1390t869r1420b903],
10	modulator	NN	O	modulator	prep_as	1	SENT_364	[p16l1443t853r1736b903],
11	of	IN	O	of	_	0	SENT_364	[p16l1760t853r1822b903],
12	drug	NN	O	drug	nn	13	SENT_364	[p16l1842t853r1970b918],
13	resistance	NN	O	resistance	prep_of	10	SENT_364	[p16l1994t853r2146b903, p16l149t930r298b973],
14	in	IN	O	in	_	0	SENT_364	[p16l317t923r372b972],
15	patients	NNS	O	patient	prep_in	1	SENT_364	[p16l389t923r609b987],
16	with	IN	O	with	_	0	SENT_364	[p16l631t923r756b973],
17	cancer	NN	O	cancer	prep_with	15	SENT_364	[p16l775t939r974b973],
18	.	.	O	.	_	0	SENT_364	[p16l775t939r974b973],

1	J	NNP	O	J	nn	4	SENT_365	[p16l996t924r1022b973],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_365	[p16l1042t923r1346b973],
3	Exper	NNP	O	Exper	nn	4	SENT_365	[p16l1365t924r1535b987],
4	Therapeut	NNP	O	Therapeut	_	0	SENT_365	[p16l1553t923r1842b987],
5	1994	CD	DATE	1994	num	4	SENT_365	[p16l1867t924r2143b982],
6	;	:	O	;	_	0	SENT_365	[p16l1867t924r2143b982],
7	270	CD	NUMBER	270	num	9	SENT_365	[p16l1867t924r2143b982],
8	:	:	O	:	_	0	SENT_365	[p16l1867t924r2143b982],
9	1186-91	CD	NUMBER	1186-91	dep	4	SENT_365	[p16l156t993r420b1043],
10	.	.	O	.	_	0	SENT_365	[p16l156t993r420b1043],

1	Tidefelt	NNP	O	Tidefelt	nn	2	SENT_366	[p16l149t1063r375b1113],
2	U	NNP	O	U	_	0	SENT_366	[p16l413t1065r478b1122],
3	,	,	O	,	_	0	SENT_366	[p16l413t1065r478b1122],
4	Elmhorm	NNP	PERSON	Elmhorm	appos	2	SENT_366	[p16l520t1063r1122b1128],
5	.	.	O	.	_	0	SENT_366	[p16l520t1063r1122b1128],

1	—	NN	O	—	_	0	SENT_367	[p16l520t1063r1122b1128],
2	.	.	O	.	_	0	SENT_367	[p16l520t1063r1122b1128],

1	Rosenborg	NNP	LOCATION	Rosenborg	nn	2	SENT_368	[p16l520t1063r1122b1128],
2	A	NNP	O	A	_	0	SENT_368	[p16l1162t1064r1227b1122],
3	,	,	O	,	_	0	SENT_368	[p16l1162t1064r1227b1122],
4	Paul	NNP	PERSON	Paul	nn	5	SENT_368	[p16l1269t1063r1395b1113],
5	C	NNP	PERSON	C	appos	2	SENT_368	[p16l1436t1064r1496b1122],
6	,	,	O	,	_	0	SENT_368	[p16l1436t1064r1496b1122],
7	et	FW	O	et	nn	8	SENT_368	[p16l1539t1071r1589b1113],
8	al.	FW	O	al.	appos	5	SENT_368	[p16l1629t1063r1691b1113],
9	.	.	O	.	_	0	SENT_368	[p16l1629t1063r1691b1113],

1	Expression	NN	O	expression	_	0	SENT_369	[p16l1735t1063r2051b1128],
2	of	IN	O	of	_	0	SENT_369	[p16l2091t1063r2153b1113],
3	human	JJ	O	human	amod	4	SENT_369	[p16l148t1133r342b1183],
4	p.	NN	O	p.	prep_of	1	SENT_369	[p16l377t1151r417b1197],
5	or	CC	O	or	_	0	SENT_369	[p16l449t1149r507b1183],
6	or	CC	O	or	_	0	SENT_369	[p16l537t1151r576b1182],
7	class	NN	O	class	nn	9	SENT_369	[p16l608t1133r743b1183],
8	glutathione	NN	O	glutathione	nn	9	SENT_369	[p16l776t1133r1094b1198],
9	S	NN	O	s	conj_or	4	SENT_369	[p16l1127t1133r1522b1183],
10	—	CD	NUMBER	—	num	11	SENT_369	[p16l1127t1133r1522b1183],
11	transferases	NNS	O	transferase	dep	9	SENT_369	[p16l1127t1133r1522b1183],
12	in	IN	O	in	prep	1	SENT_369	[p16l1554t1133r1608b1182],
13	stably	RB	O	stably	pcomp	12	SENT_369	[p16l1640t1133r1806b1198],
14	transfected	VBN	O	transfect	partmod	1	SENT_369	[p16l1837t1133r2149b1183],
15	human	JJ	O	human	amod	17	SENT_369	[p16l149t1203r342b1252],
16	NCF	NN	O	ncf	nn	17	SENT_369	[p16l377t1203r571b1253],
17	—	NN	O	—	dobj	14	SENT_369	[p16l377t1203r571b1253],
18	7	CD	NUMBER	7	num	21	SENT_369	[p16l377t1203r571b1253],
19	breast	NN	O	breast	nn	21	SENT_369	[p16l608t1203r779b1252],
20	cancer	NN	O	cancer	nn	21	SENT_369	[p16l814t1219r1000b1252],
21	cells	NNS	O	cell	dep	17	SENT_369	[p16l1034t1203r1178b1252],
22	:	:	O	:	_	0	SENT_369	[p16l1034t1203r1178b1252],
23	effect	NN	O	effect	dep	17	SENT_369	[p16l1218t1203r1379b1252],
24	on	IN	O	on	_	0	SENT_369	[p16l1415t1219r1484b1252],
25	cellular	JJ	O	cellular	amod	26	SENT_369	[p16l1520t1203r1733b1252],
26	sensitivity	NN	O	sensitivity	prep_on	23	SENT_369	[p16l1770t1203r2059b1267],
27	to	TO	O	to	_	0	SENT_369	[p16l2095t1210r2148b1252],
28	cytotoxic	JJ	O	cytotoxic	amod	29	SENT_369	[p16l150t1273r412b1338],
29	agents	NNS	O	agent	prep_to	14	SENT_369	[p16l440t1281r634b1338],
30	.	.	O	.	_	0	SENT_369	[p16l440t1281r634b1338],

1	Mol	NNP	ORGANIZATION	Mol	nn	2	SENT_370	[p16l663t1273r780b1323],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_370	[p16l806t1273r1110b1323],
3	1992	CD	DATE	1992	num	2	SENT_370	[p16l1142t1273r1598b1332],
4	;	:	O	;	_	0	SENT_370	[p16l1142t1273r1598b1332],
5	41:230	CD	NUMBER	41:230	number	6	SENT_370	[p16l1142t1273r1598b1332],
6	—	CD	NUMBER	—	dep	2	SENT_370	[p16l1142t1273r1598b1332],
7	6	CD	NUMBER	6	dep	6	SENT_370	[p16l1142t1273r1598b1332],
8	.	.	O	.	_	0	SENT_370	[p16l1142t1273r1598b1332],

1	Sauerbrey	NNP	PERSON	Sauerbrey	nn	2	SENT_371	[p16l151t1343r436b1408],
2	A	NNP	O	A	nsubj	10	SENT_371	[p16l472t1344r537b1402],
3	,	,	O	,	_	0	SENT_371	[p16l472t1344r537b1402],
4	Zintl	NNP	O	Zintl	nn	5	SENT_371	[p16l574t1343r712b1393],
5	F	NN	O	f	appos	2	SENT_371	[p16l747t1344r800b1402],
6	,	,	O	,	_	0	SENT_371	[p16l747t1344r800b1402],
7	Volm	NNP	O	Volm	nn	8	SENT_371	[p16l838t1343r1001b1393],
8	M.	NNP	O	M.	appos	5	SENT_371	[p16l1034t1344r1110b1393],
9	Resistance	NNP	O	Resistance	dep	10	SENT_371	[p16l1149t1343r1453b1393],
10	factors	NNS	O	factor	_	0	SENT_371	[p16l1488t1343r1679b1393],
11	and	CC	O	and	_	0	SENT_371	[p16l1718t1343r1818b1393],
12	proliferate	VBP	O	proliferate	conj_and	10	SENT_371	[p16l1852t1343r2148b1407],
13	activity	NN	O	activity	dobj	12	SENT_371	[p16l151t1413r361b1477],
14	in	IN	O	in	_	0	SENT_371	[p16l384t1413r438b1462],
15	childhood	NN	O	childhood	nn	18	SENT_371	[p16l461t1413r745b1462],
16	acute	JJ	O	acute	amod	18	SENT_371	[p16l768t1420r915b1462],
17	non-lymphoblastic	JJ	O	non-lymphoblastic	amod	18	SENT_371	[p16l938t1413r1471b1477],
18	leukaemia	NN	O	leukaemia	prep_in	12	SENT_371	[p16l1495t1413r1801b1462],
19	.	.	O	.	_	0	SENT_371	[p16l1495t1413r1801b1462],

1	Int	NN	O	int	nn	3	SENT_372	[p16l1827t1414r1906b1462],
2	J	NN	O	j	nn	3	SENT_372	[p16l1927t1414r1953b1463],
3	Oncol	NN	O	oncol	_	0	SENT_372	[p16l1977t1413r2148b1463],
4	1994	CD	DATE	1994	dep	3	SENT_372	[p16l156t1484r567b1543],
5	;	:	O	;	_	0	SENT_372	[p16l156t1484r567b1543],
6	5:841	CD	NUMBER	5:841	number	7	SENT_372	[p16l156t1484r567b1543],
7	—	CD	NUMBER	—	dep	3	SENT_372	[p16l156t1484r567b1543],
8	6	CD	NUMBER	6	dep	7	SENT_372	[p16l156t1484r567b1543],
9	.	.	O	.	_	0	SENT_372	[p16l156t1484r567b1543],

1	Mulder	NNP	PERSON	Mulder	nn	2	SENT_373	[p16l149t1554r359b1604],
2	TPJ	NNP	O	TPJ	_	0	SENT_373	[p16l389t1555r514b1613],
3	,	,	O	,	_	0	SENT_373	[p16l389t1555r514b1613],
4	Verspaget	NNP	O	Verspaget	nn	5	SENT_373	[p16l547t1555r837b1619],
5	HW	NNP	O	HW	appos	2	SENT_373	[p16l867t1555r1000b1613],
6	,	,	O	,	_	0	SENT_373	[p16l867t1555r1000b1613],
7	Sier	NNP	ORGANIZATION	Sier	nn	8	SENT_373	[p16l1036t1554r1148b1604],
8	CFM	NNP	ORGANIZATION	CFM	appos	2	SENT_373	[p16l1179t1555r1343b1613],
9	,	,	O	,	_	0	SENT_373	[p16l1179t1555r1343b1613],
10	et	FW	O	et	nn	11	SENT_373	[p16l1377t1561r1428b1604],
11	al.	FW	O	al.	appos	2	SENT_373	[p16l1459t1554r1522b1604],
12	.	.	O	.	_	0	SENT_373	[p16l1459t1554r1522b1604],

1	Glutathione	NN	O	glutathione	nn	2	SENT_374	[p16l1558t1554r1892b1604],
2	S	NN	O	s	nsubj	11	SENT_374	[p16l1926t1555r2146b1604],
3	—	CD	NUMBER	—	num	6	SENT_374	[p16l1926t1555r2146b1604],
4	trans	JJ	O	trans	amod	6	SENT_374	[p16l1926t1555r2146b1604],
5	—	NN	O	—	nn	6	SENT_374	[p16l1926t1555r2146b1604],
6	ferase-Tr	NN	O	ferase-tr	dep	2	SENT_374	[p16l149t1624r388b1673],
7	in	IN	O	in	_	0	SENT_374	[p16l412t1624r466b1673],
8	colorectal	JJ	O	colorectal	amod	9	SENT_374	[p16l488t1624r767b1673],
9	tumours	NNS	O	tumour	prep_in	2	SENT_374	[p16l790t1631r1021b1673],
10	is	VBZ	O	be	cop	11	SENT_374	[p16l1045t1624r1089b1673],
11	predictive	JJ	O	predictive	_	0	SENT_374	[p16l1112t1624r1397b1688],
12	for	IN	O	for	_	0	SENT_374	[p16l1420t1624r1503b1673],
13	overall	JJ	O	overall	amod	14	SENT_374	[p16l1525t1624r1720b1673],
14	survival	NN	O	survival	prep_for	11	SENT_374	[p16l1745t1624r1985b1673],
15	.	.	O	.	_	0	SENT_374	[p16l1745t1624r1985b1673],

1	Cancer	NNP	O	Cancer	nn	2	SENT_375	[p16l2012t1624r2146b1674, p16l150t1711r236b1745],
2	Res	NNP	O	Res	_	0	SENT_375	[p16l260t1697r364b1745],
3	1995	CD	DATE	1995	num	2	SENT_375	[p16l398t1695r952b1754],
4	;	:	O	;	_	0	SENT_375	[p16l398t1695r952b1754],
5	55:2696	CD	NUMBER	55:2696	num	6	SENT_375	[p16l398t1695r952b1754],
6	—	NN	O	—	dep	2	SENT_375	[p16l398t1695r952b1754],
7	702	CD	NUMBER	702	dep	6	SENT_375	[p16l398t1695r952b1754],
8	.	.	O	.	_	0	SENT_375	[p16l398t1695r952b1754],

1	Ojima	NNP	MISC	Ojima	_	0	SENT_376	[p16l151t1765r327b1830],
2	I	PRP	O	I	dep	1	SENT_376	[p16l349t1766r386b1824],
3	,	,	O	,	_	0	SENT_376	[p16l349t1766r386b1824],
4	Bounaud	JJ	O	bounaud	amod	5	SENT_376	[p16l412t1765r669b1815],
5	P	NN	O	p	appos	2	SENT_376	[p16l691t1766r820b1824],
6	.	.	O	.	_	0	SENT_376	[p16l691t1766r820b1824],

1	—	NN	O	—	_	0	SENT_377	[p16l691t1766r820b1824],
2	.	.	O	.	_	0	SENT_377	[p16l691t1766r820b1824],

1	Y	NN	O	y	nn	6	SENT_378	[p16l691t1766r820b1824],
2	,	,	O	,	_	0	SENT_378	[p16l691t1766r820b1824],
3	Ordeda	NNP	O	Ordeda	dep	6	SENT_378	[p16l847t1765r1055b1815],
4	F.	NNP	O	F.	nn	6	SENT_378	[p16l1077t1766r1129b1815],
5	Recent	JJ	O	recent	amod	6	SENT_378	[p16l1156t1766r1354b1815],
6	strategies	NNS	O	strategy	_	0	SENT_378	[p16l1378t1765r1642b1830],
7	for	IN	O	for	_	0	SENT_378	[p16l1667t1765r1750b1815],
8	the	DT	O	the	det	9	SENT_378	[p16l1771t1765r1856b1815],
9	treatment	NN	O	treatment	prep_for	6	SENT_378	[p16l1880t1773r2149b1815],
10	of	IN	O	of	_	0	SENT_378	[p16l150t1835r212b1884],
11	multi-drug	JJ	O	multi-drug	amod	12	SENT_378	[p16l229t1835r532b1899],
12	resistance	NN	O	resistance	prep_of	9	SENT_378	[p16l554t1835r834b1884],
13	in	IN	O	in	_	0	SENT_378	[p16l857t1835r910b1884],
14	cancer	NN	O	cancer	nn	15	SENT_378	[p16l933t1851r1118b1884],
15	cells	NNS	O	cell	prep_in	6	SENT_378	[p16l1139t1835r1282b1884],
16	.	.	O	.	_	0	SENT_378	[p16l1139t1835r1282b1884],

1	Exp	NNP	O	Exp	nn	4	SENT_379	[p16l1307t1836r1420b1899],
2	Opin	NNP	O	Opin	nn	4	SENT_379	[p16l1444t1835r1584b1899],
3	Ther	NNP	O	Ther	nn	4	SENT_379	[p16l1606t1835r1740b1884],
4	Patents	NNP	O	Patents	_	0	SENT_379	[p16l1761t1836r1964b1884],
5	1998	CD	DATE	1998	num	4	SENT_379	[p16l1994t1835r2146b1894],
6	;	:	O	;	_	0	SENT_379	[p16l1994t1835r2146b1894],
7	821587-98	CD	NUMBER	821587-98	dep	4	SENT_379	[p16l152t1904r467b1955],
8	.	.	O	.	_	0	SENT_379	[p16l152t1904r467b1955],

1	Taylor	NNP	ORGANIZATION	Taylor	nn	2	SENT_380	[p16l149t1975r339b2039],
2	CW	NNP	ORGANIZATION	CW	_	0	SENT_380	[p16l360t1976r487b2034],
3	,	,	O	,	_	0	SENT_380	[p16l360t1976r487b2034],
4	Dalton	NNP	PERSON	Dalton	nn	5	SENT_380	[p16l512t1975r705b2025],
5	WS	NNP	O	WS	appos	2	SENT_380	[p16l725t1976r846b2034],
6	,	,	O	,	_	0	SENT_380	[p16l725t1976r846b2034],
7	Mosley	NNP	PERSON	Mosley	nn	8	SENT_380	[p16l870t1975r1082b2039],
8	K	NNP	PERSON	K	appos	2	SENT_380	[p16l1105t1976r1169b2034],
9	,	,	O	,	_	0	SENT_380	[p16l1105t1976r1169b2034],
10	et	FW	O	et	nn	11	SENT_380	[p16l1193t1983r1243b2025],
11	al.	FW	O	al.	appos	2	SENT_380	[p16l1265t1975r1328b2025],
12	.	.	O	.	_	0	SENT_380	[p16l1265t1975r1328b2025],

1	Combination	NN	O	combination	nn	2	SENT_381	[p16l1353t1975r1724b2025],
2	chemotherapy	NN	O	chemotherapy	_	0	SENT_381	[p16l1746t1975r2148b2040],
3	with	IN	O	with	_	0	SENT_381	[p16l150t2045r275b2094],
4	cyclophosphamide	NN	O	cyclophosphamide	prep_with	2	SENT_381	[p16l304t2045r852b2109],
5	,	,	O	,	_	0	SENT_381	[p16l304t2045r852b2109],
6	vincristine	NN	O	vincristine	conj_and	4	SENT_381	[p16l884t2045r1199b2103],
7	,	,	O	,	_	0	SENT_381	[p16l884t2045r1199b2103],
8	adriamycin	NN	O	adriamycin	conj_and	4	SENT_381	[p16l1232t2045r1551b2109],
9	and	CC	O	and	_	0	SENT_381	[p16l1581t2045r1681b2094],
10	dexamethasone	NN	O	dexamethasone	conj_and	4	SENT_381	[p16l1710t2045r2148b2094],
11	(	CD	NUMBER	(	num	13	SENT_381	[p16l152t2116r395b2177],
12	CAVD	NN	O	cavd	nn	13	SENT_381	[p16l152t2116r395b2177],
13	)	NN	O	)	dep	2	SENT_381	[p16l152t2116r395b2177],
14	plus	CC	O	plus	prep	13	SENT_381	[p16l425t2115r542b2180],
15	oral	JJ	O	oral	amod	16	SENT_381	[p16l573t2115r682b2165],
16	quinine	NN	O	quinine	dep	14	SENT_381	[p16l711t2115r922b2180],
17	and	CC	O	and	_	0	SENT_381	[p16l953t2115r1053b2165],
18	verapamil	NN	O	verapamil	conj_and	16	SENT_381	[p16l1082t2115r1365b2180],
19	in	IN	O	in	_	0	SENT_381	[p16l1394t2115r1449b2164],
20	patients	NNS	O	patient	prep_in	13	SENT_381	[p16l1476t2115r1696b2180],
21	with	IN	O	with	_	0	SENT_381	[p16l1726t2115r1852b2165],
22	advanced	JJ	O	advanced	amod	24	SENT_381	[p16l1882t2115r2149b2165],
23	breast	NN	O	breast	nn	24	SENT_381	[p16l148t2186r319b2236],
24	cancer	NN	O	cancer	prep_with	20	SENT_381	[p16l344t2202r542b2236],
25	.	.	O	.	_	0	SENT_381	[p16l344t2202r542b2236],

1	Breast	NN	O	breast	nn	4	SENT_382	[p16l572t2187r753b2236],
2	Cancer	NN	O	cancer	nn	4	SENT_382	[p16l779t2187r980b2237],
3	Res	NNP	O	Res	nn	4	SENT_382	[p16l1004t2187r1108b2236],
4	Treat	NNP	O	Treat	_	0	SENT_382	[p16l1135t2187r1285b2236],
5	1997	CD	DATE	1997	num	4	SENT_382	[p16l1317t2186r1719b2245],
6	;	:	O	;	_	0	SENT_382	[p16l1317t2186r1719b2245],
7	42:7	CD	NUMBER	42:7	number	8	SENT_382	[p16l1317t2186r1719b2245],
8	—	CD	NUMBER	—	dep	4	SENT_382	[p16l1317t2186r1719b2245],
9	14	CD	NUMBER	14	dep	8	SENT_382	[p16l1317t2186r1719b2245],
10	.	.	O	.	_	0	SENT_382	[p16l1317t2186r1719b2245],

1	Rifﬂdn	NNP	O	Rifﬂdn	nn	2	SENT_383	[p16l149t2256r354b2305],
2	CD	NNP	O	CD	_	0	SENT_383	[p16l377t2256r489b2315],
3	,	,	O	,	_	0	SENT_383	[p16l377t2256r489b2315],
4	Chung	NNP	PERSON	Chung	nn	5	SENT_383	[p16l515t2256r702b2320],
5	R	NNP	PERSON	R	appos	2	SENT_383	[p16l726t2257r787b2314],
6	,	,	O	,	_	0	SENT_383	[p16l726t2257r787b2314],
7	Wall	NNP	O	Wall	nn	8	SENT_383	[p16l812t2256r949b2305],
8	DM	NN	O	dm	appos	2	SENT_383	[p16l972t2257r1101b2315],
9	,	,	O	,	_	0	SENT_383	[p16l972t2257r1101b2315],
10	et	FW	O	et	nn	11	SENT_383	[p16l1127t2263r1177b2305],
11	al.	FW	O	al.	appos	2	SENT_383	[p16l1200t2256r1262b2305],
12	.	.	O	.	_	0	SENT_383	[p16l1200t2256r1262b2305],

1	Modulation	NN	O	modulation	_	0	SENT_384	[p16l1288t2256r1620b2305],
2	of	IN	O	of	_	0	SENT_384	[p16l1644t2256r1705b2305],
3	the	DT	O	the	det	4	SENT_384	[p16l1723t2256r1808b2305],
4	function	NN	O	function	prep_of	1	SENT_384	[p16l1832t2256r2068b2305],
5	of	IN	O	of	_	0	SENT_384	[p16l2092t2256r2153b2305],
6	human	JJ	O	human	amod	8	SENT_384	[p16l148t2326r342b2376],
7	MDR1	NN	O	mdr1	nn	8	SENT_384	[p16l373t2327r565b2375],
8	P	NN	O	p	prep_of	4	SENT_384	[p16l603t2326r1026b2391],
9	—	CD	NUMBER	—	num	10	SENT_384	[p16l603t2326r1026b2391],
10	glycoprotein	NN	O	glycoprotein	dep	1	SENT_384	[p16l603t2326r1026b2391],
11	by	IN	O	by	_	0	SENT_384	[p16l1057t2326r1127b2391],
12	the	DT	O	the	det	15	SENT_384	[p16l1159t2326r1245b2376],
13	antimalarial	JJ	O	antimalarial	amod	15	SENT_384	[p16l1279t2326r1617b2376],
14	drug	NN	O	drug	nn	15	SENT_384	[p16l1650t2326r1778b2391],
15	meﬂoquine	NN	O	meﬂoquine	prep_by	10	SENT_384	[p16l1811t2326r2145b2391],
16	.	.	O	.	_	0	SENT_384	[p16l1811t2326r2145b2391],

1	Biochem	NNP	O	Biochem	nn	2	SENT_385	[p16l149t2397r406b2447],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_385	[p16l431t2397r734b2447],
3	1996	CD	DATE	1996	num	2	SENT_385	[p16l767t2397r1277b2456],
4	;	:	O	;	_	0	SENT_385	[p16l767t2397r1277b2456],
5	52:1545	CD	NUMBER	52:1545	number	6	SENT_385	[p16l767t2397r1277b2456],
6	—	CD	NUMBER	—	dep	2	SENT_385	[p16l767t2397r1277b2456],
7	52	CD	NUMBER	52	dep	6	SENT_385	[p16l767t2397r1277b2456],
8	.	.	O	.	_	0	SENT_385	[p16l767t2397r1277b2456],

1	Lerhnert	NNP	O	Lerhnert	nn	2	SENT_386	[p16l149t2467r394b2516],
2	M	NNP	O	M	_	0	SENT_386	[p16l432t2468r510b2526],
3	,	,	O	,	_	0	SENT_386	[p16l432t2468r510b2526],
4	Dalton	NNP	PERSON	Dalton	nn	5	SENT_386	[p16l552t2467r745b2516],
5	WS	NNP	O	WS	appos	2	SENT_386	[p16l783t2467r905b2525],
6	,	,	O	,	_	0	SENT_386	[p16l783t2467r905b2525],
7	Roe	NNP	PERSON	Roe	nn	8	SENT_386	[p16l947t2468r1060b2516],
8	D	NNP	PERSON	D	appos	2	SENT_386	[p16l1100t2468r1165b2526],
9	,	,	O	,	_	0	SENT_386	[p16l1100t2468r1165b2526],
10	et	FW	O	et	nn	11	SENT_386	[p16l1208t2474r1258b2516],
11	al.	FW	O	al.	appos	2	SENT_386	[p16l1298t2467r1360b2516],
12	.	.	O	.	_	0	SENT_386	[p16l1298t2467r1360b2516],

1	Synergistic	JJ	MISC	synergistic	amod	2	SENT_387	[p16l1406t2467r1722b2531],
2	inhibition	NN	O	inhibition	nsubj	12	SENT_387	[p16l1763t2467r2039b2516],
3	by	IN	O	by	_	0	SENT_387	[p16l2078t2467r2148b2531],
4	verapamil	NN	O	verapamil	prep_by	2	SENT_387	[p16l149t2537r433b2602],
5	and	CC	O	and	_	0	SENT_387	[p16l468t2537r569b2587],
6	quinine	NN	O	quinine	prep_by	2	SENT_387	[p16l602t2537r814b2602],
7	of	IN	O	of	_	0	SENT_387	[p16l849t2537r911b2587],
8	P	NN	O	p	nn	11	SENT_387	[p16l939t2537r1648b2602],
9	—	CD	NUMBER	—	num	11	SENT_387	[p16l939t2537r1648b2602],
10	glycoprotein	NN	O	glycoprotein	nn	11	SENT_387	[p16l939t2537r1648b2602],
11	—	NN	O	—	prep_of	4	SENT_387	[p16l939t2537r1648b2602],
12	mediated	VBD	O	mediate	_	0	SENT_387	[p16l939t2537r1648b2602],
13	multidrug	JJ	O	multidrug	amod	14	SENT_387	[p16l1681t2537r1961b2602],
14	resistance	NN	O	resistance	dobj	12	SENT_387	[p16l1994t2537r2146b2587, p16l149t2614r298b2657],
15	in	IN	O	in	_	0	SENT_387	[p16l324t2607r378b2656],
16	a	DT	O	a	det	21	SENT_387	[p16l405t2623r434b2657],
17	human	JJ	O	human	amod	21	SENT_387	[p16l458t2607r651b2657],
18	myeloma	NN	O	myeloma	nn	21	SENT_387	[p16l677t2607r942b2671],
19	cell	NN	O	cell	nn	21	SENT_387	[p16l967t2607r1068b2657],
20	line	NN	O	line	nn	21	SENT_387	[p16l1094t2607r1198b2657],
21	model	NN	O	model	prep_in	12	SENT_387	[p16l1225t2607r1416b2657],
22	.	.	O	.	_	0	SENT_387	[p16l1225t2607r1416b2657],

1	Blood	NN	O	blood	_	0	SENT_388	[p16l1444t2607r1618b2657],
2	1991	CD	DATE	1991	num	1	SENT_388	[p16l1650t2608r2000b2666],
3	;	:	O	;	_	0	SENT_388	[p16l1650t2608r2000b2666],
4	72:348	CD	NUMBER	72:348	number	5	SENT_388	[p16l1650t2608r2000b2666],
5	-54	CD	NUMBER	-54	dep	1	SENT_388	[p16l2012t2607r2133b2657],
6	.	.	O	.	_	0	SENT_388	[p16l2012t2607r2133b2657],

1	Solary	JJ	O	solary	amod	2	SENT_389	[p16l151t2677r333b2741],
2	E	NN	O	e	_	0	SENT_389	[p16l356t2678r413b2736],
3	,	,	O	,	_	0	SENT_389	[p16l356t2678r413b2736],
4	Caillot	NN	PERSON	caillot	nn	5	SENT_389	[p16l439t2677r632b2727],
5	D	NN	O	d	appos	2	SENT_389	[p16l654t2678r719b2736],
6	,	,	O	,	_	0	SENT_389	[p16l654t2678r719b2736],
7	Chauffert	NN	O	chauffert	nn	8	SENT_389	[p16l745t2677r1017b2727],
8	B	NN	O	b	appos	2	SENT_389	[p16l1038t2678r1100b2736],
9	,	,	O	,	_	0	SENT_389	[p16l1038t2678r1100b2736],
10	et	FW	O	et	nn	11	SENT_389	[p16l1125t2684r1175b2726],
11	al.	FW	O	al.	appos	2	SENT_389	[p16l1199t2677r1261b2726],
12	.	.	O	.	_	0	SENT_389	[p16l1199t2677r1261b2726],

1	Feasibility	NN	O	feasibility	_	0	SENT_390	[p16l1287t2677r1586b2741],
2	of	IN	O	of	_	0	SENT_390	[p16l1610t2677r1672b2726],
3	using	VBG	O	use	prepc_of	1	SENT_390	[p16l1689t2677r1842b2741],
4	quinine	NN	O	quinine	dobj	3	SENT_390	[p16l1866t2677r2093b2741],
5	,	,	O	,	_	0	SENT_390	[p16l1866t2677r2093b2741],
6	a	DT	O	a	det	10	SENT_390	[p16l2120t2693r2149b2726],
7	potential	JJ	O	potential	amod	10	SENT_390	[p16l148t2747r397b2812],
8	multidrug	JJ	O	multidrug	amod	10	SENT_390	[p16l430t2747r709b2812],
9	resistance-reversing	JJ	O	resistance-reversing	amod	10	SENT_390	[p16l742t2747r1312b2812],
10	agent	NN	O	agent	appos	4	SENT_390	[p16l1347t2755r1513b2812],
11	,	,	O	,	_	0	SENT_390	[p16l1347t2755r1513b2812],
12	in	IN	O	in	_	0	SENT_390	[p16l1548t2747r1602b2796],
13	combination	NN	O	combination	prep_in	4	SENT_390	[p16l1635t2747r1990b2797],
14	with	IN	O	with	_	0	SENT_390	[p16l2023t2747r2149b2797],
15	rnitoxanthrone	NN	O	rnitoxanthrone	prep_with	3	SENT_390	[p16l149t2817r564b2867],
16	and	CC	O	and	_	0	SENT_390	[p16l595t2817r695b2867],
17	cytarabine	NN	O	cytarabine	conj_and	15	SENT_390	[p16l725t2817r1020b2881],
18	for	IN	O	for	_	0	SENT_390	[p16l1050t2817r1133b2867],
19	the	DT	O	the	det	20	SENT_390	[p16l1160t2817r1246b2867],
20	treatment	NN	O	treatment	prep_for	3	SENT_390	[p16l1275t2824r1545b2867],
21	of	IN	O	of	_	0	SENT_390	[p16l1574t2817r1635b2867],
22	acute	JJ	O	acute	amod	23	SENT_390	[p16l1662t2825r1809b2867],
23	leukaemia	NN	O	leukaemia	prep_of	20	SENT_390	[p16l1839t2817r2145b2867],
24	.	.	O	.	_	0	SENT_390	[p16l1839t2817r2145b2867],

1	J	NNP	O	J	nn	3	SENT_391	[p16l149t2889r175b2938],
2	Clin	NNP	O	Clin	nn	3	SENT_391	[p16l201t2888r322b2938],
3	Oncol	NNP	O	Oncol	_	0	SENT_391	[p16l349t2888r520b2938],
4	1992	CD	DATE	1992	num	3	SENT_391	[p16l553t2888r1044b2947],
5	;	:	O	;	_	0	SENT_391	[p16l553t2888r1044b2947],
6	10:1730	CD	NUMBER	10:1730	number	7	SENT_391	[p16l553t2888r1044b2947],
7	—	CD	NUMBER	—	dep	3	SENT_391	[p16l553t2888r1044b2947],
8	6	CD	NUMBER	6	dep	7	SENT_391	[p16l553t2888r1044b2947],
9	.	.	O	.	_	0	SENT_391	[p16l553t2888r1044b2947],

1	Belhoussine	NNP	PERSON	Belhoussine	nn	2	SENT_392	[p16l149t2958r496b3008],
2	R	NNP	PERSON	R	_	0	SENT_392	[p16l525t2960r586b3017],
3	,	,	O	,	_	0	SENT_392	[p16l525t2960r586b3017],
4	Morjani	NNP	PERSON	Morjani	nn	5	SENT_392	[p16l617t2958r846b3023],
5	H	NNP	PERSON	H	appos	2	SENT_392	[p16l874t2960r940b3017],
6	,	,	O	,	_	0	SENT_392	[p16l874t2960r940b3017],
7	Lahlil	NNP	O	Lahlil	nn	8	SENT_392	[p16l970t2958r1139b3008],
8	R	NNP	O	R	appos	2	SENT_392	[p16l1168t2960r1229b3017],
9	,	,	O	,	_	0	SENT_392	[p16l1168t2960r1229b3017],
10	et	FW	O	et	nn	11	SENT_392	[p16l1261t2966r1312b3008],
11	al.	FW	O	al.	appos	2	SENT_392	[p16l1340t2958r1403b3008],
12	.	.	O	.	_	0	SENT_392	[p16l1340t2958r1403b3008],

1	Evidence	NN	O	evidence	conj_and	1	SENT_393	[p16l1435t2958r1699b3008],
2	for	IN	O	for	_	0	SENT_393	[p16l1728t2958r1810b3008],
3	reversal	NN	O	reversal	prep_for	1	SENT_393	[p16l1837t2958r2062b3008],
4	of	IN	O	of	_	0	SENT_393	[p16l2092t2958r2153b3008],
5	multidrug	JJ	O	multidrug	amod	6	SENT_393	[p16l149t3028r428b3093],
6	resistance	NN	O	resistance	prep_of	1	SENT_393	[p16l458t3028r739b3078],
7	by	IN	O	by	_	0	SENT_393	[p16l768t3028r838b3093],
8	quinine	NN	O	quinine	prep_by	1	SENT_393	[p16l870t3028r1081b3093],
9	in	IN	O	in	_	0	SENT_393	[p16l1111t3028r1166b3077],
10	LR73	NN	O	lr73	nn	11	SENT_393	[p16l1195t3029r1353b3078],
11	cells	NNS	O	cell	prep_in	1	SENT_393	[p16l1387t3028r1514b3078],
12	without	IN	O	without	_	0	SENT_393	[p16l1546t3028r1763b3078],
13	alteration	NN	O	alteration	prep_without	1	SENT_393	[p16l1794t3028r2061b3078],
14	of	IN	O	of	_	0	SENT_393	[p16l2091t3028r2153b3078],
15	nuclear	JJ	O	nuclear	amod	17	SENT_393	[p16l149t3098r359b3147],
16	pirarubicin	NN	O	pirarubicin	nn	17	SENT_393	[p16l379t3098r691b3162],
17	uptake	NN	O	uptake	prep_of	13	SENT_393	[p16l712t3098r901b3162],
18	and	CC	O	and	_	0	SENT_393	[p16l925t3098r1025b3147],
19	down	IN	O	down	_	0	SENT_393	[p16l1047t3098r1203b3147],
20	regulation	NN	O	regulation	prep_down	1	SENT_393	[p16l1224t3098r1513b3162],
21	of	IN	O	of	_	0	SENT_393	[p16l1536t3098r1597b3147],
22	mdrl	NN	O	mdrl	nn	24	SENT_393	[p16l1614t3098r1757b3147],
23	gene	NN	O	gene	nn	24	SENT_393	[p16l1786t3114r1918b3162],
24	expression	NN	O	expression	prep_of	1	SENT_393	[p16l1941t3114r2146b3162, p16l152t3169r281b3220],
25	.	.	O	.	_	0	SENT_393	[p16l1941t3114r2146b3162, p16l152t3169r281b3220],

1	Int	NN	O	int	nn	3	SENT_394	[p16l310t3171r389b3219],
2	J	NN	O	j	nn	3	SENT_394	[p16l413t3171r439b3220],
3	Cancer	NN	O	cancer	_	0	SENT_394	[p16l466t3170r666b3220],
4	1997	CD	DATE	1997	dep	3	SENT_394	[p16l698t3169r1153b3228],
5	;	:	O	;	_	0	SENT_394	[p16l698t3169r1153b3228],
6	73:600	CD	NUMBER	73:600	number	7	SENT_394	[p16l698t3169r1153b3228],
7	—	CD	NUMBER	—	dep	3	SENT_394	[p16l698t3169r1153b3228],
8	6	CD	NUMBER	6	dep	7	SENT_394	[p16l698t3169r1153b3228],
9	.	.	O	.	_	0	SENT_394	[p16l698t3169r1153b3228],

1	Bennis	NNP	PERSON	Bennis	nn	2	SENT_395	[p16l149t3239r344b3289],
2	S	NNP	O	S	_	0	SENT_395	[p16l382t3239r433b3298],
3	,	,	O	,	_	0	SENT_395	[p16l382t3239r433b3298],
4	Ichas	NNP	O	Ichas	nn	5	SENT_395	[p16l470t3239r617b3289],
5	F	NN	O	f	appos	2	SENT_395	[p16l653t3240r706b3298],
6	,	,	O	,	_	0	SENT_395	[p16l653t3240r706b3298],
7	Robert	NNP	PERSON	Robert	nn	8	SENT_395	[p16l743t3239r937b3289],
8	J	NNP	PERSON	J	appos	5	SENT_395	[p16l970t3240r996b3289],
9	.	.	O	.	_	0	SENT_395	[p16l1002t3280r1010b3289],

1	Differential	JJ	O	differential	amod	2	SENT_396	[p16l1048t3239r1379b3289],
2	effects	NNS	O	effect	_	0	SENT_396	[p16l1415t3239r1601b3289],
3	of	IN	O	of	_	0	SENT_396	[p16l1638t3239r1699b3289],
4	verapamil	NN	O	verapamil	prep_of	2	SENT_396	[p16l1729t3239r2013b3303],
5	and	CC	O	and	_	0	SENT_396	[p16l2048t3239r2149b3289],
6	quinine	NN	O	quinine	prep_of	2	SENT_396	[p16l150t3309r361b3373],
7	on	IN	O	on	_	0	SENT_396	[p16l387t3325r455b3358],
8	the	DT	O	the	det	9	SENT_396	[p16l480t3309r565b3358],
9	reversal	NN	O	reversal	prep_on	2	SENT_396	[p16l588t3309r813b3358],
10	of	IN	O	of	_	0	SENT_396	[p16l839t3309r900b3358],
11	doxorubicin	NN	O	doxorubicin	nn	12	SENT_396	[p16l920t3309r1263b3358],
12	resistance	NN	O	resistance	prep_of	9	SENT_396	[p16l1286t3309r1567b3358],
13	in	IN	O	in	_	0	SENT_396	[p16l1591t3309r1645b3358],
14	a	DT	O	a	det	18	SENT_396	[p16l1670t3325r1700b3358],
15	human	JJ	O	human	amod	18	SENT_396	[p16l1722t3309r1916b3358],
16	leukaemia	NN	O	leukaemia	nn	18	SENT_396	[p16l1940t3309r2146b3358, p16l149t3380r256b3430],
17	cell	NN	O	cell	nn	18	SENT_396	[p16l281t3380r381b3430],
18	line	NN	O	line	prep_in	2	SENT_396	[p16l408t3380r527b3430],
19	.	.	O	.	_	0	SENT_396	[p16l408t3380r527b3430],

1	Int	NN	O	int	nn	3	SENT_397	[p16l556t3382r635b3430],
2	J	NN	O	j	nn	3	SENT_397	[p16l659t3382r685b3431],
3	Cancer	NN	O	cancer	_	0	SENT_397	[p16l711t3381r913b3431],
4	1995	CD	DATE	1995	dep	3	SENT_397	[p16l944t3380r1418b3439],
5	;	:	O	;	_	0	SENT_397	[p16l944t3380r1418b3439],
6	62:283	CD	NUMBER	62:283	number	7	SENT_397	[p16l944t3380r1418b3439],
7	—	CD	NUMBER	—	dep	3	SENT_397	[p16l944t3380r1418b3439],
8	90	CD	NUMBER	90	dep	7	SENT_397	[p16l944t3380r1418b3439],
9	.	.	O	.	_	0	SENT_397	[p16l944t3380r1418b3439],

1	Mulders	NNP	PERSON	Mulders	nn	2	SENT_398	[p16l149t3451r384b3501],
2	TMT	NNP	O	TMT	_	0	SENT_398	[p16l407t3452r571b3510],
3	,	,	O	,	_	0	SENT_398	[p16l407t3452r571b3510],
4	Keizer	NNP	PERSON	Keizer	nn	5	SENT_398	[p16l595t3451r784b3501],
5	HJ	NNP	O	HJ	appos	2	SENT_398	[p16l804t3452r897b3510],
6	,	,	O	,	_	0	SENT_398	[p16l804t3452r897b3510],
7	Breimer	NNP	PERSON	Breimer	nn	8	SENT_398	[p16l920t3451r1154b3501],
8	DD	NNP	O	DD	appos	2	SENT_398	[p16l1173t3452r1290b3510],
9	,	,	O	,	_	0	SENT_398	[p16l1173t3452r1290b3510],
10	et	FW	O	et	nn	11	SENT_398	[p16l1314t3459r1365b3501],
11	al.	FW	O	al.	appos	2	SENT_398	[p16l1386t3451r1448b3501],
12	.	.	O	.	_	0	SENT_398	[p16l1386t3451r1448b3501],

1	In	FW	O	in	nn	3	SENT_399	[p16l1473t3452r1531b3501],
2	vivo	FW	O	vivo	nn	3	SENT_399	[p16l1552t3451r1676b3501],
3	characterisation	NN	O	characterisation	nsubj	6	SENT_399	[p16l1698t3451r2149b3501],
4	of	IN	O	of	_	0	SENT_399	[p16l150t3521r212b3570],
5	glutathione/glutathione	NN	O	glutathione/glutathione	prep_of	3	SENT_399	[p16l247t3521r907b3585],
6	S	NN	O	s	_	0	SENT_399	[p16l948t3521r1317b3571],
7	—	CD	NUMBER	—	num	9	SENT_399	[p16l948t3521r1317b3571],
8	transferase	NN	O	transferase	nn	9	SENT_399	[p16l948t3521r1317b3571],
9	system	NN	O	system	dobj	6	SENT_399	[p16l1360t3528r1555b3585],
10	in	IN	O	in	_	0	SENT_399	[p16l1593t3521r1647b3570],
11	cancer	NN	O	cancer	nn	12	SENT_399	[p16l1687t3537r1872b3570],
12	patients	NNS	O	patient	prep_in	9	SENT_399	[p16l1909t3521r2145b3585],
13	.	.	O	.	_	0	SENT_399	[p16l1909t3521r2145b3585],

1	Drug	NN	O	drug	_	0	SENT_400	[p16l149t3593r293b3656],
2	Metab	NNP	O	Metab	nn	3	SENT_400	[p16l320t3591r499b3641],
3	Rev	NN	O	rev	dep	1	SENT_400	[p16l526t3593r639b3641],
4	1995	CD	DATE	1995	num	3	SENT_400	[p16l672t3591r1182b3650],
5	;	:	O	;	_	0	SENT_400	[p16l672t3591r1182b3650],
6	27:191	CD	NUMBER	27:191	num	7	SENT_400	[p16l672t3591r1182b3650],
7	-229	CD	NUMBER	-229	dep	1	SENT_400	[p16l672t3591r1182b3650],
8	.	.	O	.	_	0	SENT_400	[p16l672t3591r1182b3650],

1	Awasthi	NNP	PERSON	Awasthi	nn	2	SENT_401	[p16l149t3661r385b3711],
2	S	NNP	O	S	_	0	SENT_401	[p16l427t3662r478b3720],
3	,	,	O	,	_	0	SENT_401	[p16l427t3662r478b3720],
4	Singhal	NNP	PERSON	Singhal	nn	5	SENT_401	[p16l522t3661r737b3726],
5	SS	NNP	O	SS	appos	2	SENT_401	[p16l779t3662r869b3720],
6	,	,	O	,	_	0	SENT_401	[p16l779t3662r869b3720],
7	He	PRP	O	he	dep	8	SENT_401	[p16l912t3663r992b3711],
8	N	NN	O	n	appos	2	SENT_401	[p16l1032t3663r1097b3720],
9	,	,	O	,	_	0	SENT_401	[p16l1032t3663r1097b3720],
10	et	FW	O	et	nn	11	SENT_401	[p16l1141t3669r1191b3711],
11	al.	FW	O	al.	appos	2	SENT_401	[p16l1231t3661r1293b3711],
12	.	.	O	.	_	0	SENT_401	[p16l1231t3661r1293b3711],

1	Modulation	NN	O	modulation	_	0	SENT_402	[p16l1336t3661r1668b3711],
2	of	IN	O	of	_	0	SENT_402	[p16l1708t3661r1770b3711],
3	doxorubicin	NN	O	doxorubicin	nn	4	SENT_402	[p16l1806t3661r2149b3711],
4	cytotoxicity	NN	O	cytotoxicity	prep_of	1	SENT_402	[p16l150t3731r488b3795],
5	by	IN	O	by	_	0	SENT_402	[p16l513t3731r584b3796],
6	ethacrynic	JJ	O	ethacrynic	amod	7	SENT_402	[p16l610t3731r904b3795],
7	acid	NN	O	acid	prep_by	1	SENT_402	[p16l933t3731r1062b3781],
8	.	.	O	.	_	0	SENT_402	[p16l933t3731r1062b3781],

1	Int	NN	O	int	nn	3	SENT_403	[p16l1092t3732r1170b3781],
2	J	NN	O	j	nn	3	SENT_403	[p16l1194t3732r1221b3781],
3	Cancer	NN	O	cancer	_	0	SENT_403	[p16l1247t3731r1448b3781],
4	1996	CD	DATE	1996	dep	3	SENT_403	[p16l1480t3731r1918b3790],
5	;	:	O	;	_	0	SENT_403	[p16l1480t3731r1918b3790],
6	68:333	CD	NUMBER	68:333	number	7	SENT_403	[p16l1480t3731r1918b3790],
7	—	CD	NUMBER	—	dep	3	SENT_403	[p16l1480t3731r1918b3790],
8	9	CD	NUMBER	9	dep	7	SENT_403	[p16l1480t3731r1918b3790],
9	.	.	O	.	_	0	SENT_403	[p16l1480t3731r1918b3790],

1	Habig	NNP	PERSON	Habig	nn	2	SENT_404	[p17l149t9r321b73],
2	WH	NNP	PERSON	WH	_	0	SENT_404	[p17l353t10r486b68],
3	,	,	O	,	_	0	SENT_404	[p17l353t10r486b68],
4	Pabst	NNP	ORGANIZATION	Pabst	nn	5	SENT_404	[p17l521t9r675b58],
5	MJ	NNP	ORGANIZATION	MJ	appos	2	SENT_404	[p17l706t10r811b68],
6	,	,	O	,	_	0	SENT_404	[p17l706t10r811b68],
7	Jakoby	NNP	PERSON	Jakoby	nn	8	SENT_404	[p17l845t9r1045b73],
8	WB	NNP	O	WB	appos	5	SENT_404	[p17l1077t10r1205b58],
9	.	.	O	.	_	0	SENT_404	[p17l1077t10r1205b58],

1	Glutathione	NN	O	glutathione	nn	2	SENT_405	[p17l1242t9r1576b59],
2	S	NN	O	s	_	0	SENT_405	[p17l1610t9r2005b59],
3	—	CD	NUMBER	—	num	4	SENT_405	[p17l1610t9r2005b59],
4	transferases	NNS	O	transferase	dep	2	SENT_405	[p17l1610t9r2005b59],
5	The	DT	O	the	det	8	SENT_405	[p17l2039t9r2148b58],
6	ﬁrst	JJ	O	ﬁrst	amod	8	SENT_405	[p17l150t79r260b129],
7	enzymatic	JJ	O	enzymatic	amod	8	SENT_405	[p17l301t79r591b144],
8	step	NN	O	step	dep	2	SENT_405	[p17l637t87r747b144],
9	in	IN	O	in	_	0	SENT_405	[p17l789t79r844b128],
10	mercapturic	JJ	O	mercapturic	amod	15	SENT_405	[p17l885t79r1224b144],
11	acid	NN	O	acid	nn	15	SENT_405	[p17l1268t79r1385b129],
12	formation	NN	O	formation	nn	15	SENT_405	[p17l1426t79r1706b129],
13	J	NNP	O	J	nn	15	SENT_405	[p17l1748t81r1774b129],
14	Biol	NNP	O	Biol	nn	15	SENT_405	[p17l1816t79r1937b129],
15	Chem	NNP	O	Chem	prep_in	8	SENT_405	[p17l1980t79r2150b129],
16	1974	CD	DATE	1974	num	15	SENT_405	[p17l156t151r674b209],
17	;	:	O	;	_	0	SENT_405	[p17l156t151r674b209],
18	249:7	CD	NUMBER	249:7	num	19	SENT_405	[p17l156t151r674b209],
19	l30	NN	O	l30	dep	2	SENT_405	[p17l156t151r674b209],
20	—	CD	NUMBER	—	number	21	SENT_405	[p17l156t151r674b209],
21	9	CD	NUMBER	9	dep	19	SENT_405	[p17l156t151r674b209],
22	.	.	O	.	_	0	SENT_405	[p17l156t151r674b209],

1	Smith	NNP	ORGANIZATION	Smith	nn	2	SENT_406	[p17l151t221r318b271],
2	MT	NNP	ORGANIZATION	MT	_	0	SENT_406	[p17l346t222r467b280],
3	,	,	O	,	_	0	SENT_406	[p17l346t222r467b280],
4	Evans	NNP	PERSON	Evans	nn	5	SENT_406	[p17l498t222r669b271],
5	CG	NNP	O	CG	appos	2	SENT_406	[p17l700t221r811b280],
6	,	,	O	,	_	0	SENT_406	[p17l700t221r811b280],
7	Doane	NNP	PERSON	Doane	appos	5	SENT_406	[p17l842t221r1251b271],
8	.	.	O	.	_	0	SENT_406	[p17l842t221r1251b271],

1	—	NN	O	—	_	0	SENT_407	[p17l842t221r1251b271],
2	.	.	O	.	_	0	SENT_407	[p17l842t221r1251b271],

1	Setzter	NN	O	setzter	nn	2	SENT_408	[p17l842t221r1251b271],
2	P	NN	O	p	_	0	SENT_408	[p17l1278t222r1331b280],
3	,	,	O	,	_	0	SENT_408	[p17l1278t222r1331b280],
4	et	FW	O	et	nn	5	SENT_408	[p17l1363t228r1413b271],
5	al.	FW	O	al.	appos	2	SENT_408	[p17l1441t221r1504b271],
6	.	.	O	.	_	0	SENT_408	[p17l1441t221r1504b271],

1	Denitrosation	NN	O	denitrosation	_	0	SENT_409	[p17l1535t221r1923b271],
2	of	IN	O	of	_	0	SENT_409	[p17l1952t221r2014b271],
3	1,3	CD	NUMBER	1,3	num	4	SENT_409	[p17l2044t221r2146b280, p17l148t291r1093b356],
4	bis	NN	O	bi	prep_of	1	SENT_409	[p17l2044t221r2146b280, p17l148t291r1093b356],
5	.	.	O	.	_	0	SENT_409	[p17l2044t221r2146b280, p17l148t291r1093b356],

1	—	NN	O	—	_	0	SENT_410	[p17l2044t221r2146b280, p17l148t291r1093b356],
2	.	.	O	.	_	0	SENT_410	[p17l2044t221r2146b280, p17l148t291r1093b356],

1	(	NN	O	(	_	0	SENT_411	[p17l2044t221r2146b280, p17l148t291r1093b356],
2	2-chloroethyl	NN	O	2-chloroethyl	nn	3	SENT_411	[p17l2044t221r2146b280, p17l148t291r1093b356],
3	)	NN	O	)	dep	1	SENT_411	[p17l2044t221r2146b280, p17l148t291r1093b356],
4	.	.	O	.	_	0	SENT_411	[p17l2044t221r2146b280, p17l148t291r1093b356],

1	—	NN	O	—	_	0	SENT_412	[p17l2044t221r2146b280, p17l148t291r1093b356],
2	.	.	O	.	_	0	SENT_412	[p17l2044t221r2146b280, p17l148t291r1093b356],

1	1	LS	NUMBER	1	_	0	SENT_413	[p17l2044t221r2146b280, p17l148t291r1093b356],
2	.	.	O	.	_	0	SENT_413	[p17l2044t221r2146b280, p17l148t291r1093b356],

1	—	NN	O	—	_	0	SENT_414	[p17l2044t221r2146b280, p17l148t291r1093b356],
2	.	.	O	.	_	0	SENT_414	[p17l2044t221r2146b280, p17l148t291r1093b356],

1	nitrosourea	NN	O	nitrosourea	_	0	SENT_415	[p17l2044t221r2146b280, p17l148t291r1093b356],
2	by	IN	O	by	_	0	SENT_415	[p17l1118t291r1188b356],
3	class	NN	O	class	nn	6	SENT_415	[p17l1215t291r1350b341],
4	mu	NN	O	mu	nn	6	SENT_415	[p17l1378t307r1467b341],
5	glutathione	NN	O	glutathione	nn	6	SENT_415	[p17l1495t291r1814b356],
6	transferase	NN	O	transferase	prep_by	1	SENT_415	[p17l1841t291r2148b341],
7	and	CC	O	and	_	0	SENT_415	[p17l151t361r251b411],
8	its	PRP$	O	its	poss	9	SENT_415	[p17l271t361r335b411],
9	role	NN	O	role	conj_and	6	SENT_415	[p17l356t361r466b411],
10	in	IN	O	in	_	0	SENT_415	[p17l487t361r541b410],
11	cellular	JJ	O	cellular	amod	12	SENT_415	[p17l562t361r776b411],
12	resistance	NN	O	resistance	prep_in	1	SENT_415	[p17l794t361r1074b411],
13	in	IN	O	in	_	0	SENT_415	[p17l1095t361r1149b410],
14	rat	NN	O	rat	nn	17	SENT_415	[p17l1169t369r1244b411],
15	brain	NN	O	brain	nn	17	SENT_415	[p17l1263t361r1409b411],
16	tumour	NN	O	tumour	nn	17	SENT_415	[p17l1429t368r1635b411],
17	cells	NNS	O	cell	prep_in	1	SENT_415	[p17l1655t361r1797b411],
18	.	.	O	.	_	0	SENT_415	[p17l1655t361r1797b411],

1	Cancer	NNP	O	Cancer	nn	2	SENT_416	[p17l1823t362r2024b411],
2	Res	NNP	O	Res	_	0	SENT_416	[p17l2043t362r2147b411],
3	1989	CD	DATE	1989	num	2	SENT_416	[p17l156t432r630b491],
4	;	:	O	;	_	0	SENT_416	[p17l156t432r630b491],
5	50:262	CD	NUMBER	50:262	num	6	SENT_416	[p17l156t432r630b491],
6	l	NN	O	l	dep	2	SENT_416	[p17l156t432r630b491],
7	—	CD	NUMBER	—	number	8	SENT_416	[p17l156t432r630b491],
8	5	CD	NUMBER	5	dep	6	SENT_416	[p17l156t432r630b491],
9	.	.	O	.	_	0	SENT_416	[p17l156t432r630b491],

1	Jungnelius	NN	PERSON	jungnelius	_	0	SENT_417	[p17l149t502r451b567],
2	U	NNP	PERSON	U	dep	1	SENT_417	[p17l473t504r538b561],
3	,	,	O	,	_	0	SENT_417	[p17l473t504r538b561],
4	Ridderstrom	NNP	O	Ridderstrom	nn	5	SENT_417	[p17l560t502r917b552],
5	M	NNP	O	M	appos	2	SENT_417	[p17l935t504r1013b561],
6	,	,	O	,	_	0	SENT_417	[p17l935t504r1013b561],
7	Hansson	NNP	PERSON	Hansson	nn	8	SENT_417	[p17l1035t504r1280b552],
8	J	NNP	PERSON	J	appos	2	SENT_417	[p17l1299t504r1326b552],
9	,	,	O	,	_	0	SENT_417	[p17l1330t543r1341b561],
10	et	FW	O	et	nn	11	SENT_417	[p17l1364t510r1414b552],
11	al.	FW	O	al.	appos	2	SENT_417	[p17l1435t502r1497b552],
12	.	.	O	.	_	0	SENT_417	[p17l1435t502r1497b552],

1	Similar	JJ	O	similar	amod	3	SENT_418	[p17l1522t502r1730b552],
2	toxic	JJ	O	toxic	amod	3	SENT_418	[p17l1749t502r1888b552],
3	effect	NN	O	effect	_	0	SENT_418	[p17l1911t502r2072b552],
4	of	IN	O	of	_	0	SENT_418	[p17l2092t502r2153b552],
5	1,3	CD	NUMBER	1,3	prep_of	3	SENT_418	[p17l156t572r1123b636],
6	.	.	O	.	_	0	SENT_418	[p17l156t572r1123b636],

1	—	NN	O	—	_	0	SENT_419	[p17l156t572r1123b636],
2	.	.	O	.	_	0	SENT_419	[p17l156t572r1123b636],

1	bis	FW	O	bis	nn	3	SENT_420	[p17l156t572r1123b636],
2	(	FW	O	(	nn	3	SENT_420	[p17l156t572r1123b636],
3	chloroethyl	NN	O	chloroethyl	_	0	SENT_420	[p17l156t572r1123b636],
4	)	NN	O	)	dep	3	SENT_420	[p17l156t572r1123b636],
5	.	.	O	.	_	0	SENT_420	[p17l156t572r1123b636],

1	—	NN	O	—	_	0	SENT_421	[p17l156t572r1123b636],
2	.	.	O	.	_	0	SENT_421	[p17l156t572r1123b636],

1	1	LS	NUMBER	1	_	0	SENT_422	[p17l156t572r1123b636],
2	.	.	O	.	_	0	SENT_422	[p17l156t572r1123b636],

1	—	NN	O	—	_	0	SENT_423	[p17l156t572r1123b636],
2	.	.	O	.	_	0	SENT_423	[p17l156t572r1123b636],

1	nitrosourea	NN	O	nitrosourea	_	0	SENT_424	[p17l156t572r1123b636],
2	on	IN	O	on	_	0	SENT_424	[p17l1151t588r1220b622],
3	lymphocytes	NNS	O	lymphocyte	prep_on	1	SENT_424	[p17l1248t572r1610b636],
4	from	IN	O	from	_	0	SENT_424	[p17l1641t572r1778b622],
5	human	JJ	O	human	amod	6	SENT_424	[p17l1805t572r1999b622],
6	subjects	NNS	O	subject	prep_from	3	SENT_424	[p17l2030t572r2146b622, p17l143t642r276b706],
7	differing	VBG	O	differ	partmod	1	SENT_424	[p17l319t642r566b706],
8	in	IN	O	in	_	0	SENT_424	[p17l606t642r660b691],
9	the	DT	O	the	det	10	SENT_424	[p17l700t642r785b691],
10	expression	NN	O	expression	prep_in	7	SENT_424	[p17l826t642r1129b706],
11	of	IN	O	of	_	0	SENT_424	[p17l1170t642r1231b691],
12	glutathione	NN	O	glutathione	nn	14	SENT_424	[p17l1267t642r1586b706],
13	transferase	NN	O	transferase	nn	14	SENT_424	[p17l1626t642r1933b691],
14	M1-1	NN	O	m1-1	prep_of	10	SENT_424	[p17l1973t642r2145b691],
15	.	.	O	.	_	0	SENT_424	[p17l1973t642r2145b691],

1	Biochem	NNP	O	Biochem	nn	2	SENT_425	[p17l149t713r406b763],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_425	[p17l431t713r735b763],
3	1994	CD	DATE	1994	num	2	SENT_425	[p17l767t714r1193b772],
4	;	:	O	;	_	0	SENT_425	[p17l767t714r1193b772],
5	47:1777	CD	NUMBER	47:1777	number	6	SENT_425	[p17l767t714r1193b772],
6	—	CD	NUMBER	—	dep	2	SENT_425	[p17l767t714r1193b772],
7	80	CD	NUMBER	80	dep	6	SENT_425	[p17l1204t714r1286b764],
8	.	.	O	.	_	0	SENT_425	[p17l1204t714r1286b764],

1	Lunel	NNP	PERSON	Lunel	_	0	SENT_426	[p17l149t783r516b833],
2	.	.	O	.	_	0	SENT_426	[p17l149t783r516b833],

1	—	NN	O	—	_	0	SENT_427	[p17l149t783r516b833],
2	.	.	O	.	_	0	SENT_427	[p17l149t783r516b833],

1	Orsini	NNP	ORGANIZATION	Orsini	nn	2	SENT_428	[p17l149t783r516b833],
2	C	NNP	ORGANIZATION	C	nsubj	21	SENT_428	[p17l541t784r601b842],
3	,	,	O	,	_	0	SENT_428	[p17l541t784r601b842],
4	Buttin	NNP	PERSON	Buttin	nn	5	SENT_428	[p17l626t783r804b833],
5	G	NNP	O	G	appos	2	SENT_428	[p17l828t783r891b842],
6	,	,	O	,	_	0	SENT_428	[p17l828t783r891b842],
7	De	NNP	O	De	nn	12	SENT_428	[p17l917t784r998b833],
8	Saint	NNP	O	Saint	nn	12	SENT_428	[p17l1024t783r1168b833],
9	V.	NNP	O	V.	nn	12	SENT_428	[p17l1190t784r1254b833],
10	A	NNP	O	A	nn	12	SENT_428	[p17l1280t784r1330b832],
11	glutathione	NN	O	glutathione	nn	12	SENT_428	[p17l1354t783r1673b848],
12	depletion	NN	O	depletion	appos	2	SENT_428	[p17l1697t783r1960b847],
13	selectively	RB	O	selectively	advmod	14	SENT_428	[p17l1986t783r2146b833, p17l149t853r309b917],
14	imposed	VBN	O	impose	partmod	12	SENT_428	[p17l345t853r586b917],
15	on	IN	O	on	_	0	SENT_428	[p17l622t869r691b902],
16	pt	JJ	O	pt	amod	18	SENT_428	[p17l731t871r771b917],
17	glutathione	NN	O	glutathione	nn	18	SENT_428	[p17l808t853r1126b917],
18	S-transferase	NN	MISC	s-transferase	prep_on	14	SENT_428	[p17l1164t853r1533b903],
19	overproducing	VBG	O	overproduce	xcomp	14	SENT_428	[p17l1570t853r1983b917],
20	cells	NNS	O	cell	dobj	19	SENT_428	[p17l2020t853r2147b902],
21	increases	VBZ	O	increase	_	0	SENT_428	[p17l149t923r408b973],
22	nitrogen	NN	O	nitrogen	nn	24	SENT_428	[p17l447t923r684b988],
23	mustard	NN	O	mustard	nn	24	SENT_428	[p17l721t923r951b973],
24	toxicity	NN	O	toxicity	dobj	21	SENT_428	[p17l988t923r1218b988],
25	.	.	O	.	_	0	SENT_428	[p17l988t923r1218b988],

1	Biochem	NNP	O	Biochem	nn	2	SENT_429	[p17l1260t923r1518b973],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_429	[p17l1554t923r1858b973],
3	1995	CD	DATE	1995	num	2	SENT_429	[p17l1903t923r2034b974],
4	;	:	O	;	_	0	SENT_429	[p17l2044t924r2143b982],
5	49	CD	NUMBER	49	dep	2	SENT_429	[p17l2044t924r2143b982],
6	:	:	O	:	_	0	SENT_429	[p17l2044t924r2143b982],
7	329	CD	NUMBER	329	number	8	SENT_429	[p17l151t994r253b1043],
8	-38	CD	NUMBER	-38	dep	5	SENT_429	[p17l264t994r384b1043],
9	.	.	O	.	_	0	SENT_429	[p17l264t994r384b1043],

1	Stenberg	NNP	PERSON	Stenberg	nn	2	SENT_430	[p17l151t1063r401b1127],
2	G	NNP	PERSON	G	_	0	SENT_430	[p17l424t1063r487b1122],
3	,	,	O	,	_	0	SENT_430	[p17l424t1063r487b1122],
4	Bjornestedt	NNP	PERSON	Bjornestedt	nn	5	SENT_430	[p17l511t1063r840b1127],
5	R	NNP	PERSON	R	appos	2	SENT_430	[p17l860t1064r921b1122],
6	,	,	O	,	_	0	SENT_430	[p17l860t1064r921b1122],
7	Mannervik	NNP	PERSON	Mannervik	nn	10	SENT_430	[p17l944t1063r1258b1112],
8	B.	NNP	PERSON	B.	nn	10	SENT_430	[p17l1277t1064r1337b1112],
9	Heterologous	NNP	PERSON	Heterologous	nn	10	SENT_430	[p17l1362t1063r1743b1127],
10	expression	NN	O	expression	appos	2	SENT_430	[p17l1767t1063r2070b1127],
11	of	IN	O	of	_	0	SENT_430	[p17l2092t1063r2153b1112],
12	recombinant	JJ	O	recombinant	amod	15	SENT_430	[p17l148t1133r506b1183],
13	glutathione	NN	O	glutathione	nn	15	SENT_430	[p17l539t1133r857b1198],
14	transferase	NN	O	transferase	nn	15	SENT_430	[p17l891t1133r1198b1183],
15	A1-1	NN	O	a1-1	prep_of	10	SENT_430	[p17l1232t1134r1371b1182],
16	from	IN	O	from	_	0	SENT_430	[p17l1411t1133r1549b1183],
17	hepatoma	NN	O	hepatoma	nn	19	SENT_430	[p17l1580t1133r1858b1198],
18	cell	NN	O	cell	nn	19	SENT_430	[p17l1891t1133r1992b1183],
19	line	NN	O	line	prep_from	15	SENT_430	[p17l2025t1133r2145b1183],
20	.	.	O	.	_	0	SENT_430	[p17l2025t1133r2145b1183],

1	Protein	NN	O	protein	nn	3	SENT_431	[p17l149t1204r354b1254],
2	Express	NNP	O	Express	nn	3	SENT_431	[p17l379t1205r602b1269],
3	Puriﬁc	NNP	O	Puriﬁc	_	0	SENT_431	[p17l629t1204r817b1254],
4	1992	CD	DATE	1992	num	3	SENT_431	[p17l851t1204r1235b1263],
5	;	:	O	;	_	0	SENT_431	[p17l851t1204r1235b1263],
6	3:80	CD	NUMBER	3:80	number	7	SENT_431	[p17l851t1204r1235b1263],
7	—	CD	NUMBER	—	dep	3	SENT_431	[p17l851t1204r1235b1263],
8	4	CD	NUMBER	4	dep	7	SENT_431	[p17l851t1204r1235b1263],
9	.	.	O	.	_	0	SENT_431	[p17l851t1204r1235b1263],

1	Widersten	NN	O	widersten	nn	2	SENT_432	[p17l148t1275r441b1324],
2	M	NN	O	m	_	0	SENT_432	[p17l465t1276r542b1333],
3	,	,	O	,	_	0	SENT_432	[p17l465t1276r542b1333],
4	Pearson	NNP	ORGANIZATION	Pearson	nn	5	SENT_432	[p17l569t1276r794b1324],
5	WR	NNP	ORGANIZATION	WR	appos	2	SENT_432	[p17l817t1276r946b1333],
6	,	,	O	,	_	0	SENT_432	[p17l817t1276r946b1333],
7	Engstrom	NNP	PERSON	Engstrom	nn	8	SENT_432	[p17l973t1276r1251b1339],
8	A	NNP	O	A	appos	2	SENT_432	[p17l1274t1260r1339b1334],
9	,	,	O	,	_	0	SENT_432	[p17l1274t1260r1339b1334],
10	et	FW	O	et	nn	11	SENT_432	[p17l1367t1282r1417b1324],
11	al.	FW	O	al.	appos	2	SENT_432	[p17l1442t1275r1504b1324],
12	.	.	O	.	_	0	SENT_432	[p17l1442t1275r1504b1324],

1	Heterologous	JJ	O	heterologous	amod	2	SENT_433	[p17l1532t1275r1914b1339],
2	expression	NN	O	expression	_	0	SENT_433	[p17l1941t1291r2146b1339, p17l152t1345r267b1395],
3	of	IN	O	of	_	0	SENT_433	[p17l295t1345r357b1395],
4	the	DT	O	the	det	12	SENT_433	[p17l379t1345r464b1395],
5	allelic	JJ	O	allelic	amod	12	SENT_433	[p17l494t1345r663b1395],
6	variant	JJ	O	variant	amod	12	SENT_433	[p17l693t1345r890b1395],
7	Mu	NN	O	mu	nn	12	SENT_433	[p17l916t1345r1175b1395],
8	—	NN	O	—	nn	12	SENT_433	[p17l916t1345r1175b1395],
9	class	NN	O	class	nn	12	SENT_433	[p17l916t1345r1175b1395],
10	glutathione	NN	O	glutathione	nn	12	SENT_433	[p17l1205t1345r1523b1410],
11	transferase	NN	O	transferase	nn	12	SENT_433	[p17l1551t1345r1858b1395],
12	p.	NN	O	p.	prep_of	2	SENT_433	[p17l1891t1363r1931b1409],
13	and	CC	O	and	_	0	SENT_433	[p17l1961t1345r2062b1395],
14	LI	NN	O	li	nn	15	SENT_433	[p17l2090t1346r2145b1409],
15	}	NN	O	}	conj_and	12	SENT_433	[p17l2090t1346r2145b1409],
16	.	.	O	.	_	0	SENT_433	[p17l2090t1346r2145b1409],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	2	SENT_434	[p17l149t1416r406b1466],
2	J	NNP	O	J	_	0	SENT_434	[p17l430t1417r457b1467],
3	1991	CD	DATE	1991	num	2	SENT_434	[p17l489t1416r1007b1475],
4	;	:	O	;	_	0	SENT_434	[p17l489t1416r1007b1475],
5	276:519	CD	NUMBER	276:519	number	6	SENT_434	[p17l489t1416r1007b1475],
6	—	CD	NUMBER	—	dep	2	SENT_434	[p17l489t1416r1007b1475],
7	24	CD	NUMBER	24	dep	6	SENT_434	[p17l489t1416r1007b1475],
8	.	.	O	.	_	0	SENT_434	[p17l489t1416r1007b1475],

1	Hao	NNP	O	Hao	nn	2	SENT_435	[p17l149t1487r266b1535],
2	X-Y	NN	O	x-y	_	0	SENT_435	[p17l289t1487r430b1545],
3	,	,	O	,	_	0	SENT_435	[p17l289t1487r430b1545],
4	Widersten	NN	O	widersten	nn	5	SENT_435	[p17l455t1486r748b1535],
5	M	NN	O	m	appos	2	SENT_435	[p17l771t1487r848b1545],
6	,	,	O	,	_	0	SENT_435	[p17l771t1487r848b1545],
7	Ridderstrom	NN	O	ridderstrom	nn	8	SENT_435	[p17l874t1486r1230b1535],
8	M	NN	O	m	appos	2	SENT_435	[p17l1252t1487r1330b1545],
9	,	,	O	,	_	0	SENT_435	[p17l1252t1487r1330b1545],
10	et	FW	O	et	nn	11	SENT_435	[p17l1356t1493r1406b1535],
11	al.	FW	O	al.	appos	2	SENT_435	[p17l1430t1486r1493b1535],
12	.	.	O	.	_	0	SENT_435	[p17l1430t1486r1493b1535],

1	Co	NNP	O	Co	nn	3	SENT_436	[p17l1521t1486r1880b1536],
2	—	CD	NUMBER	—	num	3	SENT_436	[p17l1521t1486r1880b1536],
3	variation	NN	O	variation	_	0	SENT_436	[p17l1521t1486r1880b1536],
4	of	IN	O	of	_	0	SENT_436	[p17l1903t1486r1965b1535],
5	glutathione	NN	O	glutathione	nn	7	SENT_436	[p17l1985t1486r2146b1550, p17l149t1556r326b1606],
6	transferase	NN	O	transferase	nn	7	SENT_436	[p17l353t1556r660b1606],
7	expression	NN	O	expression	prep_of	3	SENT_436	[p17l689t1556r992b1621],
8	and	CC	O	and	_	0	SENT_436	[p17l1021t1556r1121b1606],
9	cytostatic	JJ	O	cytostatic	amod	11	SENT_436	[p17l1148t1556r1418b1621],
10	drug	NN	O	drug	nn	11	SENT_436	[p17l1448t1556r1575b1621],
11	resistance	NN	O	resistance	prep_of	3	SENT_436	[p17l1602t1556r1883b1606],
12	in	IN	O	in	_	0	SENT_436	[p17l1910t1556r1965b1605],
13	HeLa	NN	O	helum	nn	14	SENT_436	[p17l1992t1558r2150b1606],
14	cells	NNS	O	cell	prep_in	7	SENT_436	[p17l150t1626r293b1676],
15	:	:	O	:	_	0	SENT_436	[p17l150t1626r293b1676],
16	establishment	NN	O	establishment	dep	3	SENT_436	[p17l325t1626r717b1676],
17	of	IN	O	of	_	0	SENT_436	[p17l743t1626r805b1676],
18	class	NN	O	class	nn	22	SENT_436	[p17l828t1626r962b1676],
19	Mu	NN	O	mu	nn	22	SENT_436	[p17l990t1627r1087b1676],
20	glutathione	NN	O	glutathione	nn	22	SENT_436	[p17l1115t1626r1434b1691],
21	transferase	NN	O	transferase	nn	22	SENT_436	[p17l1460t1626r1768b1676],
22	M3	NN	O	m3	prep_of	16	SENT_436	[p17l1795t1627r1948b1676],
23	—	CD	NUMBER	—	number	24	SENT_436	[p17l1795t1627r1948b1676],
24	3	CD	NUMBER	3	dep	22	SENT_436	[p17l1795t1627r1948b1676],
25	as	IN	O	as	_	0	SENT_436	[p17l1980t1642r2034b1676],
26	the	DT	O	the	det	28	SENT_436	[p17l2063t1626r2148b1676],
27	dominating	VBG	O	dominate	amod	28	SENT_436	[p17l150t1696r472b1760],
28	isoenzyme	NN	O	isoenzyme	prep_as	24	SENT_436	[p17l498t1696r816b1760],
29	.	.	O	.	_	0	SENT_436	[p17l498t1696r816b1760],

1	Biochem	NNP	O	Biochem	nn	2	SENT_437	[p17l846t1696r1103b1745],
2	J	NNP	O	J	_	0	SENT_437	[p17l1127t1697r1153b1746],
3	1994	CD	DATE	1994	num	2	SENT_437	[p17l1186t1696r1677b1755],
4	;	:	O	;	_	0	SENT_437	[p17l1186t1696r1677b1755],
5	297:59	CD	NUMBER	297:59	number	6	SENT_437	[p17l1186t1696r1677b1755],
6	—	CD	NUMBER	—	dep	2	SENT_437	[p17l1186t1696r1677b1755],
7	67	CD	NUMBER	67	dep	6	SENT_437	[p17l1186t1696r1677b1755],
8	.	.	O	.	_	0	SENT_437	[p17l1186t1696r1677b1755],

1	Kolm	NNP	PERSON	Kolm	nn	2	SENT_438	[p17l150t1766r312b1816],
2	RH	NNP	O	RH	_	0	SENT_438	[p17l340t1768r452b1825],
3	,	,	O	,	_	0	SENT_438	[p17l340t1768r452b1825],
4	Stenberg	NNP	PERSON	Stenberg	nn	5	SENT_438	[p17l487t1766r736b1831],
5	G	NNP	PERSON	G	appos	2	SENT_438	[p17l768t1767r832b1825],
6	,	,	O	,	_	0	SENT_438	[p17l768t1767r832b1825],
7	Widersten	NNP	O	Widersten	nn	8	SENT_438	[p17l863t1766r1156b1816],
8	M	NNP	O	M	appos	2	SENT_438	[p17l1185t1768r1262b1825],
9	,	,	O	,	_	0	SENT_438	[p17l1185t1768r1262b1825],
10	et	FW	O	et	nn	11	SENT_438	[p17l1295t1774r1346b1816],
11	al.	FW	O	al.	appos	2	SENT_438	[p17l1376t1766r1438b1816],
12	.	.	O	.	_	0	SENT_438	[p17l1376t1766r1438b1816],

1	High	JJ	O	high	amod	4	SENT_439	[p17l1471t1766r1775b1831],
2	—	NN	O	—	nn	4	SENT_439	[p17l1471t1766r1775b1831],
3	level	NN	O	level	nn	4	SENT_439	[p17l1471t1766r1775b1831],
4	bacteria	NNS	O	bacterium	_	0	SENT_439	[p17l1804t1766r2030b1816],
5	expression	NN	O	expression	dep	4	SENT_439	[p17l2060t1782r2146b1816, p17l148t1836r386b1900],
6	of	IN	O	of	_	0	SENT_439	[p17l425t1836r486b1886],
7	human	JJ	O	human	amod	10	SENT_439	[p17l519t1836r713b1886],
8	glutathione	NN	O	glutathione	nn	10	SENT_439	[p17l752t1836r1070b1901],
9	transferase	NN	O	transferase	nn	10	SENT_439	[p17l1108t1836r1416b1886],
10	P1	NN	O	p1	prep_of	5	SENT_439	[p17l1454t1837r1581b1885],
11	—	NN	O	—	dep	4	SENT_439	[p17l1454t1837r1581b1885],
12	1	CD	NUMBER	1	num	11	SENT_439	[p17l1454t1837r1581b1885],
13	by	IN	O	by	_	0	SENT_439	[p17l1625t1836r1695b1900],
14	sen1i	NN	O	sen1us	prep_by	11	SENT_439	[p17l1736t1836r2147b1900],
15	—	CD	NUMBER	—	dep	4	SENT_439	[p17l1736t1836r2147b1900],
16	synthetic	JJ	O	synthetic	amod	17	SENT_439	[p17l1736t1836r2147b1900],
17	DNA	NN	O	dna	dep	15	SENT_439	[p17l149t1906r316b1955],
18	.	.	O	.	_	0	SENT_439	[p17l149t1906r316b1955],

1	Protein	NN	O	protein	nn	3	SENT_440	[p17l346t1906r550b1955],
2	Express	NNP	O	Express	nn	3	SENT_440	[p17l575t1907r798b1970],
3	Purif	NNP	O	Purif	_	0	SENT_440	[p17l826t1906r972b1955],
4	1995	CD	DATE	1995	num	3	SENT_440	[p17l1000t1906r1437b1965],
5	;	:	O	;	_	0	SENT_440	[p17l1000t1906r1437b1965],
6	6:265	CD	NUMBER	6:265	number	7	SENT_440	[p17l1000t1906r1437b1965],
7	—	CD	NUMBER	—	num	8	SENT_440	[p17l1000t1906r1437b1965],
8	7l	NN	O	7l	dep	3	SENT_440	[p17l1000t1906r1437b1965],
9	.	.	O	.	_	0	SENT_440	[p17l1000t1906r1437b1965],

1	Lowry	NNP	PERSON	Lowry	nn	2	SENT_441	[p17l149t1978r337b2041],
2	OH	NN	O	oh	_	0	SENT_441	[p17l371t1977r486b2035],
3	,	,	O	,	_	0	SENT_441	[p17l371t1977r486b2035],
4	Roseborough	NNP	PERSON	Roseborough	nn	5	SENT_441	[p17l521t1976r901b2041],
5	NJ	NNP	O	NJ	appos	2	SENT_441	[p17l932t1978r1025b2035],
6	,	,	O	,	_	0	SENT_441	[p17l932t1978r1025b2035],
7	Farr	NNP	PERSON	Farr	nn	8	SENT_441	[p17l1059t1978r1178b2026],
8	AL	NNP	O	AL	appos	2	SENT_441	[p17l1208t1977r1317b2035],
9	,	,	O	,	_	0	SENT_441	[p17l1208t1977r1317b2035],
10	et	FW	O	et	nn	11	SENT_441	[p17l1352t1984r1403b2026],
11	al.	FW	O	al.	appos	2	SENT_441	[p17l1435t1976r1497b2026],
12	.	.	O	.	_	0	SENT_441	[p17l1435t1976r1497b2026],

1	Protein	NN	O	protein	nn	2	SENT_442	[p17l1532t1976r1738b2026],
2	measurement	NN	O	measurement	_	0	SENT_442	[p17l1769t1984r2150b2026],
3	with	IN	O	with	_	0	SENT_442	[p17l149t2046r275b2096],
4	Folin	NNP	PERSON	Folin	nn	6	SENT_442	[p17l299t2046r450b2096],
5	phenol	NN	O	phenol	nn	6	SENT_442	[p17l474t2046r667b2110],
6	reagent	NN	O	reagent	prep_with	2	SENT_442	[p17l692t2054r915b2111],
7	.	.	O	.	_	0	SENT_442	[p17l692t2054r915b2111],

1	J	NNP	O	J	nn	3	SENT_443	[p17l945t2047r971b2096],
2	Biol	NNP	O	Biol	nn	3	SENT_443	[p17l996t2046r1118b2096],
3	Chem	NNP	O	Chem	_	0	SENT_443	[p17l1144t2046r1313b2096],
4	1951	CD	DATE	1951	num	3	SENT_443	[p17l1345t2046r1854b2105],
5	;	:	O	;	_	0	SENT_443	[p17l1345t2046r1854b2105],
6	193:265	CD	NUMBER	193:265	number	7	SENT_443	[p17l1345t2046r1854b2105],
7	—	CD	NUMBER	—	dep	3	SENT_443	[p17l1345t2046r1854b2105],
8	75	CD	NUMBER	75	dep	7	SENT_443	[p17l1345t2046r1854b2105],
9	.	.	O	.	_	0	SENT_443	[p17l1345t2046r1854b2105],

1	Laemmli	NNP	LOCATION	Laemmli	nn	2	SENT_444	[p17l149t2116r405b2165],
2	UK	NNP	LOCATION	UK	_	0	SENT_444	[p17l427t2117r542b2166],
3	.	.	O	.	_	0	SENT_444	[p17l427t2117r542b2166],

1	Most	JJS	O	most	nsubj	3	SENT_445	[p17l567t2117r714b2165],
2	commonly	RB	O	commonly	advmod	3	SENT_445	[p17l735t2116r1037b2180],
3	used	VBN	O	use	_	0	SENT_445	[p17l1059t2116r1189b2165],
4	discontinuous	JJ	O	discontinuous	amod	6	SENT_445	[p17l1211t2116r1603b2165],
5	buffer	NN	O	buffer	nn	6	SENT_445	[p17l1626t2116r1801b2165],
6	systems	NNS	O	system	dobj	3	SENT_445	[p17l1824t2123r2044b2180],
7	for	IN	O	for	_	0	SENT_445	[p17l2067t2116r2150b2165],
8	SDS	NN	O	sd	nn	9	SENT_445	[p17l151t2187r275b2236],
9	electrophoresis	NN	O	electrophoresis	prep_for	6	SENT_445	[p17l305t2186r749b2251],
10	.	.	O	.	_	0	SENT_445	[p17l305t2186r749b2251],

1	Nature	NNP	O	Nature	_	0	SENT_446	[p17l778t2188r970b2236],
2	1970	CD	DATE	1970	num	1	SENT_446	[p17l1003t2186r1486b2245],
3	;	:	O	;	_	0	SENT_446	[p17l1003t2186r1486b2245],
4	227:680	CD	NUMBER	227:680	number	5	SENT_446	[p17l1003t2186r1486b2245],
5	—	CD	NUMBER	—	dep	1	SENT_446	[p17l1003t2186r1486b2245],
6	5	CD	NUMBER	5	dep	5	SENT_446	[p17l1003t2186r1486b2245],
7	.	.	O	.	_	0	SENT_446	[p17l1003t2186r1486b2245],

1	Talcott	NNP	PERSON	Talcott	nn	2	SENT_447	[p17l149t2256r351b2306],
2	RE	NNP	O	RE	_	0	SENT_447	[p17l372t2257r477b2315],
3	,	,	O	,	_	0	SENT_447	[p17l372t2257r477b2315],
4	Levin	NNP	PERSON	Levin	nn	5	SENT_447	[p17l502t2256r668b2306],
5	VA.	NNP	O	VA.	appos	2	SENT_447	[p17l690t2257r805b2306],
6	.	.	O	.	_	0	SENT_447	[p17l690t2257r805b2306],

1	Glutathione	NN	O	glutathione	nn	2	SENT_448	[p17l833t2256r1486b2320],
2	—	NN	O	—	_	0	SENT_448	[p17l833t2256r1486b2320],
3	dependent	JJ	O	dependent	amod	4	SENT_448	[p17l833t2256r1486b2320],
4	denitrosation	NN	O	denitrosation	dep	2	SENT_448	[p17l1508t2256r1879b2306],
5	of	IN	O	of	_	0	SENT_448	[p17l1902t2256r1964b2306],
6	N	NN	O	n	nn	10	SENT_448	[p17l1981t2257r2146b2315],
7	,	,	O	,	_	0	SENT_448	[p17l1981t2257r2146b2315],
8	N	NN	O	n	dep	10	SENT_448	[p17l1981t2257r2146b2315],
9	’	CD	NUMBER	’	num	10	SENT_448	[p17l1981t2257r2146b2315],
10	bis	NN	O	bi	prep_of	4	SENT_448	[p17l148t2326r1077b2390],
11	(	CD	NUMBER	(	num	12	SENT_448	[p17l148t2326r1077b2390],
12	2-chloroethyl	NN	O	2-chloroethyl	dep	2	SENT_448	[p17l148t2326r1077b2390],
13	)	CD	NUMBER	)	num	14	SENT_448	[p17l148t2326r1077b2390],
14	N	NN	O	n	dep	12	SENT_448	[p17l148t2326r1077b2390],
15	.	.	O	.	_	0	SENT_448	[p17l148t2326r1077b2390],

1	—	NN	O	—	_	0	SENT_449	[p17l148t2326r1077b2390],
2	.	.	O	.	_	0	SENT_449	[p17l148t2326r1077b2390],

1	Nitrosourea	NNP	O	Nitrosourea	_	0	SENT_450	[p17l148t2326r1077b2390],
2	(	CD	NUMBER	(	num	1	SENT_450	[p17l1100t2326r1357b2387],
3	BCNU	NNP	O	BCNU	dep	1	SENT_450	[p17l1100t2326r1357b2387],
4	)	CD	NUMBER	)	num	3	SENT_450	[p17l1100t2326r1357b2387],
5	:	:	O	:	_	0	SENT_450	[p17l1100t2326r1357b2387],
6	nitrite	JJ	O	nitrite	amod	7	SENT_450	[p17l1384t2326r1552b2375],
7	release	NN	O	release	dep	1	SENT_450	[p17l1574t2326r1771b2375],
8	catalysed	VBN	O	catalyse	partmod	7	SENT_450	[p17l1794t2326r2058b2390],
9	by	IN	O	by	_	0	SENT_450	[p17l2078t2326r2148b2390],
10	mouse	NN	O	mouse	nn	11	SENT_450	[p17l149t2412r333b2446],
11	cytosol	NN	O	cytosol	agent	8	SENT_450	[p17l360t2396r564b2461],
12	in	FW	O	in	nn	13	SENT_450	[p17l590t2396r644b2445],
13	vitro	FW	O	vitro	advmod	8	SENT_450	[p17l669t2396r816b2446],
14	.	.	O	.	_	0	SENT_450	[p17l669t2396r816b2446],

1	Drug	NN	O	drug	nn	3	SENT_451	[p17l845t2398r990b2461],
2	Metab	NNP	O	Metab	nn	3	SENT_451	[p17l1016t2396r1196b2446],
3	Dispos	NNP	O	Dispos	_	0	SENT_451	[p17l1222t2396r1418b2461],
4	1983	CD	DATE	1983	num	3	SENT_451	[p17l1452t2396r1899b2455],
5	;	:	O	;	_	0	SENT_451	[p17l1452t2396r1899b2455],
6	1l	CD	NUMBER	1l	num	7	SENT_451	[p17l1452t2396r1899b2455],
7	:175	CD	NUMBER	:175	dep	3	SENT_451	[p17l1452t2396r1899b2455],
8	—	NN	O	—	dep	7	SENT_451	[p17l1452t2396r1899b2455],
9	6	CD	NUMBER	6	num	8	SENT_451	[p17l1452t2396r1899b2455],
10	.	.	O	.	_	0	SENT_451	[p17l1452t2396r1899b2455],

1	Mannervik	NN	O	mannervik	nn	2	SENT_452	[p17l149t2467r463b2517],
2	B	NN	O	b	_	0	SENT_452	[p17l481t2468r542b2526],
3	,	,	O	,	_	0	SENT_452	[p17l481t2468r542b2526],
4	Danielson	NNP	PERSON	Danielson	nn	5	SENT_452	[p17l565t2467r854b2517],
5	UH	NNP	O	UH	appos	2	SENT_452	[p17l874t2468r989b2518],
6	.	.	O	.	_	0	SENT_452	[p17l874t2468r989b2518],

1	Glutathione	NN	O	glutathione	nn	2	SENT_453	[p17l1015t2467r1349b2518],
2	transferases	NNS	O	transferase	_	0	SENT_453	[p17l1369t2467r2026b2517],
3	—	CD	NUMBER	—	num	4	SENT_453	[p17l1369t2467r2026b2517],
4	structure	NN	O	structure	dep	2	SENT_453	[p17l1369t2467r2026b2517],
5	and	CC	O	and	_	0	SENT_453	[p17l2049t2467r2149b2517],
6	catalytic	JJ	O	catalytic	amod	7	SENT_453	[p17l150t2537r388b2601],
7	activity	NN	O	activity	dep	2	SENT_453	[p17l416t2537r642b2601],
8	.	.	O	.	_	0	SENT_453	[p17l416t2537r642b2601],

1	CRC	NN	O	crc	nn	3	SENT_454	[p17l672t2537r811b2587],
2	Crit	NN	O	crit	nn	3	SENT_454	[p17l839t2537r948b2587],
3	Rev	NN	O	rev	_	0	SENT_454	[p17l973t2538r1086b2586],
4	Biochem	NNP	O	Biochem	dep	3	SENT_454	[p17l1112t2537r1369b2586],
5	1988	CD	DATE	1988	num	4	SENT_454	[p17l1400t2537r1910b2596],
6	;	:	O	;	_	0	SENT_454	[p17l1400t2537r1910b2596],
7	23:283	CD	NUMBER	23:283	num	8	SENT_454	[p17l1400t2537r1910b2596],
8	-337	CD	NUMBER	-337	dep	3	SENT_454	[p17l1400t2537r1910b2596],
9	.	.	O	.	_	0	SENT_454	[p17l1400t2537r1910b2596],

1	Rudolph	NNP	PERSON	Rudolph	nn	2	SENT_455	[p17l149t2607r394b2672],
2	FB	NNP	PERSON	FB	_	0	SENT_455	[p17l415t2609r517b2666],
3	,	,	O	,	_	0	SENT_455	[p17l415t2609r517b2666],
4	Fromm	NNP	PERSON	Fromm	nn	5	SENT_455	[p17l542t2609r752b2657],
5	HJ	NNP	O	HJ	appos	2	SENT_455	[p17l773t2609r865b2657],
6	.	.	O	.	_	0	SENT_455	[p17l773t2609r865b2657],

1	Plotting	VBG	O	plot	_	0	SENT_456	[p17l891t2607r1115b2672],
2	methods	NNS	O	method	dobj	1	SENT_456	[p17l1138t2607r1377b2657],
3	for	IN	O	for	_	0	SENT_456	[p17l1401t2607r1484b2657],
4	analysing	VBG	O	analyse	prepc_for	1	SENT_456	[p17l1507t2607r1777b2672],
5	enzyme	NN	O	enzyme	nn	7	SENT_456	[p17l1800t2623r2020b2672],
6	rate	NN	O	rate	nn	7	SENT_456	[p17l2042t2615r2148b2657],
7	data	NNS	O	datum	dobj	4	SENT_456	[p17l150t2677r281b2727],
8	.	.	O	.	_	0	SENT_456	[p17l150t2677r281b2727],

1	Meth	NNP	O	Meth	nn	2	SENT_457	[p17l309t2677r459b2727],
2	Enzymol	NNP	O	Enzymol	_	0	SENT_457	[p17l484t2677r740b2742],
3	l979	NN	O	l979	dep	2	SENT_457	[p17l773t2677r1355b2739],
4	;	:	O	;	_	0	SENT_457	[p17l773t2677r1355b2739],
5	63	CD	NUMBER	63	number	6	SENT_457	[p17l773t2677r1355b2739],
6	(	CD	NUMBER	(	dep	2	SENT_457	[p17l773t2677r1355b2739],
7	A	DT	O	a	det	8	SENT_457	[p17l773t2677r1355b2739],
8	)	NN	O	)	dep	6	SENT_457	[p17l773t2677r1355b2739],
9	:	:	O	:	_	0	SENT_457	[p17l773t2677r1355b2739],
10	l39	NN	O	l39	dep	2	SENT_457	[p17l773t2677r1355b2739],
11	—	CD	NUMBER	—	number	12	SENT_457	[p17l773t2677r1355b2739],
12	59	CD	NUMBER	59	dep	10	SENT_457	[p17l773t2677r1355b2739],
13	.	.	O	.	_	0	SENT_457	[p17l773t2677r1355b2739],

1	Orsi	NNP	PERSON	Orsi	nn	2	SENT_458	[p17l151t2747r270b2797],
2	BA	NN	O	ba	_	0	SENT_458	[p17l298t2747r411b2805],
3	,	,	O	,	_	0	SENT_458	[p17l298t2747r411b2805],
4	Tipton	NNP	PERSON	Tipton	nn	5	SENT_458	[p17l441t2747r630b2811],
5	KF	NNP	O	KF	appos	2	SENT_458	[p17l659t2748r762b2796],
6	.	.	O	.	_	0	SENT_458	[p17l659t2748r762b2796],

1	Kinetic	JJ	O	kinetic	amod	2	SENT_459	[p17l795t2747r1001b2796],
2	analysis	NN	O	analysis	_	0	SENT_459	[p17l1032t2747r1257b2811],
3	of	IN	O	of	_	0	SENT_459	[p17l1287t2747r1348b2796],
4	progress	NN	O	progress	nn	5	SENT_459	[p17l1371t2763r1610b2811],
5	curves	NNS	O	curve	prep_of	2	SENT_459	[p17l1640t2763r1839b2796],
6	.	.	O	.	_	0	SENT_459	[p17l1640t2763r1839b2796],

1	Meth	NNP	O	Meth	nn	2	SENT_460	[p17l1870t2747r2019b2796],
2	Enzymol	NNP	O	Enzymol	_	0	SENT_460	[p17l2047t2748r2147b2796, p17l150t2817r326b2882],
3	1979	CD	DATE	1979	num	2	SENT_460	[p17l358t2817r940b2879],
4	;	:	O	;	_	0	SENT_460	[p17l358t2817r940b2879],
5	63	CD	NUMBER	63	number	6	SENT_460	[p17l358t2817r940b2879],
6	(	CD	NUMBER	(	num	8	SENT_460	[p17l358t2817r940b2879],
7	A	DT	O	a	det	8	SENT_460	[p17l358t2817r940b2879],
8	)	NN	O	)	dep	2	SENT_460	[p17l358t2817r940b2879],
9	:159	CD	NUMBER	:159	number	10	SENT_460	[p17l358t2817r940b2879],
10	—	CD	NUMBER	—	num	11	SENT_460	[p17l358t2817r940b2879],
11	75	CD	NUMBER	75	dep	8	SENT_460	[p17l358t2817r940b2879],
12	.	.	O	.	_	0	SENT_460	[p17l358t2817r940b2879],

1	Czejka	FW	MISC	czejka	_	0	SENT_461	[p17l150t2887r347b2951],
2	M	NN	O	m	dep	1	SENT_461	[p17l376t2888r453b2946],
3	,	,	O	,	_	0	SENT_461	[p17l376t2888r453b2946],
4	Bandak	NNP	PERSON	Bandak	nn	5	SENT_461	[p17l486t2887r704b2937],
5	S	NNP	O	S	appos	2	SENT_461	[p17l734t2888r785b2946],
6	,	,	O	,	_	0	SENT_461	[p17l734t2888r785b2946],
7	Simon	NNP	PERSON	Simon	nn	8	SENT_461	[p17l820t2887r1003b2937],
8	D	NNP	PERSON	D	appos	2	SENT_461	[p17l1033t2888r1098b2946],
9	,	,	O	,	_	0	SENT_461	[p17l1033t2888r1098b2946],
10	et	FW	O	et	nn	11	SENT_461	[p17l1131t2895r1182b2937],
11	al.	FW	O	al.	appos	2	SENT_461	[p17l1212t2887r1274b2937],
12	.	.	O	.	_	0	SENT_461	[p17l1212t2887r1274b2937],

1	Pharmacokinetic	JJ	MISC	pharmacokinetic	amod	2	SENT_462	[p17l1308t2887r1785b2937],
2	interactions	NNS	O	interaction	_	0	SENT_462	[p17l1817t2887r2147b2937],
3	between	IN	O	between	_	0	SENT_462	[p17l148t2957r386b3006],
4	4	CD	NUMBER	4	prep_between	2	SENT_462	[p17l425t2955r940b3021],
5	’	SYM	O	’	dep	2	SENT_462	[p17l425t2955r940b3021],
6	-	:	O	-	_	0	SENT_462	[p17l425t2955r940b3021],
7	epidoxorubicin	NN	O	epidoxorubicin	dep	2	SENT_462	[p17l425t2955r940b3021],
8	and	CC	O	and	_	0	SENT_462	[p17l980t2957r1081b3006],
9	the	DT	O	the	det	11	SENT_462	[p17l1120t2957r1205b3006],
10	multidrug	JJ	O	multidrug	amod	11	SENT_462	[p17l1245t2957r1524b3021],
11	resistance	NN	O	resistance	dep	2	SENT_462	[p17l1564t2957r1844b3006],
12	reversing	VBG	O	reverse	partmod	11	SENT_462	[p17l1884t2957r2148b3021],
13	agent	NN	O	agent	nn	14	SENT_462	[p17l151t3035r303b3092],
14	quinine	NN	O	quinine	dobj	12	SENT_462	[p17l328t3027r555b3092],
15	.	.	O	.	_	0	SENT_462	[p17l328t3027r555b3092],

1	Verlag	NNP	ORGANIZATION	Verlag	nn	3	SENT_463	[p17l584t3027r776b3092],
2	Zeitschrift	NNP	ORGANIZATION	Zeitschrift	nn	3	SENT_463	[p17l801t3027r1099b3077],
3	Naturforshong	NNP	O	Naturforshong	_	0	SENT_463	[p17l1123t3027r1538b3092],
4	1995	CD	DATE	1995	num	3	SENT_463	[p17l1571t3027r1702b3078],
5	;	:	O	;	_	0	SENT_463	[p17l1711t3027r1954b3086],
6	565	CD	NUMBER	565	number	7	SENT_463	[p17l1711t3027r1954b3086],
7	—	CD	NUMBER	—	dep	3	SENT_463	[p17l1711t3027r1954b3086],
8	70	CD	NUMBER	70	dep	7	SENT_463	[p17l1711t3027r1954b3086],
9	.	.	O	.	_	0	SENT_463	[p17l1711t3027r1954b3086],

1	Boer	NNP	PERSON	Boer	nn	2	SENT_464	[p17l149t3098r284b3147],
2	R	NNP	PERSON	R	_	0	SENT_464	[p17l308t3098r368b3156],
3	,	,	O	,	_	0	SENT_464	[p17l308t3098r368b3156],
4	Dichtl	NNP	O	Dichtl	nn	5	SENT_464	[p17l396t3097r567b3147],
5	M	NNP	O	M	appos	2	SENT_464	[p17l592t3098r668b3156],
6	,	,	O	,	_	0	SENT_464	[p17l592t3098r668b3156],
7	Borchers	NNP	PERSON	Borchers	nn	8	SENT_464	[p17l697t3097r942b3147],
8	C	NNP	O	C	appos	2	SENT_464	[p17l971t3098r1029b3156],
9	,	,	O	,	_	0	SENT_464	[p17l971t3098r1029b3156],
10	et	FW	O	et	nn	11	SENT_464	[p17l1059t3105r1108b3147],
11	al.	FW	O	al.	appos	2	SENT_464	[p17l1134t3097r1194b3147],
12	.	.	O	.	_	0	SENT_464	[p17l1134t3097r1194b3147],

1	Reversible	JJ	O	reversible	amod	2	SENT_465	[p17l1224t3097r1514b3147],
2	labelling	NN	O	labelling	_	0	SENT_465	[p17l1541t3097r1777b3162],
3	of	IN	O	of	_	0	SENT_465	[p17l1805t3097r1866b3147],
4	a	DT	O	a	det	7	SENT_465	[p17l1888t3113r1918b3147],
5	chemosensitiser	NN	O	chemosensitiser	nn	7	SENT_465	[p17l1944t3097r2146b3147, p17l152t3167r402b3216],
6	binding	NN	O	binding	nn	7	SENT_465	[p17l417t3167r625b3231],
7	domain	NN	O	domain	prep_of	2	SENT_465	[p17l644t3167r849b3216],
8	of	IN	O	of	_	0	SENT_465	[p17l867t3167r927b3216],
9	P-glycoprotein	NN	O	p-glycoprotein	prep_of	2	SENT_465	[p17l939t3167r1344b3231],
10	with	IN	O	with	_	0	SENT_465	[p17l1362t3167r1483b3216],
11	a	DT	O	a	det	18	SENT_465	[p17l1501t3183r1530b3216],
12	novel	JJ	O	novel	amod	18	SENT_465	[p17l1547t3167r1698b3217],
13	1,4-dihydropyr	JJ	O	1,4-dihydropyr	amod	18	SENT_465	[p17l1722t3167r2146b3231],
14	—	NN	O	—	nn	18	SENT_465	[p17l1722t3167r2146b3231],
15	idine	NN	O	idine	nn	18	SENT_465	[p17l149t3237r284b3287],
16	drug	NN	O	drug	nn	18	SENT_465	[p17l308t3237r432b3302],
17	transport	NN	O	transport	nn	18	SENT_465	[p17l455t3245r697b3302],
18	inhibitor	NN	O	inhibitor	prep_with	2	SENT_465	[p17l719t3237r965b3287],
19	.	.	O	.	_	0	SENT_465	[p17l719t3237r965b3287],

1	Biochemistry	NNP	O	Biochemistry	nn	2	SENT_466	[p17l992t3237r1359b3302],
2	l996	NN	O	l996	_	0	SENT_466	[p17l1389t3237r1878b3296],
3	;	:	O	;	_	0	SENT_466	[p17l1389t3237r1878b3296],
4	35:1387	CD	NUMBER	35:1387	number	5	SENT_466	[p17l1389t3237r1878b3296],
5	—	CD	NUMBER	—	dep	2	SENT_466	[p17l1389t3237r1878b3296],
6	96	CD	NUMBER	96	dep	5	SENT_466	[p17l1389t3237r1878b3296],
7	.	.	O	.	_	0	SENT_466	[p17l1389t3237r1878b3296],

1	Ishikawa	NNP	ORGANIZATION	Ishikawa	nn	2	SENT_467	[p17l149t3307r406b3357],
2	T	NN	ORGANIZATION	t	_	0	SENT_467	[p17l431t3308r488b3366],
3	,	,	O	,	_	0	SENT_467	[p17l431t3308r488b3366],
4	Akimura	NNP	PERSON	Akimura	nn	6	SENT_467	[p17l516t3307r770b3357],
5	K.	NNP	PERSON	K.	nn	6	SENT_467	[p17l796t3308r858b3357],
6	Transport	NNP	PERSON	Transport	appos	2	SENT_467	[p17l888t3308r1165b3372],
7	of	IN	O	of	_	0	SENT_467	[p17l1190t3307r1252b3357],
8	glutathione	NN	O	glutathione	nn	11	SENT_467	[p17l1274t3307r1592b3372],
9	S	NN	O	s	nn	11	SENT_467	[p17l1620t3307r1984b3372],
10	—	CD	NUMBER	—	num	11	SENT_467	[p17l1620t3307r1984b3372],
11	conjugates	NNS	O	conjugate	prep_of	6	SENT_467	[p17l1620t3307r1984b3372],
12	from	IN	O	from	_	0	SENT_467	[p17l2011t3307r2150b3357],
13	cancer	NN	O	cancer	nn	14	SENT_467	[p17l150t3393r335b3426],
14	cells	NNS	O	cell	prep_from	11	SENT_467	[p17l354t3377r498b3426],
15	:	:	O	:	_	0	SENT_467	[p17l354t3377r498b3426],
16	function	NN	O	function	dep	2	SENT_467	[p17l523t3377r759b3426],
17	and	CC	O	and	_	0	SENT_467	[p17l781t3377r881b3426],
18	structure	NN	O	structure	conj_and	16	SENT_467	[p17l903t3384r1148b3426],
19	of	IN	O	of	_	0	SENT_467	[p17l1169t3377r1231b3426],
20	the	DT	O	the	det	21	SENT_467	[p17l1246t3377r1331b3426],
21	GS	NN	O	g	prep_of	16	SENT_467	[p17l1352t3377r1516b3427],
22	.	.	O	.	_	0	SENT_467	[p17l1352t3377r1516b3427],

1	—	NN	O	—	_	0	SENT_468	[p17l1352t3377r1516b3427],
2	.	.	O	.	_	0	SENT_468	[p17l1352t3377r1516b3427],

1	X	NN	O	x	_	0	SENT_469	[p17l1352t3377r1516b3427],
2	pump	NN	O	pump	dep	1	SENT_469	[p17l1535t3393r1712b3441],
3	.	.	O	.	_	0	SENT_469	[p17l1535t3393r1712b3441],

1	In	IN	O	in	dep	4	SENT_470	[p17l1735t3378r1808b3426],
2	:	:	O	:	_	0	SENT_470	[p17l1735t3378r1808b3426],
3	Vermeulen	NNP	PERSON	Vermeulen	nn	4	SENT_470	[p17l1833t3377r2149b3426],
4	NPE	NNP	O	NPE	_	0	SENT_470	[p17l149t3449r298b3506],
5	,	,	O	,	_	0	SENT_470	[p17l149t3449r298b3506],
6	Mulder	NNP	PERSON	Mulder	nn	7	SENT_470	[p17l331t3447r541b3497],
7	GJ	NNP	O	GJ	appos	4	SENT_470	[p17l573t3448r664b3506],
8	,	,	O	,	_	0	SENT_470	[p17l573t3448r664b3506],
9	Nieuwehuyse	NNP	O	Nieuwehuyse	nn	10	SENT_470	[p17l698t3447r1085b3512],
10	H	NNP	O	H	appos	4	SENT_470	[p17l1117t3449r1182b3506],
11	,	,	O	,	_	0	SENT_470	[p17l1117t3449r1182b3506],
12	et	FW	O	et	nn	13	SENT_470	[p17l1217t3455r1267b3497],
13	al.	FW	O	al.	appos	4	SENT_470	[p17l1299t3447r1380b3506],
14	,	,	O	,	_	0	SENT_470	[p17l1299t3447r1380b3506],
15	eds	NNS	O	ed	appos	4	SENT_470	[p17l1415t3447r1522b3497],
16	.	.	O	.	_	0	SENT_470	[p17l1415t3447r1522b3497],

1	Glutathione	NN	O	glutathione	nn	2	SENT_471	[p17l1558t3447r1892b3497],
2	Stransferases	NNS	O	stransferase	_	0	SENT_471	[p17l1926t3448r2146b3497, p17l149t3517r361b3576],
3	,	,	O	,	_	0	SENT_471	[p17l1926t3448r2146b3497, p17l149t3517r361b3576],
4	structure	NN	O	structure	nn	6	SENT_471	[p17l391t3525r652b3576],
5	,	,	O	,	_	0	SENT_471	[p17l391t3525r652b3576],
6	function	NN	O	function	nn	9	SENT_471	[p17l680t3517r916b3567],
7	and	CC	O	and	_	0	SENT_471	[p17l942t3517r1043b3567],
8	clinical	JJ	O	clinical	nn	9	SENT_471	[p17l1067t3517r1275b3567],
9	implications	NNS	O	implication	appos	2	SENT_471	[p17l1300t3517r1666b3581],
10	.	.	O	.	_	0	SENT_471	[p17l1300t3517r1666b3581],

1	London	NNP	LOCATION	London	_	0	SENT_472	[p17l1694t3517r1930b3567],
2	:	:	O	:	_	0	SENT_472	[p17l1694t3517r1930b3567],
3	Taylor	NNP	PERSON	Taylor	dep	1	SENT_472	[p17l1960t3517r2150b3581],
4	and	CC	O	and	_	0	SENT_472	[p17l151t3588r251b3638],
5	Francis	NNP	PERSON	Francis	dep	1	SENT_472	[p17l276t3588r500b3647],
6	,	,	O	,	_	0	SENT_472	[p17l276t3588r500b3647],
7	1996	CD	DATE	1996	appos	3	SENT_472	[p17l535t3588r683b3639],
8	.	.	O	.	_	0	SENT_472	[p17l535t3588r683b3639],

1	199-211	CD	NUMBER	199-211	_	0	SENT_473	[p17l720t3588r984b3639],
2	.	.	O	.	_	0	SENT_473	[p17l720t3588r984b3639],

1	Berqgvist	NNP	O	Berqgvist	nn	2	SENT_474	[p17l149t3658r426b3723],
2	Y	NN	O	y	_	0	SENT_474	[p17l446t3660r511b3717],
3	,	,	O	,	_	0	SENT_474	[p17l446t3660r511b3717],
4	Churchill	NNP	ORGANIZATION	Churchill	nn	6	SENT_474	[p17l534t3658r802b3708],
5	F.	NNP	ORGANIZATION	F.	nn	6	SENT_474	[p17l821t3660r873b3708],
6	Detection	NN	ORGANIZATION	detection	appos	2	SENT_474	[p17l898t3658r1174b3708],
7	and	CC	O	and	_	0	SENT_474	[p17l1196t3658r1296b3708],
8	determination	NN	O	determination	appos	2	SENT_474	[p17l1316t3658r1711b3708],
9	of	IN	O	of	_	0	SENT_474	[p17l1732t3658r1793b3708],
10	antimalarial	JJ	O	antimalarial	amod	11	SENT_474	[p17l1810t3658r2148b3708],
11	drugs	NNS	O	drug	prep_of	6	SENT_474	[p17l150t3728r304b3793],
12	and	CC	O	and	_	0	SENT_474	[p17l335t3728r436b3778],
13	their	PRP$	O	they	poss	14	SENT_474	[p17l462t3728r592b3778],
14	metabolites	NNS	O	metabolite	conj_and	6	SENT_474	[p17l618t3728r944b3778],
15	in	IN	O	in	_	0	SENT_474	[p17l973t3728r1027b3777],
16	body	NN	O	body	nn	17	SENT_474	[p17l1053t3728r1195b3792],
17	ﬂuids	NNS	O	ﬂuids	prep_in	14	SENT_474	[p17l1223t3728r1393b3778],
18	.	.	O	.	_	0	SENT_474	[p17l1223t3728r1393b3778],

1	J	NNP	O	J	nn	2	SENT_475	[p17l1424t3729r1450b3778],
2	Chromatography	NNP	O	Chromatography	_	0	SENT_475	[p17l1479t3728r1959b3793],
3	1988	CD	DATE	1988	num	2	SENT_475	[p17l1994t3729r2146b3787],
4	;	:	O	;	_	0	SENT_475	[p17l1994t3729r2146b3787],

1	434:1	CD	NUMBER	434:1	_	0	SENT_476	[p18l149t9r432b59],
2	—	CD	NUMBER	—	number	3	SENT_476	[p18l149t9r432b59],
3	20	CD	NUMBER	20	num	1	SENT_476	[p18l149t9r432b59],
4	.	.	O	.	_	0	SENT_476	[p18l149t9r432b59],

1	Edwards	NNP	PERSON	Edwards	nn	3	SENT_477	[p18l149t79r395b129],
2	G.	NNP	O	G.	nn	3	SENT_477	[p18l429t80r492b129],
3	Measurement	NNP	O	Measurement	_	0	SENT_477	[p18l525t81r914b129],
4	of	IN	O	of	_	0	SENT_477	[p18l944t79r1005b129],
5	arten1isinin	NN	O	arten1isinin	prep_of	3	SENT_477	[p18l1033t79r1351b129],
6	and	CC	O	and	_	0	SENT_477	[p18l1383t79r1483b129],
7	its	PRP$	O	its	poss	8	SENT_477	[p18l1513t79r1577b129],
8	derivatives	NNS	O	derivative	prep_of	3	SENT_477	[p18l1610t79r1919b129],
9	in	IN	O	in	_	0	SENT_477	[p18l1951t79r2005b128],
10	biological	JJ	O	biological	amod	11	SENT_477	[p18l2034t79r2146b129, p18l149t149r342b214],
11	ﬂuids	NNS	O	ﬂuids	prep_in	3	SENT_477	[p18l370t149r540b199],
12	.	.	O	.	_	0	SENT_477	[p18l370t149r540b199],

1	Trans	NNP	ORGANIZATION	Trans	nn	7	SENT_478	[p18l571t150r730b199],
2	Royal	NNP	ORGANIZATION	Royal	nn	7	SENT_478	[p18l758t149r927b213],
3	Soc	NNP	ORGANIZATION	Soc	nn	7	SENT_478	[p18l957t150r1059b199],
4	Trop	NNP	ORGANIZATION	Trop	nn	7	SENT_478	[p18l1087t150r1223b213],
5	Med	NNP	ORGANIZATION	Med	nn	7	SENT_478	[p18l1250t149r1380b199],
6	Hyg	NNP	O	Hyg	nn	7	SENT_478	[p18l1407t150r1527b214],
7	l994	NN	O	l994	_	0	SENT_478	[p18l1562t149r2004b208],
8	;	:	O	;	_	0	SENT_478	[p18l1562t149r2004b208],
9	88	CD	NUMBER	88	num	11	SENT_478	[p18l1562t149r2004b208],
10	:	:	O	:	_	0	SENT_478	[p18l1562t149r2004b208],
11	S37	CD	NUMBER	s37	dep	7	SENT_478	[p18l1562t149r2004b208],
12	—	CD	NUMBER	—	number	13	SENT_478	[p18l1562t149r2004b208],
13	9	CD	NUMBER	9	dep	11	SENT_478	[p18l1562t149r2004b208],
14	.	.	O	.	_	0	SENT_478	[p18l1562t149r2004b208],

1	Exp	NNP	O	Exp	nn	5	SENT_479	[p18l2035t150r2147b213],
2	Opin	NNP	O	Opin	nn	5	SENT_479	[p18l151t219r290b283],
3	Ther	NNP	O	Ther	nn	5	SENT_479	[p18l316t219r450b268],
4	Patents	NNP	O	Patents	nn	5	SENT_479	[p18l474t220r677b268],
5	l998	NN	O	l998	_	0	SENT_479	[p18l712t219r1185b278],
6	;	:	O	;	_	0	SENT_479	[p18l712t219r1185b278],
7	8:1587	CD	NUMBER	8:1587	number	8	SENT_479	[p18l712t219r1185b278],
8	—	CD	NUMBER	—	dep	5	SENT_479	[p18l712t219r1185b278],
9	98	CD	NUMBER	98	dep	8	SENT_479	[p18l712t219r1185b278],
10	.	.	O	.	_	0	SENT_479	[p18l712t219r1185b278],

1	Edwards	NNP	PERSON	Edwards	nn	2	SENT_480	[p18l149t289r395b339],
2	G	NNP	PERSON	G	_	0	SENT_480	[p18l425t290r488b348],
3	,	,	O	,	_	0	SENT_480	[p18l425t290r488b348],
4	Winstanely	NNP	ORGANIZATION	Winstanely	nn	5	SENT_480	[p18l516t289r840b354],
5	PA	NN	ORGANIZATION	pa	appos	2	SENT_480	[p18l866t290r971b348],
6	,	,	O	,	_	0	SENT_480	[p18l866t290r971b348],
7	Ward	NNP	ORGANIZATION	Ward	nn	8	SENT_480	[p18l999t289r1157b339],
8	SA	NNP	ORGANIZATION	SA	appos	5	SENT_480	[p18l1185t290r1286b339],
9	.	.	O	.	_	0	SENT_480	[p18l1185t290r1286b339],

1	Clinical	JJ	O	clinical	amod	2	SENT_481	[p18l1317t289r1540b339],
2	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_481	[p18l1566t289r2067b354],
3	in	IN	O	in	_	0	SENT_481	[p18l2095t289r2149b338],
4	the	DT	O	the	det	5	SENT_481	[p18l149t359r234b409],
5	treatment	NN	O	treatment	prep_in	2	SENT_481	[p18l259t367r528b409],
6	of	IN	O	of	_	0	SENT_481	[p18l552t359r614b409],
7	tropical	JJ	O	tropical	amod	8	SENT_481	[p18l633t359r849b423],
8	diseases	NNS	O	disease	prep_of	2	SENT_481	[p18l874t359r1120b409],
9	.	.	O	.	_	0	SENT_481	[p18l874t359r1120b409],

1	Some	DT	O	some	_	0	SENT_482	[p18l1150t360r1309b409],
2	applications	NNS	O	application	dep	1	SENT_482	[p18l1335t359r1675b423],
3	and	CC	O	and	_	0	SENT_482	[p18l1703t359r1803b409],
4	limitations	NNS	O	limitation	dep	1	SENT_482	[p18l1827t359r2145b409],
5	.	.	O	.	_	0	SENT_482	[p18l1827t359r2145b409],

1	Clin	NNP	O	Clin	nn	2	SENT_483	[p18l150t430r270b480],
2	Pharmacokinetics	NNPS	O	Pharmacokinetics	_	0	SENT_483	[p18l296t430r800b480],
3	1994	CD	DATE	1994	num	5	SENT_483	[p18l835t430r968b481],
4	;	:	O	;	_	0	SENT_483	[p18l976t430r1075b489],
5	27	CD	NUMBER	27	dep	2	SENT_483	[p18l976t430r1075b489],
6	:	:	O	:	_	0	SENT_483	[p18l976t430r1075b489],
7	150	CD	NUMBER	150	number	8	SENT_483	[p18l1089t430r1187b480],
8	—	CD	NUMBER	—	dep	2	SENT_483	[p18l1197t460r1233b465],
9	62	CD	NUMBER	62	dep	8	SENT_483	[p18l1243t430r1326b480],
10	.	.	O	.	_	0	SENT_483	[p18l1243t430r1326b480],

1	Goodman	NNP	PERSON	Goodman	nn	2	SENT_484	[p18l150t500r430b550],
2	LS	NN	O	l	_	0	SENT_484	[p18l459t501r557b559],
3	,	,	O	,	_	0	SENT_484	[p18l459t501r557b559],
4	Gillman	NNP	PERSON	Gillman	nn	5	SENT_484	[p18l591t500r823b550],
5	A	NNP	O	A	appos	2	SENT_484	[p18l853t501r918b559],
6	,	,	O	,	_	0	SENT_484	[p18l853t501r918b559],
7	eds	NNS	O	ed	appos	5	SENT_484	[p18l952t500r1059b550],
8	.	.	O	.	_	0	SENT_484	[p18l952t500r1059b550],

1	Drugs	NNS	O	drug	nsubj	2	SENT_485	[p18l1093t502r1264b565],
2	used	VBN	O	use	_	0	SENT_485	[p18l1296t500r1426b550],
3	in	IN	O	in	_	0	SENT_485	[p18l1456t500r1511b549],
4	the	DT	O	the	det	5	SENT_485	[p18l1541t500r1626b550],
5	chemotherapy	NN	O	chemotherapy	prep_in	2	SENT_485	[p18l1658t500r2060b565],
6	of	IN	O	of	_	0	SENT_485	[p18l2092t500r2153b550],
7	malaria	NN	O	malaria	prep_of	5	SENT_485	[p18l149t570r363b620],
8	in	IN	O	in	_	0	SENT_485	[p18l401t570r455b619],
9	the	DT	O	the	det	11	SENT_485	[p18l494t570r579b620],
10	pharmacological	JJ	O	pharmacological	amod	11	SENT_485	[p18l618t570r1093b635],
11	basis	NN	O	basis	prep_in	2	SENT_485	[p18l1132t570r1272b620],
12	of	IN	O	of	_	0	SENT_485	[p18l1314t570r1376b620],
13	therapeutics	NNS	O	therapeutics	prep_of	11	SENT_485	[p18l1410t570r1768b635],
14	.	.	O	.	_	0	SENT_485	[p18l1410t570r1768b635],

1	New	NNP	LOCATION	New	nn	2	SENT_486	[p18l1811t571r1943b620],
2	York	NNP	LOCATION	York	_	0	SENT_486	[p18l1984t570r2143b620],
3	:	:	O	:	_	0	SENT_486	[p18l1984t570r2143b620],
4	Macmillan	NNP	ORGANIZATION	Macmillan	nn	5	SENT_486	[p18l149t640r457b689],
5	Publishing	NNP	ORGANIZATION	Publishing	dep	2	SENT_486	[p18l483t640r802b704],
6	,	,	O	,	_	0	SENT_486	[p18l483t640r802b704],
7	1975	CD	DATE	1975	appos	5	SENT_486	[p18l837t640r985b690],
8	.	.	O	.	_	0	SENT_486	[p18l837t640r985b690],

1	1704	CD	DATE	1704	num	2	SENT_487	[p18l1021t640r1155b690],
2	p.	NN	O	p.	_	0	SENT_487	[p18l1180t656r1229b704],
3	Johansson	NNP	PERSON	Johansson	nn	4	SENT_487	[p18l149t710r441b760],
4	A	NNP	O	A	dep	2	SENT_487	[p18l474t711r603b769],
5	.	.	O	.	_	0	SENT_487	[p18l474t711r603b769],

1	—	NN	O	—	_	0	SENT_488	[p18l474t711r603b769],
2	.	.	O	.	_	0	SENT_488	[p18l474t711r603b769],

1	F	NN	O	f	_	0	SENT_489	[p18l474t711r603b769],
2	,	,	O	,	_	0	SENT_489	[p18l474t711r603b769],
3	Stenberg	NNP	PERSON	Stenberg	nn	4	SENT_489	[p18l641t710r891b775],
4	G	NNP	PERSON	G	appos	1	SENT_489	[p18l927t711r990b769],
5	,	,	O	,	_	0	SENT_489	[p18l927t711r990b769],
6	Widersten	NNP	O	Widersten	nn	7	SENT_489	[p18l1026t710r1319b760],
7	M	NNP	O	M	appos	1	SENT_489	[p18l1352t712r1429b769],
8	,	,	O	,	_	0	SENT_489	[p18l1352t712r1429b769],
9	et	FW	O	et	nn	10	SENT_489	[p18l1466t718r1516b760],
10	al.	FW	O	al.	appos	1	SENT_489	[p18l1550t710r1613b760],
11	.	.	O	.	_	0	SENT_489	[p18l1550t710r1613b760],

1	Structure	NN	O	structure	nn	4	SENT_490	[p18l1652t710r2148b775],
2	—	NN	O	—	nn	4	SENT_490	[p18l1652t710r2148b775],
3	activity	NN	O	activity	nn	4	SENT_490	[p18l1652t710r2148b775],
4	relationships	NNS	O	relationship	nsubj	13	SENT_490	[p18l148t780r511b845],
5	and	CC	O	and	_	0	SENT_490	[p18l544t780r645b830],
6	thermal	JJ	O	thermal	amod	7	SENT_490	[p18l674t780r891b830],
7	stability	NN	O	stability	nsubj	13	SENT_490	[p18l923t780r1149b844],
8	of	IN	O	of	_	0	SENT_490	[p18l1181t780r1242b830],
9	human	JJ	O	human	amod	12	SENT_490	[p18l1267t780r1461b830],
10	glutathione	NN	O	glutathione	nn	12	SENT_490	[p18l1491t780r1810b845],
11	transferase	NN	O	transferase	nn	12	SENT_490	[p18l1841t780r2148b830],
12	Pl-l	NN	MISC	pl-l	prep_of	7	SENT_490	[p18l149t850r276b899],
13	governed	VBN	O	govern	_	0	SENT_490	[p18l308t850r572b914],
14	by	IN	O	by	_	0	SENT_490	[p18l596t850r665b914],
15	the	DT	O	the	det	17	SENT_490	[p18l691t850r776b899],
16	H-site	JJ	MISC	h-site	amod	17	SENT_490	[p18l802t850r974b899],
17	residue	NN	O	residue	prep_by	13	SENT_490	[p18l999t850r1204b899],
18	105	CD	NUMBER	105	dep	17	SENT_490	[p18l1236t850r1349b900],
19	.	.	O	.	_	0	SENT_490	[p18l1236t850r1349b900],

1	J	NNP	O	J	nn	3	SENT_491	[p18l1377t851r1404b900],
2	Mol	NNP	O	Mol	nn	3	SENT_491	[p18l1428t850r1545b899],
3	Biol	NNP	O	Biol	_	0	SENT_491	[p18l1571t850r1692b899],
4	1998	CD	DATE	1998	num	3	SENT_491	[p18l1724t850r2150b909, p18l150t920r233b970],
5	;	:	O	;	_	0	SENT_491	[p18l1724t850r2150b909, p18l150t920r233b970],
6	278:68798	CD	NUMBER	278:68798	dep	3	SENT_491	[p18l1724t850r2150b909, p18l150t920r233b970],
7	.	.	O	.	_	0	SENT_491	[p18l1724t850r2150b909, p18l150t920r233b970],

